Final Program - American Society for Radiation Oncology

Loading...
Final Program ASTRO 54th Annual Meeting Meeting Dates: October 28-31, 2012 | Exhibit Dates: October 28-30, 2012 BOSTON CONVENTION AND EXHIBITION CENTER | BOSTON

Advancing Patient Care

through iNNOVATiON

ANNUAL MEE TING

S C I E N C E B A S E D, PAT I E N T D R I V E N

d nloa bile – w o D Omo ASTR cial ffi the o ng app. . i ils t mee 17 for deta age

S ee p

HELD IN CONJUNCTION WITH: AMERICAN SOCIETY OF RADIOLOGIC TECHNOLOGISTS (ASRT) ASSOCIATION OF RESIDENTS IN RADIATION ONCOLOGY (ARRO) SOCIETY FOR RADIATION ONGOLOGY ADMINISTRATORS (SROA)

The power of two

O-MAR and iDose 4 off.

O-MAR and iDose 4 on.

Images courtesy of Az Ospedaliera University.

Brilliance CT Big Bore

O-MAR and iDose4 Just one glance at the images above tells the story. Philips O-MAR reduces artifacts caused by large orthopedic implants. iDose4 improves image quality* through artifact prevention and increased spatial resolution. Together they produce high image quality with reduced artifacts. These two powerful technologies can enhance many aspects of Radiation Oncology and are now available on the Brilliance CT Big Bore. Images courtesy of Udine – Santa Maria Hospital Radioterapia.

To learn more, visit www.philips.com/astro. * Improved image quality is defined by improvements in spatial resolution and/or noise reduction as measured in phantom studies.

54th ANNUAL MEETING | MEETING DATES: OCTOBER 28-31, 2012 | EXHIBIT DATES: OCTOBER 28-30, 2012

BOSTON CONVENTION AND EXHIBITION CENTER | BOSTON

Advancing Patient Care

through iNNOVATiON

Final Program d – nloa Dow mobile O ASTR cial ffi the o ng app. . ils ti mee 17 for deta age

S ee p

ANNUAL MEE TING

S C I E N C E B A S E D, PAT I E N T D R I V E N

HELD IN CONJUNCTION WITH: AMERICAN SOCIETY OF RADIOLOGIC TECHNOLOGISTS (ASRT) ASSOCIATION OF RESIDENTS IN RADIATION ONCOLOGY (ARRO) SOCIETY FOR RADIATION ONGOLOGY ADMINISTRATORS (SROA)

Welcome TO THE 54TH ANNUAL MEETING OF

THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY “Advancing Patient Care Through Innovation”

Dear Colleagues, It is my pleasure to welcome you to ASTRO’s 54th Annual Meeting, the premier forum for advancing the discipline of radiation oncology. Leading radiation oncologists, radiation physicists, radiation biologists, medical dosimetrists, radiation therapists and radiation oncology nurses from around the world have come together to interact and share the latest scientific research. A highlight of this year’s meeting will be the exploration of the concept that innovation in health care delivery systems will result in better care at a lower cost. The Presidential Symposium “Transforming Care Through Innovation” will kick off the meeting on Sunday morning. This symposium brings together distinguished experts to discuss and explore a topic that is becoming increasingly more important to clinicians and scientists alike. The Annual Meeting Scientific and Education committees, under the leadership of Lynn D. Wilson, MD, MPH, have organized an exceptional program. A record number of abstracts make up the more than 48 scientific sessions and 1,700+ poster presentations – making it the largest scientific program ever! This, combined with the educational program developed based on practice gaps, will give attendees the opportunity to increase their knowledge, skills and competence in a variety of learning formats. The keynote addresses will feature Dr. Arthur Kellermann, Rand Health; Mr. Edward Kennedy Jr., Marwood Group; and Professor Michael Porter, Harvard Business School. (see pages 40-41 for full details) Please join me in recognizing the 2012 Gold Medalists, Honorary Member and ASTRO Fellows during the Awards Ceremony on Tuesday beginning at 9:45 a.m. in the Grand Ballroom. We are all the beneficiaries of their achievements, and welcome this occasion to express our appreciation and gratitude. Be sure to take time this week to visit the Exhibit Hall featuring more than 200 companies showcasing the latest equipment and technology. Back this year, is the Industry-Expert Theater. Located in the Exhibit Hall, the Industry-Expert Theater provides attendees with an opportunity to enjoy a complimentary lunch while learning more about the featured exhibitors’ specific products. I hope you enjoy the meeting, and all that the city of Boston has to offer with its arts, culture and history.

Michael L. Steinberg, MD, FASTRO President, ASTRO Chairman, Annual Meeting Steering Committee

2

ASTRO 2012 / 54TH ANNUAL MEE TING

Table of Contents WELCOME TO THE 54TH ANNUAL MEETING Board of Directors Continuing Medical Education Annual Meeting Committee Members Abstract Reviewers Gold Medal and Honorary Member Recipients Fellow Recipients Awards

2 4 5 7 8 9 11 12

GENERAL INFORMATION 15 ASTROmobile 17 Concessions 19 Industry-Expert Theater 20 Industry Satellite Symposia 21 Shuttle Service 24 Boston Convention and Exhibition Center Floor Plans 27 SCHEDULE OF EVENTS eContouring Learning Lab 33 Live Self-Assessment Modules (SAMS) 34 Presidential Symposium 36 ARRO Program 38 Meeting Highlights 40 Nurses’ Program 42 Schedule by Day Saturday 43 Sunday 45 Monday 56 Tuesday 68 Wednesday 86 POSTER PRESENTATIONS 107 INDEXES By Author 169 By Topic 179 EXHIBITOR LISTINGS Exhibitor List 191 Exhibitor List by Product/Service Category 199 Exhibit Hall Floor Plan 203



ASTRO 2012 / 54TH ANNUAL MEE TING

3

Board of Directors Leonard L. Gunderson, MD, MS, FASTRO Chairman Michael L. Steinberg, MD, FASTRO President Colleen A. Lawton, MD, FASTRO President-elect

Phillip M. Devlin, MD Secretary/Treasurer Anthony L. Zietman, MD, FASTRO Immediate Past Chairman

Bruce G. Haffty, MD, FASTRO Education Council Chairman Laura A. Dawson, MD Education Council Vice-chairman C. Leland Rogers, MD Government Relations Council Chairman

Bharat B. Mittal, MD, FASTRO Government Relations Council Vice-chairman Najeeb Mohideen, MD Health Policy Council Chairman Brian Kavanagh, MD Health Policy Council Vice-chairman

Jacqueline P. Williams, PhD, FASTRO Research Council Chairman Mary K. Martel, PhD, FASTRO Research Council Vice-chairman Laura I. Thevenot, CAE Chief Executive Officer

4

ASTRO 2012 / 54TH ANNUAL MEE TING

Continuing Medical Education NEEDS STATEMENT Cancer is a leading cause of death worldwide. According to the World Health Organization (WHO), cancer deaths worldwide are projected to continue to rise to more than 11 million in 2030. Nearly twothirds of these patients will receive radiation therapy during their illness – most with the intent to cure the cancer. Advances in the applications, technologies and methodologies of radiation oncology continue to evolve rapidly and the delivery of radiation therapy has become more complex, making it imperative that the radiation oncology professional remain current in the state-of-the-art techniques. The American Society for Radiation Oncology is committed to providing educational programming that creates a forum for global collaboration on issues in radiation oncology to improve professional practice by increasing their level of knowledge, as required to improve competency in the field of oncology. PROGRAM DESCRIPTION AND OBJECTIVES ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. During the 2012 Annual Meeting, we will look at how innovation is fast becoming society’s response to our impending health care crisis. The effectors of change see innovation – not only technological innovations but also innovations in how care is delivered to improve outcomes and drive down cost – as the solution. The scientific program will continue to be the ideal platform to bring together clinicians, scientists and researchers from all of the oncologic disciplines to exchange ideas, promote multidisciplinary care and address the educational and professional development interests of our attendees. Scientific and educational sessions will cover specific clinical areas including breast, central nervous system, gastrointestinal, genitourinary, gynecological, head and neck, lymphoma, musculoskeletal, pediatric, sarcoma and thoracic cancers. Radiation biology and radiation physics concepts will also be explored. The Annual Meeting will feature a continued emphasis on quality and safety issues in the delivery of radiation therapy in the areas of treatment techniques, equipment, terminology and professional responsibilities. Program content has been designed to address specific documented and clinically important practice gaps in physician knowledge and competence.

ELEMENTS OF COMPETENCE The Annual Meeting program has been designed to narrow the competency gaps of patient/patientcentered care, medical knowledge, cognitive expertise, evidence-based practice, evaluation of performance in practice, interpersonal skills and communication, practice-based learning and improvement, utilization of informatics, work in interdisciplinary teams, quality improvement, professional standing and commitment to lifelong learning, thirteen of the fifteen core competencies embraced by the American Board of Medical Specialties, Accreditation Council for Graduate Medical Education and the Institute of Medicine. TARGET AUDIENCE The Annual Meeting program is intended for all health professionals in the field of oncology, with particular emphasis on radiation oncologists, radiation oncology residents, radiation biologists, radiation physicists, medical dosimetrists, radiation therapists and radiation oncology nurses. CONTINUING MEDICAL EDUCATION PHYSICIANS The American Society for Radiation Oncology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CREDIT DESIGNATION ASTRO designated this live activity for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. PHYSICISTS CAMPEP approval is pending for medical physics continuing education credit (MPCEC) hours. DOSIMETRISTS An application has been submitted to the Medical Dosimetrist Certification Board for designation of MDCB credit. NURSES This activity has been submitted to the Oncology Nursing Society (ONS) for approval to award contact hours. ONS is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ASTRO 2012 / 54TH ANNUAL MEE TING

5

PROGRAM EVALUATION PROCESS AND CONTINUING EDUCATION CREDITS You must be a full-conference or one-day only registrant to receive continuing education credit. To receive continuing education credits, you must submit an evaluation indicating the sessions that you attended no later than 30 days post meeting. All attendees will have the opportunity to complete the evaluation online at the meeting or in the comfort of your home or office once you return. When the evaluation has been completed, you will be able to print your certificate or email it to yourself for your records. Keep track of the sessions you attended throughout the meeting to save time in the evaluation process. For questions regarding continuing education credits, please visit CE Central located in the North Lobby at the Boston Convention and Exhibition Center. Visit CE Central or the Cyber Café to complete your online evaluation form and obtain your certificate. CE Central is located in the North Lobby and the Cyber Café is located in the Exhibit Hall. You will need your badge number to complete the evaluation form. Please write your badge number here for future reference.

ASTRO is an accredited provider of continuing medical education. Since our accreditation is important to us, we plan activities that are compliant with the ACCME and the content or format of CME activities and related materials will promote improvements or quality in health care and not a specific proprietary business interest or commercial bias. Planning Committee members and speakers are required to disclose the existence of any financial or other relationship with the manufacturer(s) of any commercial product(s) or provider(s) of any commercial services discussed in an educational presentation. Any conflicts of interest are resolved prior to participation. In addition to written disclosure, presenters will disclose any vested interest or their intention to discuss off‐label use of pharmaceuticals or devices, if applicable, to the audience at the beginning of their presentation and in accordance with the Accreditation Council for Continuing Medical Education standards and the Food and Drug Administration requirements. In an effort to increase transparency and easy access to all disclosures, ASTRO’s Faculty, Committee and Planner disclosure information will be available online for the 2012 Annual Meeting. Go to the ASTRO Annual Meeting Program Web page https://www.astro.org/Meetings-and-Events/ 2012-Annual-Meeting/Meeting-Program/Index. aspx. In addition, disclosure slides will be shown at the beginning of each session and every presenter is also required to display their disclosure. Disclosure information will not be printed in paper versions of the meeting materials. DISCLAIMER

Ann Smith, MD ASTRO Fairfax, VA

ASTRO is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASTRO of the uses, products or techniques presented. 123456

Your badge number

6

DISCLOSURE OF VESTED INTEREST

ASTRO 2012 / 54TH ANNUAL MEE TING

The information contained in this program is current as of September 21, 2012, and is subject to change. Program changes will be provided in an addendum and posted online.

2012 Committee Members 2011-2012 Annual Meeting Steering Committee Michael L. Steinberg, MD, FASTRO, Chairman Colleen A. Lawton, MD, FASTRO, Vice-chairman Lynn D. Wilson, MD, MPH, FASTRO, Chairman, Scientific Committee Benjamin Movsas, MD, Vice-chairman, Scientific Committee Andrea Ng, MD, Chairman, Education Committee Catherine C. Park, MD, Vice- chairman, Education Committee Lynn D. Wilson, MD, MPH, FASTRO

2011-2012 Annual Meeting Scientific Committee Lynn Wilson, MD, MPH, FASTRO, Chairman Benjamin Movsas, MD, Vice-chairman May Abdel-Wahab, MD, PhD Ross A. Abrams, MD, FASTRO Sanjeev Aggarwal, MD Kevin A. Camphausen, MD Eric Lin Chang, MD

Indrin Julian Chetty, PhD Louis S. Constine, MD, FASTRO Prajnan Das, MD, MPH Theodore L. DeWeese, MD Susan Higgins, MD W. Robert Lee, MD Alexander Lin, MD Nina A. Mayr, MD, FASTRO Radhe Mohan, PhD, FASTRO

Arnold C. Paulino, MD Timothy D. Solberg, PhD Mohan Suntharalingam, MD Katherine S. Tzou, MD Julia Compton, MD Stephanie E. Weiss, MD Christopher G. Willett, MD, FASTRO Theodore E. Yaeger, MD Gary Yang, MD

2011-2012 Annual Meeting Education Committee Andrea K. Ng, MD, MPH, Chairman Catherine C. Park, MD, Vice-chairman A. William Blackstock, MD, Immediate Past Chairman Mansoor M. Ahmed, PhD Changhu Chen, MD Brian Czito, MD Vinai Gondi, MD

Sharad Goyal, MD Kun (Kim) Huang, MD Krystyna D. Kiel, MD Joshua D. Lawson, MD W. Robert Lee, MD, MEd Brian Marples, PhD Loren K. Mell, MD Joanne M. Moar, RN, OCN Arno J. Mundt III, MD Christopher F. Njeh, PhD

Catherine C. Park, MD Baldev Patyal, PhD Narayan Sahoo, PhD Roy B. Tishler, MD, PhD Akila N. Viswanathan, MD, MPH Andrew Z. Wang, MD George D. Wilson, PhD Suzanne L. Wolden, MD Min Yao, MD

ASTRO 2012 / 54TH ANNUAL MEE TING

7

2012 Abstract Reviewers

Thank You

May Abdel-Wahab Ross Abrams * Sanjeev Aggarwal * Peter Ahn Kevin Albuquerque Kaled Alektiar * Berthe Aleman Brian Alexander Michelle Alonso-Basanta Jonathan Ashman Elizabeth Baldini James Balter Christopher Barker Glenn Stuart Bauman Beth Beadle Justin Bekelman Stanley Benedict Ranjit Bindra Slawomir Blamek Jeffrey Bogart James Bonner Kristy Brock Stephen Brown Mark Buyyounouski Kevin Camphausen * David J. Carlson Jimmy Caudell A. Bapsi Chakravarthy Arnab Chakravarti Annie Chan Bryan Chang Daniel Chang Joe Y. Chang Samuel T. Chao Allen Chen Changhu Chen Ronald Chen Bhisham Chera Indrin Chetty Steven Chmura Hak Choy Richard Chung Jay Ciezki Deborah Citrin John Coen C Norman Coleman Louis S. Constine * Joseph Contessa Bouthaina Dabaja Shari Damast Laura Dawson Jennifer De Los Santos Joseph Deasy Roy Decker Andre Dekker Thomas Delaney John DeMarco Robert Den Jun Deng Theodore DeWeese Adam Dicker * Thomas Dilling

Corinne Doll Lei Dong Jason Efstathiou * Hans Eich John Einck Issam El Naqa Mohamed Elshaikh Ronald Ennis Steven Feigenberg Felix Feng Robert Foote Eric Ford Benedick Fraass Gary Freedman * Martin Fuss David Gaffney Adam Garden Laurie Gaspar * David Gius Elizabeth Gore Alexander Gottschalk Edward Graves Michael Haddock Karl Haglund Paul Harari Mark Henderson Christopher Herbert Joseph Herman Gilda Hillman Alice Y. Ho David Hodgson Sarah Hoffe Karen Hoffman Brad Hoppe Peter Hoskin David Howell Dimitre Hristov I-Chow Hsu Geoffrey Hugo Arthur Hung Tim Illidge Salma Jabbour David Jaffray * Nora Janjan Ryan Jensen Steve Jiang William Jones III Mitchell Kamrava Paul Keall * Paul J. Kelly Youlia Kirova Eric Klein Ann Klopp Wui-Jin Koh Marisa Kollmeier Kevin Kozak Jon Kruse Greg Kubicek Charles Kunos Patrick Kupelian * Nadia Laack

to the 2012 Abstract Reviewers

Katja Langen Joshua Lawson Quynh Le Andrew Lee Peter Levendag Stanley Liauw Alexander Lin * Arthur Liu Fei-Fei Liu Billy Loo Daniel Low Andrew Lowy Join Luh Stephen Lutz * C-M Charlie Ma Shannon MacDonald Mitchell Machtay Gikas Mageras Anand Mahadevan Sheida Mani Rufus Mark Mary K. Martel Nina Mayr * Susie McCloskey Vivek Mehta Loren Mell Moyed Miften Michael Milano Drew Moghanaki Radhe Mohan Jean Moran Benjamin Movsas * Sasa Mutic Ashwatha Narayana Paul Nguyen Mark Oldham Kenneth Olivier Jatinder Palta Catherine Park Upendra Parvathaneni Abhijit Patel Shilpen Patel Arnold Paulino * Todd Pawlicki Mark Phillips Jean-Philippe Pignol Alan Pollack Lorraine Portelance Louis Potters Jean Pouliot Robert Prosnitz Rachel Rabinovitch Abram Recht Ramesh Rengan Mark Rivard Kenneth Roberts Cliff G. Robinson Ken Rosenzweig Mihaela Rosu Christian Rübe Samuel Ryu

Amit Sawant David Sebag-Montefiore Suresh Senan Jan Seuntjens Michael Sharpe Xinglei Shen Ke Sheng David Sher Helen Shih Tim Showalter Farzan Siddiqui Nicole Simone Ben Slotman William Small Jr. Ben Smith * Timothy Solberg William Song Jan-Jakob Sonke Lena Specht Baldassarre Stea Jonathan Strauss Mohan Suntharalingam * Alphonse Taghian Michael Tee Stephanie Terezakis Charles Thomas Wade Thorstad Robert Timmerman Roy Tishler Wolfgang Tome Phuoc Tran Prabhakar Tripuraneni * Alexei Trofimov Andrew Vassil Greg Videtic Akila Viswanathan Zeljko Vujaskovic Eleanor Walker Andrew Wang Joanne Weidhaas Stephanie Weiss Maria Werner-Wasik Julia White Karen Winkfield Aaron Wolfson Gayle Woloschak Rebecca Wong John Wong Ping Xia Ying Xiao Lei Xing Di Yan Fang-Fang Yin Torunn Yock Sue Yom James Yu (Weining) Ken Zhen Key * Track Chairman

Gold Medal Recipients The Gold Medal is ASTRO’s highest honor bestowed on revered members who have made outstanding contributions to the field of radiation oncology.

2012 GOLD MEDALISTS J. ROBERT CASSADY, MD, FASTRO Dr. Cassady recently retired from his position as professor and chairman of the department of radiation oncology at the Lahey Clinic in Burlington, Mass. An esteemed educator and clinician, his service spans over four decades and has had a major influence in the fields of pediatric oncology, prostate cancer and hyperthermia.

GEORGE T.Y. CHEN, PHD, FASTRO Dr. Chen is a medical physicist at the Massachusetts General Hospital, where he served as head of the radiation physics division from 1999-2008. A former member of the ASTRO Board of Directors, he is recognized for his work in multimodality image registration.

MARK W. DEWHIRST, DVM, PHD, FASTRO Dr. Dewhirst serves as the Gustavo S. Montana professor in the department of radiation oncology at Duke University in Durham, N.C., with joint appointments in pathology and biomedical engineering. A veterinary clinician and former member of the ASTRO Board of Directors, he is recognized for his contributions to the research of hypoxia, angiogenesis and the development of heat activated drug delivery using liposomes.

ASTRO 2012 / 54TH ANNUAL MEE TING

9

Honorary Member Recipient Honorary Membership is awarded annually to a distinguished cancer researcher or leader in a discipline other than radiation oncology, radiation physics or radiobiology.

2012 HONORARY MEMBER MARK P. CAROL, MD Dr. Carol is a neurosurgeon with more than 30 years of experience in the medical device and health care services arenas and is widely viewed as the “father of IMRT” and a pioneer in radiation oncology. His work with IMRT and IGRT has advanced the specialty and role of radiation oncology in the treatment of cancer and allied diseases.

10

ASTRO 2012 / 54TH ANNUAL MEE TING

Fellow Recipients PLEASE JOIN US IN CONGRATULATING THE 2012 FELLOWS: Thomas A. Buchholz, MD The University of Texas, MD Anderson Cancer Center Beth Erickson, MD Medical College of Wisconsin Francine Halberg, MD Marin Cancer Institute A. Robert Kagan, MD Southern California Kaiser Permanente Medical Group Maria D. Kelly, MB, BCh Veterans Healthcare Administration Eric E. Klein, PhD Washington University, St. Louis

Benjamin Movsas, MD Henry Ford Health System Arno J. Mundt III, MD University of California, San Diego Subir Nag, MD Kaiser Permanente Jatinder R. Palta, PhD University of Florida Timothy Whelan, BM, BCH McMaster University and Juravinski Cancer Center Joachim Yahalom, MD Memorial Sloan-Kettering Cancer Center

ASTRO 2012 / 54TH ANNUAL MEE TING

11

Awards 2012 ASTRO ANNUAL MEETING AWARD RECIPIENTS RESIDENT CLINICAL/BASIC SCIENCE RESEARCH AWARD

Richard L. Bakst, MD (Radiation and Cancer Biology) Tracy S. Bray, MD (Radiation Physics) Nitin Ohri, MD (Clinical)

BASIC SCIENCE ABSTRACT AWARD Radiation Physics

Catherine Coolens, PhD, CIPEM Yuan Yuan Ge, PhD Yu Kuang, PhD

Radiation and Cancer Biology RESIDENT DIGITAL POSTER RECOGNITION AWARD

Mohamed Abazeed, MD, PhD (Radiation and Cancer Biology) Nathan Becker, PhD (Radiation Physics) Maha Jawad, MD (Clinical)

RESIDENT POSTER VIEWING RECOGNITION AWARD Clinical Charles R. Woods, MD (1st place) Jason Sun, MD (2nd place) Jessica Wobb, MD (3rd place)

Radiation and Cancer Biology

Joshua Dilworth, MD, PhD (1st place) Yuya Yoshimoto, MD, PhD (2nd place) Ikuno Nishibuchi, MD (3rd place)

Radiation Physics

Gaurav Marwaha, MD (1st place) Daniel Habermehl, MD (2nd place) Georges Hobeika, MD (3rd place)

Kazi Ahmed, PhD Tina Dasgupta, MD, PhD Felix Y. Feng, MD Eddy S. Yang MD, PhD

ANNUAL MEETING SCIENTIFIC ABSTRACT TRAVEL AWARD

Bryan G. Allen, MD, PhD Natalie Ausborn, BS Nataniel Lester-Coll, MD Pierre Graff, MD, PhD, MS Chaitanya G. Joshi Zachary Kohutek, MD, PhD Kiran Kumar, BS Bowen Meng Takahiro Oike Gabriele Reinartz, MD Philipp Seidel, MS Kumara Swamy, MD Robert B. Taylor, MD, PhD Sean Vance, MS Joanna Yang

International – U.S. Annual Meeting Scientific Abstract Award Songbing Qin, MD

Nurse Excellence Award Michelle Wallace, RN, BSN

Annual Meeting Nurse Abstract Award Laura L. Ochoa, PhD, RN

12

ASTRO 2012 / 54TH ANNUAL MEE TING

INSIDE: General Information and Highlights ASTROmobile – Official Meeting App Shuttle Bus Schedule/Routes Boston Convention and Exhibition Center Floor Plans

You need accuracy when integrating molecular imaging with radiation therapy. That’s what you get with the GEMINI TF Big Bore. When using functional and biological information to plan or adapt radiation treatment, accuracy is vital. The GEMINI TF Big Bore PET/CT helps you keep patient positioning consistent, to improve the precision of radiation therapy. It allows you to streamline your workf low and offers the potential for more accurate tumor delineation and evaluation of treatment response, because it’s designed specifically to meet your needs. To learn more, visit www.philips.com/geminitfbigbore.

General Information BOSTON CONVENTION AND EXHIBITION CENTER 415 Summer Street Boston, MA 02210 617-954-2000 www.advantageboston.com/bcec All activities take place at Boston Convention and Exhibition Center unless specifically stated otherwise. All information is as current as of September 21, 2012, and is subject to change.

ATTENDEE REGISTRATION North Lobby, Level 1 Attendee registration counters will be located in the North Lobby of the Boston Convention and Exhibition Center.

ATTENDEE REGISTRATION HOURS Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

7:00 a.m. - 5:00 p.m. 6:30 a.m. - 5:00 p.m. 7:00 a.m. - 6:00 p.m. 7:00 a.m. - 6:00 p.m. 7:00 a.m. - 2:00 p.m.

EXHIBITOR REGISTRATION East Registration Lobby, Exhibit Level Exhibitor registration counters will be located in the East Registration Lobby on the Exhibit Level of the Boston Convention and Exhibition Center.

EXHIBITOR REGISTRATION HOURS Thursday, October 25 Friday, October 26 Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30

8:00 a.m. - 5:00 p.m. 8:00 a.m. - 5:00 p.m. 7:00 a.m. - 5:00 p.m. 7:00 a.m. - 5:00 p.m. 8:00 a.m. - 6:00 p.m. 8:00 a.m. - 5:00 p.m.

AFFILIATED MEETINGS 36th ASRT RADIATION THERAPY CONFERENCE October 28-30, 2012 Boston Marriott Copley Place The 36th Annual ASRT Radiation Therapy Conference will take place at the Boston Marriott Copley Place. ASTRO registered attendees may attend ASRT sessions by paying a reduced registration fee of $150. Proof of registration (registration confirmation or badge) is required to receive this reduced rate. If you have not registered to attend the ASRT conference but would like to do so, please register on-site at the 4th Floor Registration Desk. 29TH SROA ANNUAL MEETING October 28-31, 2012 Hyatt Regency Cambridge The 29th SROA Annual Meeting will take place at the Hyatt Regency Cambridge. ASTRO registered attendees may attend the SROA general sessions by paying a reduced registration fee of $210. Proof of registration (registration confirmation or badge) is required to receive this reduced rate. If you have not registered to attend the SROA conference but would like to do so, please register on-site at the Courtyard Reception Area.

ASTRO 2012 / 54TH ANNUAL MEE TING

15

ASTRO CAREER FAIR

ASTRO RESOURCE CENTER

Room 104 A-B, Level 1 Take advantage of the ASTRO Career Fair to connect with candidates for employment. Equipped with computers and printers for your convenience, the Career Fair is available for employers to conduct interviews with job applicants. Employers and applicants must register through the online ASTRO Radiation Oncology Career Center matching service in order to schedule interviews in the on-site Career Fair.

Booth 8043, Exhibit Hall Visit the ASTRO Resource Center in the Exhibit Hall to find out about products and services available to ASTRO members. Not a member? Stop by and learn about the benefits of membership. The Resource Center is your one-stop shop to hear about the new member benefits ASTRO is offering its members, as well as learn about its initiatives for the coming year, including the new PRQIwizard and a new error reporting system. Stop by and pick up updated patient brochures and join the new ASTRO private community – ROhub. ASTRO’s knowledgeable staff will be on hand to answer your questions about your membership.

Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30

12:00 p.m. - 6:00 p.m. 8:00 a.m. - 6:00 p.m. 8:00 a.m. - 6:00 p.m. 8:00 a.m. - 6:00 p.m.

Private interview rooms are also available. These rooms are ideal if you have multiple interviews to conduct, or just need more privacy. A limited number of meeting rooms will be available to rent for three-hour periods Saturday, October 27 through Tuesday, October 30. For more information, contact Todd Karstaedt at [email protected]

ASTRO PAC LOUNGE Room 105, Level 1 ASTRO’s political action committee (ASTRO PAC) is offering access to an exclusive lounge for all ASTRO members who have donated to the ASTRO PAC in 2012. The PAC lounge will feature Internet access, coffee and beverages, food and a place to rest between sessions. Donors will be automatically entered into a raffle, including the opportunity to win a new iPad and other great prizes. Members who have not made their contribution will be able to donate on-site. ASTRO PAC provides ASTRO with the opportunity to more fully participate in government and ensure our members’ voices are being heard by key policy makers on Capitol Hill. Be sure to stop by the lounge to get the most recent legislative and election updates. For more information, please email [email protected] or visit www.astro.org/astropac. Hours of Operation: Sunday, October 28 10:00 a.m. - 5:00 p.m. Monday, October 29 10:00 a.m. - 5:30 p.m. Happy Hour 2012 Election Preview 4:30 p.m. - 5:30 p.m. Tuesday, October 30 10:00 a.m. - 3:00 p.m.

16

ASTRO 2012 / 54TH ANNUAL MEE TING

Hours of Operation: Sunday, October 28 Monday, October 29 Tuesday, October 30

10:00 a.m. - 5:00 p.m. 10:00 a.m. - 5:00 p.m. 10:00 a.m. - 5:00 p.m.

BOSTON INFORMATION North Lobby , Level 1 Attendees can stop by the Boston Information Desk located in the North Lobby at the Boston Convention and Exhibition Center to receive restaurant recommendations and make reservations, receive Boston visitor guides, maps, destination information and local directions. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

9:00 a.m. - 5:00 p.m. 9:00 a.m. - 5:30 p.m. 9:00 a.m. - 5:30 p.m. 9:00 a.m. - 5:30 p.m. 9:00 a.m. - 2:00 p.m.

BUSINESS CENTER Located off of the North Lobby, Level 1 A FedEx Office and Print and Ship Center is conveniently located off of the North Lobby on Level 1 of the Boston Convention and Exhibition Center. The business center offers a variety of services including packing and shipping, sign production, copying and office supplies. For more information, please contact FedEx directly at 617-954-2203. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

8:00 a.m. - 5:00 p.m. 8:00 a.m. - 6:00 p.m. 8:00 a.m. - 6:00 p.m. 8:00 a.m. - 7:00 p.m. 8:00 a.m. - 5:00 p.m.

ASTROmobile Your Annual Meeting Guide ASTROmobile gives you access to the meeting program and the ability to customize your meeting experience with personalized maps and planners. • Search engines for sessions by day, track or speaker. • Search engines for exhibitors by name, booth number or product/service category. • Session and exhibitor details with location maps. • Search and view abstracts. • General meeting information. • Access your “My Plan” – your personal Annual Meeting Schedule. • Convention Center maps. • Take notes during a session or about an exhibitor and be able to access your notes from your mobile device.

ASTROmobile Login An account has been created for all registered attendees. Please log in using the following login credentials: User ID:

Badge Number (found on front of your badge)

Password: Last Name

Start using ASTROmobile – the official Annual Meeting app today! iPhone Users To access ASTROmobile using your iPhone, simply download the app, “ASTROmobile,” from the Apple store.

Smart Phone Users Go to www.astro.org/ASTROmobile in your mobile Web browser to access the 2012 ASTROmobile.

BUSINESS MEETING Tuesday, October 30, 2012 12:00 p.m. - 1:15 p.m. Room 210 A-C, Level 2 ASTRO voting members (Active, Affiliate, Allied or International members) are invited to attend the Business Meeting on Tuesday, October 30, from 12:00 p.m. - 1:15 p.m. Leaders of the Society will present on important topics of interest to ASTRO members. You should not miss this important meeting. Lunch will be served.

CE CENTRAL North Lobby, Level 1 ASTRO and American Board of Radiology (ABR) staff will be on hand to address specific attendee questions about continuing education and MOC requirements. Are you current with your MOC requirements? ABR staff at the booth can review your current status and provide guidance on moving forward in your MOC cycle. Visit one of the CE Central access stations to complete the continuing education and meeting evaluations, print a session tracking form, search for attendees using Find a Friend and search session, abstract and exhibitor information with the Online Conference Planner. Attendees may also receive assistance with completing the online evaluation and can pick up details on upcoming ASTRO events and details on ASTRO’s online offerings that meet the requirements for MOC. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

1:00 p.m. - 5:00 p.m. 8:00 a.m. - 6:00 p.m. 8:00 a.m. - 6:00 p.m. 8:00 a.m. - 6:00 p.m. 8:00 a.m. - 5:00 p.m.

CYBER CAFÉ Booth 1055, Exhibit Hall ASTRO attendees can browse the Internet and check, retrieve and send email messages at the Cyber Café in the Exhibit Hall. Hours of Operation: Sunday, October 28 Monday, October 29 Tuesday, October 30

18

10:00 a.m. - 5:00 p.m. 10:00 a.m. - 5:00 p.m. 10:00 a.m. - 5:00 p.m.

ASTRO 2012 / 54TH ANNUAL MEE TING

ELECTRONIC BUSINESS CARD Sponsored by ELEKTA Included with your badge, you will receive an electronic business card equipped with a magnetic strip containing your contact information and other demographic data. This card can be scanned in card readers located in exhibitor booths throughout the Exhibit Hall. Simply give your electronic business card to the exhibitor and your contact information will be recorded for follow-up by the exhibitor. Note: Attendee email addresses will not be included in the contact information given to exhibitors unless you provided approval when registering.

EXHIBIT HALL Halls A/B, Exhibit Level Learn about the latest products in cancer treatment and care in the Exhibit Hall. Hours of Operation: Sunday, October 28 Monday, October 29 Tuesday, October 30

10:00 a.m. - 5:00 p.m. 10:00 a.m. - 5:00 p.m. 10:00 a.m. - 5:00 p.m.

FACULTY/VIP OFFICE Room 103, Level 1 Faculty members and VIPs should check in at the Faculty/VIP Office, Room 103, to pick up registration materials and receive last-minute updates and program changes. The Faculty/VIP Office is conveniently located next to the Speaker Ready Room. Faculty and VIPs are welcome in the Faculty/VIP Office throughout the meeting. Faculty members include: • • • • • • •

Educational Session lecturers. Panel moderators and presenters. Scientific program discussants. eContouring Learning Lab presenters. Presidential Symposium lecturers. Keynote speakers and introducers. Nursing program speakers.

Note: Presenters of abstracts are not classified as faculty and should follow attendee registration instructions. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

6:30 a.m. - 6:00 p.m. 6:30 a.m. - 6:00 p.m. 6:30 a.m. - 6:00 p.m. 6:30 a.m. - 6:00 p.m. 6:30 a.m. - 5:00 p.m.

Concessions WICKED GOOD MARKET FOOD COURT

STARBUCKS

Level 1, West Side Food court that offers multiple restaurant options with a wide variety of cuisines.

Westin Boston Waterfront Hotel, Lobby Starbucks offers coffee, tea and other beverages as well as pastries, sandwiches, salads and grab and go items.

Hours of Operation: Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

11:00 a.m. - 3:00 p.m. 11:00 a.m. - 3:00 p.m. 11:00 a.m. - 3:00 p.m. 11:00 a.m. - 2:00 p.m.

OUTTAKES Level 1, Off of North Lobby Offers coffee, cold beverages, breakfast pastries and grab and go salads and sandwiches. Hours of Operation: Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

6:30 a.m. - 5:00 p.m. 7:00 a.m. - 5:00 p.m. 7:00 a.m. - 5:00 p.m. 7:00 a.m. - 4:00 p.m.

COFFEE KIOSK Level 1, Off of North Lobby Offers coffee, cold beverages and grab and go snacks. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30

7:00 a.m. - 3:00 p.m. 6:30 a.m. - 12:00 p.m. 7:00 a.m. - 12:00 p.m. 7:00 a.m. - 12:00 p.m.

Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

6:00 a.m. - 7:00 p.m. 6:00 a.m. - 7:00 p.m. 6:00 a.m. - 7:00 p.m. 6:00 a.m. - 7:00 p.m. 6:00 a.m. - 7:00 p.m.

SAUCIETY Westin Boston Waterfront, Lobby Sauciety is a modern American grill with a culinary twist that builds off of high-quality regional cuisine, and then focuses on a variety of unique and flavorful sauces, spreads, dips and chutneys that the guest is able to select from to customize each course of their meal. Breakfast and lunch served daily. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

7:00 a.m. - 2:00 p.m. 7:00 a.m. - 2:00 p.m. 6:30 a.m. - 2:00 p.m. 6:30 a.m. - 2:00 p.m. 6:30 a.m. - 2:00 p.m.

EXHIBIT HALL FOOD COURTS Halls A/B, Exhibit Hall Two food court areas will be available in the Exhibit Hall that will offer beverages, coffee and variety of food options for breakfast and lunch. At this food court, you will be able to redeem the $10 lunch voucher you received with your registration materials. Hours of Operation: Sunday, October 28 Monday, October 29 Tuesday, October 30

10:00 a.m. - 5:00 p.m. 10:00 a.m. - 5:00 p.m. 10:00 a.m. - 4:00 p.m.

The concession schedule is subject to change. ASTRO 2012 / 54TH ANNUAL MEE TING

19

FIRST AID North Lobby First Aid Office, Level 1 First Aid is located in North Lobby at the Boston Convention and Exhibition Center. The phone number is 617-954-2222, or dial ext. 2222 from a house phone. In an emergency, please contact first aid or go to ASTRO Registration and have a staff person contact security. Hours of Operation: Monday, October 22 Tuesday, October 23 Wednesday, October 24 Thursday, October 25 Friday, October 26 Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31 Thursday, November 1

8:00 a.m. - 5:00 p.m. 8:00 a.m. - 5:00 p.m. 8:00 a.m. - 5:00 p.m. 8:00 a.m. - 5:00 p.m. 8:00 a.m. - 5:00 p.m. 7:00 a.m. - 6:00 p.m. 6:30 a.m. - 7:30 p.m. 7:00 a.m. - 7:30 p.m. 7:00 a.m. - 10:00 p.m. 7:00 a.m. - 8:00 p.m. 7:00 a.m. - 5:00 p.m.

INDUSTRY-EXPERT THEATER Front of Hall A, Exhibit Hall This activity allows companies to present their noteworthy products and services through a live presentation in the Industry-Expert Theater located in the Exhibit Hall. Seating is available on a first-come, first-served basis. A box lunch will be provided. The Industry-Expert Theater content and views expressed therein are those of the exhibitor and not of ASTRO.

Sunday, October 28

Tuesday, October 30

Time: 12:45 p.m. - 1:45 p.m.

Time: 12:00 p.m. - 1:00 p.m.

Clinical Trial Update: Anchored Transponder in Lung Cancer Patients Goals and Objectives of the Trial, Current Status and Future Potential

The Role of Zevalin in the Treatment of Lowgrade or Follicular Lymphoma

Presented by Varian Medical Systems Contact: Shari Huffine Phone: 650-424-5938

Monday, October 29 Time: 12:30 p.m. - 1:30 p.m. Accuray Showcases Leading-edge Treatment Solutions at ASTRO 2012 With New Clinical Advancements in the Field of Radiosurgery and Radiation Therapy Presented by Accuray Contact: [email protected]

20

ASTRO 2012 / 54TH ANNUAL MEE TING

Presented by Spectrum Pharmaceuticals Inc. Contact: Linda Azarbal Phone: 949-743-9347

INDUSTRY SATELLITE SYMPOSIA ASTRO has reviewed and approved these symposia as appropriate for presentation. These symposia represent the content and views of the sponsors and are not part of the official ASTRO Annual Meeting.

Advances in Technology Clinical Forum Saturday, October 27 11:00 a.m. – 6:00 p.m. Westin Boston Waterfront Hotel, Grand Ballroom Accreditation: The Institute for Medical Education is accredited by the Institute for Medical Quality/ California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Institute for Medical Education takes responsibility for the content, quality and scientific integrity of this CME activity. CME Credits: The Institute for Medical Education designates this live activity for a maximum of 6 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. MPCEC credits are pending approval. This activity is hosted by The Institute for Medical Education and is supported by an unrestricted educational grant from Varian Medical Systems. To register, visit www.regonline.com/2012CFBostonMA. Prostate News Tonight From Symptom Control to Survival: The Changing Role of the Radiation Oncologist in the Management of mCRPC Sunday, October 28 6:00 p.m. – 6:30 p.m. – Registration 6:30 p.m. – 8:00 p.m. – Prostate News Tonight CME Dinner Symposium Westin Copley Place, America Ballroom, 4th Floor Accreditation: This live activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of University of Hawaii at Hilo College of Pharmacy and The Foundation for Men’s Health. The University of Hawaii at Hilo College of Pharmacy is accredited by the Hawaii Medical Association to provide continuing medical education for physicians. CME Credits: The University of Hawaii Hilo College of Pharmacy designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

independent medical education grant from Bayer HealthCare Pharmaceuticals. For more information, visit www.FoundationforMensHealth.org. On-site registration is available but space is limited; please arrive by 6:00 p.m. The Present and Future of Genomics in DCIS Sunday, October 28 7:00 p.m. – 10:00 p.m. Westin Boston Waterfront Hotel, Commonwealth Ballroom Accreditation: EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Credits: EXCEL Continuing Education designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This live activity is supported by an educational grant from Genomic Health. This activity is sponsored by EXCEL Continuing Education. To register, or for more information, visit www.excelcme.com. Advancing Patient Care Through Innovation: The Role of Proton Therapy Monday, October 29 6:00 p.m. – 7:30 p.m. with reception to follow Institute of Contemporary Art Accreditation: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continual medical education for physicians. CME Credits: The University of Florida College of Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This live activity is supported by an unrestricted educational grant from IBA Particle Therapy. This activity is hosted by The University of Florida College of Medicine. Preregistration is REQUIRED to attend. For more information and to register online, please visit http://proton.cme.ufl.edu.

This program is jointly sponsored by the University of Hawaii at Hilo College of Pharmacy and The Foundation for Men’s Health and supported by an ASTRO 2012 / 54TH ANNUAL MEE TING

21

INFORMATION DESK

PARKING

North Lobby, Level 1 Have a question? Stop by the Information Desk to get your questions answered.

Both valet and self parking is available at the Boston Convention and Exhibition Center. ASTRO does not validate for parking.

Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

Valet Parking Valet parking is available at the Boston Convention and Exhibition Center for $25 per day. From Summer Street, turn onto East Side Drive and the valet area will be immediately on your right.

7:00 a.m. - 5:00 p.m. 6:30 a.m. - 5:00 p.m. 7:00 a.m. - 6:00 p.m. 7:00 a.m. - 6:00 p.m. 7:00 a.m. - 3:15 p.m.

LOST AND FOUND North Lobby, Level 1 To report a missing item, to check to see if an item has been turned into security or to turn in a lost item, please stop by the Information Desk located in the North Lobby. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

7:00 a.m. - 5:00 p.m. 6:30 a.m. - 5:00 p.m. 7:00 a.m. - 6:00 p.m. 7:00 a.m. - 6:00 p.m. 7:00 a.m. - 3:15 p.m.

LUNCH VOUCHER Attendees will receive a lunch voucher valued at $10 that can be used at food outlets in the Exhibit Hall only. This voucher was provided to all attendees and exhibitors with their registration materials. Duplicates will not be issued for lost vouchers.

LUGGAGE/COAT CHECK Room 101, Level 1 Luggage and coat check will be available at the Boston Convention and Exhibition Center for $3 per item. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

22

6:30 a.m. - 6:00 p.m. 6:00 a.m. - 6:00 p.m. 7:00 a.m. - 7:00 p.m. 7:00 a.m. - 6:30 p.m. 7:00 a.m. - 5:30 p.m.

ASTRO 2012 / 54TH ANNUAL MEE TING

Self Parking Self parking is available in the South parking lot at the Boston Convention and Exhibition Center and is $12 per day. From Summer Street, turn onto East Side Drive and drive past the valet area. Continue straight along the side of the Boston Convention and Exhibition Center. At the end of the building, make a right and go down the ramp. At the bottom of the ramp, turn left and the entrance to the South parking lot will be in front of you.

POSTER VIEWING Hall C, Exhibit Hall Poster Viewing Hours: Sunday, October 28 Monday, October 29 Poster Reception Tuesday, October 30

10:00 a.m. - 5:00 p.m. 10:00 a.m. - 6:45 p.m. 5:30 p.m. - 6:45 p.m. 10:00 a.m. - 5:00 p.m.

Includes posters from the following categories: • Breast • Central Nervous System • Gastrointestinal • Genitourinary • Gynecological • Head and Neck • Health Services Research • History • Informatics/Bioinformatics • Lung • Lymphoma/Hematologic Malignancies • Nonmalignancies • Palliative Care • Pediatric Cancer • Quality of Life • Radiation and Cancer Biology • Radiation Physics • Sarcomas and Cutaneous Tumors

POSTER VIEWING SESSION AND RECEPTION* Monday, October 29 5:30 p.m. - 6:45 p.m. Hall C, Exhibit Level During this session, all poster presenters are asked to stand by their poster to answer questions about their research. New this year will be a presentation area where the poster award winners will provide highlights of their research and be available for questions. The presentation schedule will be available in the poster viewing area. Each full-conference attendee, exhibitor and Monday one-day conference attendee will receive one drink ticket that can be used for complimentary beverage at the Poster Viewing Session and Reception on Monday, October 29. After your ticket has been redeemed, drinks will be available for purchase. You must be 21 years of age to consume alcoholic beverages. Your drink ticket will be included with your badge in your registration materials.

PRESS ROOM Room 151 A-B, Level 1 Abstract presenters are encouraged to bring press releases promoting their presentation in Boston to the Press Room. For more information or for assistance writing or distributing your release, please contact ASTRO Media Relations at 1-800-962-7875 or [email protected], or visit the online press room at www.astro.org. Hours of Operation: Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

8:00 a.m. - 5:00 p.m. 7:00 a.m. - 4:00 p.m. 7:00 a.m. - 4:00 p.m. 7:00 a.m. - 12:00 p.m.

For Press Room guidelines, visit www.astro.org.

*This session is not accredited for continuing medical education credits.

ASTRO 2012 / 54TH ANNUAL MEE TING

23

Shuttle Service Complimentary shuttle service will be provided between the Boston Convention and Exhibition Center and official ASTRO hotels. The shuttle drop-off and pick-up locations are on Level 1 on the east and west sides of the Boston Convention and Exhibition Center. Please refer to signs in the convention center and your hotel lobby for the most current information. Hours of Operation:

Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30

7:00 a.m. - 6:00 p.m.* 6:30 a.m. - 7:00 p.m.* 6:30 a.m. - 7:30 p.m.* 6:30 a.m. - 7:15 p.m.*



Wednesday, October 31

6:30 a.m. - 6:00 p.m.*

*Indicates the last time shuttle buses depart the Boston Convention and Exhibition Center returning to official ASTRO hotels. The last shuttle departs hotels approximately 45 minutes prior to this last time.

HOTELS AND BOARDING LOCATIONS

All travel times are approximate pending time of day, day of week and traffic conditions. Route

1

2

3

4

5

6

Hotel

Boarding Location at Hotel

Hyatt Regency Boston Downtown

Curbside on Chauncey

Omni Parker House Hotel

NE corner of Tremont and Beacon

Hilton Boston Back Bay

At Sheraton Boston Hotel, on Dalton

Sheraton Boston Hotel

Curbside on Dalton

Boston Park Plaza

Curbside on Columbus

Courtyard by Marriott Boston Tremont

Curbside on Tremont

Doubletree Hotel Boston Downtown

At Courtyard by Marriott, on Tremont

W Boston

At Courtyard by Marriott, on Tremont

Boston Marriott Long Wharf

Curbside in front

InterContinental Boston

Curbside in front

Boston Marriott Copley Place

Curbside in front, on Huntington

Colonnade Hotel

At Boston Marriott Copley Place

Fairmont Copley Plaza

At Boston Marriott Copley Place

Westin Copley Place Boston

At Boston Marriott Copley Place

Embassy Suites Boston at Logan Airport

Curbside on Porter

Hilton Boston Logan Airport

Side of hotel

Hyatt Harborside

At Water Taxi Pickup

Approximate one-way travel time

Frequency in minutes

17-22 minutes

Peak 10-15 Nonpeak 15-20

22-27 minutes

Peak 10-15 Nonpeak 15-20

17-22 minutes

Peak 10-15 Nonpeak 15-20

13-18 minutes

Peak 10-15 Nonpeak 15-20

22-27 minutes

Peak 10-15 Nonpeak 15-20

17-22 minutes

Peak 10-15 Nonpeak 15-20

Renaissance Boston Waterfront Walk Hotels

Seaport Hotel Westin Boston Waterfront

24

ASTRO 2012 / 54TH ANNUAL MEE TING

No Shuttle Service

SMOKING Boston Convention and Exhibition Center is a nonsmoking facility.

SPEAKER READY ROOM Room 102 A-B, Level 1 Faculty members and abstract presenters must upload their PowerPoint presentation in advance of their session in order to have it pre-loaded onto the ASTRO conference network. To ensure presentations have been properly uploaded, faculty members and abstract presenters are asked to check in at the Speaker Ready Room to review the information and make any last minute edits. Presentations should be saved on a portable device and brought to the Speaker Ready Room at least 24 hours in advance of presentation, or upon arrival at the Boston Convention and Exhibition Center. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

6:30 a.m. - 6:00 p.m. 6:30 a.m. - 6:00 p.m. 6:30 a.m. - 6:00 p.m. 6:30 a.m. - 6:00 p.m. 6:30 a.m. - 5:00 p.m.

Thank you to the groups who have so generously donated to the 2012 Survivor Circle Passport Program: (List as of September 21, 2012) Pitts Little Corp RC Billing Landauer Medical Physics

TECHNOLOGY HELP DESK North Lobby, Level 1 Need help using ASTROmobile, the official app for the Annual Meeting? Have questions about the touch screen interactive wayfinder stations that will help you navigate the convention center? Stop by the Technology Help Desk located in the North Lobby at the Boston Convention and Exhibition Center to get your technology related questions answered. Hours of Operation: Saturday, October 27 Sunday, October 28 Monday, October 29 Tuesday, October 30 Wednesday, October 31

7:00 a.m. - 5:00 p.m. 6:30 a.m. - 5:00 p.m. 7:00 a.m. - 6:00 p.m. 7:00 a.m. - 6:00 p.m. 7:00 a.m. - 3:15 p.m.

SURVIVOR CIRCLE ASTRO Resource Center - Booth 8043, Exhibit Hall In 2003, ASTRO created the Survivor Circle as a way to honor cancer survivors. Each year, ASTRO partners with two local patient support organizations and features them at the Survivor Circle at the Annual Meeting. It was our hope that by partnering with local organizations in the cities that host our meeting, we would be able to not only give back to the cities we visit, but also help raise awareness of these important organizations among our members. Through generous donations from exhibitors and attendees, ASTRO raises funds for the two organizations featured in the Survivor Circle. Since its inception, the Survivor Circle has raised nearly $200,000 for our partner organizations. Stop by the Survivor Circle, located in booth 8043 to learn more about the recipients of this year’s Survivor Circle Grant — Arms Around Arlington Center for Cancer Support and Surviving and Moving Forward: The SAMFund for Young Adult Survivors of Cancer.

ASTRO 2012 / 54TH ANNUAL MEE TING

25

TRANSPORTATION

VIRTUAL POSTERS

Boston offers a number of convenient transportation options to help attendees easily get around the city.

Hall C, Exhibit Hall Computer terminals and seating are available to view the virtual poster displays at your leisure. Correspond with presenters or forward a presentation to a colleague or your home office.

Airport Boston Logan Airport is 12 miles from downtown Boston. Outbound scheduled buses, shared ride and long distance vans, taxis and hotel and rental car courtesy vans are located in the arrival area of each terminal. Taxi On average, a one-way taxi ride from the airport to downtown can range from $20 to $45. All areas within a 12 mile radius of downtown Boston are charged by meter. All fares departing Boston Logan Airport are charged an additional fee of $2.25, plus a $5.25 fee for harbor tunnel crossings. If you are going to a hotel outside the 12 mile radius of downtown Boston, there will be a flat rate charged. Subway Boston’s downtown transportation system, better known as the “T,” connects all of Boston and its suburbs by subway, standard rail, bus and commuter boat. The “T” connects the airport with the convention centers and hotels, as well as point-topoint access anywhere in the city. The Silver Line offers direct public transportation to the Boston Convention and Exhibition Center from both Boston Logan Airport and downtown Boston via the Seaport World Trade Center.

VIRTUAL MEETING All full-conference attendees receive the Virtual Meeting with their registration at no additional cost. With the Virtual Meeting, you can extend your learning experience with access to the 2012 ASTRO sessions long after the meeting is over. You will receive streaming content that has been digitally recorded live and published as audio synchronized to the speaker presentations*. Approximately six weeks after the meeting, full conference attendees will receive an email with a link providing access to the Virtual Meeting. *Presentations are included in the Virtual Meeting as approved per faculty.

26

ASTRO 2012 / 54TH ANNUAL MEE TING

Hours of Operation: Sunday, October 28 Monday, October 29 Tuesday, October 30

10:00 a.m. - 5:00 p.m. 10:00 a.m. - 6:45 p.m. 10:00 a.m. - 5:00 p.m.

WIRELESS INTERNET ACCESS Complimentary wireless Internet access is provided in all common areas and session rooms throughout the Boston Convention and Exhibition Center. Attendees can bring their laptop to check email, complete the evaluation or surf the Internet. Laptops must have a Wi-Fi card to connect.

ASTRO 2012 / 54TH ANNUAL MEE TING

  Restrooms

EXHIBIT LEVEL

052

E Elevator

Escalator

 

 

ASTRO Sessions

Exhibitor Registration

 

Floor Plans

27

ASTRO 2012 / 54TH ANNUAL MEE TING

161



160

E Elevator

159

 

E

E

Escalator





E

158

157

156

E

Skybridge

E

 

E

153



104 AB 101

Press Office

151

102

 Concessions

103

Room



Faculty/VIP Office Speaker Ready



Career Fair

eContouring Learning Lab

154

105

T Public Transit

 

EXHIBIT HALL A/B

 Shuttle Bus





Food Court



PAC Lounge

E

Main Entrance to Exhibit Hall

  Restrooms

107

POSTERS HALL C

108

 

Skybridge

28

ASTRO Sessions

ASTRO Offices

First Aid

Technology Desk

   Information and

 

CE Central

Business Center

Coat Check

ASTRO Attendee Registration

MEETING LEVEL 1

109



Poster Entrance

Floor Plans

CATWALK M255

FS PANTRY 131

Open to Exhibit Hall below

CATWALK K255

ASTRO 2012 / 54TH ANNUAL MEE TING

  Restrooms

EMER. ELEC. K230

E

E

E Elevator

MEETING LEVEL 2

ST-K4

 

 

 

259

Escalator

260

E FOOD COURT MECHANICAL SHAFT

212 211

 

CATWALK J255

258

FS699.2

Open to Exhibit Hall below

CATWALK G255

210

 

256

E

E

FB

ASTRO Sessions

257

FOOD COURT MECHANICAL SHAFT

209 208

 

FB

 

255

E

 

FB

254

206

CATWALK F255

253

FS699.1

Open to Exhibit Hall below

CATWALK D255

205

FS220.1

FS710.2

204 203

Floor Plans

Skybridge to Westin Boston Waterfront Hotel

ITEM

ITEM

29

30

ASTRO 2012 / 54TH ANNUAL MEE TING

Open to Exhibit Hall below

  Restrooms

E Elevator

BALLROOM LEVEL

ST-M4

ST-K4

Escalator

Open to Exhibit Hall below Open to Exhibit Hall below

 

 

Grand Ballroom General Session

AREAWAY A315

E

E

FB

FB

FB

Floor Plans

INSIDE: eContouring Learning Lab Live SAM Sessions Presidential Symposium ARRO Program Meeting Highlights Nurses’ Program Schedule of Events by Day

How do we make real progress in CT solutions? By making real connections. Designing our CT meant understanding the needs of doctors while also considering the best possible patient care. The result? The Brilliance CT Big Bore simulation system that puts the patient in the same position for planning as for treatment. So you can adapt the simulations to your detailed needs and can customize to produce more accurate, virtually artifact free 4D images. To see how, visit us at www.philips.com/bigboreCT.

eContouring Learning Lab These sessions are designed to provide crucial clinical education for professionals. Attendees will have an opportunity to discuss issues such as imaging, target delineation, quality assurance and its frequency and achievable accuracy.

Schedule Kenneth Hu, MD, Program Chairman Sarah Hoffe, MD, Program Co-chairman Room: 153A-C

Saturday, October 27

Sunday, October 28

8:00 a.m. - 9:30 a.m.

8:00 a.m. - 9:30 a.m.

Esophageal Cancers

Head and Neck Cancers II

Sarah Hoffe, MD, Moffitt Cancer Center Ken Meredith, MD, Moffitt Cancer Center

Avraham Eisbruch, MD, University of Michigan Health Systems Suresh Mukherji, MD, University of Michigan Health Systems

10:30 a.m. - 12:00 p.m. Lymphoma Stephanie Terezakis, MD, Johns Hopkins University Steve Cho, PhD, Johns Hopkins University

10:30 a.m. - 12:00 p.m. Gynecological Cancers Arno J. Mundt III, MD, University of California San Diego Beth A. Erickson, MD, Medical College of Wisconsin

1:00 p.m. - 2:30 p.m. Lung Cancers Billy W. Loo, MD, PhD, Stanford University

1:00 p.m. - 2:30 p.m. Gastrointestinal Cancers

3:30 p.m. - 5:00 p.m. Head and Neck Cancers I Christopher Nutting, MD, Royal Marsden Hospital

Karyn Goodman, MD, MS, Memorial Sloan-Kettering Cancer Center Corinne Winston, MD, Memorial Sloan-Kettering Cancer Center Ross Abrams, MD, FASTRO, Rush University Medical Center

3:30 p.m. - 5:00 p.m. Prostate Cancers Michael J. Zelefsky, MD, Memorial Sloan-Kettering Cancer Center Ticketed event. Separate registration required. ASTRO 2012 / 54TH ANNUAL MEE TING

33

Live Self-Assessment Modules (SAMs) Back by popular demand, Annual Meeting participants will have an opportunity to earn Self-Assessment Module (SAM) credit in addition to CME credit. Attendees wishing to earn SAM credit must preregister for each of the SAMs they wish to participate in. All Live SAM sessions are open to paid meeting attendees, but only Live SAM ticket holders can participate in the Live SAM component of these sessions. Preregistration is required and can be done on-site at the registration desk if seats are available. ASTRO staff will email you 30-days post-meeting with your individual score and directions on how to print your certificate of completion from the ASTRO website. Your SAM credits will be uploaded into your My MOC Transcript page on the ASTRO website and if you choose, you can have your credits automatically transferred to the ABR through the credit gateway. Each of these sessions will be submitted to the ABR for Self-Assessment Module (SAM) qualification.

Live SAM Policy •

• •

Live SAM registrants MUST be in the designated Live SAM room 15 minutes prior to the start of the session. If you are not in the room at this time, your seat may be given away to another attendee on the wait list. No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session. Registrants must answer all of the required assessment and evaluation questions in order to receive credit for the Live SAM. Participants who do not complete the required questions will NOT receive SAM credit and will NOT receive a refund.

If you have any questions about the Live SAMs, SAM requirements or MOC, please visit the CE Central in the North Lobby.

Live SAM Session: Ticket and Seperate Registration is required to participate in the Live SAM Component of the session.

34

ASTRO 2012 / 54TH ANNUAL MEE TING

Live SAM Schedule

Sunday, October 28

Tuesday, October 30

Educational Session 103

Educational Session 312

4:15 p.m. - 5:45 p.m.

Pancreatic Cancer: Current Treatment Approaches and Controversies

1:15 p.m. - 2:45 p.m.

Low/High Grade Gliomas – An Update

Room: 107 A-C

Room: 107 A-C

Christopher H. Crane, MD, MD Anderson Cancer Center Joseph Herman, MD, MS, Johns Hopkins University

Changhu Chen, MD, University of Colorado Daphne Adele Haas-Kogan, MD, University of California San Francisco John Kirkpatrick, MD, PhD, Duke University

Monday, October 29 11:00 a.m. - 12:30 p.m.

Educational Session 212 Integration of Systemic Treatment with Radiation Therapy for Head and Neck Cancer

Room: 107 A-C

Ezra Cohen, MD, University of Chicago David Rosenthal, MD, MD Anderson Cancer Center Roy Tishler, MD, PhD, Dana-Farber Cancer Institute

4:00 p.m. - 5:30 p.m.

Panel 08

Brachytherapy Fundamentals and Evolving Paradigms

Wednesday, October 31 11:00 a.m. - 12:30 p.m.

Educational Session 411 Advanced Treatment of Non-small Cell Lung Cancer: Using All the Tools (Imaging, Motion Correction and IMRT) Promises and Pitfalls – A Case Based Approach

Room: 107 A-C

Indrin Julian Chetty, PhD, Henry Ford Health System Craig W. Stevens, MD, PhD, H. Lee Moffitt Cancer Center James J. Urbanic, MD, Wake Forest Univeristy School of

Room: 107 A-C

Robert Cormack, PhD, Harvard Medical School Beth Erickson, MD, Medical College of Wisconsin Christian Kirisits, DSc, Medical University of Vienna Paul Nguyen, MD, Dana-Farber/Brigham and Women’s Cancer Center

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

35

Presidential Symposium Transforming Care through Innovation

Sunday, October 28

8:00 a.m. - 12:45 p.m. 8:00 a.m. - 8:10 a.m.

|

Room: Grand Ballroom

Welcome Address

8:10 a.m. - 8:20 a.m.

SESSION I: Introduction

8:10 a.m. - 8:20 a.m.

Why Innovation?

8:20 a.m. - 9:50 a.m.

SESSION II: The Promise of Innovation

Phillip Devlin, MD Massachusetts General Hospital, Harvard Medical School

Michael L. Steinberg, MD, FASTRO President, ASTRO

8:20 a.m. - 8:50 a.m.

Featured Presentation: What is Innovation in Health Care and Can It Be Taught?

Roberta B. Ness, MD, MPH The University of Texas School of Public Health

8:50 a.m. - 9:25 a.m.

Featured Presentation: Transforming Radiation Oncology Care – The Promise of Innovation

Edward C. Halperin, MD New York Medical College

9:25 a.m. - 9:50 a.m.

Featured Presentation: Medical Evidence Reconsidered – Thinking Beyond the Randomized Clinical Trial

John P. Concato, MD Yale School of Medicine

10:00 a.m. - 10:15 a.m.

BREAK

10:15 a.m. - 11:15 a.m.

SESSION III: Advancing Innovation in Radiation Oncology – Redesign, Repurpose, Restructure

10:15 a.m. - 10:35 a.m.

The Future of Technological Innovation in Radiation Oncology

T. Rockwell Mackie, PhD University of Wisconsin School of Medicine

10:35 a.m. - 10:55 a.m.

Biological Innovation: Radiobiology Beyond the Radio-sensitization

William H. McBride, DSc, PhD David Geffen School of Medicine at UCLA

10:55 a.m. - 11:15 a.m.

Phase I Trials in Radiation Oncology – Robert D. Timmerman, MD An Idea Whose Time has Come? UT Southwestern Medical Center

36

ASTRO 2012 / 54TH ANNUAL MEE TING

11:15 a.m. - 12:15 p.m.

SESSION IV: Innovative Designs for Delivery of Radiation Oncology Care

11:15 a.m. - 11:35 a.m. Safety – Out of the Box: Black Box, Big Brother



Daniel Low, PhD David Geffen School of Medicine at UCLA

11:35 a.m. - 11:55 a.m.

Smarter Radiation Oncology

Louis Potters, MD, FASTRO North Shore-LIJ Health System Hofstra North Shore-LIJ School of Medicine

11:55 a.m. - 12:15 p.m.

Accountable Care and Novel Payment Systems: Will Radiation Oncology Endure?

Najeeb Mohideen, MD Northwest Community Hospital

12:15 p.m. - 12:35 p.m.

SESSION V: Lessons Learned

12:15 p.m. - 12:35 p.m.

What Did We Learn Today? The Real Time Learning Health System for Radiation Oncology

12:35 p.m. - 12:45 p.m.

Concluding Remarks

Anthony L. Zietman, MD FASTRO, Massachusetts General Hospital, Harvard Medical School Michael L. Steinberg, MD FASTRO, President, ASTRO

ASTRO 2012 / 54TH ANNUAL MEE TING

37

ARRO Program Saturday, October 27

Monday, October 29

ARRO Career Seminar*

ARRO Poster Walk With a Professor*

10:00 a.m. - 5:30 p.m. Room: 160 A-C

12:30 p.m. - 1:45 p.m. (Box Lunch)

Room: Hall C – Poster Lounge

Refer to page 39 for program schedule.

6:30 p.m. - 8:30 p.m.

ARRO Reception*

12:30 p.m. - 1:45 p.m.

Ned Devine’s 1 Faneuil Hall Marketplace, Quincy Market Boston, MA 02109

(Box Lunch)

Shuttle Service will not be provided to the ARRO Reception. However, if departing from the Boston Convention and Exhibition Center for the reception, you are welcome to take shuttle bus route #4 from the convention center to the Boston Marriott Long Wharf. Ned Devine’s is an approximate 7-10 minute walk from the Boston Marriott Long Wharf.

Sunday, October 28

How to Review a Scientific Paper Workshop* Room: 159 Moderator: W. Robert Lee, MD, MEd, Duke University Robert J. Amdur, MD, University of Florida Soren M, Bentzen, DSc, PhD, University of Wisconsin Anthony V. D’Amico, MD, PhD, FASTRO, Brigham and Women’s Hospital Lynn D. Wilson, MD, MPH, FASTRO, Yale University School of Medicine Anthony L. Zietman, MD, FASTRO, Massachusetts General Hospital

12:45 p.m. - 1:45 p.m.

ARRO Annual Luncheon* Room: 160 A-C

5:30 p.m. - 6:45 p.m.

Poster Viewing Session and Reception* Room: Hall C

Guest Speaker: Leonard L. Gunderson, MD, MS, FASTRO, Chairman, ASTRO Board of Directors

6:15 p.m. - 6:45 p.m.

ARRO and Medical Students Meet and Greet Room: Hall C - Poster Lounge *This session is not accredited for continuting medical education credits.

Wednesday October 31 12:30 p.m. - 1:30 p.m.

ARRO Meet the Professor Luncheon* Ticketed Event: Seperate registration required.

38

ASTRO 2012 / 54TH ANNUAL MEE TING

Room: 160 A-C

ARRO Career Seminar* Saturday, October 27, 2012

10:00 a.m. - 5:30 p.m. Room: 160 A-C

This year’s program combines a variety of timely topics for residents at all stages of training. Using the audience interactive system, several presentations identified with the interactive symbol are intended to facilitate interaction among participants from different communities. 10:00 a.m. - 10:10 a.m.

Opening Remarks – ARRO Executive Committee

10:10 a.m. - 10:30 a.m. 2012 Global Health Scholar Award Presentations 10:10 a.m. - 10:20 a.m. Tracy Bray, MD, Loyola University Medical Center 10:20 a.m. - 10:30 a.m. Niraj Mehta, MD, University of California Los Angeles Affiliated Hospitals 10:30 a.m. - 11:00 a.m. Keynote Address: Mentorship and Career-Life Balance Nancy P. Mendenhall, MD, University of Florida William M. Mendenhall, MD, University of Florida 11:00 a.m. - 11:45 a.m. Aspects of Physics to Consider in Your First Practice Rebecca M. Howell, PhD, MD Anderson Cancer Center 11:45 a.m. - 12:15 p.m. Incorporating Brachytherapy Into Your Future Practice Bradley R. Prestidge, MD, MS, President, American Brachytherapy Society 12:15 p.m. - 12:45 p.m.

Break – Box Lunch

12:45 p.m. - 1:45 p.m.

Residents as Teachers: Using Teaching Principles to Enhance Medical Education, Health Care Teamwork and Patient Care Alisa Nagler, JD, EdD, Duke University

1:45 p.m. - 2:30 p.m. Applying for Jobs and Entering Practice: A Panel Discussion* Moderator: Lisa A. Kachnic, MD, Boston Medical Center Panelists: Julie A. Bradley, MD, University of Florida Eileen P. Connolly, MD, PhD, Columbia University Medical Center Stephen L. Harris, MD, Radiation Oncology Associates of New England 2:30 p.m. - 2:45 p.m.

Afternoon Break

2:45 p.m. - 4:15 p.m. Negotiations Inside and Outside the Clinic Melissa Brodrick, MEd, Ombudsman, Harvard Medical School 4:15 p.m. - 4:50 p.m. Practice Entry Survey Results Terry J. Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute 4:50 p.m. - 5:00 p.m.

Audience Feedback and Evaluation



5:00 p.m. - 5:25 p.m. Legal Aspects of Entering Practice Terry J. Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute 5:25 p.m. - 5:30 p.m Closing Remarks Aparna Kesarwala, MD, PhD, Chairman, ARRO Executive Committee * This Program is not accredited for continuing medical education credits.

ASTRO 2012 / 54TH ANNUAL MEE TING

39

Meeting Highlights Sunday, October 28 3:30 p.m. - 4:15 p.m.

Featured Lecture: Improvements and Innovation at the Center for Devices and Radiological Health* Room: 160 A-C

Michael O’Hara, PhD, Food and Drug Administration Introduction by Howard Sandler, MD, MS, FASTRO, Cedars Sinai Medical Center * This session is not accredited for continuting medical education credits.

board of directors of the American College of Emergency Physicians, Kellermann was subsequently given the College’s highest award for leadership. Elected to the Institute of Medicine (IOM) in 1999, Kellermann co-chaired the IOM Committee on the Consequences of Uninsurance, which issued six reports on this topic between 2001 and 2004. He also served on the IOM’s Committee on the Future of Emergency Care in the U.S. Health System and the Committee on Effectiveness of National Biosurveillance Systems: BioWatch and the Public Health System. As a Robert Wood Johnson Health Policy Fellow (2006–07), Kellermann worked for the professional staff of the Committee on Oversight and Government Reform, U.S. House of Representatives. A clinician and researcher, he practiced and taught emergency medicine for more than 25 years in public teaching hospitals in Seattle, Memphis and Atlanta.

Monday, October 29 9:45 a.m. - 10:45 a.m.

Keynote Address I

Room: Grand Ballroom Arthur L. Kellermann, MD, MPH, RAND Health Introduction by Susan A. McCloskey, MD, University of California Los Angeles Arthur Kellermann is vice president and director of RAND Health and holds the Paul O’Neill Alcoa Chair in Policy Analysis at the RAND Corporation. Before joining RAND, he was a professor of emergency medicine and public health and associate dean for health policy at the Emory School of Medicine in Atlanta. Kellermann founded Emory’s Department of Emergency Medicine and served as its first chairman from 1999 - 2007. He established the Emory Center for Injury Control, and holds “excellence in science” awards from two organizations: the Society for Academic Emergency Medicine and the Injury Control and Emergency Health Services Section of the American Public Health Association. A two-term member of the

40

ASTRO 2012 / 54TH ANNUAL MEE TING

Monday, October 29 1:45 p.m. - 2:30 p.m.

Presidential Address: The Patient Not Treated Room: Grand Ballroom

Michael L. Steinberg, MD, FASTRO, President, ASTRO Introduction by Paul E. Wallner, DO, FASTRO, 21st Century Oncology

Tuesday, October 30

Wednesday, October 31

Keynote Address II: Future Trends in Cancer Survivorship*

Keynote Address III: Value-based Health Care Delivery

9:45 a.m. - 10:45 a.m.

Room: Grand Ballroom

9:45 a.m. - 10:45 a.m.

Room: Grand Ballroom

Edward M. Kennedy Jr., President and Co-founder, Marwood Group Introduction by Jay S. Loeffler, MD, FASTRO, Massachusetts General Hospital

Michael E. Porter, PhD, MBA, Harvard Business School Introduction by Bruce G. Haffty, MD, FASTRO, UMDNJ Robert Wood Johnson Medical School

Mr. Kennedy is the president and co-founder of Marwood Group and Co., a health care focused financial services firm with offices in New York, Washington, London and Kuwait specializing in proprietary health care research, asset management and private equity advisory services. Previously, Mr. Kennedy served as an associate and later as counsel to the law firm of Wiggin and Dana located in New Haven, Conn. Mr. Kennedy’s health law practice focused primarily on state and federal regulatory and reimbursement issues affecting hospitals, home care agencies, long-term care providers, physicians and mental health providers. In addition, Mr. Kennedy served as director of legal and regulatory affairs at the Connecticut Hospital Association, counseling acute care providers and policy-makers on a wide variety of emerging health care issues. Mr. Kennedy has also been an active leader in the civil rights movement for persons with disabilities. In his disability law practice, he advised companies about how to best expand opportunities for persons with disabilities and how to avoid liability under the Americans with Disabilities Act. He continues to serve on the corporate and advisory boards of numerous disability organizations and lectures nationwide on topics relating to health and disability law. Mr. Kennedy received an undergraduate degree from Wesleyan University, a master’s degree from Yale University’s School of Forestry and Environmental Studies, and a law degree from the University of Connecticut School of Law. * This session is not accredited for medical education credits.

Michael E. Porter is a leading authority on competitive strategy, the competitiveness and economic development of nations, states and regions, and the application of competitive principles to social problems such as health care, the environment and corporate responsibility. Professor Porter is generally recognized as the father of the modern strategy field, as has been identified in a variety of rankings and surveys as the world’s most influential thinker on management and competitiveness. He is the Bishop William Lawrence University Professor, based at Harvard Business School. A University professorship is the highest professional recognition that can be awarded to a Harvard faculty member. In 2001, Harvard Business School and Harvard University jointly created the Institute for Strategy and Competitiveness, dedicated to furthering Professor Porter’s work. He is the author of 18 books and more than 125 articles. He received a BSE with high honors in aerospace and mechanical engineering from Princeton University in 1969, where he was elected to Phi Beta Kappa and Tau Beta Pi. He received an MBA with high distinction in 1971 from the Harvard Business School, where he was a George F. Baker Scholar and a PhD in Business Economics from Harvard University in 1973.

ASTRO 2012 / 54TH ANNUAL MEE TING

41

Nurses’ Program A

ARON

A series of sessions have been identified throughout the Annual Meeting Program that are pertinent for radiation oncology nurses. The Nurses’ Reception and Luncheon also give nurses the opportunity to network with their fellow nurses.

Sunday October, 28

Monday, October 29

When a Patient in Radiation Has a Cardiac Device

Role of the Advanced Practice Nurse (APN) in a Radiation Oncology Setting

11:00 a.m. - 12:30 p.m. Room: 204 A-B

Mary Ellyn Witt, MS, RN, University of Chicago Medical Center

12:45 p.m. - 1:45 p.m.

Nurses’ Welcome and Orientation Luncheon* Room: 257 A-B

Joanne Moar, RN, OCN, Massachusetts General Hospital

3:30 p.m. - 5:00 p.m.

Bare Facts and Treatments Regarding Skin Toxicities Room: 204 A-B

Marilyn Haas, PhD, ANP-BC, Mission Hospital Barbara Holmes Gobel, RN, MS, AOCN, Northwestern Memorial Hospital Pamela Viale, RN, MS, CS, ANP, AOCNP, University of California San Francisco

5:30 p.m. - 6:30 p.m.

Nurses’ Reception* Room: 257 A-B

Guest Speakers – John Grace and Joan Raducha John Grace, a cancer survivor and his wife Joan Raducha will discuss “Surviving and Thriving - With Cancer a Part of Our Lives 2005-2012”. They will discuss the experience of being diagnosed and then treated for head and neck, then lung and most recently appendix cancers. They will describe facing the diagnosis, the treatment experience, and the challenges of decision making regarding treatment options and continuance. And finally, they will talk about how they have come to thrive by learning to live with cancer as a part of their lives. *Event open to Nurse and Nurse Practitioner attendees only. 42

ASTRO 2012 / 54TH ANNUAL MEE TING

11:00 a.m. - 12:30 p.m. Room: 259 A-B

Vanna M. Dest, MSN,APRN, BC, AOCN, Smilow Cancer Hospital Yale New Haven, Saint Raphael Campus Diane Doyle, MS, APRN, BC, AOCN, Massachusetts General Hospital Elene Viscosi, APRN, BC, Massachusetts General Hospital

Tuesday, October 30 8:00 a.m. - 9:30 a.m.

Educational Session 304 Improving Outcomes in Geriatric Patients Through Use of Comprehensive Geriatric Assessment Tools Available to Make It Happen

Room: 153 A-C

Diane Cope, PhD, ARNP, Florida Cancer Specialists and Research Institute Lynn Heup, GNP-BC/AOCNP, MS, Emory Healthcare

1:15 p.m. - 2:45 p.m.

Protons, Neutrons and Advanced Technologies in Radiation Therapy Room: 206 A-B

Jeanne Sixta, RN, BSN, OCN, NIU Institute of Neutron Therapy at Fermilab Catherine Mannix, RN, MSN, OCN, The Clark Center for Radiation Oncology Michael Kirk, PhD, Mass General North Shore Center for Outpatient Care

3:00 p.m. - 4:30 p.m.

Adult Cancer Survivors: One Size Doesn’t Fit All Room: 153 A-C

Richard Boyajian, RN, MS, NP, Dana-Farber Cancer Institute

Saturday | October 27 8:00 a.m - 9:30 a.m.

1:00 p.m - 4:00 p.m.

Esophageal Cancers

Room: 159

eContouring Learning Lab Room: 153 A-C

Sarah E. Hoffe, MD, Moffitt Cancer Center Ken Meredith, MD, Moffitt Cancer Center

10:30 a.m. - 12:00 p.m.

eContouring Learning Lab Lymphoma

Room: 153 A-C Stephanie Terezakis, MD, Johns Hopkins University Steve Cho, MD, Johns Hopkins University

10:00 a.m. - 5:30 p.m.

ARRO Career Seminar* Box Lunch Provided

Room: 160 A-C

Refer to page 39 for full program schedule. *This session is not accredited for continuing medical education credits.

1:00 p.m. - 2:30 p.m.

eContouring Learning Lab Lung Cancers

Room: 153 A-C Billy W. Loo, MD, Stanford University

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

Award Recipient

Live Interactive SAMs/ Session Separate registration required

Young Physicians’ Session*

Shilpen A. Patel, MD, Moderator, University of Washington Reshma Jagsi, MD, University of Michigan Anthony Zietman, MD, FASTRO, Massachusetts General Hospital David C. Beyer, MD, FASTRO, Arizona Oncology Services Kenneth MacDonald , MD, Providence Medical Center Tim R. Williams, MD, FASTRO, Lynn Cancer Institute Sameer R. Keole, MD, Radiation Medicine Associates Theodore L. DeWeese, MD, Johns Hopkins School of Medicine Louis Potters, MD, FASTRO, North Shore-LIJ Health System Stephen M. Hahn, MD, University of Pennsylvania School of Medicine Terry J. Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute Nancy Mendenhall, MD, University of Florida William Mendenhall, MD, University of Florida Paul E. Wallner, DO, FASTRO, 21st Century Oncology This workshop will address several key issues facing early career physicians and will provide a forum for open discussion among peers. Distinguished faculty will share their experience and insights on several topics, to include: • Jumping Ship – How, when, where and why to change jobs when you are early-career. • Negotiating a contract when you are established in the field. • Changing from private practice to academics (or vice versa). • Maintenance of Certification - How? What? Where? When? The educational focus is targeted toward young physicians, less than 10 years in practice. *This session is not accredited for continuing medical education credits.

ASTRO 2012 / 54TH ANNUAL MEE TING

43

Saturday | October 27 3:30 p.m. - 5:00 p.m.

eContouring Learning Lab Head and Neck Cancers I

Room: 153 A-C Christopher M. Nutting, MD, Royal Marsden Hospital

ARRO Reception

6:30 p.m. - 8:30 p.m. Ned Devine’s 1 Faneuil Hall Marketplace, Quincy Market Boston, MA 02109 Shuttle service will not be provided to the ARRO Reception. However, if departing from the Boston Convention and Exhibition Center for the reception, you are welcome to take shuttle bus route #4 from the convention center to the Boston Marriott Long Wharf. Ned Devine’s is an approximate 7-10 minute walk from the Boston Marriott Long Wharf.



44

ASTRO 2012 / 54TH ANNUAL MEE TING

Sunday | October 28 6:30 a.m. - 8:00 a.m.

10:30 a.m. - 12:00 p.m.

International Attendee Welcome Breakfast

eContouring Learning Lab Gynecological Cancers

Room: 205 A-C

Room: 153 A-C

8:00 a.m. - 8:10 a.m.

Welcome Address

Arno Mundt III, MD, University of California San Diego Beth A. Erickson, MD, Medical College of Wisconsin

Phillip M. Devlin, MD, Massachusetts General Hospital, Harvard Medical School

11:00 a.m. - 12:30 p.m.

8:00 a.m. - 9:30 a.m.

When a Patient in Radiation Has a Cardiac Device

Room: Grand Ballroom

eContouring Learning Lab

Nurses’ Session Room: 204 A-B

A

Head and Neck Cancers II

ARON

Room: 153 A-C

Mary Ellyn Witt, MS, RN, University of Chicago Medical Center

Avraham Eisbruch, MD, University of Michigan Health Systems Suresh Mukherji, MD, University of Michigan Health Systems

8:00 a.m. - 12:45 p.m.

Presidential Symposium Transforming Care Through Innovation

Room: Grand Ballroom

12:45 p.m. - 1:45 p.m.

ARRO Annual Luncheon Room: 160 A-C

Guest Speaker: Leonard L. Gunderson, MD, MS, FASTRO, Chairman, ASTRO Board of Directors

See page 36 for full schedule.

12:45 p.m. - 1:45 p.m.

Nurses’ Welcome and Orientation Luncheon

10:00 a.m. - 5:00 p.m.

Exhibit Hall Opens

Room: 257 A-B

Room: Halls A/B

A

ARON

Joanne Moar, RN, OCN, Massachusetts General Hospital

10:00 a.m. - 5:00 p.m.

Poster Viewing

Room: Hall C, Exhibit Hall

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

45

Sunday | October 28 12:45 p.m. - 1:45 p.m.

Health Policy Socioeconomic Luncheon* 2013 Radiation Oncology Coding and Reimbursement Update - A Discussion on the Challenges Affecting the Specialty in the Current Reimbursement Environment

Room: 107 A-C

Box Lunch Provided

A preview of the 2013 proposed rule changes to the Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment System, as well as other payment and coding changes for 2013, will be presented. Speakers will provide details on Medicare spending trends for radiation oncology services. The session will conclude with a discussion of actions taken by the Medicare agency and private payers to control health care spending and how ASTRO has actively engaged with them and other stakeholders to address these concerns. Co-moderators: Joel Cherlow, MD, PhD, Long Beach Memorial Medical Center Thomas Eichler, MD, Thomas Johns Cancer Center Speakers: David C. Beyer, MD, FASTRO, Arizona Oncology Services Najeeb Mohideen, MD, Northwest Community Hospital *This session is not accredited for continuing medical education credits.

1:00 p.m. - 2:30 p.m.

eContouring Learning Lab Gastrointestinal Cancers

Room: 153 A-C

Karyn A. Goodman, MD, MS, Memorial Sloan-Kettering Cancer Center Corinne B. Winston, MD, Memorial Sloan-Kettering Cancer Center Ross Abrams, MD, FASTRO, Rush University Medical Center

1:45 p.m. – 3:15 p.m.

Scientific Session A

Clinical Trials and Innovation in Care

Room: 210 A-C

Co-moderators: Lynn D. Wilson Benjamin Movsas 1:45 Stefano Arcangeli 5 Is Stereotactic Body Radiation Therapy (SBRT) an Attractive Option for Unresectable Liver Metastases? Early Results From a Phase II Trial 1:52 Tracy S. Bray 6 Prospective Evaluation of Dual-energy Imaging in Patients Undergoing Image Guided Radiation Therapy for Lung Cancer: Initial Clinical Results Resident Clinical/Basic Science Research Award Winner

1:59

David Jaffray

Discussant

2:04 Howard M. Sandler Radium-223 Chloride Safety and Use of External Beam Radiation Therapy (EBRT) in the Phase III Randomized Trial (ALSYMPCA) in Patients With Castration-resistant Prostate Cancer (CRPC) and Bone Metastases

Ticketed Event/Seperate registration required

46

ASTRO 2012 / 54TH ANNUAL MEE TING

7

Sunday | October 28 2:11 Mary K. Gospodarowicz 8 Final Analysis of Intergroup Randomized Phase III Study of Androgen Deprivation Therapy (ADT) + Radiation Therapy (RT) in Locally Advanced Prostate Cancer (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110; NCT00002633)

1:45 p.m. - 3:15 p.m.

2:18

9

1:45 Julie Jung Kang 14 Radiation of Potential Local Cancer Stem Cell Niches Improves Survival of Patients With Glioblastoma Multiforme

10

1:55 Kyle Cuneo 15 Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma

Jason Efstathiou

Discussant

2:23 Arnab Chakravarti A Revised RTOG Recursive Partitioning Analysis (RPA) Model for Glioblastoma Based Upon Multi-platform Biomarker Profiles 2:30 Gregory Cairncross IDH Status Predicts Benefit From PCV+RT in Anaplastic Oligodendroglioma (RTOG 9402) 2:37

Kevin Camphausen

Discussant

2:42 Beryl McCormick 11 Low Risk Breast Ductal Carcinoma In Situ (DCIS): Results From the RTOG Phase III 9804 Trial 2:49 Kavita Dharmarajan 12 Patterns of Relapse From a Phase III Study of Response-based Therapy for Intermediate-risk Hodgkin lymphoma (AHOD0031): A Report From the Children’s Oncology Group 2:56 Jonathan J. Beitler RTOG 90-03: Final Report

13

3:03 Peter Hoskin LBA3 FoRT: A Phase III Multi Center Prospective Randomized Trial of Low Dose Radiotherapy for Follicular and Marginal Zone Lymphoma

Scientific Session B

CNS I - Primary Brain Tumors

Room: 206 A-B

Moderators: Changhu Chen Joseph Contessa

2:05 Lawrence Kleinberg 16 An American Brain Tumor Consortium (ABTC) Phase I Trial of Veliparib (ABT-888), Temozolomide (TMZ), and Concurrent Radiation Therapy (RT) for Newly Diagnosed Glioblastoma Multiforme (GBM): Need for Modification to Approach for Combining These Therapies 2:15 Meiling Deng 17 A Phase I/II Clinical Trial of Dose Escalation on Biological Target Volume With Intensity Modulated Radiation Therapy: The Long-term Results 2:25 Linda Chen Increased Radiation Dose to the SVZ Improves Survival in Patients With GBM

18

2:35 Andrew Trister 19 A Novel Metric of Patient-specific Response to Treatment for Glioblastoma Discriminates Patients With Pseudo-progression 2:45 Siham Sabri 20 Novel Role of O6-methylguanine Methyltransferase in the Invasion/proliferation Dichotomy in Glioblastoma

ASTRO 2012 / 54TH ANNUAL MEE TING

47

Sunday | October 28 2:55 Toshihiko Luchi 21 Hypo-fractionated IMRT With TMZ for GBMs Tailor-made Setting of Treatment Doses Owing to MGMT-methylation Status

2:35 Marta Scorsett 27 Stereotactic Body Radiation Therapy With Ablative Dose on Liver Metastases: Radiation Induced Liver Disease (Rild) and Toxicity Assessment

3:05

2:45 Anand Mahadevan Stereotactic Body Radiotherapy for Unresectable Intrahepatic and Hilar Cholangiocarcinoma

28

2:55 Michael Chuong Stereotactic Body Radiation Therapy (SBRT) for Borderline Resectable and Locally Advanced Pancreatic Cancer Is Effective and Well-Tolerated

29

Arnab Chakravarti

Discussant

1:45 p.m. - 3:15 p.m.

Scientific Session C

GI I - Hypofractionated and Stereotactic Radiotherapy for Hepatic/Biliary/Pancreatic Tumors

Room: 259 A-B

Moderators: Bryan Chang Charles Thomas

3:05

1:45 Hany Soliman 22 Phase II Trial of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases

1:45 p.m. - 3:15 p.m.

1:55 Foster Lasley 23 Phase I-II trial of Stereotactic Body Radiotherapy (SBRT) in Patients With Hepatocellular Carcinoma, Chil Pugh’s Class scientific session (CPC) A and B: Interim Analysis of Treatment Variables Affecting Toxicity and Outcome 2:05 Anthony Brade 24 Phase I Study of Sorafenib and SBRT for Advanced Hepatocellular Carcinoma 2:15 Alexander Kirichenko 25 Outcomes of Stereotactic Radiotherapy (SRT) for Primary and Metastatic Liver Tumors with 3-D CT and Single Photon Emission Computed Tomography (3-D CT/SPECT) Treatment Planning 2:25 Anthony Brade Phase I Study of Sorafenib and Whole Liver Radiotherapy (WLRT) or Stereotactic Body Radiotherapy (SBRT) for Liver Metastases

48

ASTRO 2012 / 54TH ANNUAL MEE TING

26

Karyn Goodman

Discussant

Scientific Session D

GU I - Prostate Cancer: Toxicity/Second Cancers

Room: 258 A-C

Moderators: Ronald Chen Timothy Showalter 1:45 Phillip Gray 30 Patient-reported Quality of Life in Prostate Cancer Patients Treated With 3-D Conformal, Intensity Modulated or Proton Beam Radiotherapy 1:55 James Yu 31 Proton Radiotherapy for Prostate Cancer in the Medicare Population: Patterns of Care and Comparison of Early Toxicity With Intensity Modulated Radiotherapy 2:05 Daniel Spratt 32 Long-term Survival and Toxicity of Patients Treated With Ultra-high-dose IMRT for Localized Prostate Cancer 2:15 Raymond Mak 33 Acute and Late Urinary Toxicity After Radiation Therapy in Men With and Without an Intact Prostate Gland: A Secondary Analysis of RTOG 9408 And 9601 Suggesting This Toxicity Is Not Due to Bladder Injury 2:25 Jeff Michalski 34 Dose Volume Analysis of Grade 2+ Late GI Toxicity on RTOG 0126 After High-dose 3-D CRT or IMRT

Sunday | October 28 2:35 Tiziana Rancati 35 Rectal Toxicity 7 Years After High-dose Radiation for Prostate Cancer: Clinical and Dosimetric Predictors 2:45 Joanne Jang 36 Long-term Quality of Life After Definitive Treatment for Prostate Cancer: Patient Reported Outcomes in the Second Post-treatment Decade 2:55 Hima Musunuru Second Primary Cancers Occurring After I-125 Brachytherapy As Monotherapy for Early Prostate Cancer

37

3:05 Jay Ciezki 38 Twenty-year Competing Risk Analysis of Secondary Malignancies After External Beam Radiation for Post-Operative Treatment of Prostate Cancer Patients From the SEER Database

2:25 Rania Hashem 43 Defining the Impact of the Use of Oral Contrast in Pelvic Intensity Modulated Radiation Therapy (IMRT): An RTOG 0418 Secondary Analysis 2:35 Daniel Simpson 44 CT and MRI-based Image-guided Brachytherapy for Cervical Cancer: A Multi-institutional Report 2:45 Nina Mayr 45 Low-perfusion Tumor Subvolumes, Assessed by the Heterogeneity Functional Risk Volume Method, and Treatment Outcome in Cervical Cancer: Does Hemoglobin Matter? 2:55 Maria Thomas 46 Intratumoral Heterogeneity Assessed by Extraction of Texture Features From PET Images of Cervical Cancer Patients

GYN I - Cervical Cancer

3:05 Shankar Siva 47 Routine Follow-up Rarely Detects Disease Recurrence After a Complete Response on FDG-PET in Patients With Locally Advanced Cervical Cancer

Moderators: Ann Klopp Sheida Mani

1:45 p.m. - 3:15 p.m.

1:45 p.m. - 3:15 p.m.

Scientific Session E Room: 254 A-B

1:45 William Small Jr. 39 RTOG 0417: Efficacy of Bevacizumab in Combination With Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma 1:55 Masaru Wakatsuki 40 Impact of Boost Irradiation on Pelvic Lymph Node Control in Patients With Cervical Cancer 2:05 Ajeet Gandhi 41 Early Clinical Outcomes of Intensity Modulated vs. Conventional Pelvic Radiotherapy for Locally Advanced Carcinoma Cervix : A Prospective Randomized Study 2:15 He Zhu 42 Longitudinal Study of Acute Hematologic Function in Cervical Cancer Patients Treated With Chemoradiotherapy

Scientific Session F

Head and Neck I – Target Delineation/Patterns of Failure

Room: 052 A-B

Moderators: James Bonner Jimmy Caudell 1:45 Krzysztof Skladowski 48 Continuous Accelerated Irradiation of 7-days-a-week (CAIR) Has Given the Same Long-term Results Like 7 Fractions in 5-days-a-week. Report on Phase III Clinical Trial in Head and Neck Cancer Patients 1:55 Mitchell Machtay 49 Long-term Outcome From RTOG 99-03: RT With or Without Erythropoietin for Anemic Head and Neck Cancer Patients 2:05 Juliette Thariat 50 Predicting the Response to EGFR Tyrosine Kinase Inhibitor Gefitinib in Head and Neck Cancer, The Carissa Gortec 2004-02 Study ASTRO 2012 / 54TH ANNUAL MEE TING

49

Sunday | October 28 2:15

Quynh-Thu Le

Discussant

2:25 Christopher Spencer 51 Limiting High Level II and Contralateral Retropharyngeal Lymph Node (RPN) Treatment in Selected Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) 2:35 Kenneth Hu 52 Five-year Outcomes of Oropharynx (OPX) Targeted Radiotherapy (RT) for Metastastic Squamous Cell Carcinoma of Unknown Primary (MUP) in the Head and Neck 2:45 Abrahim Al-Mamgani Unilateral Neck Irradiation for Well-lateralized Oropharyngeal Cancer: Excellent Outcome, Low Toxicity Profile and Good Quality of Life Scores

Avraham Eisbruch

1:45 p.m. - 3:15 p.m. Biologic Prognostic/Predictive Factors

Room: 109 A-B

Moderators: Kevin Kozak Nicole Simone

2:55 Alan Pollack 62 Prospective Validation of Diagnostic Tumor Tissue Ki-67 as the Most Significant Predictor of Outcome in Men Treated for Prostate Cancer on a Randomized Trial

1:45 p.m. - 3:15 p.m.

1:45 Joshua Anderson 55 Kinomic Profiling Identifies Pathways of Her2 Targeted Therapy Resistance in Her2 Positive Breast Cancer Cell Lines

Scientific Session H

Adaptive Radiation Therapy

Room: 205 A-C

Moderators: Lei Dong Jean Pouliot

56

2:05 Yoko Harima 57 Apolipoprotein C-ii Is a Potential Serum Biomarker As a Prognostic Factor of Patients With Locally Advanced Cervical Cancer After Chemoradiotherapy

ASTRO 2012 / 54TH ANNUAL MEE TING

2:35 Jeff Bruce 60 The Role of microRNAs in Human Nasopharyngeal Carcinoma

3:05 Terence Williams 63 Caveolin-1 Expression Correlates With Outcomes in Pancreatic Ductal Carcinoma: A Secondary Analysis of RTOG 9704.

Scientific Session G

50

2:25 Xiong Wei 59 Vimentin (EMT Marker Protein) Score Predicts Resistance to Erlotinib and Radiotherapy for Patients With Stage III Non-small Cell Lung Cancer on a Prospective Phase II Trial

2:45 Daniel Oh 61 Radiation Induced Gene Signature Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Discussant

1:55 Philip Wong A Potential Prognostic micro-RNA Signature for Distant Metastasis in Soft-tissue Sarcomas

58

53

2:55 Annie Chan 54 Intensity Modulated Radiation Therapy and Level IB Nodal Coverage for Oropharyngeal Carcinoma 3:05

2:15 Kelly MacArthur A Telomerase-based Assay Tracks Changes in Circulating Tumor Cells in Patients Undergoing Radiation Therapy

1:45 Martha Matuszak 64 The Importance of Dry Run Credentialing for RTOG 1106/ACRIN 6697: A Trial of Individualized Adaptive Radiotherapy for Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) 1:55 Q. Jackie Wu 65 Knowledge-based Organ-at-risk Sparing Models and Individualized Trade-offs in IMRT Planning

Sunday | October 28 2:05 Camille Noel 66 Risk Analysis for Clinical Implementation of Adaptive Radiation Therapy 2:15 Xiaojian Chen Online Adaptive Replanning for Partial Breast Irradiation

67

2:25 Scott Merrick 68 Superiority of a Real-time Planning Technique Over Image Guided Radiation Therapy for the Treatment of Primary Prostate Cancers 2:35 Nienke Holtzer 69 Roll and Pitch Correction in Head and Neck Patients by Rapid Adaptation of Volumetric Modulated Arc Treatment Plans 2:45 Guillaume Cazoulat 70 How Accurate Is Deformable Image Registration to Calculate Cumulative Dose From Fraction to Fraction in Prostate IGRT? 2:55 X. Allen Li Combined Online and Offline Adaptive Radiation Therapy

Manpreet Bedi 1002 Increase in Tumor Size on MRI is Associated With Greater Pathologic Necrosis and Poor Survival in Patients With Soft Tissue Sarcoma of Extremity and Body Wall Treated With Neoadjuvant Radiotherapy Martin Vallieres 1003 FDG-PET Features and Outcomes in Patients With Soft Tissue Sarcomas of the Extremities] Adam Liss 1004 Predictive Factors for Chronic Lower Extremity Edema After Multimodality Limb-sparing Therapy of Soft Tissue Sarcoma of the Proximal Lower Extremity Upendra Parvathaneni 1005 The Safety and Efficacy of Primary Radiation Therapy Without Upfront Surgery for Merkel Cell Carcinoma David Roberge 1006 Interobserver Variation in Suspicious Edema Definition for Pre-operative Radiotherapy in Soft Tissue Sarcoma of the Extremity

71

3:05 Nadia Octave 72 Automatic Process for Daily Treatment Plan Selection With a New Online/Offline Adaptive IGRT Technique Using Daily Cone Beam CT

1:45 p.m. - 3:15 p.m.

Digital Poster Discussion 01 Sarcoma/Skin Cancer

Room: 156 A-C

Discussants: Christopher Barker Thomas DeLaney Lara Best 1001 Use of Protoporphyrin Fluorescence to Determine Clinical Target Volume Margins for Non-melanotic Skin Cancers Treated With Primary Radiotherapy

Neil Desai 1007 Reduced Toxicity With Intensity Modulated Radiotherapy (IMRT) for Desmoplastic Small Round Cell Tumor (DSRCT) Angela Hong 1008 Extracorporeal Radiation Therapy As Part of the Limb Salvage Management: A Review of 99 Cases C. Jillian Tsai 1009 Dermatofibrosarcoma Protuberans: Long-term Outcomes of Fifty Three Patients Treated With Conservative Surgery and Radiation Therapy Joost Nuyttens 1010 Impact of Different Immobilization Devices and Set-up Correction Protocols on Required CTV-PTV Margins in Patients With a Sarcoma of the Lower Extremities Mauricio Cambeiro 1011 Conservative Surgery and Intraoperative Radiotherapy for Locally Recurrent Soft Tissue Sarcomas of the Extremities and the Superficial Trunk

ASTRO 2012 / 54TH ANNUAL MEE TING

51

Sunday | October 28 Afshin Rashtian 1012 Preoperative Stereotactic Body Radiation Therapy (SBRT) With Cyberknife for Soft Tissue Sarcoma (STS)

1:45 p.m. - 3:15 p.m.

Digital Poster Discussion 02 Lung

Room: 157 A-C Discussants: Clifford G. Robinson Robert Timmerman Megan Daly 1013 Patterns of Care for Thoracic Stereotactic Body Radiotherapy Among Practicing Radiation Oncologists in the United States John Cuaron 1014 Stereotactic Body Radiation Therapy for Primary Lung Cancers >3cm Todd DeWees 1015 Defining Optimal Comorbidity Measures for Patients With Medically Inoperable Early Stage Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Body Radiation Therapy (SBRT) Yung Hsien Liu 1016 Stereotactic Ablative Radiotherapy for Multiple Primary Lung Cancer Ditte Eklund Nygaard 1017 Interfractional Variation of Respiratory Lung Tumor Displacement Jonathan Abelson 1018 Feasibility of Pulmonary Interstitial Lymphography-guided Targeting in Stereotactic Ablative Radiotherapy of Lung Tumors Melissa Liriano 1019 Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC): Predictors of Surgical Drop Out Michael Milano 1020 Definitive Radiation for Stage I Non-small Cell Lung Cancer: A Population-based Study of Survival 52

ASTRO 2012 / 54TH ANNUAL MEE TING

Sashendra Senthi 1021 Using Deformable Dose Registration to Improve Planning for High-dose Thoracic Re-Irradiation Alexandros Papachristofilou 1022 Prospective International Trial of Endobronchial Implantation of Electromagnetic Fiducials for Localization and Real-time Tracking of Tumors in Lung Cancer Patients Undergoing Radiotherapy (RT) Line Claude 1023 Acute Radiation Pneumonitis in Non-small Cell Lung Cancer: Is Respiratory-gated Control Useful? Results of a French Prospective Randomized Study Nathan Becker 1024 Analysis of Serial FDG 4-D PET Images Acquired During Radiotherapy in Advanced Lung Cancer Patients Resident Digital Poster Recognition Award Winner – PHYSICS

1:45 p.m. - 3:15 p.m.

Educational Session 101 Difficult Cases in Breast Cancer

Room: 253 A-C

Jay R. Harris, MD, FASTRO, Dana-Farber Cancer Institute Thomas Buchholz, MD, PhD, FASTRO, MD Anderson Cancer Center Terry Mamounas, MD, Northeastern Ohio Universities Colleges of Medicine Julia White, MD, Stephanie Spielman Comprehensive Breast Center Center Eric Winer, MD, Dana-Farber Cancer Institute

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required.

Award Recipient

Live Interactive SAMs/ Session Separate Registration required

Sunday | October 28 1:45 p.m. - 3:15 p.m.

Educational Session 102 Challenging Cases of Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma

Room: 107 A-C

Peter Mauch, MD, FASTRO, Harvard Medical School David Hodgson, MD, Princess Margaret Hospital Bouthaina Dabaja, MD, MD Anderson Cancer Center Richard Hoppe, MD, FASTRO, Stanford University Ann LaCasce, MD, Harvard Medical School

1:45 p.m. - 3:15 p.m.

ASTRO’s 2012 Workforce Survey Results and Discussion*

Moderator: Robert Miller, MD, MS, Chairman, ASTRO Membership committee, Mayo Clinic College of Medicine Panelists: Surjeet Pohar, MD, Chairman, ASTRO Workforce Subcommittee, Lourdes Hospital Christine Olsen, MD, MS, Vice-chairman, ASTRO Workforce Subcommittee, Dana-Farber Cancer Institute/Brigham and Women’s Hospital Anna Arnone, Member Relations and Communications Vice President, ASTRO Anushree Vichare, MBBS, MPH, Measure Development Manager, ASTRO *This session is not accredited for continuing medical education credits.

Room: 204 A-B

This session will provide an overview of the results from ASTRO’s 2012 Radiation Oncology Workforce Survey. The session will summarize the overall results and the results for each workforce segment including radiation oncologists, radiation oncology residents, physician assistants in radiation oncology, nurse practitioners in radiation oncology, nurses in radiation oncology, radiation physicists, medical dosimetrists, radiation therapists/technologists and practice managers/administrators. The presenters will answer the following research questions: 1. What are the characteristics of the current radiation oncology workforce? 2. What are the needs and concerns of the current workforce? 3. What are the opportunities for improving quality and safety in patient care? 4. What can we predict about the characteristics and needs of the future radiation oncology workforce?

Symbol Key:

A

3:30 p.m. - 4:15 p.m.

Featured Lecture: Improvements and Innovation at the Center for Devices and Radiological Health Room: 160 A-C

Michael O’Hara, PhD, Food and Drug Administration Introduction by Howard M. Sandler, MD, FASTRO, Cedars-Sinai Medical Center

3:30 p.m. - 5:00 p.m.

eContouring Learning Lab Prostate Cancers

Room: 153 A-C

Michael J. Zelefsky, MD, Memorial Sloan-Kettering Cancer Center

ARON

Ticketed Event/ Nurses’ Separate Session registration required

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

53

Sunday | October 28 3:30 p.m. - 5:00 p.m.

4:15 p.m. - 5:45 p.m.

Bare Facts and Treatments Regarding Skin Toxicities

Innovative Approaches to the Management of Spinal Metastasis

Nurses’ Session Room: 204 A-B

A

ARON

Marilyn Haas, PhD, ANP-BC, Mission Hospital Barbara Holmes Gobel, RN, MS, AOCN, Northwestern Memorial Hospital Pamela Viale, RN, MS, CS, ANP, AOCNP, University of California San Francisco

4:15 p.m. - 5:45 p.m.

Panel 01

The Role of Innovation in Breast Conservation – Cure, Convenience and Cost

Room: 253 A-C

Moderators: Reshma Jagsi, MD, University of Michigan Benjamin Smith, MD, MD Anderson Cancer Center Panelists: Reshma Jagsi, MD, University of Michigan Benjamin Smith, MD, MD Anderson Cancer Center Gary Freedman, MD, University of Pennsylvania Andre Konski, MD, Wayne State University School of Medicine

54

ASTRO 2012 / 54TH ANNUAL MEE TING

Panel 02

Room: 052 A-B

Moderators: Eric Lin Chang, MD, USC Keck School of Medicine Simon Lo, MD, UH Seidman Cancer Center Panelists: Eric Lin Chang, MD, USC Keck School of Medicine Simon Lo, MD, UH Seidman Cancer Center Arjun Sahgal, MD, Princess Margaret Hospital Peter Gerszten, MD, PhD, MPH, University of Pittsburgh Medical Center Samuel Ryu, MD, Henry Ford Hospital

4:15 p.m. - 5:45 p.m.

Panel 03

Pareto Frontiers: Physician-Driven Treatment Planning

Room: 210 A-C

Moderators: Sasa Mutic, PhD, Washington University School of Medicine Todd Pawlicki, PhD, University of California, San Diego Panelists: Kevin Moore, PhD, University of California San Diego Daniel Low, PhD, University of California Los Angeles Thomas Bortfeld, PhD, Massachusetts General Hospital

Sunday | October 28 4:15 p.m. - 5:45 p.m.

4:15 p.m. - 5:45 p.m.

Cancer Survivorship: Multidisciplinary Care of Patients After Treatment Completion

Radiation/Chemoradiation and Biological Targeting

Moderator: Ronald Chen, MD, University of North Carolina at Chapel Hill Panelists: Lawrence B. Marks, MD, FASTRO, University of North Carolina Lawrence Berk, MD, PhD, University of South Florida Moffitt Cancer Center Stephen Edge, MD, Roswell Park Cancer Institute Ronald Chen, MD, University of North Carolina at Chapel Hill Janet de Moor, PhD, MPH, National Cancer Institute

George Wilson, PhD, William Beaumont Hospital Robert Bristow, MD, PhD, Princess Margaret Hospital-University of Toronto

Panel 04

Room: 109 A-B

4:15 p.m. - 5:45 p.m.

Panel 05

Impact of Genetic Factors, Autoimmunity and Comorbidity on Radiotherapy Toxicity

Room: 258 A-C

Moderator: Bin Teh, MD, The Methodist Hospital Panelists: Zhongxing Liao, MD, Cancer Hospital of FuDan University Arnold Paulino, MD, The Methodist Hospital David E.Wazer, MD, FASTRO, Tufts Medical Center

Educational Session 104 Room: 254 A-B

5:30 p.m. - 6:30 p.m.

Nurses’ Reception* Room: 257 A-B

A



ARON

John Grace, a cancer survivor and his wife Joan Raducha will discuss “Surviving and Thriving - With Cancer a Part of Our Lives 2005-2012”. They will discuss the experience of being diagnosed and then treated for head and neck, then lung and most recently appendix cancers. They will describe facing the diagnosis, the treatment experience, and the challenges of decision making regarding treatment options and continuance. And finally, they will talk about how they have come to thrive by learning to live with cancer as a part of their lives. *Event open to Nurse and Nurse practitioner attendees only.

4:15 p.m. - 5:45 p.m.

Educational Session 103 Pancreatic Cancer: Current Treatment Approaches and Controversies

Room: 107 A-C

Christopher Crane, MD, MD Anderson Cancer Center Joseph Herman, MD, MS, Johns Hopkins University

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required.

Award Recipient

Live Interactive SAMs/ Session Separate Registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

55

Monday | October 29 8:00 a.m. - 9:30 a.m.

8:00 a.m. - 9:30 a.m.

Optimal Sequencing of Radiotherapy and Types of Reconstruction Post-mastectomy

Management of Oropharynx Cancer and Associated Toxicities

Lori J. Pierce, MD, FASTRO, University of Michigan Kelly Hunt, MD, MD Anderson Cancer Center Bernard Lee, MD, MBA, Beth Israel Deaconess Medical Center Karen Hoffman, MD, MD Anderson Cancer Center Alice Ho, MD, Memorial Sloan-Kettering Cancer Center

Adam Garden, MD, MD Anderson Cancer Center Avraham Eisbruch, MD, University of Michigan Health Systems

Educational Session 201 Room: 205 A-C

8:00 a.m. - 9:30 a.m.

Educational Session 202 Role of Biologic Imaging in CNS Tumors

Room: 153 A-C

Michael Chan, MD, Wake Forest University Medical Center John Fiveash, MD, University of Alabama at Birmingham

8:00 a.m. - 9:30 a.m.

Educational Session 203 Challenging Cases in GI Malignancy

Room: 107 A-C

Theodore Hong, MD, Massachusetts General Hospital Prajnan Das, MD, MS, MD Anderson Cancer Center Sam Yoon, MD, Massachusetts General Hospital Caio Rocha-Lima, MD, University of Miami

Educational Session 205 Room: 210 A-C

8:00 a.m. - 9:30 a.m.

Educational Session 206 Historical Perspective of Pediatric Radiation Oncology, Particle Radiation Therapy and Combined Modality for GI Malignancies

Room: 206 A-B

Gustavo S. Montana, MD, FASTRO, Duke University Medical Center Edward Halperin, MD, New York Medical College Herman D. Suit, MD, FASTRO, Massachusetts General Hospital Christopher G. Willett, MD, FASTRO, Duke University Medical Center

8:00 a.m. - 9:30 a.m.

Educational Session 207 Updated Roles and Rules for Radiation Therapy of Indolent and Aggressive Lymphomas

Room: 109 A-B

Andrea Ng, MD, Brigham and Women’s Hospital Joachim Yahalom, Memorial Sloan-Kettering Cancer Center

8:00 a.m. - 9:30 a.m.

Educational Session 204 Management of High-risk Prostate Cancer (Including Post-operative XRT)

Room: 258 A-C

Alan Pollack, MD, PhD, University of Miami Miller School of Medicine Richard Valicenti, MD, UC Davis Medical Center Yoshiya Yamada, MD, Memorial Sloan-Kettering Cancer Center

8:00 a.m. - 9:30 a.m.

Educational Session 208 Cancer Emergencies

Room: 160 A-C

Charles Thomas, MD, Oregon Health and Science University James Yu, MD, Yale University School of Medicine Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

56

ASTRO 2012 / 54TH ANNUAL MEE TING

Award Recipient

Live Interactive SAMs/ Session Separate Registration required

Monday | October 29 11:00 a.m. - 12:30 p.m.

8:00 a.m. - 9:30 a.m.

Educational Session 209 Radiobiology of Hypofractionation and IMRT

Room: 052 A-B

Michael Joiner, PhD, Wayne State University Robert Timmerman, MD, University of Texas Southwestern Medical Center

Scientific Session I Best of Physics

Room: 210 A-C Moderators: David Jaffray Paul Keall 11:00 Paige Summers Comparison of Clinical Parameters for Proton Therapy in the United States

8:00 a.m. - 9:30 a.m.

Educational Session 210 Image Guidance in the Treatment Room: Technology and Strategies

73

Room: 253 A-C

11:10 Shyam Rao 74 A Novel Voxel-Based Analysis of the Development of Trismus Following Chemoradiation for Oropharyngeal (OPC) Cancer

Sasa Mutic, PhD, Washington University School of Medicine Jean-Pierre Bissonnette, PhD, Princess Margaret Hospital Patrick Kapelian, MD, University of California Los Angeles

11:20 Xiaofeng Yang 75 Ultrasound Nakagami Imaging to Evaluate Neck Fibrosis Following Head and Neck Radiotherapy: A Feasibility and Reproducibility Study 11:30 John Bayouth Establishing a Relationship Between Radiosensitivity of Lung Tissue and Ventilation

9:45 a.m. - 10:45 a.m.

Keynote Address I

Room: Grand Ballroom Arthur L. Kellermann, MD, MPH, RAND Health Introduction by Susan A. McCloskey, MD, University of California Los Angeles

76

11:40 Joseph Deasy 77 Independent Test of a Model to Predict Radiation Pneumonitis After Definitive Radiotherapy for Locally Advanced NSCLC: Heart Irradiation Is (Again) a Statistically Significant Risk Factor 11:50 Francisco Salguero 78 Significance of Microscopic Disease Extension in Regional Control of Lung Cancer

10:00 a.m. - 5:00 p.m.

Exhibit Hall

Room: Halls A/B, Exhibit Hall 12:00 Kristin Karlsson 79 A Retrospective Study of Bronchial Doses and Radiation Induced Atelectasis After SBRT of Lung Tumours Located Close to the Bronchial Tree

10:00 a.m. - 6:45 p.m.

Poster Viewing

Room: Hall C, Exhibit Hall

Symbol Key:

A

12:10 Ngoc Pham Pre-treatment PET Predicts Clinical Radiation Pneumonitis in Esophageal Cancer Patients

80

ARON

Ticketed Event/ Nurses’ Separate Session registration required

Award Recipient

Live Interactive SAMs/ Session Separate Registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

57

Monday | October 29 12:20 Carmen Ares 81 Chordomas and Chondrosarcomas of the Skull Base: Clinical Outcomes of the Paul Scherrer Institute Experience Using Spot Scanning Proton Radiation Therapy

12:10 Mina Shenouda 89 Prognostic Outcome of Local-regional Recurrence in Breast Cancer Patients Treated by Breast Conservation Treatment 12:20

Meena Moran

Discussant

11:00 a.m. - 12:30 p.m.

Scientific Session J

11:00 a.m. - 12:30 p.m.

Scientific Session K

Breast I - Early-stage Local Therapy

Room: 205 A-C

CNS II - Low Grade, Benign and Spine

Room: 206 A-B

Moderators: Jennifer De Los Santos Eleanor Walker 11:00 Randi Cohen Improved Survival With Adjuvant Radiation in Elderly Women With Early-stage Breast Cancer

Moderators: Helen Shih Stephanie Weiss 82

11:10 Kenneth Roberts 83 Temporal Trends in Radiation Modalities Among Older Women With Favorable Risk Breast Cancer 11:20 Mariam Korah 84 Implications of Omitting Radiation After Breast Conserving Surgery in Elderly Women With Low-risk Invasive Breast Cancer 11:30 Weisi Yan 85 Age, Hormonal Receptor Status, Ethnicity and Adjuvant Radiation Therapy As Predictive Factors for Cancer - Related Death in Elderly Patients Aged 70 Years and Older With Early-stage pT1a,b N0 Breast Cancer: A NCI-SEER Database Analysis

11:00 Ryan Youland 90 Five Decades of Adult Low-grade Gliomas: Patterns of Care Over Time 11:10 Helen Shih Proton Therapy for Low Grade Gliomas: A Pilot Study

91

11:20 John Lucas 92 Predictors of Durability of Response for Gamma Knife Stereotactic Radiosurgery in the Treatment of Trigeminal Neuralgia 11:30 Jona Hattangadi Single Fraction Proton Beam Stereotactic Radiosurgery (PSRS) for Inoperable Cerebral Arteriovenous Malformations (AVMs)

93

11:40 Sounok Sen 86 Understanding Costs and Value of Newer Radiation Modalities Among Older Women With Breast Cancer

11:40 Anoop Haridass 94 Technique for Using Dynamic CT Angiography (dCTA) for FrameleScientific Session Stereotactic Radiosurgical (SRS) Planning of Intracranial Arterio Venous Malformations (AVM)

11:50 Charles Simone 87 Cardiac Toxicity is Not Increased 25 Years After Treatment of Early-stage Breast Carcinoma With Mastectomy or Breast Conservation Therapy From the National Cancer Institute Randomized Trial

11:50 Colin Champ 95 Long term Outcomes of Low Dose Fractionated Stereotactic Radiotherapy of 46.8 Gy for Acoustic Schwannomas: The Thomas Jefferson University Experience

12:00 Irene Karam 88 Treatment Patterns and Locoregional Recurrence Outcomes in Patients With pN0(i+) Breast Cancer

12:00 Emily Tanzler The Role of Proton Radiotherapy for Multiple Meningiomas

58

ASTRO 2012 / 54TH ANNUAL MEE TING

96

Monday | October 29 12:10 Yoshiya Yamada 97 Dynamic Contrast Enhanced MRI Based Assessment of Tumor Response to High Dose Spine Stereotactic Radiosurgery 12:20 Ameen Al-Omair 98 The risk of Vertebral Compression Fracture (VCF) Post-spine Stereotactic Body Radiotherapy (SBRT) and Evaluation of the Spinal Instability Neoplastic Score (SINS)

11:00 a.m. - 12:30 p.m.

11:50 Ravi Shridhar 105 Preoperative Dose Painting IMRT Chemoradiation to 56 Gy In Esophageal Cancer Doubles Pathologic Complete Response Rate Without Increasing Toxicity 12:00 Brian Czito 106 A Phase I/II Study of Capecitabine (Cape), Oxaliplatin (Ox), Panitumumab (Pmab) and External Beam Radiation Therapy (RT) for Patients With Esophagogastric Carcinoma (EC) 12:10

Scientific Session L

Theodore Hong

Discussant

GI II - Esophageal and Gastric: Understanding Toxicity-improving Outcomes

11:00 a.m. - 12:30 p.m.

Moderators: William Jones Rebecca Wong

Health Services Research I – Clinical Trials and Guidelines

Room: 160 A-C

11:00 Masamitsu Hatakenaka 99 Acute Cardiac Impairment Associated With Concurrent Chemoradiotherapy for Esophageal Cancer 11:10 Jingya Wang 100 Radiation Modality Is a Strong Predictor for Postoperative Pulmonary and GI Complications after Trimodality Therapy for Esophageal Cancer 11:20 Matthew McCurdy 101 Predicting Symptomatic Radiation Pneumonitis Using Exhaled Nitric Oxide and [18F] Fluorodeoxyglucose Positron Emission Tomography



11:30 Xueying Qiao 102 A Prospectively Randomized Study of Clinical Target Volume Margins for Three-dimensional Conformal Radiotherapy in Patients With Squamous Cell Carcinoma of Thoracic Esophagus 11:40 Heath Skinner Metformin Use is Associated With Improved Response to Neoadjuvant Chemoradiation in Esophageal Adenocarcinoma

103



104

Withdrawn

Scientific Session M Room: 153 A-C

Moderators: Karen Hoffman Robert Prosnitz 11:00 Stephen Edge 107 Impact of Guideline Changes in the Elderly With Early Breast Cancer (BC): Practice Patterns at NCCN Institutions 11:10 Daniela Buscariollo 108 Comparison of the Level of Evidence Supporting Practice Guidelines in Cancer Care Between Therapeutic Modalities 11:20 Cary Gross 109 An Assessment of the Collective Efforts of Clinical Trials to Provide Evidence-based Practice Guidelines in Cancer Care 11:30

Bruce Minsky

Discussant

11:40 Alysa Fairchild 110 Does Quality of the EORTC Dummy Run Predict Outcomes of Multi-center Clinical Trials?



11:50 Sanjay Aneja 111 The Funding of Phase 3 Clinical Trials Examining Radiation Compared With That of Other Modalities

ASTRO 2012 / 54TH ANNUAL MEE TING

59

Monday | October 29 12:00 Kaveh Zakeri 112 Improving the Efficiency of Clinical Trials Through Selection Models 12:10 Kosj Yamoah 113 Radiation Intensification in the Context of Concurrent Chemotherapy: Fruitful or Futile? A 20-year Meta-analysis of Phase III Randomized Controlled Trials Across Session Different Disease Sites 12:20 Sabine Mueller 114 Retrospective Cohort Analysis of Risk of First and Recurrent Stroke in Childhood Cancer Survivors Treated With Cranial Radiation Therapy

11:00 a.m. - 12:30 p.m.

Scientific Session N

Lung I - SBRT: Efficacy/Response Assessment/ Toxicity

Room: 052 A-B

Moderators: Steven Feigenberg Ramesh Rengan 11:00 Yasushi Nagata 115 Stereotactic Body Radiation Therapy for T1N0M0 Non-small Cell Lung Cancer: First Report for Inoperable Population of a Phase II Trial by Japan Clinical Oncology Group (JCOG 0403) 11:10 Christopher Platta 116 Sublobar Resection With Intraoperative 125I Brachytherapy vs. Stereotactic Body Radiation Therapy for Treatment of Clinical Early Stage q Non-small Cell Lung Cancer in Patients Not Eligible for Lobectomy 11:20 Suresh Senan 117 Patterns of Disease Recurrence Following Either Stereotactic Ablative Radiotherapy (SABR) or Lobectomy By Video-assisted Thoracoscopic Surgery (VATS) In Stage I-II Non-small Cell Lung Cancer: Outcomes of a Propensity Score-matched Analysis

60

ASTRO 2012 / 54TH ANNUAL MEE TING

11:30 Patrick Cheung 118 A Phase II Study of Accelerated Hypofractionated 3-Dimensional Conformal Radiotherapy for Inoperable T1-3 N0 M0 Non-small Cell Lung Cancer: NCIC CTG BR.25 11:40

Brian Kavanagh

Discussant

11:50 Sinisa Stanic 119 No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236 12:00 Lane Rosen 120 Monitoring the Response of Stereotactic Body Radiotherapy (SBRT) in Patients With Early-stage Lung Cancer Using Serial Positron Emission Tomography (PET) 12:10 Rainer Klement 121 Is There a Dose Response Relationship for Pulmonary Function Changes After Stereotactic Body Radiotherapy for Early Stage NSCLC? 12:20 Hiroshi Onishi 122 Stereotactic Body Radiotherapy in 95 Patients With Lung Tumors Composed of Ground-glass Opacity (GGO): Results of a Retrospective Multi-center study

11:00 a.m. - 12:30 p.m.

Scientific Session O

Palliative Care/Quality of Life

Room: 109 A-B

Moderators: Stephen Thomas Lutz Anand Mahadevan 11:00 Clayton Hess 123 Prospective Psychosocial Distress Screening in Radiation Oncology Patients at a Tertiary Academic Medical Center: What Does Implementation of Current NCCN Distress Management Guidelines Actually Accomplish?

Monday | October 29 11:10 Michael Buckstein 124 Genome Wide Association Study to Identify Genetic Variants Associated With the Development of Erectile Dysfunction Following Radiotherapy for Prostate Cancer 11:20 Luluel Khan 125 Predictive Factors for Overall Quality of Life in Advanced Cancer Patients From Eortc Qlq-pal-15 11:30

Nora Janjan

Discussant

11:40 James Murphy Inequality In Palliative Radiotherapy: A Population-based Analysis

11:10 Brian Winey 132 In Vivo Treatment Verification Using In-room PET in Proton Radiation Therapy: First Clinical Trials and Evaluation of Short-length Scan 11:20 Julia-Maria Osinga 133 Proton and Ion Beam Radiotherapy: A Microscopic Dosimetry System for Radiobiology and Treatment 11:30 Byung Jun Min 134 Applications of Proton Digital Tomosynthesis in Proton Beam Therapy

126

11:50 Chris Fosker 127 Tailoring Palliative Radiotherapy (RT) Towards the End of Life – The Importance of ECOG Performance Status 12:00 Sophia Lane 128 Radiotherapy for Intubated Patients With Malignant Airway Obstruction: Futile or Facilitating Extubation? 12:10 Monica Krishnan 129 Factors Predicting Life Expectancy in Patients With Metastatic Cancer Receiving Palliative Radiotherapy 12:20 Christina Son 130 Dosimetric Predictors of Radiation-induced Vaginal Stenosis in Rectal and Anal Cancer Patients

11:00 a.m. - 12:30 p.m.

Scientific Session P Particle Therapy

Room: 258 A-C Moderators: Jatinder Palta Alexei Trofimov

11:40 Tsunashima Yoshikazu 135 Experimental Evaluation of the Interplay Effect and Motion Management by Respiratory Gating in Synchrotron Based Spot Scanning Proton Beam Delivery 11:50 Satoshi Nakamura 136 Development of Fast And High-spatial-resolution Three-dimensional Dosimetry Equipment for Both the Narrow Beam and the Broad Beam in Proton Therapy 12:00 Harald Paganetti 137 Advanced Dose Calculation to Reduce Uncertainties in Treatment Planning and Delivery for Proton Therapy Patients 12:10 Vadim Moskvin 138 Skin Reaction for Spine and Brain Patients at a Health Proton Therapy Center: A Retrospective Study and Physics Consideration

12:20 Brian Yeh 139 Adaptive Replanning Is Required During Intensity Modulated Proton Therapy for Head And Neck Cancers

11:00 Maria Francesca Spadea 131 Contrast Enhanced Proton Radiography for In-room Soft-tissue Based Setup

ASTRO 2012 / 54TH ANNUAL MEE TING

61

Monday | October 29 11:00 a.m. - 12:30 p.m.

Digital Poster Discussion 03 Biology

Room: 156 A-C Discussants: Robert Den Gayle Woloschak Felix Feng 1025 A Tissue-specific Long Non-coding RNA Controls Homologous Recombination in Prostate Cancer Basic Science Abstract Award Winner -BIOLOGY

Somaira Nowsheen 1026 Synthetic Lethal Interactions Between EGFR and PARP Inhibition in Triple Negative Breast Cancer

Richard Bakst 1033 Low Dose Radiation to the Nerve Alone Impairs Perineural Invasion Independent of Cancer Cell Death Resident Clinical/Basic Science Research Award Winner – BIOLOGY

Mohamed Abazeed 1034 Nrf2 Pathway Activation Regulates Radiation Resistance in Lung Squamous Cell Carcinoma Resident Digital Poster Recognition Award Winner - BIOLOGY

Serah Choi 1027 Quantitative Proteomics Reveal ATM Kinase-dependent Exchange in DNA Damage Response Complexes

Brian Baumann 1035 An Integrated Method for Reproducible, Accurate Image-guided Stereotaxic Cranial Irradiation of Brain Tumors Using the Small Animal Radiation Research Platform (SARRP)

Susan McGovern 1028 Extracellular Domain Mutations in EGFR Occur Uniquely in Glioblastoma and Favor Ligand Independent Formation of the Active State

Dwight Heron 1036 Apoptosis Imaging With 18F-ML-10 Is an Early Predictor of Response of Brain Metastases Treated With Stereotactic Radiosurgery

Nishant Gandhi 1029 Novel Hsp90 Inhibitor NVP-AUY922 Radiosensitizes Prostate Cancer Cells

11:00 a.m. - 12:30 p.m.

Digital Poster Discussion 04 Genitourinary

Joshua Silverman 1030 Pilot Trial of Radiotherapy and GM-CSF in Metastatic Cancer: Abscopal Responses Christopher Willey 1031 Kinomic Proband Model of Radiation Response From Patient-derived Gbm Xenolines Samayita Das 1032 Carbon Irradiation Exerts Potent Antiangiogenic Effects Via Downregulation of Vascular Endothelial Growth Factor in Lung and Prostate Cancer Models

62

ASTRO 2012 / 54TH ANNUAL MEE TING

Room: 157 A-C Discussants: Ronald Ennis Andrew K. Lee Shinichi Shimizu 1037 Decreasing Acute and Late Toxicity Using Urethral Dose Reduction and Smaller Safety Margin Around CTV for Prostate Cancer Intensity-Modulated Radiation Therapy (IMRT) With a Real-Time Tumor-Tracking (RTRT) System George Rodrigues 1038 The Prostate Cancer Risk Stratification (ProCaRS) Project: Recursive Partitioning Risk Stratification Analysis

Monday | October 29 Ayal Aizer 1039 Physician Bias, Referral to a Medical Oncologist and Active Surveillance in Low-risk Prostate Cancer

11:00 a.m. - 12:30 p.m.

Kris Huang 1040 Primary Prostate Radiotherapy: Where Are We Failing?

Room: 253 A-C

Michael Yassa 1041 Late Consequential Effects of Hypofractionated Radiotherapy in Prostate Cancer: Impact of Acute Toxicity on Toxicity at 4 Years and 8 Years Natasha Townsend 1042 Recursive Partitioning Analysis of Intermediate-risk Prostate Cancer Patients Identifies Subgroup Risk Categories Zvi Symon 1043 Volumetric Modulated Arc Therapy With a Gentle Hypofractionated Concomitant Integrated Prostate Boost: Toxicity and Quality of Life Outcomes Amar Challapalli 1044 Establishing the Use of [11C]Choline PET-CT As an Image-based Biomarker in Prostate Cancer: Evaluation of [11 C]Choline Parameters Following Neoadjuvant Androgen Deprivation and Radical Radiotherapy David Beyer 1045 Brachytherapy Alone May Be Sufficient for Most Early Prostate Cancer Patients Drew Moghanaki 1046 Elective Pelvic Lymph Node Irradiation, Without Androgen Deprivation Therapy, During Post-prostatectomy Salvage Radiotherapy Jesse Alexander 1047 Pre-plan Dosimetry As a Predictor of Clinical Outcome for 125I Permanent Prostate Implants (PPI) Jeffrey Martin 1048 Do Testosterone Kinetics After Radiation Therapy (RT) Predict Biochemical Failure (BCF) for Low- and Intermediate-risk Prostate Cancer (CaP)?

Educational Session 211 Difficult Cases in Endometrial and Vaginal Cancer

Arno Mundt, MD, UC San Diego Radiation Oncology Kaled Alektiar, MD, Memorial Sloan-Kettering Cancer Center Ann Klopp, MD, MD Anderson Cancer Center Ellen Jones, MD, PhD, UNC Radiation Oncology Beth Erickson, MD, Medical College of Wisconsin

11:00 a.m. - 12:30 p.m.

Educational Session 212 Integration of Systemic Treatment with Radiation Therapy for Head and Neck Cancer

Room: 107 A-C

Roy Tishler, MD, PhD, Dana-Farber Cancer Institute Ezra Cohen, MD, University of Chicago David Rosenthal, MD, MD Anderson Cancer Center

11:00 a.m. - 12:30 p.m.

Nurses’ Session

Role of the Advanced Practice Nurse (APN) in a Radiation Oncology Setting

Room: 259 A-B

A

ARON

Vanna M. Dest, MSN, APRN, BC, AOCN, Smilow Cancer Hospital Yale New Haven, Saint Raphael Campus Diane Doyle, MS, APRN, BC, AOCN, Massachusetts General Hospital Elene Viscosi, APRN, BC, Massachusetts General Hospital

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

Award Recipient

Live Interactive SAMs/ Session Separate Registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

63

Monday | October 29 11:00 a.m. - 12:00 p.m.

Foreign Language Poster Walks*

Room: Hall C, Poster Check-in Desk International Poster Walks will be offered in Chinese and Spanish, and will review selected abstracts based on disease site. Please note that this event is open to International attendees only. Please refer to the details below for further information. CHINESE POSTER WALK Faculty: W. Ken Zhen, MD Disease Site: Head and Neck

Moderator: Nina A. Mayr, MD, FASTRO, The Ohio State University Panelists: Colleen F. Lawton, MD, FASTRO ASTRO President-elect, Medical College of Wisconsin Reshma Jagsi, MD, University of Michigan Barit L. Madsen, MD, Peninsula Cancer Center Mary K. Martel, PhD, FASTRO, MD Anderson Cancer Center Nancy S. Tarbell, MD, FASTRO, Harvard Medical School

SPANISH POSTER WALK Faculty: Adela Poitevin, MD Disease Site: Breast, CNS and Prostate

12:30 p.m. - 1:45 p.m.

*This session is not accredited for continuing medical education credits.

Box Lunch Provided

How to Review a Scientific Paper Workshop* Room: 159

12:30 p.m. - 1:45 p.m.

AAWR/ASTRO Luncheon* A Mentorship Panel for Women in Radiation Oncology

Room: 257 A-B

Join us for the annual AAWR/ASTRO Luncheon Panel. This diverse panel of accomplished women radiation oncologists will discuss and answer questions on professional advancement in academic and community practice, opportunities and challenges and involvement in health care politics, for women in Radiation Oncology.

Moderator : W. Robert Lee, MD, MEd, Duke University Workshop Faculty: Robert J. Amdur, MD, University of Florida Soren M. Bentzen, DSc, PhD, University of Wisconsin Anthony V. D’Amico, MD, PhD, FASTRO, Brigham and Women’s Hospital Lynn D. Wilson, MD, MPH, FASTRO, Yale University School of Medicine Anthony L. Zietman, MD, FASTRO, Massachusetts General Hospital

12:30 p.m. - 1:45 p.m.

ARRO Poster Walks With a Professor Box Lunch Provided

Room: Hall C, Poster Lounge

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

64

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

Monday | October 29 1:45 p.m. - 2:30 p.m.

Presidential Address: The Patient Not Treated Room: Grand Ballroom

Michael L. Steinberg, MD, FASTRO, President, ASTRO Introduction by: Paul E. Wallner, DO, FASTRO, 21st Century Oncology

2:30 p.m. – 3:45 p.m.

Plenary Session

Room: Grand Ballroom Co-moderators: Lynn D. Wilson Benjamin Movsas 2:30 p.m. Robert C. Miller LBA1 N09C6 (Alliance) - A Phase III, Randomized Double-blind Study of Doxepin Rinse vs. Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy

3:06 p.m. Michael J. Zelefsky 3 Results of a Prospective Randomized Double-blind Placebo-controlled Trial Evaluating the Use Prophylactic Sildenafil Citrate During Radiation Therapy in the Treatment of Prostate Cancer 3:13 p.m.

2:37 p.m.

Paul Harari

2:42 p.m. Nadia Laack Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-brain Radiation Therapy (WBRT): First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial 2:49 p.m.

Vinai Gondi

1

Discussant

2:54 p.m. Nitin Ohri 2 Radiation Therapy Protocol Deviations are Associated With Inferior Clinical Outcomes: A Meta-analysis of Cooperative Group Clinical Trials Resident Clinical/Basic Science Award Winner – CLINICAL 3:01 p.m.

Ross Abrams

Thomas Pisansky

Discussant

Discussant 3:18 p.m. Timothy J. Whelan LBA2 Interim Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation (APBI) Using 3-D Conformal External Beam Radiation Therapy (3-D CRT) 3:25 p.m.

Bruce Haffty

Discussant

3:30 p.m. Aileen B Chen 4 Patient Beliefs About Palliative Radiation Therapy (RT) in Incurable Lung Cancer 3:37 p.m.

Thomas Lynch

Discussant

Discussant

ASTRO 2012 / 54TH ANNUAL MEE TING

65

Monday | October 29 4:00 p.m. - 5:30 p.m.

4:00 p.m. - 5:30 p.m.

Post Mastectomy Radiotherapy After Neo- adjuvant Chemotherapy: Update on Indications for Treatment

Brachytherapy Fundamentals and Evolving Paradigms

Panel 06

Panel 08

Room: 210 A-C

Moderator: Catherine Park, MD, University of California, San Francisco Panelists: Yunn-Yi Chen, MD, PhD, University of California, San Francisco Barbara L. Fowble, MD, FASTRO, University of California, San Francisco Terry Mamounas, MD, Northeastern Ohio Universities Colleges of Medicine Thomas Buchholz, MD, PhD, FASTRO, MD Anderson Cancer Center

Room: 107 A-C

Moderator: Robert Cormack, PhD, Harvard Medical School Panelists: Beth Erickson, MD, Medical College of Wisconsin Christian Kirisits, DSc, Medical University of Vienna Paul Nguyen, MD, Dana-Farber/Brigham and Women’s Cancer Center Robert Cormack, PhD, Harvard Medical School

4:00 p.m. - 5:30 p.m.

Panel 09

The Role of Innovation in Palliation – Is the Benefit Worth the Cost?

4:00 p.m. - 5:30 p.m.

Panel 07

Room: 160 A-C

Innovations in Stereotactic Body Radiation Therapy for Lung Cancer

Room: 205 A-C

Moderators: Andrea Bezjak, MD, Princess Margaret Hospital Joe Chang, MD, PhD, MS, MD Anderson Cancer Center Panelists: Indrin Julian Chetty, PhD, Henry Ford Health System Billy Loo, MD, PhD, Stanford University Ben Slotman, MD, PhD, VU University Medical Center

Moderators: Carol Hahn, MD, Duke University Medical Center Stephen Thomas Lutz, MD, Blanchard Valley Regional Health Center Panelists: Carol Hahn, MD, Duke University Medical Center Eric Lin Chang, MD, USC Keck School of Medicine Simon Lo, MD, UH Seidman Cancer Center Stephen Thomas Lutz, MD, Blanchard Valley Regional Health Center

4:00 p.m. - 5:30 p.m.

Panel 10

Cancer Genesis, Treatment and Late Effects Across the Age Spectrum

Room: 153 A-C

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required.

Award Recipient

Live Interactive SAMs/ Session Separate Registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

66

Moderators: Louis S. Constine, MD, FASTRO, University Rochester Medical Center Panelists: Jacqueline Williams, PhD, FASTRO, University of Rochester Medical Center Lawrence Marks, MD, FASTRO, University of North Carolina

Monday | October 29 Louis S. Constine, MD, FASTRO, University Rochester Medical Center Lois Travis, ScD, MD, University of Rochester Medical Center

4:00 p.m. - 5:30 p.m.

5:30 p.m. - 6:30 p.m.

2012 NCI/ASTRO Diversity Session and Reception* Improving Cancer Care Globally: A Call to Service in Radiation Oncology

Room: 159

Educational Session 213 Cancer of the Colon, Rectum and Anus

Room: 258 A-C

Karyn Goodman, MD, MS, Memorial Sloan-Kettering Cancer Center Brian Czito, MD, Duke University Medical Center

4:00 p.m. - 5:30 p.m.

Educational Session 214 Volumetric Modulated Arc Therapy: Planning and Quality Assurance

Room: 253 A-C

Charles Mayo, PhD, Mayo Clinic Todd Pawlicki, PhD, University of California, San Diego Jean Moran, PhD, University of Michigan

5:30 p.m. - 6:45 p.m.

Poster Viewing Session and Reception* Room: Hall C

During this session, all poster presenters are asked to stand by their poster to answer questions about their research. New this year will be a presentation area where the poster viewing award winners will provide highlights of their research and be available for questions. The presentation schedule will be on-site. *This session is not accredited for continuing Medical Education Credits.

Members of the National Cancer Institute and Cancer Disparities Research Partnership (CDRP) project invite you to join them for an in-depth look at the disconcerning disparities in cancer care around the globe. Expert speakers who have completed groundbreaking work to improve the delivery of radiation oncology services in developing nations will share their stories and insights. Moderator: Patrick Maguire, MD, Coastal Carolina Radiation Oncology

Desperate and Disparate in a Time of Many Transitions: Improving All Research and Practice in Radiation Oncology Introduction: Bhadrasain Vikram, MD, National Cancer Institute Speaker: Glenn Jones, MD, Peel Regional Cancer Center

Cambodian Radiation Therapy Project Introduction: Luqman Dad, MD, Annapolis Radiology Associates Speaker: Tracy Bray, MD, Loyola University Medical Center

Possible Business Models for Radiation Therapy Facilities in Bangladesh Introduction: Bhadrasain Vikram, MD, National Cancer Institute Speaker: Richard Love, MD, Ohio State University *This session is not accredited for continuing medical education credits.

ASTRO 2012 / 54TH ANNUAL MEE TING

67

Tuesday | October 30 8:00 a.m. - 9:30 a.m.

8:00 a.m. - 9:30 a.m.

Breast Cancer Management: Early Stage Disease

Improving Outcomes in Geriatric Patients Through Use of Comprehensive Geriatric Assessment, Tools Available to Make It Happen

Educational Session 301

Educational Session 304

Room: 258 A-C

Meena Moran, MD, Yale University School of Medicine Julia Wong, MD, Brigham and Women’s Hospital

Room: 153 A-C

A

ARON

8:00 a.m. - 9:30 a.m.

Educational Session 302 Esophagus and Gastric Cancer: Contemporary Treatment Approaches

Room: 253 A-C

Diane Cope, PhD, ARNP, Florida Cancer Specialists and Research Institute Lynn Heup, GNP-BC/AOCNP, MS, Emory Healthcare

8:00 a.m. - 9:30 a.m.

Educational Session 305 Gary Yang, MD, Loma Linda University Harvey Mamon, MD, PhD, Brigham and Women’s Hospital

External Beam Radiotherapy for Prostate Cancer: Dose, Volume, Fractionation

Room: 205 A-C

8:00 a.m. - 9:30 a.m.

Jason Efstathiou, MD, PhD, Massachusetts General Hospital Eric Horwitz, MD, Fox Chase Cancer Center

Controversies in the Management of Interactive Endometrial Cancer

8:00 a.m. - 9:30 a.m.

Educational Session 303 Room: 107 A-C

William Small Jr., MD, FASTRO, The Robert H. Lurie Comprehensive Cancer Center of Northwestern University Julian Schink, MD, Northwestern Univsersity Feinberg School of Medicine

Educational Session 306 Radiation Oncology in the Developing World – How to Bridge the Gap

Room: 052 A-B

Bernard J. Cummings, MB, ChB, FASTRO, Princess Margaret Hospital Jatinder Palta, PhD, University of Florida Mario Baeza, OCN, Instituto de Radiomedicina Tim R. Williams, MD, FASTRO, Lynn Cancer Institute

8:00 a.m. - 9:30 a.m.

Educational Session 307

Symbol Key:

A

Room: 206 A-B

ARON

Ticketed Event/ Nurses’ Separate Session registration required

68

Pediatric Tumors: Update on Pediatric Sarcomas and Hodgkin’s Lymphoma

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

Stephanie Terezakis, MD, Johns Hopkins School of Medicine Suzanne Wolden, MD, Memorial Sloan-Kettering Cancer Center

Tuesday | October 30 8:00 a.m. - 9:30 a.m.

Educational Session 308 Soft Tissue and Bone Sarcoma – Management of Difficult Cases

Room: 204 A-B

9:45 a.m. - 10:45 a.m.

Keynote Address II: Future Trends in Cancer Survivorship* Room: Grand Ballroom

Elizabeth Baldini, MD, Brigham and Women’s Hospital Thomas DeLaney, MD, Massachusetts General Hospital Chandrajit Raut, MD, Brigham and Women’s Hospital R. Lor Randall, MD, University of Utah Robert Maki, MD, PhD, Mount Sinai School of Medicine

Edward M. Kennedy Jr., President and Co-founder, Marwood Group Introduction by: Jay S. Loeffler, MD, FASTRO, Massachusetts General Hospital *This sesson is not accredited for continuing Medical Education Credits.

8:00 a.m. - 9:30 a.m.

10:00 a.m. - 5:00 p.m.

Cell Death Processes and Bystander Effects: Relevant to Clinical Radiotherapy

Room: Halls A/B

Theodore DeWeese, MD, Johns Hopkins School of Medicine Frank Pajonk, MD, PhD, UCLA Health systems Kevin Prise, MD, Queen’s University Belfast

10:00 a.m. - 5:00 p.m.

Educational Session 309 Room: 109 A-B

8:00 a.m. - 9:30 a.m.

Educational Session 310 Practical Use of Image Registration and Data Fusion for Planning, Delivery and Adaptation of Radiotherapy

Room: 160 A-C

Kristy Brock, PhD, Princess Margaret Hospital Marc Kessler, PhD, University of Michigan Patrick Kupelian, MD, University of California , Los Angeles

Exhibit Hall

Poster Viewing

Room: Hall C, Exhibit Hall 10:45 a.m. - 12:00 p.m.

Awards Ceremony

Gold Medal, Honorary Member, Fellows and Survivor Circle

Room: Grand Ballroom

The Awards Ceremony is held in honor of ASTRO’s 2012 award recipients and Fellows. Show your appreciation for these premier leaders by joining in the celebration of their accomplishments.

ASTRO 2012 / 54TH ANNUAL MEE TING

69

Tuesday | October 30 12:00 p.m. - 1:15 p.m.

Business Meeting Room: 210 A-C

ASTRO voting members (Active, Affiliate, Allied or International members) are invited to attend the Business Meeting. Leaders of the Society will discuss and make presentations on important topics of interest to ASTRO members. You should not miss this important meeting. Lunch will be served.

Scientific Session Q

GU II - Prostate Cancer: Prognostic Factors

Room: 258 A-C

2:35

Moderators: Alan Pollack Andrew Wang 1:15 Arie Dosoretz 140 A Decision Analysis to Assess the Value of Prostate Cancer Screening: A Shift in Focus From Prostate Cancer Specific Mortality to Distant Metastasis Free Survival 1:25 George Rodrigues 141 The Prostate Cancer Risk Stratification (ProCaRS) Project: Database Construction and Outcome Analysis 1:35 Jonathan Schoenfeld 142 Single Nucleotide Polymorphism in Inflammatory Gene RNASEL Predicts Outcome After Radiotherapy for Localized Prostate Cancer 1:45 Danielle Margalit 143 Genetic Variation in the Antioxidant Gene Superoxide Dismutase 2 (SOD2) and Response to Radiation Therapy (RT) for Prostate Cancer (PCa)

70

ASTRO 2012 / 54TH ANNUAL MEE TING

2:15 Neelam Tyagi 146 Quantifying Tumor Agressiveness Using Diffusion Weighted MRI for Prostate Cancer 2:25 Radka Stoyanova 147 Determinants of Prostate Biopsy Positivity Two Years After Radiotherapy for Men With Prostate Cancer Treated on a Randomized Trial

1:15 p.m. - 2:45 p.m.

1:55 Felix Feng Validation of a Genomic-clinical Classifier for Predicting Clinical Progression in Post-prostatectomy High-risk Prostate Cancer.

2:05 Daniel Krauss 145 Neuroendocrine Differentiation in Gleason Score 7-10 Prostate Adenocarcinoma Treated With Primary Radiotherapy: A New Prognostic Variable to be Considered

144

Theodore DeWeese

Discussant

1:15 p.m. - 2:45 p.m.

Scientific Session R

Head and Neck II - Treatment Toxicity

Room: 052 A-B

Moderators: Beth Beadle Roy Tishler 1:15 Sophie Otter 148 Atlas Based Dose Volume Modeling of Individual Patient Dose-distribution (Oral and Pharyngeal Mucosa) to Predict the Risk of Acute Grade 3 Oral and Pharyngeal Mucositis 1:25 Marianne Feen Roenjom 149 Hypothyroidism After Primary Radiotherapy in Squamous Cell Carcinoma of the Head and Neck (HNSCC) 1:35 Samuel Swisher-McClure 150 Risk of Fatal Cerebrovascular Accidents (CVA) in Patients Treated With Radiotherapy (RT) or Surgery for Early Stage Glottic Larynx Cancer Withdrawn



151

Tuesday | October 30 1:45 John Lukens 152 Late Consequential Surgical Bed Soft Tissue Necrosis in Advanced Oropharyngeal Squamous Cell Carcinomas (OP-SCC) Treated With Transoral Robotic Surgery (TORS) and Postoperative Radiation (PORT) 1:55 Aashish Bhatt 153 Impact of Transcutaneous Neuromuscular Electrical Stimulation for Dysphagia in Head and Neck Cancer Patients Treated With Definitive Chemoradiation 2:05 Tessa Goldsmith 154 Swallowing Function After Proton Beam Therapy for Nasopharyngeal Cancer: A Prospective Study 2:15 Katherine Hutcheson 155 Swallowing Outcomes After Adaptive Radiotherapy for Oropharyngeal Cancer: Results of a Prospective Trial 2:25 Bharat Mittal 156 Effect of Recombinant Human Deoxyribonuclease (rhDNase) on Oropharyngeal Secretions in Patients With Head and Neck Cancers Treated With Radio-chemotherapy

1:15 p.m. - 2:45 p.m.

Scientific Session S Pediatrics I - CNS

Room: 154

Moderators: Arthur Liu Torunn Yock

1:35 Jonathan Verma 159 Reproducibility of Patient Positioning in Supine and Prone Craniospinal Irradiation in the Treatment of Medulloblastoma 1:45 Raymond Mailhot 160 A Consensus Atlas for Whole Ventricular Irradiation for Pediatric Germ Cell Tumors: Survey Results and Guidelines 1:55 Rachel Jimenez Proton Radiotherapy for High-risk Pediatric Medulloblastoma: Outcomes for Very Young Children Treated With Upfront Chemotherapy

161

2:05 Harold Agbahiwe 162 A Prospective Study of Cerebral, Frontal Lobe and Temporal Lobe Volume, and Neuropsychologic Performance in Children With Primary Brain Tumors Treated With Cranial Radiation 2:15 Arnold Paulino 163 Impact of Target Volume on Local Control After Intensity Modulated Radiation Therapy (IMRT) for Pediatric Low Grade Glioma 2:25 Kristin Redmond 164 Motor Dysfunction Following Cranial Irradiation for Pediatric Brain Tumors: A Prospective Study 2:35 Tamara Vern-Gross 165 Prospective Evaluation of Local Control and Late Effects of Image Guided Radiotherapy in Childhood High Grade Glioma

1:15 Jihyeon Joo 157 Treatment Outcome of Radiation Therapy for Intracranial Germinoma: Suggestion of Radiation Field When Combined to Upfront Chemotherapy 1:25 Patrik Brodin 158 Reducing the Risk of Neurocognitive Impairment by Protecting the Neurogenic Niches During Radiation Therapy for Pediatric Medulloblastoma

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

71

Tuesday | October 30 1:15 p.m. - 2:45 p.m.

1:15 p.m. - 2:45 p.m.

Lung II - Biologics and Chemo/Radiation Therapy

Lymphoma - Outcomes (Efficacy, Toxicity) and Innovations

Moderators: Shilpen Patel Gregory Videtic

Moderators: Louis S. Constine Kenneth Roberts

1:15 Gregory Gan 166 Ablative Local Therapy Extends the Clinical Benefit of Crizotinib in Alk-positive Lung Cancer

1:25 Hans Theodor Eich 173 Involved Field (IF) vs. Extended Field (EF) Radiotherapy (RT) for Patients in Early Unfavorable Stages of Hodgkin Lymphoma: 10-year Update of the HD8 Trial of the German Hodgkin Study Group (GHSG)

Scientific Session T

Scientific Session U

Room: 160 A-C

1:25 Yasumasa Nishimura 167 Phase II Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) 1:35 Marcos Santos 168 Meta Analysis of Toxicities in Phase I or II Trials Studying the Use of Target Therapy (TT) Combined to Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC) 1:45 Ritsuko Komaki 169 The Phase II Trial of Erotinib and Radiotherapy Following Chemoradiotherapy for Patients With Stage III Non-small Cell Lung Cancer Has Shown a Favorable Response Profile 1:55

Hak Choy

Discussant

2:05 Weili Wang 170 Single Nucleotide Polymorphisms in DNA Repair Genes May Be Associated With Survival in Patients With Non-small Cell Lung Cancer Treated With Definitive Radiotherapy 2:15 Mohamad Fakhreddine 171 Poor Glycemic Control During Radiochemotherapy Contributes to Reduced Local Control and Overall Survival in Patients With Non-small Cell Lung Cancer 2:25 James Welsh 172 Implications of KRAS Mutations on Outcomes in Non-small Cell Lung Cancer Treated With Radiation Therapy 72

ASTRO 2012 / 54TH ANNUAL MEE TING

Room: 153 A-C

1:35 Berthe Aleman Second Cancer Risk 40 Years After Hodgkin Lymphoma Treatment

174

1:45 Maja Vestmoe Maraldo Involved Node Radiotherapy for Hodgkin Lymphoma: Treatment Outcome in a Single-institution Cohort

175

1:55

Andrea Ng

Discussant

2:05 Marianne Aznar 176 Deep-inspiration Breath Hold vs. IMRT in Minimizing Late Side Effects in Hodgkin Lymphoma 2:15 Gabriele Reinartz 177 Stage-adapted Radiotherapy for Treatment of Localized Gastric Marginal Zone Lymphoma in 326 Patients: Results of the German Study Group on Gastrointestinal Lymphoma (DSGL) 2:25 Andrea Russo 178 Low-dose Involved Field Radiation in the Palliation of Non-Hodgkin Lymphoma: Predictors of Response and Treatment Failure

Tuesday | October 30 2:35 Bouthaina Dabaja 179 Mid-Therapy PET Scan Significantly Predict Outcome in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Chemotherapy Alone But Not When Consolidation Radiation Is Added 2:45 Run-Ye Wu 180 Patterns of Local Extension and Regional Spread in Early Stage Nasal NK/T-cell Lymphoma Based on Magnetic Resonance Imaging

1:15 p.m. - 2:45 p.m.

Scientific Session V

Translational Radiobiology

2:15 Qifeng Wang 187 ATM Polymorphisms Are Associated With Radiosensitivity for Patients With Esophageal Squamous Cell Carcinoma Underwent Preoperative Radiotherapy 2:25 Ruth White 188 Cancer Stem Cell Specific MicroRNA Aberrations in a Model of Recurrent Squamous Cell Carcinoma: Implications for Targeted Radiosensitization 2:35 Caroline Chung Phase I Dose Escalation Study of Sunitinib and Radiosurgery for Brain Metastases

Room: 109 A-B

Moderators: Fei-Fei Liu Phouc Tran 1:15 Eddy Yang 181 Human HER2+ Breast Cancer Susceptibility to Poly(ADP-Ribose) Polymerase Inhibitors Independent of a Homologous Recombination Repair Defect Basic Science Abstract Award Winner – BIOLOGY

1:25 Kamila Nowak 182 PF02340166 Inhibits ALK Downstream Effectors and Increases Sensitivity to Radiation in Cells Harboring the EML4-ALK Fusion 1:35 Yuta Shibamoto 183 IMAX (Immunity-maximized) Cancer Therapy: Combination of Dendritic Cell-based Vaccine and Intensity Modulated Radiation 1:45 In Ah Kim MicroRNA-200c Increases Radiosensitivity of Human Cancer Cells With Activated EGFR or HER2-Associated Signaling

2:05 Ji-Hong Hong 186 Combination of Vessel-targeting Agents With Fractionated Radiotherapy: The Role of SDF-1/ CXCR4 Pathway

184

1:55 Harriet Eldredge 185 Whole Brain Radiotherapy and Chloroquine in Patients With Brain Metastases: Outcomes and Response Related to IDO2 Gene Single-Nucleotide Polymorphisms

189

1:15 p.m. - 2:45 p.m.

Scientific Session W

Radiobiological Modeling

Room: 204 A-B

Moderators: Joseph Deasy Mary Martel 1:15 Almut Troeller 190 Comparison of Normal Tissue Complication Probability (NTCP) Model Outcomes for Conformal Radiotherapy (CRT) vs. Intensity Modulated Radiotherapy (IMRT) of Prostate Cancer 1:25 Timothy Schultheiss 191 A Cross-species Model for Radiation Myelopathy 1:35 Chul Hee Min 192 Dose Response Relationship for Permanent Alopecia in Pediatric Medulloblastoma Patients Treated With Proton Radiotherapy

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

73

Tuesday | October 30 1:45 Quentin Diot 193 Modeling of Radiographic Changes in Normal Lung Tissue in Patients Treated With Conventional and Hypofractionated Radiation Therapy 1:55 Sangkyu Lee A Bayesian Network Approach for Multivariate Radiation Pneumonitis Modeling

194

2:05 Ellen X.Huang Independent Test of a Model to Predict Severe Acute Esophagitis

195

2:15 Lindsey Appenzoller 196 Predicting Dose-Volume Histograms for Organs at Risk in IMRT Planning 2:25 Mariana Guerrero 197 Radiobiological Modeling Based on FDG PET Data for Esophageal Cancer 2:35 Di Yan 198 Radio-inducible Adaptive Response Effect on Hypo-fractionation of Lung Cancer Radiotherapy

1:15 p.m. - 2:45 p.m.

Scientific Session X

IGRT Process and Technologies

1:45 Sarah Geneser 202 The Impact of Errors in Non-rigid Medical Image Registration Methods on Dose Warping Accuracy 1:55 Bowen Meng 203 Single Scan Scatter Correction in Cone Beam CT Using a Stationary Boundary Blocker and Compressed Sensing Based Scatter Estimation 2:05 Paul Keall 204 Real-time Tumor Deformation Tracking Using Dynamic Multi leaf Collimator (DMLC) Basic Science Abstract Award Winner – PHYSICS

2:15 Su-Min Zhou 205 Using Respiratory Invariant Points Obtained From 4-D Simulation Study to Provide Accurate Body Setup Correction for Gated Radiotherapy Patients 2:25 Hao Li 206 Generation of Virtual Monochromatic (VM) CBCT From Dual kV/MV Beam Projections 2:35 John DeMarco 207 Patient-specific Quantification of the Dosimetric Impact of Motion During Radiotherapy: A Clinically Usable Tool

Room: 205 A-C

Moderators: Stanley Benedict Katja Langen 1:15 Sukhjeet Batth 199 Differences in Clinical Outcome Among Patients Treated by Intensity Modulated Radiotherapy With and Without Image-Guidance for Head and Neck Cancer 1:25 Karen Vineberg 200 The Influence of Rotation on Delivered Dose in Oropharyngeal Cancer 1:35 Michael Howard 201 Using Mathematical Modeling to Specify Treatment Margins for Prostate Cancer May Reduce Radiation Dose to Bladder and Rectum

74

ASTRO 2012 / 54TH ANNUAL MEE TING

1:15 p.m. - 2:45 p.m.

Digital Poster Discussion 05 Breast

Room: 156 A-C Discussants: Lena Specht Jean Wright Maha Jawad 1049 Seven-year Clinical Outcomes Following Accelerated Partial Breast Irradiation Stratified by ASTRO Consensus Groupings Resident Digital Poster Recognition Award Winner – CLINICAL

Tuesday | October 30 Robert Hong 1050 Results of the SAVI Research Collaborative Group Registry: Correlating Clinical Toxicity With Dosimetric Parameters in Patients Treated With APBI Using Strut-Based Brachytherapy

Mylin Torres 1058 Prospective Longitudinal Study of Radiation-induced Cutaneous Toxicity in Breast Cancer Patients Undergoing Breast Conserving Therapy

Betro Sadek 1051 Does Lobular Carcinoma In-Situ (LCIS) at the Surgical Margins Increase the Risk of Local Failure in Patients With Invasive Breast Cancer Receiving Conservative Treatment?

Gonzalo Vazquez 1059 Long-term Changes in Pulmonary Function After Incidental Lung Irradiation for Breast Cancer: A Prospective Study With 7-year Follow-up

Tiffany Tam 1052 Multifocal/Multicentric Breast Cancer Is Associated With Increased Local Recurrence Erin Kane 1053 Compliance of Previously Treated Left Breast Cancer Patients With RTOG 1005 Guidelines David Weksberg Outcomes and Predictive Factors for Salvage Therapy After Locoregional Recurrence Following Breast Conserving Therapy With Neoadjuvant Chemotherapy

1054

Nils Arvold 1055 Brain Metastases After Breast-Conserving Therapy for Early-stage Breast Cancer: Incidence and Characteristics by Subtype Zachary Zumsteg 1056 Breast-Conserving Therapy Achieves Equivalent Locoregional Outcomes Compared to Mastectomy in Women With T1-2N0 Triple Negative Breast Cancer Manjeet Chadha 1057 Does Post Mastectomy Radiation Therapy (PMRT) After Deep Inferior Epigastric Perforator Flap (DIEP) Reconstruction Increase Complications?

Emma Fields 1060 Male Breast Cancer in the United States: A Surveillance, Epidemiology and End Results Analysis

1:15 p.m. - 2:45 p.m.

Digital Poster Discussion 06 Gastrointestinal

Room: 157 A-C Discussants: A. Bapsi Chakravarthy Salma K. Jabbour Aryavarta Kumar 1061 Outcomes of Liver Resection for Hepatocellular Carcinoma Patients: A Cleveland Clinic Experience Claudia Menichelli 1062 SBRT for Liver Metastases: Results on 173 Treated Lesions Jeffrey Meyer 1063 Single-fraction Stereotactic Irradiation of Liver Metastases: Preliminary Results of a Phase I Trial Iris Ernst 1064 Individualized High Precision Radiotherapy for Liver Tumors Based on 4-D List Mode PET/CT Jie Ding 1065 Radiosensitivity Enhancement of Human Hepatocellular Carcinoma Cell Line SMMC-7721 by Sorafenib Through the MEK/ERK Signal Pathway

ASTRO 2012 / 54TH ANNUAL MEE TING

75

Tuesday | October 30 John Mikell 1066 Tumor Size on Abdominal MRI vs. Pathologic Specimen in Resected Pancreatic Adenocarcinoma: Implications for Radiotherapy Planning David Horowitz 1067 Management of Borderline Resectable Pancreatic Adenocarcinoma With Neoadjuvant GTX Chemotherapy Followed by Combined Chemoradiation Andrzej Wojcieszynski 1068 The Impact of Radiation Therapy Sequence on Survival and Cardiopulmonary Mortality in the Combined Modality Treatment of Esophageal Cancer: A SEER Analysis Youling Gong 1069 Salvage Concurrent Radio-chemotherapy for Post-operative Local Recurrence of Squamous Cell Esophageal Cancer Marcel Verheij 1070 Performance of a Nomogram Predicting Disease-specific Survival After an R0 Resection for Gastric Cancer in Patients Receiving Postoperative Chemoradiotherapy Terence Sio 1071 Outcome of Transplant-Fallout Patients With Unresectable Cholangiocarcinoma Gang Cai 1072 Phase II Study of Irinotecan and Capacitabine Concurrent With Intensity-Modulated Radiation Therapy in the Treatment of Recurrent Rectal Rancer

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required.

76

Award Recipient

Live Interactive SAMs/ Session Separate Registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

1:15 p.m. - 2:45 p.m.

Educational Session 311 Advances in Treatment Planning for Prostate Cancer

Room: 253 A-C

Cynthia Menard, MD, Princess Margaret Hospital Mark Buyyounouski, MD, MS, Fox Chase Cancer Center

1:15 p.m. - 2:45 p.m.

Educational Session 312 Low/High Grade Gliomas – An Update

Room: 107 A-C

Changhu Chen, MD, University of Colorado Daphne Adele Haas-Kogan, MD, University of California San Francisco John Kirkpatrick, MD, PhD, Duke University

1:15 p.m. - 2:45 p.m.

Nurses’ Session

Protons, Neutrons and Advanced Technologies in Radiation Therapy

Room: 206 A-B

A

ARON

Jeanne Sixta, RN, BSN, OCN, NIU Institute of Neutron Therapy at Fermilab Catherine Mannix, RN, MSN, OCN, The Clark Center for Radiation Oncology Michael Kirk, PhD, Mass General North Shore Center for Outpatient Care

Tuesday | October 30 3:00 p.m. - 4:30 p.m.

Scientific Session Y

Breast II - Treatment Techniques

Room: 205 A-C

Moderators: Sanjeev Aggarwal Alice Ho

4:10 N. Rodriguez de Dios 215 Interim Cosmetic Results and Toxicity Using 3-D Conformal External Beam Radiotherapy to Deliver Accelerated Partial Breast Irradiation in Patients With Early-stage Breast Cancer 4:20

3:00 Etin-Osa Osa 208 Prospective Randomized Trial of Prone Accelerated Whole Breast Radiotherapy With a Concurrent Daily vs. Weekly Boost to the Tumor Bed: Acute Toxicity 3:10 Ran Peng 209 Intensity Modulated Radiotherapy With Integrated Boost After Breast Conservative Surgery in Breast Cancer Patients: A Prospective Study 3:20 Florian Wuerschmidt 210 Dose to LAD Might Be Critical in Prone Whole Breast Irradiation: A Dosimetric Comparison of Coronary Arteries and Heart in Prone vs. Supine Whole Breast Irradiation 3:30 Chirag Shah 211 Should Ductal Carcinoma In Situ Be Removed From the ASTRO Cautionary Group for Off-Protocol Use of Accelerated Partial Breast Irradiation (APBI)? A Pooled Analysis of Outcomes for 300 Patients With DCIS Treated With APBI 3:40 Peter Chen 212 Clinical Efficacy of Two vs. 5-day Accelerated Partial Breast Irradiation Delivered Via Balloon-based Brachytherapy: Results of A Matched Pair Analysis 3:50 Alphonse Taghian 213 Three-dimensional Conformal External-Beam Accelerated Partial Breast Irradiation (3-D APBI): Results of a Phase I Dose Escalation Study

Julia White

Discussant

3:00 p.m. - 4:30 p.m.

Scientific Session Z

GI III - Pancreatic Cancer

Room: 206 A-B

Moderators: Michael Haddock Sarah Hoffe 3:00 Natalie Ausborn BRCA Expression: A Biomarker in Resectable Pancreatic Cancer?

216

3:10 David Yu 217 A Synthetic Lethal Screen Identifies Genes That Mediate Gemcitabine Resistance in Pancreatic Cancer 3:20 Sunpreet Rakhra 218 A Multi-institute Retrospective Review of Concurrent Full-dose Gemcitabine With Radiation vs. Concurrent Fluorouracil With Radiation for Locally Advanced Pancreatic Cancer 3:30 Jordan Kharofa 219 Neoadjuvant Chemoradiation With IMRT in Resectable and Borderline Resectable Pancreatic Cancer (PCa) 3:40 Shane Lloyd 220 A Comparison of Three Treatment Strategies for Locally Advanced and Borderline Resectable Pancreatic Cancer

4:00 Robert Kuske 214 Accelerated Partial Breast Irradiation for Select Breast Cancers in the Presence of Augmentation

ASTRO 2012 / 54TH ANNUAL MEE TING

77

Tuesday | October 30 3:50 Francoise Mornex 221 Revisiting the Multimodal Adjuvant Treatment of Pancreatic Carcinoma Through Optimized Regimen Combining Gemcitabine Plus Oxaliplatin Chemotherapy Followed by Concurrent Gemcitabine and Modern Radiation Therapy: Long-term Survival Favorable Results 4:00 William Hall 222 Influence of Adjuvant Radiation Therapy Dose and Fraction on Overall Survival for Pancreatic Adenocarcinoma 4:10 Thomas Brunner 223 Results of a Multi-center Randomised Phase II Trial Of Resection +/- Neoadjuvant Chemoradiotherapy in Pancreatic Cancer 4:20

Edgar Ben-Josef

Discussant

3:00 p.m. - 4:30 p.m.

Scientific Session AA GU III - Prostate Cancer: High risk/Androgen Deprivation/Metastatic PCA

Room: 258 A-C

Moderators: Mark Buyyounouski Paul Nguyen 3:00 Zachary Zumsteg 224 Short-term Androgen Deprivation Decreases Distant Metastasis and Prostate Cancer Specific Mortality in Intermediate-risk Prostate Cancer Patients Undergoing Dose Escalated External Beam Radiotherapy 3:10 Daniel Hamstra 225 Gleason Pattern 5 Is Associated With an Increased Risk for Metastasis Following Androgen Deprivation Therapy (ADT) and Radiation: An Analysis of RTOG 9202 and 9902

78

ASTRO 2012 / 54TH ANNUAL MEE TING

3:20 Nancy Mendenhall 226 Early Patterns of Failure in a Prospective Trial of Concomitant Docetaxel and Proton Therapy for High-risk Prostate Cancer 3:30 Nicholas Sanfilippo 227 Long-term Follow-up of a Prospective Phase I-II Study of Concurrent Paclitaxel and Radiation Therapy With Hormonal Ablation in Locally Advanced Prostate Cancer 3:40 Chi Zhang 228 Metformin Improves Prostate Cancer Specific Survival and Inhibits the Development of Castrate Resistant Metastasis 3:50 Arti Parekh 229 Identification of Comorbidities That Place Men at Highest Risk of Harm from Androgen Deprivation Therapy for Prostate Cancer 4:00 Scott Morgan 230 Who Dies from Prostate Cancer? An Analysis of the SEER Database 4:10 Kimberley Mak 231 Diabetes and Cardiovascular Mortality in Men With Locally Advanced Prostate Cancer: Updated Analysis from RTOG 92-02 4:20 Rahul Tendulkar 232 Mortality in Men Treated With Radiotherapy and Androgen Deprivation for High-risk Prostate Cancer in the Modern Era is Driven by Non-Prostate Cancer Deaths

Tuesday | October 30 3:00 p.m. - 4:30 p.m.

Scientific Session BB GYN II - Endometrial, Vulvar, Vagina, Ovarian Cancer

Room: 109 A-B

Moderators: Lilie Lin William Small 3:00 Hannah Yoon 233 Contouring Guidelines of the Inguinal Lymph Nodes Using Lymphangiograms for the Delivery of Radiotherapy in Gastrointestinal, Gynecological and Genitourinary Cancers 3:10 Mei Ling Yap 234 The Prognostic Significance of Human Papilloma Virus and P16 In Patients With Vulvar Squamous Cell Carcinoma Treated With Radiotherapy 3:20 Aaron Brown 235 Involved-field Radiation Therapy for Locoregionally Confined Ovarian Cancer 3:30 Larissa Lee 236 Non-serous Histology and Platinum Sensitivity Are Prognostic in Localized Recurrent Ovarian Cancer Treated With Radiation Therapy (RT) 3:40 Ji Hyun Kim 237 Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy 3:50 Richard Cattaneo II 238 Interval Between Hysterectomy and Start of Radiation Treatment is Predictive of Recurrence in Patients With Endometrial Carcinoma. A single Institution Experience 4:00 Emily Dunn 239 Predictive Factors for Recurrence Following Post-operative Vaginal Cuff Brachytherapy Alone for Stage I Endometrial Cancer

4:10 Dane Cohen 240 A Cost Analysis of Two Different Planning Strategies for the Delivery of Vaginal Vault Brachytherapy 4:20 Jared Robbins 241 The Impact of Age-adjusted Charlson Comorbidity Index on Survival in Patients With Early-stage Uterine Carcinoma. A Single Institution Study

3:00 p.m. - 4:30 p.m.

Scientific Session CC Health Services Research II - Quality of Care

Room: 204 A-B

Moderators: Prajnan Das Timothy Showalter 3:00 Anand Shah 242 Physician Evaluation of Web-based Consumer Health Information on Proton Therapy for Prostate Cancer 3:10 Patricia Hardenbergh 243 Linking Community Cancer Center Physicians to Disease Site-specific Experts 3:20 Nabeel Arastu The Incidence and Factors Associated With Unplanned Hospital Admissions in Patients Receiving Radiation Therapy

244

3:30 Susan McCloskey 245 Adapting the PRO-CTCAE for Patient Reporting of Toxicity in Radiation Oncology 3:40 Louis Potters 246 How Treatment Pathways Can Be Used to Measure the Value of Cancer Care in the Era of the Accountable Care Act 3:50 Robin Famiglietti 247 Determinants of Patient Satisfaction for Patients Receiving Radiation Therapy

ASTRO 2012 / 54TH ANNUAL MEE TING

79

Tuesday | October 30 4:00 Amit Maity Improving Safety Culture Through Incident Reporting

248

4:10 Aaron Kusano 249 Burnout in Academic Chairs of Radiation Oncology in the United States: The SCAROP Survey

3:40

Maria Werner-Wasik

Discussant

3:50 Ben Wilkinson 255 Volumetric Analysis of FDG-PET Uptake After Local Recurrence Following Stereotactic Body Radiotherapy for Early-stage Non-small Cell Lung Cancer

4:20 Hodaka Numasaki 250 Japanese Structure Survey of Radiation Oncology in 2009 Based on Institutional Stratification of Patterns of Care Study

4:00 Victor Mangona 256 SUV Kinetics of Weekly 18F FDG-PET During Radiotherapy Predict Eventual Outcome in Locally-advanced Non-small Cell Lung Cancer (NSCLC)

3:00 p.m. - 4:30 p.m.

4:10 Nadya Shusharina Correlation of FDG Avid Volumes of Initial and Recurrent Lung Cancers After Radiotherapy or Chemoradiotherapy

Scientific Session DD Lung III - Toxicity and Brain/PET

Room: 160 A-C

Moderators: Jeffrey Bogart Roy Decker 3:00 Hidenari Hirata Acquired Resistance to EGFR Tyrosine Kinase Inhibitors is Associated With Low Efficacy of Radiotherapy for Brain Metastases From EGFR-mutant Lung Adenocarcinoma

251

257

4:20 Daniel Tandberg 258 Prognosis and Patterns of Failure of Patients With NSCLC Having Hypermetabolic Mediastinal Lymph Nodes on Preoperative PET but N0-N1 Disease on Pathological Analysis

3:00 p.m. - 4:30 p.m. 3:10 Hong Qing Zhuang 252 Phase II Study of WBRT With or Without Concurrent Erlotinib for Patients With Brain Metastases From Lung Adenocarcinoma 3:20 Brian Alexander 253 Aggressive Therapy to the Thoracic Primary is Associated With Improved Survival in Patients With Non-small Cell Lung Carcinoma Presenting With Synchronous Metastases Limited to the Brain 3:30 Elizabeth Gore 254 Phase III Comparison of Prophylactic Cranial Irradiation vs. Observation in Patients With Locally Advanced Non-small Cell Lung Cancer: Updated Analysis of RTOG 0214

80

ASTRO 2012 / 54TH ANNUAL MEE TING

Scientific Session EE Biodosimetry and Normal Tissue Radiobiology

Room: 254 A-B

Moderators: Deborah Citrin Brian Marples 3:00 Naduparambil Jacob 259 Circulating MicroRNA-21 As a Sensitive Marker for Radiation Biodosimetry 3:10 Deborah Citrin 260 Bone Marrow Mesenchymal Stromal Cell Infusion Improves Radiation-induced Cutaneous Fibrosis in a Murine Model 3:20 Junqiang Tian Darinaparsin: Tumor Radiosensitizer That Radioprotects Intestinal Epithelium

261

Tuesday | October 30 3:30 Melvin Chua 262 DNA Double-strand Break Repair and Induction of Apoptosis In Relation to Late Normal Tissue Responses Following Radiotherapy for Early Breast Cancer 3:40 Cullen Taniguchi 263 Prolyl Hydroxylase Inhibition Protects Against and Mitigates Radiation-Induced Gastrointestinal Toxicity Through Improved Integrity and Function of the GI Epithelium 3:50 Saikat Das 264 Probability of Radiographic Radiation Pneumonitis (RP) and Fibrosis (RF) After Stereotactic Ablative Radiotherapy (SABR) for Lung Cancer using NTCP model 4:00 Brian Marples 265 A New Use for an Old Treatment: Radiation Therapy and Alzheimer’s Disease 4:10 Mackenzie McGee 266 Ionizing Radiation May Lead to Downregulation of Amyloid Precursor Proteins Causing Significant Reductions in β-Amyloid Plaque Burden in a Murine Model for Alzheimer’s Disease 4:20 Alexander Stessin 267 Fty720, Sphingosine 1-phosphate Receptor Modulator, Selectively Radioprotects Hippocampal Neural Stem Cells

3:00 p.m. - 4:30 p.m.

Scientific Session FF Tumor Imaging and Delineation

Room: 052 A-B

Moderators: Indrin Chetty Jan-Jakob Sonke 3:00 Catherine Coolens 268 Feasibility of a Novel 4-D Perfusion CT Method for Response Assessment in Hepatocelullar Carcinoma Patients Treated With Radiation And Sorafenib Basic Science Abstract Award Winner – PHYSICS

3:10 Jiajia Ge 269 Planning Four-dimensional Computational Tomography (4-D CT) Cannot Adequately Represent Daily Intrafractional Motion of Abdominal Tumors 3:20 Gregory Perkins 270 Prospective Study of Three-dimensional Isotropic MRI-SIM Imaging of the Head and Neck At 1.5T: Comparison With Two-dimensional Imaging Sequences 3:30 Nataliya Kovalchuk 271 Repeat CT Simulation During Whole Breast Irradiation Can Influence the Selection of Treatment Modality for Breast Cancer Tumor Bed Boost 3:40 Ion Moraru 272 Multimodality Image-based Target and Normal Structure Delineation for Dose Painting of Pancreatic Cancer 3:50 Xin Ming A Novel Auto-segmentation Method for Lung Tumor on 18F-FDG PET images

273

4:00 Cungeng Yang 274 Deformable Breast MRI and CT Registration for Radiation Treatment Planning Using B-Spline With Rigidity and Feature Point Distance Regularization

ASTRO 2012 / 54TH ANNUAL MEE TING

81

Tuesday | October 30 4:10 Christian Hollensen 275 Does the Progress in Radiotherapy Make Higher Demand to Inter-observer Variability Correction? A Case Study of IMRT and Volumetric Arc Therapy 4:20 Eman Al Sulaimani 276 Evaluation of an Internal Surrogate for Mediastinal Lymph Node Localization

Digital Poster Discussion 07 Central Nervous System

Room: 156 A-C

Discussants: Laurie Gaspar Samuel Ryu Rebecca Wong 1073 Radiological Diagnosis of Malignant Spinal Cord Compression – A More Favorable Entity? Scott Soltys 1074 Stereotactic Radiosurgery for the Treatment of Spinal Metastases: Analysis of Tumor Control and Patterns of Failure 1075

D. Michael Lovelock 1076 Correlation of Local Failure With Measures of Dose Insufficiency in the High-dose Single-fraction Treatment of Bony Metastases Shahed Badiyan 1077 I-125 Episcleral Plaque Brachytherapy for Uveal Melanoma: A 15 Year Single Institution Experience

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

82

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

Bradford Perez 1079 Evaluating the Relationship Between Prescription Dose and Overall Survival Among Patients Treated With I-125 Brachytherapy for Posterior Uveal Melanoma Kavita Mishra 1080 Long Term Update on UCSF-LBNL Prospective, Randomized Trial: Charged Particles vs. Iodine-125 Plaque Therapy in the Management of Uveal Melanoma

3:00 p.m. - 4:30 p.m.

Matthias Guckenberger Variability in Spine Radiosurgery Treatment Planning – Results of an International Multi-institutional Study

Leonel Kahn 1078 I-125 Plaque Brachytherapy for Choroidal Melanoma: Mature Single-institution Outcomes

Yuta Shibamoto 1081 Primary Central Nervous System Lymphoma (PCNSL) Treated by Radiotherapy: A Nationwide Survey of 2005-2009 Patients and Comparison With 1985-2004 Data Alexander Stessin 1082 The Role of Postoperative Radiotherapy in the Treatment of Meningeal Hemangiopericytoma: A Surveillance, Epidemiology and End Results (SEER)-based Analysis Carolyn Barnes 1083 Fractionated Proton Beam Therapy of Acoustic Neuromas and Hearing Preservation Stephanie E. Combs 1084 Long Term Results and Patient Self-reported Outcome in Patients Treated With Fractionated Stereotactic Radiotherapy (FSRT) or Stereotactic Radiosurgery (SRS) for Acoustic Neuroma

Tuesday | October 30 3:00 p.m. - 4:30 p.m.

Aaron Wild 1094 Utility of Fiducials in Image-guided SBRT for Patients With Locally Advanced Pancreatic Cancer: Analysis of Visibility and Migration

Digital Poster Discussion 08 SBRT Techniques

Room: 157 A-C

Discussants: Daniel Low Gikas Mageras Benjamin Fahimian 1085 Prospectively Gated CBCT for Volumetric Image Guidance in SBRT Joerg Rottmann 1086 Real-time Tracking of Markerless Lung Tumors During SBRT With Continuous MV Imaging Robert Taylor 1087 Intrafraction Fiducial Tracking With Real-time Treatment Intervention in Lung SBRT Gitte Persson 1088 Feasibility and Stability of Trans-thoracic Implanted Markers in Peripheral Lung Tumors for Stereotactic Body Radiotherapy Joanne Zhung 1089 Evaluation of RTOG Guidelines for Monte Carlo Based Lung SBRT Planning Michael Velec 1090 Impact of Dose-probability PTV Margins and Mean Respiratory Position on Liver SBRT Dose James Christensen 1091 Treatment Dose Verification in Liver SBRT Using a Deformable Respiratory Motion Model and Treatment Beam’s-eye-view Fluoroscopy With Tumor Tracking Peng Dong 4pi Radiotherapy for Liver SBRT

1092

Wensha Yang 1093 Is Cone Beam CT Alone Sufficient for Localization of Pancreas/Liver Tumor During Free-breathing SBRT?

Claudio Sole 1095 Stereotactic Ablative Radiotherapy Delivered by Image Guided Helical Tomotherapy for Extracraneal Oligometastasis Wilko Verbakel 1096 Digital Tomosynthesis Performance for Spine Tracking

3:00 p.m. - 4:30 p.m.

Educational Session 313 Head and Neck Case Presentations

Room: 253 A-C

Louis B. Harrison, MD, FASTRO, Beth Israel Medical Center Robert Amdur, MD, University of Florida Robert Haddad, MD, Dana-Farber Cancer Institute, Havard Medical School Avraham Eisbruch, MD, University of Michigan Health Systems Adam Jacobson, MD, Beth Israel Medical Center

3:00 p.m. - 4:30 p.m.

Educational Session 314 Radiation Oncology in the Era of Delivery System and Payment Reform

Room: 107 A-C

C. Leland Rogers, MD, Gamma West Cancer Services Miranda Kim, MD, MBA, University of Pennsylvania Health Systems Lee Newcomer, MD, United Healthcare Justin Bekelman, MD, University of Pennsylvania Najeeb Mohideen, MD, Northwest Community Hospital Dean Rosen, Mehlman Vogel Castagnetti

ASTRO 2012 / 54TH ANNUAL MEE TING

83

Tuesday | October 30 3:00 p.m. - 4:30 p.m.

4:45 p.m. - 6:15 p.m.

Adult Cancer Survivors: One Size Doesn’t Fit All

Innovative Clinical Trial Designs

Nurses’ Session

Panel 12

Room: 153 A-C

A

ARON

Richard Boyajian, RN, MS, NP, Dana-Farber Cancer Institute

4:45 p.m. - 6:15 p.m.

Panel 11

Quality Control of Lung SBRT: From 4-D Simulation to 4-D Verification

Room: 210 A-C

Moderators: Stanley Benedict, PhD, University of Virginia Health System Fang-Fang Yin, PhD, Duke University Medical Center Panelists: Jeffrey Bradley, MD, Washington University School of Medicine Jing Cai, PhD, Duke University Medical Center Krishni Wijesooriya, PhD, University of Virginia

Room: 253 A-C

Moderators: Brian Alexander, MD, Dana-Farber/Brigham and Women’s Cancer Center Giovanni Parmigiani, PhD, Dana-Farber/Brigham and Women’s Cancer Center Panelists: Donald Berry, PhD, MD Anderson Cancer Center Kathleen Blake, MD, MPH, Center for Medical Technology Policy Michael Krams, MD, Janssen Pharmaceuticals Daniel Normolle, PhD, University of Pittsburgh Lorenzo Trippa, PhD, Dana-Farber/Brigham and Women’s Cancer Center

4:45 p.m. - 6:15 p.m.

Panel 13

Patient Reported Outcomes: “Hearing the Patient’s Voice” in a User-friendly and Meaningful Way

Room: 109 A-B

Moderator: Benjamin Movsas, MD, Henry Ford Health System Panelists: Debroah Watkins-Bruner, PhD, RN, Emory University Jeff Sloan, MD, Mayo Clinic Benjamin Movsas, MD, Henry Ford Health System Ronald Chen, MD, University of North Carolina at Chapel Hill

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

84

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

Tuesday | October 30 4:45 p.m. - 6:15 p.m.

4:45 p.m. - 6:15 p.m.

Primer on Cost-effectiveness Analysis in Radiation Oncology

Hypofractionation in the Management of CNS Tumors

Panel 14

Room: 107 A-C

Moderators: Justin Bekelman, MD, University of Pennsylvania David Sher, MD, MPH, Rush University Medical Center Panelists: G. Scott Gazelle, MD, PhD, Massachusetts General Hospital James Chambers, PhD, MPharm, Tufts Medical Center Eve Wittenberg, MPP, PhD, Harvard School of Public Health Andre Konski, MD, MBA, Wayne State University School of Medicine

Educational Session 315 Room: 153 A-C

Eric Lin Chang, MD, USC Keck School of Medicine Michael Milano, MD, PhD, University of Rochester Timothy Solberg, PhD, UT Southwestern Medical Center

4:45 p.m. - 6:15 p.m.

Educational Session 316 An Overview of Projection Imaging and Digital Concepts for Radiation Oncology

Room: 258 A-C

Peter Balter, PhD, MD Anderson Cancer Center Mary Kara Bucci, MD, Anchorage Radiation Therapy Center

4:45 p.m. - 6:15 p.m.

Panel 15

Tumor Metabolism and Radiation Response

Room: 160 A-C

Moderators: Mark W. Dewhirst, DVM, PhD, FASTRO, Duke University Medical Center Bradly Wouters, PhD, Ontario Cancer Institute Panelists: Matthew Vander Heiden, MD, FASTRO, Massachusetts Institute of Technology Ruth Muschel, MD, PhD, University of Oxford, Gray Institute Thomas Brunner, MD, University of Oxford Jann- Nagina Sarkaria, MD, Mayo Clinic

ASTRO 2012 / 54TH ANNUAL MEE TING

85

Wednesday | October 31 8:00 a.m. - 9:30 a.m.

8:00 a.m. - 9:30 a.m.

Challenging Cases in the Management of Newly Diagnosed and Recurrent Prostate Cancer

Challenging Lung Cancer Cases

Educational Session 401

Room: 258 A-C

Anthony V. D’ Amico, MD, PhD, FASTRO, Brigham and Women’s Hospital Juanita Crook, MD, University of British Columbia Adam Kibel, MD, Washington University School of Medicine W. Robert Lee, MD, MS, MEd, Duke University Malcolm Mason, MD, Cardiff University

Educational Session 404 Room: 253 A-C

Benjamin Movsas, MD, Henry Ford Health System Branislav Jeremic, MD, PhD, University of Kragujevac Zane Hammoud, MD, Henry Ford Hospital Corey Langer, MD, University of Pennsylvania

8:00 a.m. - 9:30 a.m.

Educational Session 405 8:00 a.m. - 9:30 a.m.

Educational Session 402 Management of Less Common Head and Neck Cancer Including Unknown Primary, Sinonasal Cancer and Salivary Gland Cancer

Room: 205 A-C

Min Yao, MD, PhD, University Hospitals Case Medical Center Nancy Lee, MD, Memorial Sloan-Kettering Cancer Center Quynh-Thu Le, MD, Stanford University

Controversies on the Role of Radiation Therapy in the Management of Hodgkin Lymphoma (HL)

Room: 153 A-C

Peter M. Mauch, MD, FASTRO, Harvard Medical School Lena Specht, MD, PhD, Rigshospitalet, University of Copenhagen

8:00 a.m. - 9:30 a.m.

Educational Session 406 Integration of Safety in Quality Assurance Programs

8:00 a.m. - 9:30 a.m.

Educational Session 403 Difficult Cases in Cervical and Vulvar Cancer Management

Room: 107 A-C Patricia J. Eifel, MD, FASTRO, MD Anderson Cancer Center Anthony Russell, MD, Massachusetts General Hospital Lilie Lin, MD, University of Pennsylvania Akila Viswanathan, MD, Brigham and Women’s Hospital Catheryn Yashar, MD, University of California San Diego

86

ASTRO 2012 / 54TH ANNUAL MEE TING

Room: 109 A-B

Benedick A. Fraass, PhD, FASTRO, Cedars-Sinai Medical Center Ramon Alfredo Siochi, PhD, University of Iowa Hospital and Clinic

Wednesday | October 31 8:00 a.m. - 9:30 a.m.

Educational Session 407 ASTRO/PROS Session: Challenging Cases in Childhood Brain Tumors

Room: 206 A-B

Nadia Laack, MD, MS, Mayo Clinic Anita Mahajan, MD, MD Anderson Cancer Center Daniel Hamstra, MD, PhD, The University of Michigan

9:45 a.m. - 10:45 a.m.

Keynote Address III: Value-based Health Care Delivery

Room: Grand Ballroom Professor Michael E. Porter, PhD, Harvard Business School Introduction by: Bruce G Haffty, MD, FASTRO, UMDNJ Robert Wood Johnson Medical Center

8:00 a.m. - 9:30 a.m.

Educational Session 408 Alpha Particle Therapy is Here: Incorporating Novel Radiopharmaceuticals into Your Practice

Room: 204 A-B

Michael Tomblyn, MD, MS, H. Lee Moffitt Cancer Center James Welsh, MD, MS, Fermi National Accelerator Laboratory

8:00 a.m. - 9:30 a.m.

Educational Session 409 Molecular Radiobiology - Concepts and Clinical Applications

Room: 254 A-B

Brian Marples, PhD, William Beaumont Hospital Anthony Chalmers, MD, Beatson West of Scotland Cancer Centrer

8:00 a.m. - 9:30 a.m.

Educational Session 410 Advanced Treatment Technologies: Design, Control Systems and Commissioning

11:00 a.m. - 12:30 p.m.

Scientific Session GG

Breast III - Locally Advanced/New Modalities

Room: 205 A-C

Moderators: Shannon MacDonald Rachel Rabinovitch 11:00 Jee Suk Chang 277 Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 13-Year Follow-up 11:10 Dayssy Diaz 278 Locoregional Outcomes in Clinical Stage IIB Breast Cancer After Neoadjuvant Therapy and Mastectomy With or Without Chest Wall and Supraclavicular Radiation 11:20 Alexander Louie 279 Prospective Evaluation of Radiation Pneumonitis in Neoadjuvant Concurrent Docetaxel and Radiation Therapy for Locally Advanced Breast Cancer

Room: 210 A-C

Lei Xing, PhD, Stanford University Timothy Solberg, PhD, UT Southwestern Medical Center James Balter, PhD, University of Michigan

11:30 Yasuhiro Ogawa 280 Non-surgical Breast-conservation Treatment (KORTUC-BCT) Using a New Image-guided, Enzyme-targeted and Breast Cancer Stem Cell-Targeted Radiosensitization Treatment (KORTUC II) for Patients With Stage I or II Breast Cancer

ASTRO 2012 / 54TH ANNUAL MEE TING

87

Wednesday | October 31 11:40 Shannon MacDonald 281 Prospective Pilot Study of Proton Radiation Therapy for Invasive Carcinoma of the Breast Following Mastectomy in Patients With Unfavorable Anatomy; First Reported Clinical Experience

11:00 a.m. - 12:30 p.m.

11:50 Rajni Sethi 282 Phase I/II Study of Prone Accelerated IMRT to Treat the Breast, Level III Axilla and Supraclavicular Nodes

11: 00 Kimberly Johung 286 The Radiosensitivity of Tyrosine Kinase Driven Non-small Cell Lung Cancer

Scientific Session HH CNS III – Metastasis

Room: 109 A-B

Moderators: Michele Alanso-Basanta Martin Fuss

12:00 Charlotte Dai Kubicky 283 Prognostic Significance of Number of Positive Lymph Nodes (+ LNs) in Women With T1-2N1 Breast Cancer Treated With Mastectomy: Should Patients With 1, 2 and 3 + LNs Be Grouped Together?

11:10 Ana Kiess 287 Ipilimumab and Stereotactic Radiosurgery for Melanoma Brain Metastases

12:10 Aparna Kesarwala 284 Symptoms, Physical Impairments and Function in Breast Cancer Patients With 1-3 Positive Axillary Lymph Nodes

11:20 A. Gabriella Wernicke 288 Phase I/II Study of Neurosurgical Resection and Intra-operative Cesium-131 Radio-isotope Brachytherapy in Patients With Newly Diagnosed Brain Metastases

12:20 Melissa Skolny 285 A Nomogram for Estimating the Risk of Lymphedema Following Treatment for Breast Cancer

11:30 Leslie Modlin 289 Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Post-operative Resection Cavity for Brain Metastases 11:40 Zachary Kohutek 290 Clinical Factors Associated With Radiation Necrosis After Stereotactic Radiosurgery for Brain Metastases 11:50 Kapila Kalakota 291 Validation of the Breast Cancer Specific Graded Prognostic Assessment (GPA) for Patients With Breast Cancer With Brain Metastases 12:00 Brett Cox 292 Spinal Cord Toxicity With Highdose, Single Fraction Spinal Stereotactic Radiosurgery 12:10 Penny Sneed 293 Risk Factors for Radiation Necrosis After Gamma Knife Radiosurgery for Brain Metastases 12:20

88

ASTRO 2012 / 54TH ANNUAL MEE TING

Glenn Stuart Bauman

Discussant

Wednesday | October 31 11:00 a.m. - 12:30 p.m.

Scientific Session II

GU IV- Bladder Cancer/Kidney Cancer/ Seminoma

Room: 204 A-B

Moderators: Anne Kiltie Stanley Liauw 11:00 Rodney Ellis 294 Stereotactic Radiosurgery for Renal Cancer: Phase I Safety and Toxicity 11:10 Stacey Fedewa 295 Utilization of Potentially Curative Therapies for Muscle Invasive Bladder Cancer: Results From the National Cancer Data Base 11:20 Robert Huddart 296 Results of the SPARE Feasibility Study – Selective Bladder Preservation Against Radical Excision in Muscle Invasive T2/T3 Transitional Cell Carcinoma of the Bladder (CRUK/07/011) 11:30 Jason Efstathiou 297 Factors Associated With Clinical-Pathologic Stage Discrepancy in Bladder Cancer Patients Treated With Radical Cystectomy: Implications for Treatment Selection and Comparative Studies 11:40 Justin Bekelman 298 Radical Cystectomy (RC) vs. Bladder Preservation Therapy (BPT) for Muscle-Invasive Bladder Cancer

12:10 Christopher Hallemeier 301 Long-term Outcomes of Radiotherapy for Stage II Testicular Seminoma 12:20

Nicholas James

Discussant

11:00 a.m. - 12:30 p.m.

Scientific Session JJ

Health Services Research III – Large Population-based and Decision Analysis

Room: 153 A-C

Moderators: B. Ashleigh Guadagnolo Rinaa Punglia 11:00 Trevor Royce 302 Does Patient Life Expectancy (LE) Affect Receipt of Routine Cancer Screening in the United States? A Population-Based Study 11:10 B. Ashleigh Guadagnolo 303 A Population-based Study to Assess Utilization of Radiation Therapy at the End of Life Among U.S. Medicare Beneficiaries 11:20

Cary Gross

Discussant

11:30 Gary Walker 304 Evaluating the Accuracy of Receipt of Breast Radiation Therapy in the Surveillance, Epidemiology and End Results Database Withdrawn

305

11:50 William Shipley 299 Long-term Outcomes After Bladder Preserving Combined Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of RTOG 8802, 8903, 9506, 9706, 9906 and 0233

11:40 Carl Nelson 306 Certificate of Need (CON) Status and Its Impact on Overtreatment of Low-risk Prostate Cancer in the Elderly

12:00 Benjamin Goldsmith 300 Common Iliac Nodal Involvement in Clinical T2 Bladder Cancer: Implications for Definitive Radiation

11:50 Pavan Jhaveri Emergence of Integrated Urology-Radiation Oncology Practices in the State of Texas

ASTRO 2012 / 54TH ANNUAL MEE TING

307

89

Wednesday | October 31 12:00 Nataniel Lester-Coll 308 Balancing Competing risks of Recurrence and Death From High-risk Prostate Cancer vs. Cardiovascular Mortality in Men Treated With Hormonal Therapy: A Decision Analysis 12:10 Ravi Parikh 309 Primary Radiotherapy vs. Radical Prostatectomy for High-risk Prostate Cancer: A Decision Analysis

11:00 a.m. - 12:30 p.m.

Scientific Session KK

Biologic Radiosensitizers I

Room: 206 A-B

Moderators: Christopher Barker Amit Maity 11:00 Tina Dasgupta 310 Survival Advantage With Radiation Combined With A Selective BRAFV600E Inhibitor In An Orthotopic, Intracranial Model Of BRAFV600E-mutated High-grade Gliomas Basic Science Abstract Award Winner – BIOLOGY 11:10 David Viertl 311 Tumor Radiosensitization Induced by a-RasGAP Derived Peptide and Its Pharmacokinetic in Mice 11:20 Yong Cha 312 Aging-related Tumor Suppressor SIRT2 Modulates Cancer Metabolism Through Regulation of Pyruvate Kinase M2 (PKM2) 11:30 Kazi Ahmed 313 NF-kB-Mediated β1-integrin Overexpression in Radioresistance of Malignant Breast Cells in Three-dimensional Culture Basic Science Abstract Award Winner – BIOLOGY

314

11:50 Amit Maity 315 Inhibition of Autophagy As a Strategy to Augment Radiosensitization by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 12:00 Manuel Roehrich 316 Triple Therapy of Radiation and Combined Integrin and EGFR Blockade in an Orthotopic Glioblastoma Model 12:10 Vasu Tumati 317 AZD5438, an Inhibitor of CDK 1, 2 and 9, Enhances the Radiosensitivity of Non-small Cell Lung Carcinoma Cells 12:20 Heping Yan 318 Targeting of Radiation Inducible Antigen on Human Lung Cancer Cells

11:00 a.m. - 12:30 p.m.

Scientific Session LL

Patient Safety and Quality Assurance

Room: 253 A-C

Moderators: Benedick Fraass Todd Pawlicki 11:00 Stephen Kry 319 Algorithms Used in Heterogeneous Dose Calculations Show Systematic Error As Measured With the Radiological Physics Center’s Anthropomorphic Thorax Phantom Used for RTOG Credentialing 11:10 Dan Ruan 320 Plan Quality Inference and Cross Validation for Standardization and Consistency Evaluation 11:20 Tarun Podder 321 AAPM-ESTRO Guidelines for Image-Guided Robotic Brachytherapy: Report from Task Group 192



90

11:40 Henning Willers Recombinational DNA Repair Defects in Lung Cancer and PARP Inhibitor Sensitivity

ASTRO 2012 / 54TH ANNUAL MEE TING

Wednesday | October 31 11:30 Heming Zhen 322 The Impact of TPS and Machine Delivery Errors on Clinical Outcomes As Estimated by Biological Models 11:40 Olivier De Hertogh 323 The Weakest Link – Medical Physicists Need Dedicated Software and Further Training to Improve the Quality of Rotational IMRT 11:50 Samantha Price 324 A Real-time Scintillating Fiber Detector to Improve Patient Safety in External Beam Radiotherapy

11:10 Parag Parikh 329 Comparison of Onboard Low-field MRI vs. CBCT/ MVCT For Anatomy Identification in Radiotherapy 11:20 Matthew Abramowitz 330 Noninvasive Real-time Prostate Tracking Using a Transperineal Ultrasound Approach 11:30 Christoph Tremmel 331 Dual Energy CT: Treatment Planning for Proton and Ion Radiotherapy Beyond Standard Tissue Composition

12:00 Maria Anna Czerminska 325 Data Integrity Verification System to Improve Safety of Radiation Therapy Treatments

11:40 Wilfred Ngwa In Vitro Dose Enhancement From Gold Nanoparticles During Low-dose-rate Gamma Irradiation With I-125 Brachytherapy Seeds

12:10 Daniel Letourneau 326 Multi-center Collaborative Quality Assurance Program for the Province of Ontario, Canada: First Year Results

11:50 Yusung Kim 333 Local Targeted Delivery of Micro-size Radiotherapy-source Using Temperature-sensitive Hydrogel (RT-GEL)

12:20 Andrea Lo 327 A Province-wide Quality Assurance (QA) Review of Stereotactic Body Radiotherapy (SBRT) Treatment Planning for Lung Cancer

12:00 Lanade Souza-Lawrence 334 Novel Applications of an Injectable Radio-opaque Hydrogel Tissue Marker for Management of Thoracic Malignancies

11:00 a.m. - 12:30 p.m.

12:10 Manish Sethi 335 Tunable Drug Release of Polymeric Nanoparticles for the Delivery of DNA Double-strand Break Repair Inhibitors

Scientific Session MM

Emerging Technologies and Concepts

Room: 210 A-C

Moderators: James Balter Fang-Fang Yin 11:00 Yu Kuang 328 Development of XFCT Imaging Strategy for Monitoring the Spatial Distribution of Platinum Drugs: Instrumentation and Phantom Validation Basic Science Abstract Award Winner – PHYSICS

332

12:20 Xiaoming Chen 336 In Vivo Evaluation of the Therapeutic Effects of Non-thermal Focused Ultrasound, Radiation and Their Combination for Prostate Cancer Therapy

ASTRO 2012 / 54TH ANNUAL MEE TING

91

Wednesday | October 31 11:00 a.m. - 12:30 p.m.

11:00 a.m. - 12:30 p.m.

Sarcoma and Cutaneous Tumors

Head and Neck

Moderators: Jonathan Ashman Elizabeth Baldini

Discussants: Annie Chan Loren Mell

Scientific Session NN

Digital Poster Discussion 09

Room: 254 A-B

11:00 Michael Macmanus FDG-PET Scanning Has a High Impact on the Management of Patients With Merkel Cell Carcinoma

Room: 156 A-C

337

11:10 Matthew Johnson 338 Absolute Lymphocyte Count As a Prognostic Factor for Merkel Cell Carcinoma 11:20 Naamit Gerber 339 Survival of Adult Rhabdomyosarcoma Patients Treated on Multimodality Protocols 11:30 Ajay Bhatnagar 340 Non-melanoma Skin Cancer Treated With Electronic Brachytherapy: Results At Two Years 11:40 Yen-Lin Evelyn Chen 341 Prognosis of Radiation Associated Bone and Soft Tissue Sarcomas 11:50 Terence Sio 342 Intensity Modulated (IMRT) and Intraoperative Electron (IOERT) Radiation Therapy for Retroperitoneal and Intrapelvic Sarcoma 12:00 Sean McBride Retroperitoneal Sarcoma (RPS): Evaluation of Loco-regional Recurrences (LRR) After Pre- operative Radiation Therapy (RT) and Potential Benefit of Dose Escalation Using Dose Painting

343

12:10 Katsuya Maruyama 344 Carbon Ion Radiotherapy for Chondrosarcoma 12:20 Charles Catton Interfractional Changes of Retroperitoneal Sarcomas During Pre-operative Radiotherapy

92

ASTRO 2012 / 54TH ANNUAL MEE TING

345

Robert Olson 1097 25 Year Survival Outcomes for Squamous Cell Carcinomas of the Head and Neck: Population-based Outcomes from a Canadian Province Nikhil Rao 1098 Factors Predicting for Local Control in Patients With Desmoplastic Melanoma Dennis Sopka 1099 Dysplasia at the Margin? Investigating the Case for Subsequent Therapy in Squamous Cell Carcinoma of the Oral Tongue Shao Hui Huang 1100 Temporal Regression of Cervical Lymph Node in N2-N3 Head and Neck Cancer Treated With Primary Radiotherapy ± Chemotherapy: Stratified by HPV Status Klaudia Hunter 1101 The Effect of Differences in Planned and Delivered Parotid Doses on Salivary Output John Waldron 1102 Neck-specific Outcome of N2-N3 Head and Neck Cancer Treated With Radiation +/- Chemotherapy Rachit Kumar 1103 Radiation Dose to the Floor of Mouth Muscles Predicts Swallowing Complications After Chemoradiation in Oropharyngeal Squamous Cell Cancer Jiade Lu 1104 Multi-national Survey on Delivery of Radiation Therapy for Nasopharyngeal Carcinoma

Wednesday | October 31 Yahua Zhong 1105 Phase II Trial of Docetaxel and Cisplatin Neoadjuvant Chemotherapy Followed by Intensity Modulated Radiotherapy With Concurrent Cisplatin in Advanced Nasopharyngeal Carcinoma Jiayi Huang 1106 A Matched Pair Comparison of Intensity Modulated Radiation Therapy With Cetuximab vs. Intensity Modulated Radiation Therapy with Platinum-based Chemotherapy for Locally Advanced Head Neck Cancer Harry Quon Phase II Study of Radiotherapy Dose De-intensification for HPV-Associated Oropharyngeal Carcinoma

1107

Jia-Shing Wu 1108 Long-term Outcome of a Risk-adapted Protocol for Nasopharyngeal Carcin

11:00 a.m. - 12:30 p.m.

Digital Poster Discussion 10

Bridget Koontz 1112 Significant Variation in Provider Discussion of Sexual Side Effects With Radiotherapy Patients William Wong 1113 Symptoms and Quality of Life in Men Before and After Radiation Therapy for Prostate Cancer Jai Prakash Agarwal 1114 Improved Quality of Life (QOL) Outcomes in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Treated With Intensity Modulated Radiation Therapy (IMRT) Compared to Three Dimensional Conformal Radiotherapy (3-D CRT): Evidence From a Prospective Randomized Study Clayton Hess 1115 The Hess Radiotherapy Coping Index (HRCI or “Hershey”), A Feasibility Study: A Practical Psychosocial Assessment for the Busy Radiation Oncology Practice Christine Hill-Kayser 1116 Positive Impact of Internet-based Survivorship Care Plans on Health Care and Lifestyle Behaviors

Palliative - Quality of Life

Room: 157 A-C

Discussants: Thomas Dilling Mark Henderson

Samuel Chao Spine Stereotactic Body Radiation Therapy Outcomes Correlated to Dosimetric Factors

Mark Hurwitz 1109 Magnetic Resonance Guided Focused Ultrasound Surgery for Painful Bone Metastases Is a Safe and Effective Treatment in Patients for Whom Radiation Therapy Is Contraindicated: Results of a Multi-center Phase III Trial

Ying Hou 1118 Correlation Between Dose-volume Parameters and Patient-Reported Quality of Life (QOL) During Image Guided Intensity Modulated Radiation Therapy (IGRT) for Prostate Cancer

Zachary Epstein-Peterson 1110 Postoperative Radiation Therapy For Bone Metastases: The Role of Coverage of the Surgical Hardware and Dose Intensity in Treatment Outcomes

1117

Bradford Hoppe 1119 Patient-reported Quality of Life Following Treatment of Prostate Cancer With Proton Therapy

Andrew Chiang 1111 Incidence of Pain Flare Following Stereotactic Body Radiotherapy for Bone Metastases

ASTRO 2012 / 54TH ANNUAL MEE TING

93

Wednesday | October 31 11:00 a.m. - 12:30 p.m.

1:30 p.m. - 3:00 p.m.

Scientific Session OO

Educational Session 411 Advanced Treatment of Non-small Cell Lung Cancer: Using All the Tools (Imaging, Motion Correction and IMRT) Promises and Pitfalls – A Case Based Approach

Room: 107 A-C

Indrin Julian Chetty, PhD, Henry Ford Health System Craig Stevens, MD, PhD, H. Lee Moffitt Cancer Center James Urbanic, MD, Wake Forest Univeristy School of Medicine

11:00 a.m. - 12:30 p.m.

Educational Session 412 Interstitial Brachytherapy for Prostate Cancer: LDR and HDR, Alone and With External Beam Radiotherapy

Room: 258 A-C

Michael Ghilezan, PhD, OCN, Michigan Health Professionals/21 century Oncology Mira Keyes, MD, British Columbia Cancer Agency Al Taira, MD, Western Radiation Oncology I-Chow Hsu, MD, University of California, San Francisco

12:30 p.m. - 1:30 p.m.

ARRO Meet the Professor Luncheon Room: 160 A-C

Breast IV - Prognostic Factors

Room: 258 A-C

Moderators: Steven Chmura Gary Freedman 1:30 Gaorav Gupta 346 Intact RB1 Pathway is Associated With Favorable Distant Metastasis-free Survival in Triple Negative Breast Cancer 1:40 Pauline Truong 347 Is Triple Negative Subtype Associated With Higher Locoregional Recurrence Risk in Women With pT1-2N0 Breast Cancer Treated With Mastectomy? 1:50 Robert Prosnitz 348 Molecular Subtype Predicts Outcome in Nearly All Subsets of Women With Early-stage Invasive Breast Cancer Defined by Traditional Clinical and Pathological Prognostic Factors. 2:00 Meena Moran 349 Association Between Tumor Molecular Subtype and Disease Presentation in Patients With Early-stage Breast Cancer 2:10 Atif Khan 350 Basal Subtype, As Approximated by Triple-negative Phenotype, is Associated With Locoregional Recurrence in a Case-control Study of Women With 0-3 Positive Lymph Nodes After Mastectomy 2:20 Audrey Zaccariotto 351 Triple Negative Breast Cancer: Which Factors Predict for Local Recurrence? A Study of the CORS Group

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

94

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

2:30 Paul Sperduto 352 The Effect of Tumor Subtype on the Time From Primary Diagnosis to Development of Brain Metastases and Survival in Women With Breast Cancer

Wednesday | October 31 2:40 Tony Fyles 353 Post-Menopausal Women With Luminal a Subtype May Not Require Breast Radiotherapy – Results From a Randomized Clinical Trial of Tamoxifen + Radiation 2:50 Jin-Min Nam Targeting Beta1 Integrin Suppresses Invasive Recurrence in a Three-dimensional Model of Radiation Treated Ductal Carcinoma In Situ



Withdrawn

359

2:10 Woong Sub Koom 360 Patterns of Regional Recurrence After Curative D2 Resection for Stage III (N3) Gastric Cancer: Implications for Postoperative Radiotherapy

354

1:30 p.m. - 3:00 p.m.

Scientific Session PP GI IV - GI Cancer: An Antiperistaltic Look

Room: 153 A-C

Moderators: Vivek Mehta May Abdel-Wahab 1:30 Samuel Ngan 355 Long-term Quality of Life in Patients Treated In TROG 01.04: A Randomised Trial Comparing Short Course and Long Course Preoperative Radiotherapy for Rectal Cancer 1:40 Reena Engineer 356 Escalated Radiation Dose Without Chemotherapy Does Not Improve Resectability for Locally Advanced Unresectable Rectal Cancer Over Standard Chemo-radiation: Results of a Phase II Randomized Study. 1:50 Jerome Landry 357 Phase II Study of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX) and Bevacizumab in Patients With Locally Advanced Rectal Cancer: ECOG 3204 2:00 Corinne Doll 358 The Significance of Co-expression of Epidermal Growth Factor Receptor (EGFR) and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of RTOG 98-11

2:20 Jessica Freilich 361 Comparative Outcomes for 3-D Conformal vs. Intensity Modulated Radiation Therapy for Esophageal Cancer 2:30 Jeffrey Vainshtein 362 Prognostic Value of CA 19-9 in a Phase I/II Trial of Dose Escalated Intensity Modulated Radiation Therapy (IMRT) With Concurrent Full-dose Gemcitabine (G) in Unresectable Pancreatic Cancer 2:40

Joseph Herman

Discussant

1:30 p.m. - 3:00 p.m.

Scientific Session QQ GU V - Prostate Cancer: Hypofractionation/ Brachytherapy

Room: 254 A-B

Moderators: Jay Ciezki Drew Moghanaki 1:30 Karen Hoffman 363 Toxcity and Dosimetic Parameters Related to Conventional vs. Dose-escalated, Hypofractionated Radiation in Prostate Cancer. 1:40 Giorgio Arcangeli 364 Updated Results and Pattern of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer 1:50 Alan Katz 365 Five-year Biochemical Control Rates for Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer: A Multi-institutional Pooled Analysis

ASTRO 2012 / 54TH ANNUAL MEE TING

95

Wednesday | October 31 2:00 Robert Meier 366 Stereotactic Body Radiotherapy for Intermediate-risk Organ-confined Prostate Cancer: Interim Toxicity and Quality of Life Outcomes from a Multi-Institutional Study 2:10 Harvey Quon 367 Dose Escalation of Five-Fraction Radiotherapy for Prostate Cancer: Quality of Life Comparison of Two Prospective Trials 2:20 Donald Fuller 368 Prospective Evaluation of SBRT for Low- and Intermediate-Risk Prostate Cancer: Emulating HDR Brachytherapy Dose Distribution

1:50 Randa Tao 373 Real-time Peer Review Quality Assurance Conferences Incorporating Physical Examination for Head and Neck Cancer Radiation Therapy Result in Clinically Meaningful Target Volume Alteration: Results of a Prospective Volumetric Analysis 2:00 Ajay Kapur Streamlining the Head and Neck Treatment Process in Radiation Medicine Using a Kaizen Approach

374

2:10 Annie Chan 375 A Phase II Trial of Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

2:30 Mark Shilkrut 369 The Addition of Low-does-rate Brachytherapy and Androgen Deprivation Therapy Decreases Prostate Cancer Death Compared to Dose-escalated External Beam Radiation Therapy for High-risk Prostate Cancer

2:20 Tony Wang 376 Patterns of Failure (POF) After Salvage Re-irradiation (re-RT) for Recurrent Head and Neck Cancer (HNC): Implications for Field Design and Consolidation Therapy

2:40 Atsunori Yorozu 370 A Dose-response Analysis of Biochemical Control and Toxicity for I-125 Prostate Brachytherapy

2:30 Man Hu 377 The Prognostic Value of Hypoxia-Reoxygenation During Chemoradiotherapy in Locoregionally Advanced Head and Neck Cancer

2:50

Patrick Kupelian

Discussant

1:30 p.m. - 3:00 p.m.

Scientific Session RR Head and Neck III - Reirradiation/Quality Assurance

2:40 Maria Grazia Ghi 378 Cetuximab/Radiotherapy (CET+RT) vs. Concomitant Chemoradiotherapy (cCHT+RT) With or Wothout Induction Docetaxel/Cisplatin/5Fluorouracil (TPF) in Locally-advanced Head and Neck Squamous Cell Carcinoma (LASCCHN). Preliminary Results on Toxicity of a Randomiz

Room: 205 A-C

Moderators: Alexander Lin Farzan Siddiqui 1:30 L. Matthew Scala 371 High-dose-rate (HDR) Intraoperative Brachytherapy and Radical Surgical Resection in the Management of Recurrent Head and Neck Cancer 1:40 Julian Hong 372 Predictive Factors for Locoregional Control After Salvage Reirradiation of Recurrent Head and Neck Cancer 96

ASTRO 2012 / 54TH ANNUAL MEE TING

2:50

Sharon Spencer

Discussant

Wednesday | October 31 1:30 p.m. - 3:00 p.m.

2:40 Jayaji Moré 385 Acute Changes in Composition of Exhaled Breath Predict Radiation Pneumonitis Following Stereotactic Ablative Radiotherapy

Scientific Session SS Lung IV - Fractionation and Toxicity

Room: 210 A-C

Moderators: Andrea Bezjak Joe Y. Chang 1:30 Elisabetta Parisi 379 Accelerated Hypofractionated Radiotherapy Using Tomotherapy Plus Chemotherapy for Inoperable Locally Advanced Lung Cancer: Preliminary Results From a Prospective Phase II Trial 1:40 Jeffrey Kuremsky 380 Hypofractionated Radiotherapy for Stage I and II Non-small Cell Lung Cancer 1:50 Christoph Poettgen 381 Accelerated Hyperfractionated Radiotherapy Within Trimodality Therapy Concepts for Stage IIIa/b Non-small Cell Lung Cancer: Markedly Higher Rate of Pathologic Complete Remissions Than With Conventionally Fractionated Radiochemotherapy 2:00

Ken Rosenzweig

Discussant

2:10 Alerson Molotievschi 382 Late Esophageal Stricture Correlates With Decreased Overall Survival For Locally Advanced Non-small Cell Lung Cancer Treated With Radiotherapy: A Potential Confounder of Dose Escalation? 2:20 Marco Trovo 383 High-dose Radiation Therapy Delivered With Tomotherapy to the Intact Lung for Malignant Pleural Mesothelioma 2:30 Yevgeniy Vinogradskiy 384 Using Genetically Based Normal Tissue Toxicity Models to Personalize Prescription Dose: A Proof of Principle Virtual Study

2:50 David Raben 386 Initial Cooperative Group Experience of Bevacizumab (Bev) Plus Concomitant Chemoradiotherapy (CRT) in Patients With Inoperable Locally-advanced Stage III Non-small Cell Lung Cancer (LA-NSCLC): Preliminary Results of S0533

1:30 p.m. - 3:00 p.m.

Scientific Session TT Informatics/Bioinformatics

Room: 109 A-B

Moderators: David Gius Andrew Vassil 1:30 Leah Schubert Analysis of an International Error Reporting Database to Enhance Patient Safety

387

1:40 Kevin Moore 388 Inter-institutional Quality Control of IMRT Treatment Planning 1:50 Patrick Kupelian 389 Collection of Treatment Plan Parameters and Related Quality Indices Into Radiotherapy Registries 2:00 Olivier Gayou 390 Reducing the Potential for Catastrophic Radiation Error by Using Historical Treatment Data 2:10 Benjamin King 391 Implementation of Tablet Computers (iPad) in a Radiation Oncology Clinic 2:20 Peter Gabriel 392 A Semi-Automated Electronic System for Managing Physician Peer Review of Treatment Plans

ASTRO 2012 / 54TH ANNUAL MEE TING

97

Wednesday | October 31 2:30 Wade Smith 393 Protons Versus X-rays for CNS Tumors: A Decision Model 2:40 Senthil Gandhidasan 394 Contrasting Oncology Information System Implementations and Their Impact on the Health Care Delivery in Radiation Oncology 2:50 Timothy Meier 395 Continuous Quality Improvement in Radiation Oncology is Feasible at a Major Tertiary Teaching Institution

2:20 Kavita Dharmarajan 401 Radiotherapy Quality Assurance on AHOD0031: A Report From the Quality Assurance Review Center (QARC) and the Children’s Oncology Group 2:30 Torun Yock 402 Health-related Quality of Life (HrQOL) in Children Treated With Proton Radiotherapy for Extra-cranial Tumors: A Prospective Study 2:40 Joanna Yang Long-term Results of Radiation Therapy for Rhabdomyosarcoma in Very Young Children

403

2:50 Benjamin Laser 404 Evaluation of the Use of Carbon-11 Methionine PET Scans in Pediatric Patients With Craniopharyngioma

1:30 p.m. - 3:00 p.m.

Scientific Session UU Pediatrics II - Non-CNS Tumors

Room: 206 A-B

Moderators: Nadia Laack Arnold Paulino

1:30 p.m. - 3:00 p.m.

Scientific Session VV

1:30 Safia Ahmed 396 Clinical Outcomes In Adult and Pediatric Ewing Sarcoma: A Single Institution Comparative Study 1:40 Joanna Yang 397 Local, Regional and Central Nervous System Control Using IMRT in Parameningeal Rhabdomyosarcoma Patients 1:50 Daya Nand Sharma 398 Role of Extracorporeal Irradiation in Malignant Bone Tumors 2:00 Suzanne Wolden Total Body Irradiation in Very Young Children

399

2:10 Chi Zhang Epidemiology and Patterns of Care in Craniopharyngioma

400

Biologic Radiosensitizers II

Room: 204 A-B

Moderators: James Bonner Felix Feng 1:30 James Hansen 405 A Rare Cell-penetrating Anti-DNA Antibody Inhibits DNA Repair, Sensitizes Tumors to DNA-Damaging Therapy and Is Synthetically Lethal to BRCA2- Deficient Cancer Cells 1:40 Philipp Seidel 406 Does Initial or Persistent DNA damage Correlate With the Enhanced RBE of Carbon vs. Photon Radiotherapy? 1:50 Mohammad Hedayati 407 Exploiting Androgen-induced DNA Double Strand Breaks: Optimally Sequencing Androgen Suppression and Radiation for the Treatment of Prostate Cancer 2:00 Peter Paximadis 408 PTEN Modulation of Androgen Receptor Response to External Beam Radiation in Murine Prostate Cancer Cell Lines

98

ASTRO 2012 / 54TH ANNUAL MEE TING

Wednesday | October 31 2:10 James Bonner 409 The Role of STAT-3 in Cetuximab-Induced Radiosensitization in Head and Neck Cancer Cells

Alec Block 1123 Analysis and Reduction of Daily kV Planar Imaging Dose in IGRT Patients

2:20 Kathryn Huber 410 Sequence Dependent Radiosensitization of EGFR Mutant NSCLC by Gefitinib is Mediated by Senescence

Elisabeth Weiss 1124 Do Surrogates Reliably Represent Lung Tumor Motion? Assessment of Intrafraction Motion Variability of Lung Tumors, Implanted Markers and Carina

2:30 Alexander Whitley 411 Erlotinib Induces Synthetic Lethality With the Poly (ADP-Ribose) Polymerase (PARP) Inhibitor ABT-888 in Esophageal Cancer 2:40 Michael Spiotto 412 A High Throughput Cell Based Screen Identifies Compounds That Inhibit the Viral Oncoprotein E6 in Human Papillomavirus-positive Cancers 2:50 Michael Baine 413 Unbiased Analysis of Pancreatic Cancer Radiation Resistance Reveals Cholesterol Biosynthesis As a Potent Novel Target for Radiosensitization

1:30 p.m. - 3:00 p.m.

Digital Poster Discussion 11 IGRT Technologies and Processes

Room: 156 A-C

Discussants: Kristy Brock Radhe Mohan Mauro Iori 1120 Voxel-based Dose-painting With a Commercial Treatment Planning System by Using Two Different Planning Methods Carsten Brink 1121 Using Mid-ventilation Phase for Calculation of Treatment Plan for Lung Cancer Patients Might Not Be Optimal Dimitri Hristorv 1122 Prone Partial Breast Coronal Arc Irradiation: Combining Intensity Modulated Delivery With Dynamic Motion of the Couch

John van Sornsen de Koste 1125 Evaluating Digital Tomosynthesis (DTS) for Image-guided Stereotactic Lung Radiotherapy Yi Rong 1126 Respiratory-gated Deep-inspiration Breath Hold Left Breast Irradiation Incorporating Real-time 3-D Surface Optical Tracking and Integrated MV Cine Acquisition Adam Riegel 1127 Ultrasound-compatible Thermoplastic Masks for Patient Immobilization During Intensity Modulated Radiation Therapy of Head and Neck Cancer Taeho Kim 1128 Audiovisual Biofeedback Improves Anatomical Position Management in Breath-hold Andrew Godley 1129 Segmentation Guided Deformable Registration of Large Organ Variation in the Prostate Region PengPeng Zhang 1130 Short Arc Digital Tomosynthesis As an Image Enhancement Step for Detection And Localization of Implanted Markers Margie Hunt 1131 MV-kV Intra-fractional Imaging During Volume Modulated Arc Therapy (VMAT): Initial Clinical Results

ASTRO 2012 / 54TH ANNUAL MEE TING

99

Wednesday | October 31 1:30 p.m. - 3:00 p.m.

3:15 p.m. - 4:45 p.m.

Stereotactic Body RT: Clinical, Biological and Physics/QA Update

Linac-based Image Guidance for Spatial and Dosimetric Treatment Verification

Educational Session 413 Room: 253 A-C

Teamor Nurushev, PhD, Henry Ford Health System Roy Decker, MD, PhD, Yale University Jan-Jakob Sonke, PhD, The Netherlands Cancer Institute (NKI-AVL)

1:30 p.m. - 3:00 p.m.

Educational Session 414 Cervical Cancer Management: Novel Approaches to Image-Guidance

Room: 107 A-C

Akila Viswanathan, MD, Brigham and Women’s Hospital

Panel 17

Room: 253 A-C

Moderators: Radhe Mohan, PhD, FASTRO, MD Anderson Cancer Center Mihaela Rosu, PhD, Virginia Commonwealth University Panelists: David Jaffray, PhD, Princess Margaret Hospital Marc Kessler, PhD, University of Michigan Jan-Jakob Sonke, PhD, The Netherlands Cancer Institute (NKI-AVL)

3:15 p.m. - 4:45 p.m. 3:15 p.m. - 4:45 p.m.

Panel 16

Hypofractionation Dose-response Models for SRS, SBRT, FSRT: Biology, Physics and Clinic

Room: 210 A-C

Moderators: J. Martin Brown, PhD, FASTRO, Stanford University X. Allen Li, PhD, Medical College of Wisconsin Panelists: Zhibin Huang, PhD, East Carolina University Brian Kavanagh, MD, University of Colorado Denver Nina A. Mayr, MD, FASTRO, Ohio State University Marc S Mendonca, PhD, Indiana University School of Medicine

100

ASTRO 2012 / 54TH ANNUAL MEE TING

Panel 18

Evidence-based Management of Testicular Seminoma, Stage I and II

Room: 254 A-B

Moderators: Clair Beard, MD, Dana-Farber/Brigham and Women’s Cancer Center Panelists: Peter Chung, MD, Princess Margaret Hospital Jason Efstathiou, MD, PhD, Massachusetts General Hospital Karen Hoffman, MD, MD Anderson Cancer Center

Wednesday | October 31 3:15 p.m. - 4:45 p.m.

3:15 p.m. - 4:45 p.m.

Multi-modality Approach to the Management of Liver Malignancy and Metastasis

ASTRO Highlights in Spanish

Panel 19

Educational Session 415

Room: 107 A-C

Moderators: Huan Giap, MD, PhD, Scripps Proton Therapy Center Riad Salem, MD, MBA, Northwestern University Panelists: Ricky Sharma, MD, PhD, University of Oxford Riad Salem, MD, MBA, Northwestern University Andrew Kennedy, MD, Wake Radiology Oncology Huan Giap, MD, PhD, Scripps Proton Therapy Center

Room: 204 A-B

Beatriz E. Amendola, MD, FASTRO, Innovative Cancer Institute Pablo Castro Pena, MD, Instituto de Radioterapia- Fundacion Marie Curie Silvia Zunino, MD, PhD, Instituto Privado de Radioterapia Higinia Cardenes, MD, Indiana University Roberto Diaz, MD, PhD, Emory University Marcela de la Torre, MD, University of Buenos Aires

3:15 p.m. - 4:45 p.m.

Educational Session 416 Treatment Option for Patients with Early-stage Non-small Cell Lung Cancer

3:15 p.m. - 4:45 p.m.

Panel 20

Biological Controversies and How They Impact Conventional Radiotherapy

Room: 153 A-C

Room: 258 A-C

Jeffrey Bogart, MD, State University of New York Frank Detterbeck, MD, Yale Thoracic Surgery

Moderators: Brian Marples, PhD, William Beaumont Hospital George Wilson, PhD, William Beaumont Hospital Panelists: Søren Bentzen, DSc, PhD, University of Wisconsin School of Medicine and Public Health Kevin Camphausen, MD, National Cancer Institute Daniel Zips, MD, University of Tubingen, Germany

Symbol Key:

A

ARON

Ticketed Event/ Nurses’ Separate Session registration required

Award Recipient

Live Interactive SAMs/ Session Separate registration required

ASTRO 2012 / 54TH ANNUAL MEE TING

101

NOTES

102

ASTRO 2012 / 54TH ANNUAL MEE TING

A S T R O

55 T H

A N N UA L

M E E T I N G

Meeting Dates: September 22-25, 2013 • Exhibit Dates: September 22-24, 2013 • Georgia World Congress Center • Atlanta

PATIENTS Hope • Guide • Heal

FIRST

MARK YOUR CALENDAR WITH THESE IMPORTANT 2013 ANNUAL MEETING DATES CALL FOR ABSTRACTS SITE OPENS:

December 2012

CALL FOR ABSTRACTS DEADLINE:

February 15, 2013

Please note the early deadline for 2013 abstracts!

ANNUAL MEE TING

S C I E N C E B A S E D, PAT I E N T D R I V E N

www.astro.org/annualmeeting

Join us next year in Atlanta!

NOTES

104

ASTRO 2012 / 54TH ANNUAL MEE TING

INSIDE: Poster Presentations Poster Viewing Hours

The Poster Viewing area is located in Hall C.

Sunday, October 28: Monday, October 29:

10:00 a.m. - 5:00 p.m. 10:00 a.m. - 5:00 p.m. Poster Viewing Session and Reception 5:30 p.m. - 6:45 p.m. Tuesday, October 30: 10:00 a.m. - 5:00 p.m.

NOTE EARLY DEADLINE FOR 2013 ABSTRACTS! CALL FOR ABSTRACTS SITE OPENS: December 5, 2012 CALL FOR ABSTRACTS DEADLINE: February 15, 2013

2012 AMBASSADOR Recognition ASTRO proudly recognizes our 2012 Corporate Ambassadors for their outstanding year-round leadership and support of radiation oncology.

Poster Presentations by Track BREAST CANCER 2001 Louis Keiler Community Hospital Experience With Accelerated Partial Breast Brachytherapy 2002 Vangipuram Shankar Daily Cone Beam CT Image Guidance for Oncoplastic BCT IMRT Treatments - Should It Be a Routine! 2003 Naoki Nakamura Effects of Geometrical Uncertainties on Whole Breast Radiotherapy: Comparison Between Four Different Techniques 2004 Lana de Souza-Lawrence Phase I/II Trial of Partial Breast Irradiation (PBI) With Various Concurrent Chemotherapy Regimens: Assessment of Skin Toxicity, Cosmetic Outcomes and Disease Recurrence 2005 Lana de Souza-Lawrence Addition Of FDG-PET Decreases Inter-observer Variability in Delineation of the Lumpectomy Cavity for Patients Who Have Poor Cavity Visualization by CT Alone

2010 Jinli Ma Irradiation of the Chest Wall and Regional Nodes As Integrated Volume With IMRT for Breast Cancer: the Dosimetry and Acute Side Effects 2011 Jean Wright Rate of Moist Desquamation in Patients Receiving Radiation for Breast Cancer After Mastectomy vs. Breast Conserving Surgery 2012 Youlia Kirova Second Malignancies After Breast Cancer Treatment: Long-term Results 2013 Ben Taylor Survival for Patients With Inflammatory Breast Cancer Receiving Mastectomy is Associated With Radiation Sequence and Race 2014 Sarahatul Bahiah Yusoff Bilateral Breast and Regional Nodal Irradiation in Early-stage Breast Cancer - A Dosimetric Comparison of IMRT and 3-D Conformal Radiation Therapy 2015 Wee Yao Koh Hypofractionated Breast Radiotherapy: Acute Toxicity in Asian Skin Types

2006 Hiroshi Sekine Virtual Computer Simulation of Skin Erythema During and After Breast Conserving Therapy Using Generalized LQ Model

2016 Elise Furet How to Boost the Breast Tumor Bed After Oncoplastic Surgical Procedure Using Surgical Clips and Image Registration?

2007 Himanshu Nagar Is There a Tradeoff in Using Modified High Tangent Field Radiation for Treating an Undissected Node Positive Axilla?

2017 Thomas Churilla Does Regional Micrometastatic Disease Influence Local Management in Breast Cancer? A SEER Database Analysis

2008 Ewa Szumacher Development of a Patient Decision Aid for Older Women With Stage 1 Breast Cancer Considering Adjuvant Treatment Post-lumpectomy

2018 Thomas Churilla Predictors of Metastatic Disease in Clinical T1 Node Negative Breast Cancer: A SEER Database Analysis

2009 Florian Wuerschmidt Intraoperative Radiotherapy With Low Energy Photons (INTRABEAM) As Boost Irradiation: Results in 546 Pts. Treated at Two Community Breast Cancer Centers

2019 Olga Vujovic The Significance of Time Interval From Clinical Presentation to Definitive Breast Surgery in Node Negative Breast Carcinoma With Long-term Follow-up: Clinical Implications

2020 Neeta Kannan Is There an Advantage to Delivering Breast Boost in the Lateral Decubitus Position? 2021 Patrick Maguire Oncoplastic Surgery and Radiation Therapy for Breast Conservation: Patient and Physician Reported Outcomes 2022 Sabina Venarini Visualization of the Left Anterior Descending Coronary Artery on Computed Tomographic Images Used for the Planification of Breast Radiation Treatments 2023 Kara Leonard Breast Boost Using Noninvasive Image Guided Breast Brachytherapy vs. En Face Electrons: A Matched Pair Analysis 2024 Chirag Shah Outcomes and Toxicities of Three-dimensional Conformal Accelerated Partial Breast Irradiation 2025 Matthew Hardee Impact of Histological Subtype on the Outcome of Breast Cancer Brain Metastases Patients Treated With Gamma Knife Radiosurgery 2026 Rumiko Kinoshita Co-overexpression of GEP100 With EGFR Correlates With Early Recurrence After Breast Conservation Therapy (BCT) 2027 Patrick Joseph Bonavitacola Incidental Axillary Coverage Comparison Between 3-D CRT and Hybrid IMRT for Whole Breast Irradiation 2028 Sudha Mahalingam Accelerated Partial Breast Irradiation Using Single Lumen Balloon Catheter for Early Breast Cancer: A Community Hospital Experience 2029 Michelle Kim Pathologic Complete Response to Neoadjuvant Chemotherapy Plus Trastuzumab Predicts for Improved Survival in Women With HER2-Positive Breast Cancer

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

107

BREAST CANCER/continued

2039 Withdrawn

2030 Stefan Claes A Clinical Study Comparing a Hydroactive Colloid Gel to a Dexpanthenol Cream for the Treatment of Skin Reactions in Breast Irradiation

2040 Min Xu The Influence of Delineator and Delineating Criterion on the Delineation of the Tumor Bed Target and Whole Breast Target After Breast-conserving Surgery

2031 David Marcus Breast Conservation Rates and Outcomes in Post-Menopausal Women With Estrogen Receptor-positive Breast Cancer Treated With Neoadjuvant Hormonal Therapy or Chemotherapy

2041 Jun Deng Kilo-Voltage Imaging Doses to Organs-at-Risk in CBCT-guided Breast Radiotherapy

2032 Adam Currey Impact of Sociodemographic Factors on Management of Breast Cancer: Results of QRRO Survey 2033 Jessica Wobb Impact of the Number of Cautionary/ Unsuitable Risk Factors on Outcomes Following Accelerated Partial Breast Irradiation 2034 Kristin Kowalchik Classification System for Identifying Women at Risk for Altered Partial Breast Irradiation (PBI) Recommendations Following Breast Magnetic Resonance Imaging (MRI) 2035 Ana Maria Mena Acute Toxicity and Cosmetic Outcome Evaluation in 294 Breast Cancer Patients (pts) Treated With Hypofractionated Radiotherapy (HPRT) After Conservative Surgery 2036 Nidhi Patni A Comparison of Acute and Chronic Toxicity Profile Between Conventional and Hypofractionated Whole Breast Irradiation in Patients Undergoing Breast Conserving Surgery 2037 Suzhen Wang Comparisons of Clinical Target Volumes Based on Three-dimensional CT and Four-dimensional CT Stimulation Images of Breast Irradiation After Breast-conserving Surgery 2038 Sara Pentimalli Phase I-II Study of Hypofractionated Simultaneous Integrated Boost (SIB) for Adjuvant Radiation Therapy in Early Breast Cancer Patients: A Report of Feasibility and Acute Toxicity Results in the First 50 Treatments 108

2042 Timothy Harris Matched-Pair Analysis of Women Treated With DIEP Reconstruction With or Without Radiation 2043 Jinyu Xue Dosimetric Comparison of Post Mastectomy Scar Boost Using HDR Skin Flap vs. Electron Field 2044 Lisa Klepczyk The Influence of Race and Hormone Receptor Status on Recurrence in Patients With Ductal Carcinoma in Situ (DCIS) 2045 Brandon Stone Clinical Target Volumes for Accelerated Partial Breast Irradiation: Are They Equivalent? A Volumetric Analysis 2046 Bartosz Urbanski Preliminary Evaluation of Breast Cancer Patient’s Treatment After Breast Conserving Therapy (BCT), IORT and EBRT 2047 Thomas Lanni Comparison of Reimbursement and Cost Efficacy Between Accelerated Partial Breast Irradiation Modalities 2048 Eric Mellon Toxicity Analysis of Accelerated Partial Breast Irradiation in Patients Treated With Daily Image Guidance and Reduced Treatment Margins 2049 Phillip Prior CT-based Planning for Node Positive Breast Cancer Does Not Result in Excess Lung and Heart Doses 2050 Charu Sharma Physician Preferences for Post-mastectomy Radiation Techniques in Breast Cancer Patients With Unreconstructed Chest Walls

ASTRO 2012 / 54TH ANNUAL MEE TING

2051 Tamara Linne Secondary Angiosarcoma After Breast-Conserving Therapy Treated With Hyperfractionated Radiotherapy With a Median Follow-up of 6.7 Years 2052 Carolina Fasola Local Regional Recurrence Among Patients With Pleomorphic Lobular Carcinoma in Situ: Is There a Role for Radiotherapy? 2053 Marco Krengli Prone vs. Supine Position for Adjuvant Breast Radiotherapy: A Comparative Planning Study 2054 Wei Wang 4-D CT-based Target Motion and Treatment Planning Variance for Whole Breast Radiotherapy Account for Breathing Motion 2055 Wei Wang Dose Distribution Analysis in Whole Breast Intensity Modulated Radiotherapy Based on 4-D CT And 3-D CT 2056 Josef Hammer Nodal Status and Tumor Location – An Unorthodox Relationship in Breast Cancer Patients 2057 Steven Feigenberg Near 25 percent Complete Pathologic Response Following Preoperative Accelerated Partial Breast Radiotherapy (APBI) Using Three-dimensional Conformal Radiotherapy (3-D CRT) 2058 Zhaozhi Yang Simultaneous Integrated Boost in Breast Conserving Radiotherapy: Is Replanning Necessary for Seroma Shrinkage? 2059 Michelle Wallace Clinical Outcomes Following Accelerated Partial Breast Irradiation Stratified by Estrogen Receptor Status 2060 Erminia Infusino A Comparative Study of Breast Radiotherapy in Prone Position vs. Supine Position in Moderate Deep Inspiration Breath-hold (mDIBH) Technique Using Active Breathing Control

2061 Adam Currey The Importance of Three-dimensional CT Treatment Planning to Optimize Outcomes From Accelerated Partial Breast Irradiation (APBI) With Brachytherapy in Early-stage Breast Cancer 2062 Steven Plimpton Rethinking the Supraclavicular Field: Anterior Wedged Pair 3-D Conformal Radiotherapy vs. Single Anterior Oblique Field as Treatment of the Axillary Apex and Supraclavicular Fossa in Node Positive Breast Cancer 2063 Shana Coplowitz Association of Pain and Pre-treatment Transforming Growth Factor Beta-1 (TGF-β1) Levels As an Early Predictive Biomarker in Patients Treated With Intracavitary Accelerated Partial Breast Irradiation (IAPBI): Results of a Prospective Study 2064 Eric Christenson Preoperative Accelerated Partial Breast Radiation Is Associated With Decreased Cd8+ Cells in Patients With Early Breast Cancer 2065 Sua Yoo Partial Breast Extra-cranial Radiosurgery: A Dosimetric Evaluation of Treatment Delivery Accuracy 2066 Naoko Sanuki Outcomes of Clinically Node Negative Breast Cancer Without Axillary Dissection: Can the Preserved Axilla Be Safely Treated With Radiation After a Positive Sentinel Node Biopsy?

2070 Kujtim Latifi Comparing Heart and Lung Dose-Volumes Between RTOG 0413 and RTOG 1005 Standards for Patients Treated With Whole Breast Irradiation 2071 Matthew Abrams Investigation on the Benefit of PMRT in Women With High Risk N0 Breast Cancer 2072 Aparna Surapaneni Effect of Radiation on Breast Cancer Specific Survival for Elderly Women With Early Stage (T1N0 ER+) Breast Cancer: Review of the SEER Database 2073 Maha Jawad Impact of Lymphovascular Space Invasion, Extensive Intraductal Component and Multi-focality on Outcomes Following Accelerated Partial Breast Irradiation

2081 Peng Dong 4pi Therapy for Partial Breast Irradiation 2082 Anton Khouri Partial Breast Re-Irradiation for Patients With Ipsilateral Breast Tumor Recurrence 2083 David Grew Objective Definition of the Phenotype of Radiation-induced Breast Fibrosis by the Moisture Meter D 2084 Orlan Macdonald Radiotherapy and Male Breast Cancer: A Population-Based Registry Analysis

2074 Amy Woolley An Audit to Assess Electronic Portal Imaging (EPI) and Cone Beam CT (CBCT) Image Verifcation Methods in 16 Breast Patients 2075 Melanie Letourneau Outcomes in Post-mastectomy Patients Treated by Adjuvant Radiotherapy Without Application of Bolus 2076 Daniela Bejarano Comparative Analysis of Acute Radiation Dermatitis in Breast Cancer Treatment: Concomitant vs. Sequential Paclitaxel and Radiotherapy

2067 Musaddiq Awan Can Breast MRI Select Patients For Treatment With Pre-operative APBI?

2077 Susu Yan Functional and Molecular Imaging of the Axilla As the Patient Is in Position for Radiation Therapy Using a Robotic Multi-pinhole SPECT System

2068 Frederick Cope Exploitation Targeting of the CD206 Receptor in Lymph Node-Resident Reticuloendothelial Cells With a Novel Synthetic 99mTc-ligand (Tilmanocept) Significantly Enhances Localization in Contrast to 99mTc-Colloid: A New Meta-analysis

2078 Steven Finkelstein Dosimetric Variables Correlating With Excellent and Good Cosmetic Outcomes in a Large, Retrospective Study of APBI With a Strut-based Breast Brachytherapy Applicator

2069 Mazen Mislmani Comparison of Different Radiation Techniques to Achieve Normal Tissue Sparing and Target Volume Coverage in the Treatment of Left Sided Early-stage Breast Cancer

2080 Lindsay Weinshank Once Daily Radiation Therapy for Inflammatory Breast Cancer: The Mayo Clinic Experience

2085 Ralph Vatner Minimal Acute Toxicity Associated With Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer 2086 Lynn Chang Identifying Risk Factors for Locoregional Recurrence Following Post-mastectomy Radiotherapy 2087 Paris-Ann Ingledew A Comprehensive Evaluation of the Quality of Online Resources for Breast Cancer Patients 2088 Sonia Nguyen A Tangled Web: An Evaluation of the Usage of Web-based Information by Breast Cancer Patients 2089 Philippe Coucke Variability of Whole Breast Target Volume Delineation Between Prone and Supine Position: A Multicentric Study 2090 Mark Hallman Impact of Regional Nodal Irradiation on Outcomes of Breast Cancer Patients With 1-3 Positive Axillary Nodes

2079 Joseph Panoff The Role of Hormone Therapy for Node Negative Breast Cancer Patients With ER + Tumors 1cm or Less

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

109

BREAST CANCER/continued 2091 Akkamma Ravi Long-term results of Accelerated Partial Breast Irradiation (APBI) for Early-stage Node Negative Breast Cancer Treated by MammoSite: Evaluation of Loco-regional Recurrence and Cosmesis With Respect to Body Mass Index (BMI)

2100 Ahmed Salem Comparison Between Combined Photon-electron, Photon-only and Electron-only Beams in Supraclavicular Irradiation: A Dosimetric Study 2101 Afshin Rashtian Intra-operative Radiotherarpy (IORT) for Ductal Carcinoma in Situ (DCIS): A Single Institution Study

2092 Mieke Govers Late Toxicity and Cosmetic Outcome in Patients With Breast Cancer Treated With Intra-operative Radiotherapy As an Electron Boost

2102 Angela Lin Cardiac Sparing With Breath Hold Technique: A Dosimetric Evaluation of Benefits in Different Patient Populations

2093 Noah Taylor Set-up Error Due to Divergence in AccuBoost Image Guided Brachytherapy: Important Clinical Implications

2103 Margriet Sattler CTV Boost Margin for Adjuvant Breast Radiotherapy - Results of a Study Comparing US vs.CT Imaging

2094 Carmen Popescu Simultaneous Couch and Gantry Dynamic Arc Rotation (C-G Darc) in the Treatment of Breast Cancer With Accelerated Partial Breast Radiation Therapy (APBRT) 2095 Valentina Ovalle Results of a National Breast Cancer Program in Chile: 318 Women Treated Under Standardized Clinical Guidelines 2096 Edwin Crandley Efficiency and Accuracy of Goggle-based Visual Feedback for Voluntary Deep Inspiration Breath Hold (DIBH) Radiation Therapy of the Left Breast 2097 Alan Slomowitz An Imaging Comparison of Implantable Markers for Delineating Target Volumes for Soft Tissue

2104 Lisa Goggin Estimation of Skin Dose for Post-implant Breast Cancer Patients Using Monte Carlo Simulation 2105 Vincent Vinh-Hung Topographic Changes of Surgical Clips for Breast Tumor Bed Localization Between Prone and Supine Setup 2106 Bevan Ly Comparison of Clinical Outcomes in Early-stage Triple Negative Breast Cancer Treated With Mastectomy vs. Breast Conserving Therapy

2111 Sarah Quirk Partial Breast ITV Margin From Population Respiratory PDF 2112 Michael Wong A Single-Institutional Experience Using the Strut-Adjusted Volume Implant for Accelerate Partial Breast Irradiation 2113 Heather Leggett Dosimetric Comparison of Sequential Electron vs. Simultaneous Integrated Boost (SIB) Techniques for Adjuvant Breast Radiotherapy 2114 Afshin Rashtian Intra-operative Radiotherapy (IORT) for Invasive Breast Cancer. A Single Institution Study 2115 Cristiane Takita Assessment of Prognostic Features in Treatment Decision for Ductal Carcinoma in Situ of the Breast 2116 Lisa Goggin Dosimetric Comparison Between 3-D Conformal and CyberKnife Plans for Accelerated Partial Breast Irradiation 2117 Jiho Nam Improving Dose Homogeneity and Target Coverage in the Axillary Region With Minimizing Apical Lung Dose Using Simple Forward-planned Intensity Modulated Radiation Therapy in Breast Cancer Patients

2107 Grace Lee Impact of Local Regional Nodal Radiotherapy Field Design on Patterns of Recurrence in Women With Locally Advanced Breast Cancer

2118 Shih fan Lai Treatment Outcome, Relapse Patterns and Prognostic Factors of Adult Medulloblastoma Patients

2108 Jennifer Zook An Optimum Treatment Technique for Chestwall Irradiation in Breast Cancer

CENTRAL NERVOUS SYSTEM

2098 Abigail Milby Incidence and Patterns of Distant Metastases For Patients With Early-stage Breast Cancer After Breast Conservation Treatment: Competing Risks Analysis

2109 Jayoung Lee Improved Local Control Rate in Three-dimensional Radiation Therapy Era in Early Breast Cancer After Breast-conserving Surgery

2099 Manisha Palta Use of Adjuvant Radiotherapy in Elderly Patients With Early-stage Breast Cancer: Changes in Practice Patterns After Publication of Cancer and Leukemia Group B (CALGB) 9343

2110 Rebekah Young A Retrospective Study Evaluating Toxicity in Women With DCIS Undergoing Hypofractionated Adjuvant Radiation Therapy After Breast Conserving Surgery

2119 Salvador Villa Comparison of Two Consecutive Prospective Series of Unresectable High-grade Glioma Patients Treated With or Without Neoadjuvant (na) Chemotherapy Before Standard Radiochemotherapy and Adjuvant Temozolamide 2120 Kazuhiro Miwa Re-irradiation of Recurrent Glioblastoma Multiforme Using Amino Acid PET/CT/MRI Image Fusion for Helical Tomotherapy-based Image Guided Intensity Modulated Radiation Therapy

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 110

ASTRO 2012 / 54TH ANNUAL MEE TING

2121 Yurie Tsutsumi Efficacy of Reirradiation for Patients With Recurrent High-grade Glioma 2122 Hyeon Kang Koh Fractionated Stereotactic Radiotherapy With Intensity Modulation As an Optic Nerve and Chiasm Sparing Technique in High Grade Gliomas 2123 Kengo Ogura Recurrence Patterns of Glioblastoma in the Era of Temozolomide 2124 Sanjay Aneja The Influence of Regional Health System Resources on Receipt of Post-operative Radiation Therapy for Glioblastoma Multiforme 2125 Sonal Mayekar Evaluating Changes in Radiation Treatment Volumes and Outcomes from Post-operative to Same-day Planning MRI in High Grade Gliomas: A Prospective Study 2126 Andrew Bishop Valproic Acid Use during Radiotherapy for Glioblastoma is Associated With Improved Survival 2127 Stephen Lewis Patterns of Failure As a Function of Clinical Target Volumes in Patients With GBM Treated With Radiotherapy (RT), Temozolamide and Bevacizumab 2128 Kuldeep Sharma Target Volume Delineation in Post-operative Glioblastoma. Comparison of Flouro-Deoxy Glucose-Positron Emission Tomography (FDG-PET) vs. Magnetic Resonance Imaging (MRI) 2129 Krishna Veeravalli Invasiveness of Human Glioma Stem Cells Controlled by Cord Blood Stem Cells Via Regulation of Integrin α6, N-cadherin and Erk Interactions 2130 Andrew Bishop Anti-epileptic Drug Associated Rash Is Not More Prevalent During Radiation Therapy

2131 Clement Ho Incidence and Outcome of Symptomatic Venous Thromboembolism in Patients With Glioblastoma Multiforme in Southern Alberta 2132 Krishna Reddy Hypofractionated Intensity Modulated Radiotherapy Altered Patterns of Failure in Patients With Glioblastoma Multiforme Treated on a Phase II Trial 2133 Krishna Reddy Prospective Evaluation of Health-related Quality of Life and Neurocognitive Status in Patients With Glioblastoma Multiforme Treated on a Phase II Trial of Hypofractionated Radiotherapy With Temozolomide 2134 Soleakhena Ken Dynamic Susceptibility-weighted Contrast-enhanced Magnetic Resonance Imaging in Glioblastoma for a Longitudinal Assessment of Tumor Perfusion Wth Cerebral Blood Volume 2135 Minesh Mehta Phase I Safety and Pharmacokinetic (PK) Study of Veliparib in Combination With Whole Brain Radiation Therapy (WBRT) in Patients (pts) With Brain Metastases 2136 Menachem Yondorf Impact of the Extent of Resection (EOR) on the Volume of Brain Tissue Exposed to Radiation in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) 2137 Robert Kosztyla Comparison of High-grade Glioma Relapses With Radiotherapy Target Volumes Obtained From MRI and 18F-FDOPA PET 2138 Michael Christensen Tumor Volume for Glioblastoma As Defined by Tryptophan PET Offers Superior Coverage of Recurrence Site Than Standard MRI-based GTV 2139 Hyejung Cha Favorable Outcomes of Adjuvant Radiotherapy for Intracranial Ependymoma: A Single Institution Experience

2140 Alexandra Deviers Evaluation of Lactate As a Predictive Marker of Survival and Local Response to Radiotherapy in Patients With GBM 2141 Stephan Bodis Preliminary Experience of Pre-operative RT for Patients With Glioblastoma Multiforme 2142 Menachem Yondorf NTCP Modeling of Dose-escalation Hypofractionated Stereotactic Radiation Therapy (HFSRT) for Patients With Subtotally Resected (STR) Newly Diagnosed Glioblastoma Multiforme (GBM) 2143 Barbara Diletto Is There a Role for Concomitant Low-dose Fractionated Radiotherapy and Chemotherapy in Recurrent or Progressive Glioblastoma? 2144 Maria E. Rodriguez-Ruiz Patterns of Failure In Patients With Glioblastoma Treated With Surgery and Intensity Modulated Radiation Therapy and Temozolamide 2145 Reshma Munbodh Quantification of Tumor Growth Kinetics in Patients Showing Progression From Low-grade to High-grade Gliomas 2146 Anna Paulsson Comparison of Clinical Outcomes for Single Focus and Multifocal Glioblastoma 2147 Jessica Guarnaschelli Prospective Trial Evaluating Difference in Radiation Target Volume on 3t vs. 1.5 T MR for Patients With Malignant Gliomas 2148 Ann Morris Smaller Margins in the Treatment of Glioblastoma Multiforme: The University of Iowa Experience 2149 Ryan Abel Distinguishing Pseudoprogression From True Progression by FLAIR Volumetric Characteristics Compared to 45 Gy Isodose Volumes in Treated Glioblastoma Patients

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

111

CENTRAL NERVOUS SYSTEM/ continued 2150 Rahul Bhandari Five Fraction Image Guided Radiosurgery for Benign Meningiomas 2151 Yoshimasa Mori Gamma Knife Stereotactic Radiosurgery for Non-benign Meningioma 2152 Inga Grills Mean Cochlear Dose Predicts Hearing Preservation in Acoustic Neuroma Patients Treated With Gamma Knife Stereotactic Radiosurgery 2153 Alex Johnson Short Course Radiotherapy for Acoustic Neuromas 2154 Nicholas Zaorsky Fractionated Stereotactic Radiotherapy and Stereotactic Radiosurgery for the Treatment of Olfactory Groove Meningiomas: Observations of 13 Patients With or Without Prior Surgery 2155 Sang Min Yoon Treatment Outcomes of World Health Organization Grade II (Atypical) Meningiomas After Surgery With or Without Postoperative Upfront Radiotherapy

2160 Laura Ochoa Long-term Outcomes After Fractionated External Bream Radiation (EBRT) for Pituitary Adenoma: A 25 Year Update of the Mallinckrodt Institute of Radiology Experience 2161 Chia-Lin Tseng Spinal Cord Motion Considerations for Spine Stereotactic Body Radiotherapy (SBRT): Does the Cord Move? 2162 Zhibin Huang Re-irradiation With Stereotactic Body Radiotherapy (SBRT): Analysis of Human Spinal Cord Tolerance Using the Generalized Linear-quadratic Model 2163 Robert Ebeling, III Dosimetric Accuracy of Ray-Tracing Algorithm for Treatment of Thoracic Spine Lesions Using Robotic Radiosurgery 2164 Huifang Anna Zhai Analysis of Robustness of a Combined Cranial Photon and MLC-based Spinal Proton Field Matching Technique for Delivery of Craniospinal Irradiation 2165 Raphael Pfeffer Craniospinal Irradiation (CSI) Wth VMAT: Implementation and Individual Quality Assurance

2156 Matthew Hardee Radiologic and Clinical Outcomes for Acoustic Neuromas Treated With Gamma Knife Radiosurgery in the Lower Dose Ranges

2166 Mark Edson Treatment Trends and Outcomes by Age in Myxopapillary Ependymoma of the Spine

2157 Rajni Sethi Marginal Misses in Gamma Knife Radiosurgery for Meningiomas: Are Treatment Volume and Dose Adequate?

2167 Yucai Wang Outcomes After Surgery and Radiotherapy for Spinal Myxopapillary Ependymoma: Update of the MD Anderson Cancer Center Experience

2158 Igor Barani Adaptive Hybrid Surgery: Feasibility of Planned Subtotal Resection of Benign Skull Base Tumors Followed bBy Radiosurgery to Minimize Morbidity Without Compromising Tumor Control

2168 Hadley Sharp Feasibility of Radiosurgical Decompression of Metastatic Epidural Spinal Cord Compression (MESCC) in Nonoperable Patients

2159 Paul Menzel Low-dose Conformal Radiotherapy for Ipilimumab-induced Hypophysitis

2169 Shingo Toyama Long-term Result of Carbon-ion Radiotherapy for Locally Advanced or Unfavorably Located Choroidal Melanoma: CT Based Two-port Orthogonal Therapy Can Reduce the Incidence of Neovascular Glaucoma

2170 Nobutaka Mizoguchi Carbon-ion Radiotherapy for Locally Advanced Primary or Post-operative Recurrent Epithelial Carcinoma of Lacrimal Gland: A Phase I/II Dose-escalation Study 2171 Sewit Teckie Primary Intraocular Lymphoma: Excellent Outcomes With Ocular Radiation Therapy Alone 2172 Shravan Kandula Association of Complete Clinical Response and Long-Term Outcome Among Patients With Biopsy-proven Orbital Pseudotumor Receiving Modern Radiotherapy 2173 Savita Dandapani The USC Experience in Treating Medium Sized Choroidal Melanomas With Eye Physics Eye Plaque Brachytherapy (125-I) 2174 Dan Kunaprayoon Stereotactic Radiosurgery in the Treatment of Ocular Melanoma 2175 Nisha Patel Predictors of Tumor Recurrence and Enucleation After Iodine-125 Plaque Brachytherapy for Iris Melanomas 2176 Mostafa Heydarian A Noninvasive Eye Fixation and Monitoring System for the Treatment of Choroidal Melanoma (CM) Using the Gamma Knife Perfexion (GK) 2177 Bree Eaton Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases 2178 Daniel Kim Outcomes of Patients Treated With A Second Course of Stereotactic Radiosurgery for Locally or Regionally Recurrent Brain Metastases After Prior Stereotactic Radiosurgery 2179 Peter Gerszten A Multi-national Report on Methods for Institutional Credentialing for Spine Radiosurgery 2180 Henry Park Skull Base Chordoma and Chondrosarcoma: An Update of National Radiotherapy Patterns and Survival Outcomes in the Modern Era

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 112

ASTRO 2012 / 54TH ANNUAL MEE TING

2181 Jonathan Schoenfeld Melanoma Brain Metastases Treated With Brain-Directed Radiation Followed by Ipilimumab 2182 Yazan Abuodeh Review of Patients With Brain Metastasis Treated With Fractionated Stereotactic Radiation Therapy to Surgical Resection Cavity 2183 Young Hee Park Comparison of Five Prognostic Indices in Patient With Brain Metastases Who Treated With Radiotherapy 2184 Jeannie Han The Significance of Optic Nerve Involvement by Skull Base Meningioma and Its Impact on Radiographic Control After Treatment With Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy 2185 Arshin Sheybani High-dose Hyperfractionated Stereotactic Photon Radiation Therapy for Skull Based Chordomas 2186 Byoung-Hyuck Kim Reduced-dose Radiotherapy by the Chemoresponsiveness for the Primary Central Nervous System Lymphoma 2187 Francesca Caparrotti Whole Brain Radiotherapy With Simultaneous Integrated Boost to 1-4 Brain Metastases: A Prospective Study 2188 Kevin Shiue High vs. Standard Isodose Lines Has Equivalent Efficacy in Gamma Knife Treatment of 1-3 Brain Metastases 2189 Alexander Louie Multidisciplinary Assessment and Reporting of Fitness to Drive in Brain Tumor Patients: A Gray Matter 2190 Madeera Kathpal Use of a Non-coplanar Half-beam Block on the Lower Spinal Field to Decrease the Maximum Bowel and Cumulative Dose iIn Craniospinal Irradiation 2191 Hubert Pan Frameless, Real-Time, Surface Imaging Guided Radiosurgery (SIG-RS): Clinical Outcomes for Brain Metastases

2192 Itai Pashtan Proton Radiosurgery for Management of Brain Metastases 2193 David Roberge “Tri-modality” Therapy for Large Brain Metastases 2194 Akifumi Miyakawa Fractionated Stereotactic Radiotherapy for Metastatic Brain Tumors Recurring After Gamma Knife Radiosurgery: Acceptable Toxicity and Improved Local Control 2195 Nils Arvold Physician Recommendations for Steroid and Anticonvulsant Use Following Stereotactic Radiosurgery 2196 Tomohiko Matsuyama Fractionated Stereotactic Radiation Therapy (FSRT) For Brain Metastases From Non-small Lung Carcinoma; Relationship Between the Number of Metastases and Intracranial Relapse 2197 Paul Rava Stereotactic Radiosurgery As Salvage for Brain Metastases from Small Cell Lung Cancer 2198 Paul Rava Associating Risk With Survival and Brain Recurrence in Patients With Non-small Cell Lung Cancer Treated Aggressively for Synchronous Brain Metastases 2199 Roshan Prabhu Clinical Outcomes for a Novel 6 Degrees of Freedom Image Guided Immobilization and Localization Method for Frameless Radiosurgery for Brain Metastases 2200 Lijun Ma How Millimeter Margins Impact RTOG9005 Tolerance Dose Levels for Intracranial Stereotactic Radiosurgery

2203 Jonathan Leeman Linear Accelerator Based Stereotactic Radiosurgery for the Treatment of Brainstem Metastases 2204 John Flickinger Subtraction-fusion of New-minus-old Magnetic Resonance Images Can Identify Additional Brain Metastases in 24 percent of Repeat Radiosurgery Procedures 2205 Diandra Ayala-Peacock Predictive Factors for Distant Brain Failure After Primary Radiosurgical Management of Brain Metastases 2206 Edward Marchan Multileaf Collimator-based Linac Radiosurgery for Arteriovenous Malformations: The Emory Experience 2207 Sameer Nath TRIC or Tumor: Regrowing Lesions Following Radiosurgery for Brain Metastases - Proposal For a Histopathologic Scale based on Correlation With Survival 2208 Stefan Becker A New Mathematical Model to Simulate the Progression of Brain Metastasis 2209 Carmen Tundisi Is the Graded Prognostic Assessment (GPA) Reliable for Patients Previously Treated for Brain Metastases? 2210 Eric Ojerholm Gamma Knife Radiosurgery to Four or More Brain Metastases in Patients Without Prior Intracranial Radiation or Surgery 2211 David Roy Stereotactic Radiosurgery and Radiotherapy for the Treatment of Brain Metastases in Thyroid Carcinoma

2201 Dong Soo Lee Early Volumetric Change and Treatment Outcomes After Palliative Radiotherapy for Brain Metastasis

2212 Lauren Tait Outcomes of Gamma Knife Radiosurgery in Synchronous vs. Metachronous Small Cell Lung Carcinoma Brain Metastases

2202 Kristina Young A Retrospective Review of SBRT for Larger Brain Metastases or Post-resection Cavities

2213 Ryan Funk The Washington University Experience of Gamma Knife Radiosurgery for Aggressive Meningioma

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

113

CENTRAL NERVOUS SYSTEM/ continued 2214 Daniel Bernad Prophylactic Cranial Irradiation in Patients With Limited Stage Small Cell Lung Cancer: A Pilot Study Investigating the Effects of Radiation Therapy on Neurocognitive Function 2215 Maya Mathew Ipilimumab in Melanoma With Limited Brain Metastasis Treated With Stereotactic Radiosurgery 2216 Susannah Yovino Eliminating or Modifying Vertex Fields Significantly Reduces Normal Tissue Dose in Brain Tumor Patients 2217 Valentina Ovalle Radiosurgery of AVMs: A Single Center Experience in Chile, 1996 - 2010 2218 Sean Szeja Frameless Hypofractionated Stereotactic Radiation Therapy for Brain Metastases 2219 Yasuaki Harasaki Safety and Efficacy of Vemurafenib Combined With Stereotactic Radiosurgery for Brain Metastases in BRAF+ Melanoma 2220 Marc Leyrer Radiation-Induced Taste and Smell Toxicity: A Dose Volume Histogram Analysis of a Prospective Observational Study 2221 Ashwatha Narayana Use of Vemurafenib, a BRAF Inhibitor Along With Radiation Therapy in Melanoma Brain Metastasis 2222 Peyman Kabolizadeh Fractionated Stereotactic Radiosurgery for Large Brain Metastases 2223 Donald Cannon Impact of Radiotherapy and Extent of Resection in Choroid Plexus Carcinoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) Database

2224 Hany Soliman Outcomes for Post-surgical Hypofractionated Stereotactic Cavity Radiotherapy (HSCRT) As Salvage for Patients With Prior Whole Brain Radiation (wbrt) As Compared to Upfront Adjuvant Hscrt

GASTROINTESTINAL CANCER 2225 Yoshiki Kajiya Hyperbaric Oxygen Therapy for Reducing Adverse Events of Chemoradiotherapy for Esophageal Cancer 2226 Laurent Quero Evaluation of Early Response to Concomitant Chemoradiotherapy by Interim 18-FDG PET-CT Imaging in Patients With Locally Advanced Oesophageal Carcinomas 2227 Connie Yip CT Prognostication in Oesophageal Cancer Treated With Definitive Chemoradiation: Is Still Relevant 2228 Noriko Kobayashi Tumor Response After Small Dose of Chemoradiotherapy in Patients With Esophageal Carcinoma 2229 Hae-jin Park The Influence of Circumferential Resection Margin Status on Loco-Regional Recurrence in Esophageal Squamous Cell Carcinoma 2230 Feng-Ming Wang 5-beam Simplified Intensity Modulated Radiotherapy for Patients With Cervical Esophageal Carcinoma 2231 Shigehiro Kudo Preliminary Result of a Multicenter Phase II Study of Chemoradiotherapy With Docetaxel for Elderly Patients With Stage II/III Esophageal Carcinoma 2232 Ryuta Koike Definitive Chemo-radiotherapy (CRT) Using Intensity Modulated Radiotherapy (IMRT) Boost for Cervical Esophageal Cancer

2233 Hitoshi Ito Radiation therapy for Stage IA Esophageal Squamous Cancer 2234 Yoshinori Ito Phase II Trial of 5-fluorouracil In Combination With Cisplatin and Concurrent Radiotherapy (50.4 Gy) With Elective Nodal Irradiation for Clinical Stage II/III Esophageal Cancer 2235 Kazushige Atsumi Prognostic Value of FDG-PET In Definitive Chemoradiotherapy for Esophageal Cancer 2236 Shuchai Zhu Characteristics of the Lymph Node Metastases and Their Affect in Target Region Delineation in Prophylactic Postoperative Radiotherapy for Thoracic Esophageal Carcinoma 2237 Samuel Cooper Cervical Esophageal Cancer: A Population Based Study 2238 Yufeng Cheng Tumor-stroma Ratio is an Independent Predictor for Survival in Esophageal Squamous Cell Carcinoma 2239 Srinivas Chilukuri Prospective Study Evaluating Image Guided Volumetric Modulated Arc Therapy With Concurrent Weekly Cisplatinum for Inoperable Thoracic Esophageal Cancer 2240 Connie Yip CT Tumour Heterogeneity in Prognostication of Primary Oesophageal Cancer Treated With Definitive Chemoradiation 2241 Kristin Kowalchik Early Outcomes and Toxicity in Patients Treated With Bimodality or Trimodality Therapy for Esophageal Carcinoma With Intensity Modulated Radiation Therapy (IMRT) 2242 Roberto Innocente Salvage Treatment in Locoregional Recurrent Esophageal Carcinoma (EC) Using Intensity Modulated Radiation Therapy -Helical Tomotherapy (IMRT-HT) 2243 Joseph Killoran Application of FLT PET to Radiotherapy Treatment Planning of Esophageal Cancer

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 114

ASTRO 2012 / 54TH ANNUAL MEE TING

2244 Abraham Wu Definitive Chemoradiation for Adenocarcinoma of the Esophagus and Gastroesophageal Junction 2245 Takayuki Hashimoto Concurrent Chemo-proton Therapy Using 5-Fluorouracil and Cisplatin for Esophageal Cancer 2246 Wei Lu Pre-Chemoradiotherapy FDG PET/CT Can Not Identify Residual Metabolically Active Areas in Patients With Locally Advanced Esophageal Cancer 2247 Yuji Murakami Treatment Results of Definitive Radiation Therapy for Elderly Patients With Esophageal Squamous Cell Carcinoma 2248 Ligang Xing Tumor 18F-FDG Heterogeneity Assessed by PET Image Texture Analysis and Its Impact on Target Delineation for Esophageal Squamous Cell Carcinoma 2249 Yuichi Ishida Neoadjuvant Concurrent Chemoradiotherapy Followed by Definitive High-dose Radiotherapy or Surgery for Operable T3 Squamous Cell Carcinoma of Thoracic Esophagus 2250 Wei Wang Comparison of the Planning Target Volume Based on Three-dimensional CT and Four-dimensional CT Images off Thoracic Esophageal Cancer 2251 Shilpen Patel Tumor Length As a Prognostic Factor in Esophageal Cancer Management 2252 Bhupesh Parashar Adenocarcinoma Is Associated With Improved Survival Compared to Squamous Cell Carcinoma in Patients With Esophagus Cancer Treated With Radiation: A Seer Analysis 2253 Ravi Shridhar Lymph Node Dissection in Esophageal Cancer After Neoadjuvant Radiotherapy: A SEER Database Analysis

2254 Feng-Ming Hsu Changes of Pulmonary Fluorodeoxyglucose Uptake After Neoadjuvant Concurrent Chemoradiation in Predicting Postoperative Pulmonary Complications for Patients With Esophageal Cancer

2263 Ravi Shridhar Increased Survival Associated With Surgery and Radiation Therapy in Metastatic Gastric Cancer: A Seer Database Analysis 2264 Junichi Fukada Inter- and Intra-fraction Gastric Motion Study: Impact of Breathing and Stomach Filling

2255 Jeremy Tey Clinical Outcome of Palliative Radiotherapy in Locally Advanced, Symptomatic Gastric Cancer in the Modern Era 2256 Hua Ren Preliminary Results of Ongoing Phase II Study of Postoperative Intensity Modulated Radiotherapy (IMRT) Combined With Capecitabine for High Risk Gastric Cancer Patients 2257 Xin Wang A Phase I Study of Concurrent Capecitabine and Intensity Modulated Radiotherapy (IMRT) As Adjuvant Treatment for Locally Advanced Gastric Cancer 2258 Li Zhang Comparing Capecitabine Plus Oxaliplatin vs. Capecitabine Plus Oxaliplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer 2259 Jean Owen Sociodemographic Factors Associated With Management of Gastric Cancer: QRRO/CURE Results 2260 Aditi Aggarwal Megavoltage CT (MVCT) Based Evaluation of Internal Target Volume in Patients Undergoing Tomotherapy Based Image Guided Intensity Modulated Radiation for Gastric Cancers 2261 Ligang Xing Phase I Study of Docetaxel, 5-fluorouracil and Cisplatin With Concurrent Radiotherapy for Unresectable Locally Advanced Gastric Adenocarcinoma 2262 Shilpen Patel Analysis of Treatment Modalities for Gastric Adenocarcinoma

2265 Gene-Fu Liu Clinical Outcomes for Gastric Cancer Following Adjuvant Chemoradiation Utilizing Intensity Modulated Radiation Therapy 2266 Richard Lee Proton Therapy May Allow Elective Nodal Coverage in the Setting of Neoadjuvant Radiotherapy for Pancreatic Head Cancers Without Significantly Increasing Normal Tissue Exposure 2267 Roger Ove Chemoradiation in the Management of Pancreatic Neuroendocrine Tumors (PNET) 2268 Malolan Rajagopalan Pathologic Response With Neoadjuvant Chemotherapy and Stereotactic Body Radiotherapy for Borderline Resectable and Locally-advanced Pancreatic Cancer 2269 Akihito Nishioka Safety and Efficacy of Enzyme-Targeting Radiosensitization With Intraoperative Radiotherapy for Locally Advanced Pancreatic Cancer 2270 Chi Lin Borderline Resectable Pancreatic Adenocarcinoma: Tumor Volume and CA19-9 Reduction Following Neoadjuvant Chemotherapy and Fractionated Stereotactic Body Radiotherapy Correlates With Pathologic Response 2271 Amy Farkas Pancreatic Tumor Motion and Required Margins to Account for Motion 2272 Maged Ghaly Duodenal Sparing Stereotactic Body Radiation Therapy for the Treatment of Locally Advanced Pancreatic Cancer

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

115

GASTROINTESTINAL CANCER/ continued 2273 Yolanda Tseng Dosimetric and Clinical Predictors of Nausea and Vomiting: An Exploratory Analysis of a Prospective Phase I/II Trial With Neoadjuvant Accelerated Short Course Radiation Therapy With Capecitabine for Resectable Pancreatic Cancer 2274 Thomas Brunner A Comparison of Four Target Volume Definitions for Pancreatic Cancer: Two Concepts Including the Lymphatics (RTOG And ARO) and Two Concepts Only Treating the Primary Tumour (Michigan and UK-SCALOP) 2275 Severine Racadot Dummy Run in the Phase Iii Lap07 Pancreatic Cancer Trial: First Evaluation of Quality of Radiotherapy Planning 2276 Keun Yong Eom Dose-Volumetric Parameters Affect the Development of Diabetes Mellitus in Patients Treated with Post-operative Chemoradiotherapy Following Pancreaticoduodenectomy 2277 Aaron Wild SBRT as a Novel Treatment Option for Locally Recurrent Pancreatic Cancer After Failure of Definitive Multimodality Therapy: A Multi-institutional Case Series 2278 Lindsay Sales Neoadjuvant Chemoradiation in the Treatment of Local-Regional Pancreatic Adenocarcinoma 2279 Eric Mellon Outcomes of Adjuvant Radiotherapy and Lymph Node Dissection in Pancreatic Cancer: A Seer Analysis 2280 Ahmet Tunceroglu Dose-painted Intensity Modulated Radiation Therapy May Offer Improved Morbidity As Compared to 3-D CRT 2281 Cengiz Gemici Salvage Chemoradiotherapy for Loco-regional Recurrence After Adjuvant Gemcitabine in Patients With Resected Pancreatic Adenocarcinoma

2282 Wungki Park A Loss of Function Genetic Screen Identifies Determinants of Sensitivity to PARP Inhibitor ABT-888 in Pancreatic Cancer

2293 Sung hoon Kim The Impact of Beam Angle Configuration of Intensity-modulated Radiotherapy on the Normal Liver in Advanced Hepatocellular Carcinoma

2283 Chiyoko Makita Clinical Outcomes of Proton Beam Therapy for Cholangiocarcinoma

2294 Jean-Emmanuel Bibault Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Prognostic Factors Analysis

2284 Brandon Barney Clinical Outcomes and Toxicity using Stereotactic Body Radiotherapy (SBRT) for Advanced Cholangiocarcinoma 2285 Tae Ryool Koo Extrahepatic Bile Duct Cancer: Analysis of Treatment Outcomes and Patterns of Failure 2286 Tomoki Kimura The Treatment Results and Dosimetric Analysis of Stereotactic Body Radiation Therapy (SBRT) With Transarterial Chemoembolization (TACE) for Hepatocellular Carcinoma (HCC) 2287 Zhao-Chong Zeng Is It Time to Adopt EBRT As an NCCN Strategy for Intermediate/Advanced HCC? 2288 Zhi-Yong Yuan CyberKnife Stereotactic Body Radiation Therapy for Liver Metastases 2289 Chie Toramatsu The Role of Spot Scanning Proton Therapy in the Treatment of Large abdominal tumors: A comparative Planning Study of Hepatocellular Carcinoma 2290 RyoongJin Oh Tolerance of Cirrhotic Liver Comparing With Normal Liver to Stereotactic Body Radiotherapy 2291 Harriet Eldredge The Predictive Value of Functional Tumor Volume and Total Lesion Glycolysis in Patients With Liver Metastases From Uveal Melanoma Undergoing 90Yttrium Selective Internal Radiation Therapy 2292 Jeong Il Yu Predictive Factors for Child-Pugh Score Elevation in Hepatocellular Carcinoma Patients Treated With Conformal Radiation Therapy: Dose-Volume Histogram Analysis

2295 Withdrawn 2296 Bree Eaton Image-based Dosimetry for 90Y Selective Internal Radiation Therapy (SIRT) of Hepatic Metastatic Melanoma: Dose-Volume Analysis Predict FGD-PET Response 2297 Erik Lappinen Combination of Surgery and Stereotactic Radiotherapy (SRT) with 3-D SPECT/CT Treatment Planning for Primary and Metastatic Liver Tumors 2298 Yousri Rostom Efficacy and Safety of Three-dimensional Conformal Radiotherapy in Treatment of Portal Vein Thrombosis in Hepatocellular Carcinoma Patients 2299 Fumiaki Isohashi Patterns of Radiotherapy Practice for Bile Duct Cancer in Japan: Results of the Japanese Radiation Oncology Study Group (JROSG) Survey (2000-2008) 2300 Shigeo Takahashi Portal Vein and Bile Duct Toxicity Following Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) 2301 Chisa Hashizume Novalis Stereotactic Body Radiotherapy (SBRT) for Hepatoma and Liver Metastasis: Evaluation of the Optimal Dose 2302 Pramod Gupta Outcomes of Adjuvant Chemoradiation in Resected Gall Bladder Carcinoma: A Single Institution Experience from North India

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 116

ASTRO 2012 / 54TH ANNUAL MEE TING

2303 Seung Heon Lee Promising early results of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma With Respiratory Gated Radiation Therapy 2304 Jung Ho Im Higher Radiation Dose May Benefit Patients With Extrahepatic Bile Duct Cancer Undergoing Curative Resection 2305 Ann Shing Lee Individualized Hypofractionated Radiation Therapy (IHRT) for Advanced Hepatocellular Carcinoma (HCC): Single Institution Experience With 98 patients 2306 Yi Rui Zhai Outcomes of Intraoperative Electron Radiotherapy (IOERT) Combined With Radical Surgery for Early Stage Hepatocellular Carcinoma: A Pilot Study 2307 Withdrawn 2308 Po-Ming Wang Results From a Phase II Non-Randomized Trial on 145 Patients With Hepatocellular Carcinoma Treated With Volumetric Modulated Arc Therapy 2309 Martin Fuss Transarterial Ethiodol-based Hepatocellular Carcinoma (HCC) Embolization (TACE): Impact on Image-guidance for SBRT and HFxRT

2314 Jennifer Wo Phase I Study of Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer 2315 Jun Won Kim Clinical Features of Hepatocellular Carcinoma Patients Undergoing Resection After Concurrent Chemoradiotherapy 2316 Caitlin Schonewolf Patterns of Failure in Colorectal Patients With Liver Metastases Following Yttrium-90 Radioembolization 2317 Aaron Wild Concurrent vs. Sequential Sorafenib Therapy in Combination With Radiation for Hepatocellular Carcinoma: A Preclinical Study

2327 Ning Li Phase I Clinical Study of Concurrent Chemoradiation With Hydroxycamptothecin for Unresectable or Locally Relapsed Rectal Cancer

2318 Lauren Hertan Adjuvant Radiation Therapy in Resected Ampullary Carcinoma: Impact on Survival Outcomes

2328 NingNing Lu A Long-term Survival Analysis for Phase II Study of Postoperative Concurrent Capecitabine and Radiotherapy for Patients With Stage II/III Rectal Cancer

2319 Chiao-Ling Tsai Investigation on Sonic Hedgehog Signaling Pathway for Radiation Sensitization in Hepatocellular Carcinoma

2329 Ji Zhu The Strategy of Chemoradiotherapy First for Synchronous Distant Metastases Rectal Cancer: A Phase Ii Clinical Trial

2320 Sheen Cherian Stereotactic Radiation (SBRT) for Primary Liver Malignancie

2330 David Chia Efficacy of Palliative Radiation Therapy in Symptomatic Rectal Cancer in the Modern Era

2321 Hyunsik Yoon Dosimetric Analysis of Gastroduodenal Toxicity by Endoscopy in Cirrhotic Patients After Radiotherapy for Hepatocellular Carcinoma

2311 Shixiong Liang Evaluation of the Prognostic Value of Different Staging System for Hepatocellular Carcinoma Undergoing Conformal Radiotherapy

2322 Ki Mun Kang Preliminary Report of Stereotactic Body Radiotherapy With Respiratory Motion Tracking for Liver Tumors

2313 Michelle Stinauer Toxicity of combined SBRT and Selective Internal Radiation Therapy for Liver Metastases

2325 Jee Suk Chang Propensity Score Analysis of Anastomotic Leakage After Rectal Cancer Resection: Risk Factors and Radiation Effects 2326 May Abdel-Wahab Does Radiation Improve Survival of T2N1 or T3N0 Rectal Adenocarcinomas in Population-based Series?

2310 Ping Li Clinical Outcomes of γ-ray Stereotactic Body Radiation Therapy for Patients With Primary Hepatic Carcinoma of Stage I/II

2312 Chun-Ming Huang Clinical Experience of Helical Tomotherapy for Unresectable Hepatocellular Carcinoma

2324.5 Hee Ji Han Radiotherapy Outcome of Advanced Hepatocellular Carcinoma Greater Than 10 cm

2323 Mark Ziegler Efficacy of Radioembolization Treatments With Yttrium-90 Microspheres for Hepatocellular Carcinoma and Liver Metastases 2324 Mark Lobo Retrospective Analysis of the Yttrium-90 Microspheres in Hepatocellular Carcinoma: The University of Virginia Experience

2331 Jonathan Whaley Clinical Utility of Integrated FDG PET-CT Imaging in the Clinical Management and Radiation Treatment Planning of Locally Advanced Rectal Cancer 2332 Benhua Xu The Preliminary Results of Intense Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Prospective Non-randomized Phase II Study 2333 Yan-yang Wang Is Belly board Still Needed in IMRT for Rectal Cancer? The Change of Bladder Volume Affects the Determination

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

117

GASTROINTESTINAL CANCER/ continued 2334 Jessica Smith Clinicopathologic Comparison of High-dose-rate Endorectal Brachytherapy and Conventional Chemoradiotherapy Among Patients With Locally Advanced Low Rectal Cancer 2335 Konstantin Lavrenkov Experience Update of Neoadjuvant Chemo-radiotherapy for Locally Advanced Rectal Cancer Using UFT and Leucovorin 2336 Chia-Chun Wang Pre-operative Prone-position Volumetric Modulated Arc Therapy With Concurrent Bevacizumab and Chemotherapy in Locally Advanced Rectal Cancer 2337 Yong Cai Phase II Trial of Modified Short-time Preoperative Radiotherapy in Resectable Mid-low Rectal Cancer 2338 Ching-Wei Tzeng Intraoperative Radiation Therapy for Locally Advanced Primary and Recurrent Colorectal Cancer: Ten-Year Institutional Experience 2339 Luke Peng SEER-based Analysis of the Impact of Preoperative or Postoperative Radiotherapy on Survival Outcomes for T3N0 Rectal Cancer 2340 Tzu-I Jonathan Yang Predictors of Hematologic Toxicity During Pelvic Radiotherapy 2341 Daniel Bernad Late Effects From Pre-operative Endorectal Brachytherapy and Total Mesorectal Excision in Rectal Cancer Patients: Analysis on Bowel, Urinary and Stoma Function 2342 Jinhong Jung Clinical Results of Stereotactic Body Radiation Therapy for Lung Metastases From Colorectal Cancer 2343 Kara Leonard The Role of Local Radiotherapy in the Treatment of Metastatic Rectal Cancer

2344 Leire Arbea Four-week Neoadjuvant Intensity Modulated Radiation Therapy With Concurrent Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer Patients: A Single Institution Experience With Long-term Follow-up

2354 Michael Chuong Comparative Outcomes of Intensity Modulated Radiation Therapy vs. 3-D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal

2345 Maria Gambacorta Atlas-based Auto-segmentation Clinical Validation of Pelvic Volumes And Normal Tissue in Rectal Tumors

2355 Rosanna Yeung One vs. Two Cycles of Mitomycin C in Concurrent Chemoradiation for Treatment of Anal Canal Carcinoma: An Analysis of Outcomes and Toxicity

2346 Marsha Laufer Neoadjuvant Radiotherapy Use in Locally Advanced Rectal Cancer at National Comprehensive Cancer Network (NCCN) Centers

2356 Omar Mahmoud A Comparative Study of Conventional Radiotherapy vs. Intensity Modulated Radiotherapy in the Management of Patients With Anal Canal Cancer

2347 Aryavarta Kumar Peri-operative Complications in Patients With Inflammatory Bowel Disease Who Received Chemoradiation for Colorectal Malignancy

2357 Veronique Vendrely French Multicentric Clinical Evaluation of Helicoidal Tomotherapy for Anal Cancer in a Cohort of 69 Consecutive Patients

2348 Jared Sturgeon Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum 2349 Naichang Yu Interfractional Rectal Motion During External Beam Radiation Therapy for Patients With Rectal Cancer 2350 Joshua Meyer Young Age at Diagnosis Increases Risk of Lymph Node Positivity in Early-stage Rectal Cancer 2351 Jun Won Kim Molecular Markers Aid Prediction of Treatment Failure After Surgical Resection and Adjuvant Chemoradiation for Locally Advanced Rectal Cancer 2352 Jose Bazan Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity in Patients Receiving Pelvic IMRT and Concurrent Chemotherapy 2353 Fleure Gallant Association of Dosimetric Parameters and Acute Hematologic Toxicity in Anal Canal Patients Treated with Chemoradiation using 3-D Conformal vs. Intensity Modulated Radiotherapy Techniques

2358 Sheela Hanasoge Re-irradiation for Cancers of the Rectum and Anal Canal: The Emory University Experience 2359 Joost Nuyttens Inguinal Node Recurrence to the Untreated Groin in Patients With Anal Carcinoma 2360 Lisa Kachnic Dose-painted Intensity Modulated Radiation Therapy for Anal Cancer: No Differences in Treatment Toxicity and Early Outcomes Between Human Immunodeficiency Virus Positive and Negative Patients 2361 Suzanne Sachsman Analysis of HIV Negative and Positive Patients With Anal Squamous Cell Carcinoma Treated With Definitive Chemo-radiation Therapy at LAC/USC: An Update 2362 Sindu Vivekanandan Split-course Chemoradiotherapy: An Effective Alternative Treatment of Anal Cancer in Elderly Patients 2363 Craig Baden Intensity Modulated Radiation Therapy (IMRT) vs. Three-dimensional Conformal Radiation Therapy (3-D CRT) for Squamous Cell Carcinoma of the Anal Canal: Average Weekly Radiation Dose and Clinical Outcomes

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 118

ASTRO 2012 / 54TH ANNUAL MEE TING

2364 Vaiibhav Patel The Use of Gamma Knife Radiosurgery in Gastrointestinal Brain Metastasis: A Single Institution Experience 2365 Evan White Reduced Toxicity in Inflammatory Bowel Disease Patients Treated With Intensity Modulated Radiation Therapy (IMRT) 2366 Nitika Thawani Reduced Myelotoxicity in pelvic malignancies With Bone Marrow Sparing IMRT 2367 Chi Lin Comparison of Prognostic Factors and Survival Outcome Between Primary Malignant Melanoma in Gastrointestinal Track and Cutaneous Malignant Melanoma

GENITOURINARY CANCER 2368 Ryan Burri Rectal Balloons and the Risk of Secondary Rectal Malignancy After IMRT for Prostate Cancer 2369 Steven Finkelstein White Blood Cell Counts Remain Stable Following Standard Radiation Approaches for High-risk Adenocarcinoma of the Prostate 2370 Damien Weber Intensity Modulated Proton and Photon Therapy for Early Prostate Cancer With or Without Transperineal Injection of a Polyethylen Glycol Spacer: A Treatment Planning Comparison Study

2373 Daniel Adam Jones Neurovascular Bundle (NVB) Sparing Technique In Prostate Brachytherapy 2374 Hiromichi Ishiyama High-dose-rate (HDR) Brachytherapy and Hypofractionated External Beam Radiotherapy Combined With Long-term Hormonal Therapy for High-risk Prostate Cancer 2375 Kotaro Terashima Can Belly Board Reduce Respiratory-induced Prostate Motion in the Prone Position? Assessed by Cine-magnetic Resonance Imaging 2376 Masahiro Morimoto Comparison of Acute Genitourinary and Gastrointestinal Adverse Events of Localized Prostate Cancer Treated With Monotherapy Using Intensity Modulated Radiation Therapy or Three-dimensional Conformal Radiation Therapy or Permanent Implant Brachytherapy 2377 John Hegde Preoperative 3-Tesla Multiparametric Endorectal MRI Findings and the Odds of Upgrading and Upstaging at Radical Prostatectomy in Men With Clinically Localized Prostate Cancer 2378 Kamran Ahmed Role of Stereotactic Body Radiation Therapy in Oligometastatic, Hormone Refractory Prostate Cancer 2379 Takashi Mizowaki Interim Outcomes of a High-dose Whole Pelvic IMRT for Very High-risk Group of Patients With Locally Advanced Prostate Cancer

2371 Waleed Mourad Long-term Outcomes of Postprostatectemy Salvage Radiation Therapy (PsRT) Dose Intensification (81Gy)

2380 Alan Katz Stereotactic Body Radiation Therapy Offers A Safe, Non-Invasive Treatment for Prostate Cancer Patients Over 70 Years Old

2372 Waleed Mourad Dosimetric and Biological Impacts of Simultaneous Integrated Brachytherapy Boost (SIBB) Delivered Via Pd103 Seeds followed by External Beam Radiotherapy (EBRT) on Prostate Cancer

2381 Jonathan Andrew Haas Stereotactic Body Radiotherapy for Low-Intermediate Risk Prostate Cancer 2382 Ravinder Clayton Utilization of Radiation Therapy in Metastatic Castration Resistant Prostate Cancer Following the Introduction of Abiraterone into Clinical Oncology Practice

2383 Israel Fortin Fiducial Markers (fm) in the Prostate Bed for Post Prostatectomy External Beam Radiation Therapy: Improved Accuracy As Compared to the Use of Surgical Clips 2384 Shawn Malone Preliminary Results of a Randomized Trial of Optimal Timing of Dose Escalated (76 Gy) Radiation and 6 Months ADT in Prostate Cancer 2385 Vikram Velker Predictors of Prostate Bed Contouring Variability: An International Contouring Challenge 2386 Hiraku Sato Comparison of Soft-tissue Matching on Daily Cone-beam Computed Tomography and Fluoroscopy-based Bony-structure Matching in the Target Localization for the IMRT of Prostate Cancer 2387 Yutaka Shiraishi Assessment of Late Rectal Toxicity After I-125 Prostate Brachytherapy Using Equivalent Uniform Dose 2388 Breanne Terakedis The Effect of Prostate MRI on Cancer Staging and Radiotherapy Treatment Recommendations 2389 Magali Lecavalier-Barsoum Hypofractionated IMRT With Simultaneous Integrated Boost for High-risk Prostate Cancer Patients: Acute Toxicity Report 2390 Hong Ye A Matched Pair Analysis of Long-term Clinical Outcomes and Toxicities for Low-risk Prostate Cancer Patients Treated With Low-dose-rate or High-dose-rate Brachytherapy 2391 Shinichi Takahashi Optimal Acquisition Parameter Selection for CT Simulators Reducing Seed Artifacts in Permanent Seed Implants 2392 Michael Dominello Volumetric Modulated Arc Therapy Decreases Incidence of Acute Rectal Toxicity in the Treatment of Low- and Intermediate-risk Prostate Cancer

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

119

GENITOURINARY CANCER/ continued 2393 Christophe Hennequin 18(F)choline PET/CT and Prostate MRI for Staging of Biochemical Relapse After Radiotherapy of Prostate Cancer 2394 Magali Quivrin Multiparametric MRI-based Dosimetric Parameters Best Predict Short-term Time Course of PSA After Iodine 125 Permanent Prostate Implantation for Localized Prostate Cancer 2395 Andrew Lee Patient Quality of Life After Proton Therapy (1.8 vs 2 Gray Equivalents) for Prostate Cancer 2396 Jeremy Karlin An Exploratory Analysis of Prostate Brachytherapy Cases Using the Proposed Activity-Based Medical Event Definition 2397 Eric Vigneault The Long-term Experience of Permanent Seed Implant Monotherapy in Low- and Intermediate-risk Prostate Cancer 2398 Shigeyuki Takamatsu Clinical Assessment of Proton Therapy of Prostate Cancer Patients With Auto Activation PET/CT 2399 Constantine Mantz Real-time Target Tracking Prostate SBRT: Quality of Life and Disease Outcomes From a Phase II Trial Utilizing Varian Trilogy and the Calypso 4-D Localization System 2400 Shinji Kariya High-dose-rate Brachytherapy Combined With External Beam Radiotherapy for Localized Prostate Cancer: Clinical Predictive Factor for Biochemical Relapse-free Survival 2401 Manabu Aoki PSA Response to Tri-modality (HDR Brachytherapy, Hypofractionated 3-D CRT, Neoadjuvant/Adjuvant Androgen Therapy) Predicts Biochemical Progression Free Survival in Localized Prostate Cancer

2402 Colleen Lawton RTOG Protocol 05-18: A Phase III Randomized Trial to Evaluate the Efficacy of Zometa for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy (RT) and Long-term Lutenizing Hormone-releasing Hormone (LHRH) Agonist 2403 Ovidiu Marina Dose-Escalated Adaptive Image Guided Radiotherapy vs. High-dose-rate Brachytherapy Monotherapy for Gleason 7 Intermediate-risk Prostate Cancer: A Matched-pair Analysis

2411 Kevin Diao Comparative Patient-reported Quality of Life (QOL) During Radiation Therapy (RT) in Patients Receiving Definitive RT vs. Post-prostatectomy RT for Prostate Cancer 2412 Harold Wallace Autoscan Transperineal Ultrasound of the Pelvis for Prostate Gland Localization: A Feasibility Study 2413 Catherine Duarte Impact of Race on Prostate Cancer Treatment Selection and Cause-Specific Mortality: A SEER Database Analysis

2404 Julia Luisa Munoz Garcia Metabolic Alterations After Normalization of Testosterone Levels in Patients With Prostate Cancer Treated With Androgen Deprivation

2414 Ovidiu Marina Mean Per-core Biopsy Volume As a Predictor of Failure for Gleason 7 Prostate Cancer Patients Undergoing High-dose-rate Brachytherapy (HDR)

2405 Shelly X. Bian The Influence of Age and Cormorbidity on the Benefit of Adding Androgen Deprivation to Dose-Escalated Radiation in Men With Intermediate Risk Prostate Cancer

2415 Abdenour Nabid Adherence to Long-term Androgen Blockade in Localised High-risk Prostate Cancer and Causes of Noncompliance

2406 Michael Bernstein PSA Bounce Predicts for a Favorable Prognosis Following Brachytherapy, but an Unfavorable Prognosis After External Beam Radiotherapy: A Meta-analysis 2407 Jennifer Croke Impact of Radical Prostatectomy on Rectal Position and Implications for CTV Definition for Post-operative Prostate Radiotherapy 2408 Jose Hinojosa Gomez C11-Acetate Positron Emission Tomography (PET) for Prostate Cancer Patients Undergoing Radiotherapy 2409 Anshu Jain Predicting the Risk of Secondary Malignancies Associated With Pelvic Nodal Irradiation in the Treatment of Prostate Cancer 2410 Nikul Sheth Validation of Inverse Planning Simulated Annealing Class Solution for Prostate High-dose-rate Brachytherapy

2416 Whoon Jong Kil Hypofractionated Proton Radiotherapy for Low- and Intermediate-risk Prostate Cancer Is Not Associated With Post-Treatment Testosterone Suppression 2417 Juan Salinas Early Results of Hypofractionated VMAT IGRT in Prostate Cancer 2418 Gregor Spira More Space More Dose: Dose Report of the First Patients With Intermediate and High-risk Prostate Cancer Treated in Cologne With Spaceoar Hydrogel Before HDR-brachytherapy Boost and External Beam IMRT 2419 Viola Chen Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer: The Georgetown Experience 2420 Jose Lopez Torrecilla Construction of Nomograms for Predicting the Development of Metastases and Biochemical Failure in Cancer of Prostate Treated With Radiotherapy From Patients of Spanish Cancer Prostate Register (recap)

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 120

ASTRO 2012 / 54TH ANNUAL MEE TING

2421 Thomas Sheldon Transperineal Ultrasound/CT Fusion for LDR Prostate Brachytherapy Post-planning 2422 Richard Gewanter Does Low PSA Predict for Worse Outcome in Patients With Gleason 8-10 Localized Prostate Cancer Treated With Radiotherapy? 2423 Ferran Ferrer Interfraction Motion in Image Guided Radiotherapy for Prostate Cancer. Protocol code: IGRT-Prostate 1-09 2424 Juanita Crook In-vivo Validation of Ultra-sound (US)-based High-dose-rate (HDR) Prostate Brachytherapy (BT) Planning: Comparison of US Needle Tip Reconstruction to CT Gold Standard

2432 Takeshi Tamura Improvement of Pollakisuria after Intensity Modulated Radiation Therapy (IMRT) for Prostate Cancer: Association With Prostate Volume 2433 Emile van Lin MR-guided Focal Cryoablation of Prostate Cancer Recurrence Following Radiotherapy: Feasibility and Early Results 2434 Shea Wilcox Efficacy of Androgen Deprivation in Combination With Dose-Escalated Image Guided Intensity Modulated Radiotherapy for Prostate Cancer: 5 Year Outcomes From a Single Institution

2425 Michael Peroski Prostate Brachytherapy Outcomes in a Rural Community Cancer Center

2435 Koyo Kikuchi Three-dimensional Summation of Rectal Doses During Combined Seed Implant Brachytherapy and External Beam Radiotherapy for Prostate Cancer

2426 Richard Marshall Long-term Treatment Outcomes and Morbidity Following the Brachytherapy Management of Localized Prostate Cancer

2436 Roberto Bortolus High-risk Prostatic Cancer: Radiotherapy and Concomitant Docetaxel. Guone (North-East Uro-oncology Group) Experience

2427 Armando Felix Morbidity Results in a Prospective Randomized Trial of Hypofractionation vs. Standar Fractionation for Prostate Cancer Using Conformal Radiotherapy

2437 Jerry Liu Adjusted Intermediate- and High-risk Stratification for Prostate Cancer Is More Prognostic Than Current NCCN Risk Grouping

2428 Goura Kishor Rath Impact of Beam Energy Variations and Setup Error in the Treatment of Prostate Cancer

2438 Filippo Alongi Moderate Hypofractionation and Simultaneous Integrated Boost With Volumetric Modulated Arc Therapy by Rapidarc for Prostate Cancer: Report of Feasibility and Acute Toxicity

2429 Jason Wong First Report on Seed Migration to the Lung With the Use of a Thinner I125 Radioactive Seed Within 20 Gauge Needles for Permanent Seed Prostate Brachytherapy 2430 Boris Naydich Comparative Dosimetric Analysis of Computer vs. Nomogram Based Intra-Operative Planning for Prostate Seeds Implants 2431 Vinita Takiar MRI-based Sector Analysis Enhances Prostate Pd-103 Brachytherapy Quality Assurance in a Phase II Prospective Trial of Intermediate-risk Patients

2442 Fazilet Dincbas Rectum and Bladder Dose Variations During the Course of Image Guided Radiotherapy for Postoperative Prostate Cancer 2443 Lisa McGee Impact of Proton Therapy to the Prostate Alone vs. the Whole Pelvis on Patient-Reported Outcomes and Toxicities in High-risk Prostate Cancer Patients 2444 Sujay Vora Nine-year Outcome and Toxicity in Patients Treated with IMRT for Clinically Localized Prostate Cancer 2445 Jonathan Tward Demographics and Comparative Effectiveness of Surgery and Radiation Therapy in Men With Gleason Pattern 5 Prostate Cancer

2439 Thomas Pugh Prospective Quality of Life and Toxicity between Passively Scattered and Spot-Scanning Proton Therapy for Prostate Cancer 2440 Richard Stock The Relative Effects of Biologically Effective Dose (bed) vs. Adjuvant Androgen Suppression (as) on Biochemical Control and Post-treatment Biopsy Results Following the Brachytherapy Management of Prostate Cancer

2441 Nancy Mendenhall The Value of Dose Constraints in Minimizing Rectal Toxicity in Patients Receiving Radiation Therapy for Prostate Cancer: Three-year Analysis of Toxicity Outcomes in Two Prospective Trials of Image Guided Proton Therapy for Early- and Intermediate-risk Prostate Cancer

2446 Gael Drean Voxel-based Analysis of Dose for Toxicity Prediction in Prostate Cancer Radiotherapy 2447 Juan Ospina Random Forest Are Strong Competitors of Published NTCP Models for Rectal and Bladder Toxicity Prediction 2448 Christopher King Critical Utility of Ultrasensitive PSA for High-risk Patients Eligible for Adjuvant Radiotherapy Following Radical Prostatectomy 2449 Vladimir Turkevich Clinical Experience With the Use of the Exablate Magnetic Resonance Guided Focused Ultrasound Surgery (MRGFUS) System for Focal Treatment of Low-risk Prostate Cancer 2450 Andrew Hollander Interfraction Motion of the Full Seminal Vesicles in Prostate Radiotherapy Using a Daily Endorectal Balloon

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

121

GENITOURINARY CANCER/ continued 2451 Sinisa Stanic Analysis of True Delivered Dose to the Prostate Fossa Utilizing Daily Cone Beam CT in Postprostatectomy Patients Who Failed Salvage Intensity Modulated Radiation Therapy 2452 James Welsh Evidence Supporting the Assertion That the Current Definition of Medical Events Is Imperfect for Prostate Permanent Implant Brachytherapy 2453 Robert Fratamico Toxicity Analysis of Prostate Seed Implant (PSI) Combined With Photovaporization of the Prostate (PVP) to Treat Prostate Cancer (PC) in Men With Bladder Outlet Obstruction (BOO) Compared to PSI Alone in Men Without BOO 2454 Mark Ranck Refining Intermediate-risk Prostate Cancer: An Analysis of Prostate Biopsy Pathology and Implications for Hormone Therapy With Dose Escalated Radiation 2455 Derek Suderman Comparison of Adjuvant vs. Salvage Radiotherapy After Prostatectomy: A Population Based Analysis 2456 William Foster Impact of Implantation Technique on Biochemical Disease-free Survival in I-125 Treated Prostate Cancer Patients 2457 Maged Ghaly Phase I Dose-escalation Study of (SBRT) for Localizes Prostate Cancer 2458 Yi Le Development of a Non-template based Permanent Prostate Brachytherapy Treatment Planning System for Penile Bulb Avoidance 2459 Apsara Windsor Endorectal Balloons in Post-prostatectomy Radiotherapy: Improved Stability of Clinical Target Volumes and Reduction of Geographical Miss

2460 Yeohan Song ERG Gene Fusions As a Prognostic Tumor Biomarker in Prostate Cancer Patients Treated With Salvage Radiotherapy 2461 Steven Frank Prostate Brachytherapy Long-term Outcomes, Quality of Life and Patient-reported Satisfaction: The MD Anderson Cancer Center Experience 2462 Akihiro Hayashi Elevation of Baseline PSA Levels after Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer: Discrimination From Biochemical Failure 2463 Jared Robbins Outcomes for Hormone-Naïve Patients Who Achieved Undetectable PSA After Salvage Prostate Bed Radiation Treatment Post-prostatectomy 2464 Carlo Greco Feasibility and Preliminary Rectal Toxicity Data of Transperineal Polyethylene Glycol Gel Spacer Implantation Prior to Hypofractionated VMAT in Prostate Cancer 2465 Zvi Symon Do Prostate Cancer Patients With Extremely High PSA Benefit From Radiation Therapy? A Population Based Study 2466 Taisuke Inomata The Excellent Biochemical Failure Free Survival Rate of High-dose-rate Brachytherapy Combined With External Beam Radiation Therapy in Patients With Prostate Cancer

2470 Lev Tsvang Pelvic Volumetric Modulated Arc Therapy With Hypofractionated Concomitant Integrated Prostate Boost: An Isoeffective Dose Comparison 2471 Brett Cox Aggressive Intrafraction Motion Management Is Required for SBRT for Localized Prostate Cancer 2472 Brandon Nguyen Catheter Geometries for Prostate Tumor Targeted HDR Brachytherapy 2473 Takuya Nishimura Exceptionally High Incidence of Symptomatic Grade 2 - 4 Late Rectal Toxicity in Radiotherapy of Prostate Cancer in 2.2 Gy Hypofractionation Using Image Guided Intensity Modulated Radiation Therapy 2474 Takuya Kaminuma Comparison of the Objective and Subjective Assessments of Urinary Condition in Hypofractionated Carbon-ion Radiotherapy for Localized Prostate Cancer 2475 Kristina Sjödin Quality of Life Assessment in Patients Receiving a Spacer Between Prostate and Anterior Rectal Wall to Optimize Radiotherapy of Localized Prostate Cancer 2476 Hussam Hijazi Early Toxicity Comparison of Three Different Brachytherapy Boost Fractionation Schemes for Prostate Cancer

2467 Ryan Smith Prediction of True Dosimetric Parameters Over the Life of the Implant in Prostate Brachytherapy

2477 Samuel Swisher-McClure MRI-based Evaluation of Interfraction Motion in Post-Prostatectomy Radiation Therapy (PPRT) With Daily Endorectal Balloon (ERB)

2468 Amit Jotwani Rectum and Bladder Dose Variations During Prostate IGRT: An Evaluation of Bowel and Bladder Preparation Protocol

2478 Nathan Tonlaar Image Guided Adaptive Radiotherapy for Prostate Cancer: Toxicity Comparison for 3-D Conformal vs. Intensity Modulated Beams

2469 Kristina Maletz Identifying Prostate Cancer Subgroups With Decreased Survival Following Adjuvant Androgen Deprivation Therapy

2479 Amarjit Sen Stereotactic Body Radiotherapy (SBRT) for Low-risk Prostate Cancer: Plan Comparison Between Rapidarc With Real Time Tracking by Calypso Beacons and Helical Tomotherapy

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 122

ASTRO 2012 / 54TH ANNUAL MEE TING

2480 Usama Mahmood Decreasing Utilization of Brachytherapy for the Treatment of Prostate Cancer: A National Patterns of Care Analysis Using NCCN Risk Categorization

2490 Ana Paula Galerani PSA Levels After Salvage High-dose-rate (HDR) Brachytherapy in Patients With Locally Recurrent Prostate Cancer After External Beam Radiotherapy

2481 Joelle Helou Intraprostatic Boost Using Highdose-rate Brachytherapy (HDR-BT) According to Gross Tumor Volume (GTV) Location for Prostate Cancer: A Dosimetric Feasibility Study

2491 Moshiur Anwar Role of Endorectal MRI And MRSI in Defining the Dominant Intraprostatic Lesion in Prostate Cancer: Quantitative Analysis of Imaging Contour Compared to Whole-mount Histopathology

2482 Seth Blacksburg The Potential Impact of Medications on Biochemical Control Following Definitive Management of Prostate Cancer 2483 Tamim Niazi What Daily Image Guidance Is Needed for Prostate Cancer Patients Post Radical Prostatectomy? Data From a pilot phase II study 2484 Felix Sedlmayer EBRT of Prostate Cancer: Does Rectal Spacer Application Show Influence on Inter- and Intra-fraction Prostate Mobility? 2485 David Cuthbert Dose Conformality and Acute Toxicity Analysis in Patients With Prostate Adenocarcinoma Treated With Volumetric Modulated Arc Therapy (VMAT) vs. Conventional Intensity Modulated Radiation Therapy (IMRT) 2486 Sarah Kerns Genome Wide Association Study to Identify Genetic Variants Associated With Urinary Symptoms Following Radiotherapy for Prostate Cancer 2487 David Bowes A Randomized Trial Comparing Seed Loss and Displacement of Anchorseeds to Standard Uncoated Loose Seeds 2488 John Hayes HDR Boost Combined With Short-term Androgen Blocade Produces Excellent Long Term Outcome in High-risk Prostate Cancer 2489 Francisco Gomez-Veiga Low-dose-rate Brachytherapy for the Treatment of Post Prostatectomy Local Recurrence. A Phase II Trial

2492 Eric Ko Association of Genetic Factors With PSA Response in Prostate Cancer Patients Receiving Definitive Radiotherapy

2500 Marie Hjalm-Eriksson Long-term Effects on Quality of Life After Treatment of localized Prostate Cancer, A Comparison of Four Different Treatment Modalities 2501 Adrian Anton Dosimetry Evaluation of MIM Symphony LDR Brachytherapy Treatment Planning for Prostate Seed Implant (PSI) 2502 Kenneth Tokita Acute Normal Tissue Toxicities for 148 Combined Therapy Prostate Carcinoma Patients 2503 Marie Charissoux Updated Results of the Montpellier IMRT Prostate Cancer Cohort: Focus on Elderly Patients

2493 Monica Shukla Pre-radiotherapy PSA Is Predictive of Biochemical Progression Free Survival Following Post-prostatectomy Salvage Radiotherapy 2494 Nita Patel Correlation Between PSA Bounce, Time to Nadir and Biochemical Failure in Patients With Prostate Cancer Treated With a Combination of HDR-Brachytherapy and Hypofractionated External Beam Radiotherapy 2495 Young Kwok Long-term Follow-up of Combined Modality Therapy With Pelvic External Radiation Followed by Cs-131 Brachytherapy Boost in Men with High-risk Prostate Cancer

2504 Rafi Kabarriti Predictive Value of Psa Trend During snd After Post Prostatectomy Salvage Radiation Therapy 2505 Gilles Crehange Duration of Androgen Deprivation Combined With Radiotherapy Does Not Jeopardize Time to Castration Resistance iIn Men With Unfavorable Intermediate- and High-risk Prostate Cancer 2506 Benjamin Guix Dose Escalation With High-dose 3-D Conformal (HD-3-D CRT) or Low-dose 3-D Conformal Radiotherapy (LD-3-D CRT+HDR-B) For Intermediate- or High-risk Prostate Cancer: Higher Disease Control and Survival With Lower Toxicity

2496 Elizabeth Ester Intermediate-risk Prostate Cancer Treated With Definitive Low-dose-rate Brachytherapy

2507 Dorothy Boo In Support of Brachytherapy for Young Men with Prostate Cancer

2497 Michael Repka Do Loose Sources vs. Stranded Improve Postimplant Dosimetry for Prostate Seed Implants?

2508 Waleed Mourad The Impact of Sequence of Bimodality Approach on Low-risk Prostate Cancer Outcomes

2498 Douglas Kelly Dose Painting a Prostate Peripheral Zone Boost With Helical Tomotherapy IMRT

2509 Gilles Crehange Prostate Metabolism After the Completion of Exclusive Radiation Is More Depleted After Seeds Brachytherapy Compared to External Beam Radiotherapy for Prostate Cancer Patients

2499 Olivier Chapet Injection of Hyaluronic Acid (HA) to Better Preserve the Rectal Wall in Prostate Hypofractionated Radiotherapy (HFR)

ASTRO 2012 54TH ANNUAL MEE TING

123

GENITOURINARY CANCER/ continued 2510 Richard Lee Association Between Biochemical Outcome and Pre-salvage Radiation Therapy PSA Is Not Different for Obese and Non-obese Men 2511 Michael Leapman Hematuria After Prostate Brachytherapy 2512 Lester Greer Dosimetric Comparison of Photon Stereotactic Ablative Radiotherapy (SABR) and Proton SABR in the Treatment of Prostate Cancer Patients 2513 Laura D’Alimonte Variability of Bladder Volumes in Men Receiving Radiotherapy to the Prostate 2514 Randal Henderson Three-Year Analysis of Urinary Toxicity in Two Prospective Trials of Image Guided Proton Therapy for Early- and Intermediate-risk Prostate Cancer: Outcomes in Men With Moderate to Severe Pretreatment Urinary Obstructive Symptoms 2515 Sindy Magnan Long Term Experience of HDR Brachytherapy Boost for Localized Prostate Cancer 2516 Sameer Keole Initial Report of Toxicities in Men With Prostate Cancer Treated With Uniform Scanning Protons 2517 Moshiur Anwar Comparison of PSA Kinetics Between Hypofractionated Stereotactic Body Radiotherapy, Conventionally Fractionated External Beam Radiation and High-dose-rate Brachytherapy 2518 Daniel Schroyer Dosimetric and Clinical Comparison of Anchor Seeds (AS) vs. non-Anchor Seeds (NAS) Using Real-time US Dosimetry and Day 30 CT Dosimetry for Low-dose-rate Prostate Brachytherapy 2519 David Berlach Iodine and Palladium Implants of High-risk Prostate Cancers Both Achieve Excellent Biochemical Failure Free Survival

2520 Brian Moran Preliminary Results of a Prospective, Randomized Trial Evaluating Quality of Life Outcomes After Prostate Brachytherapy Using 18g vs. 20g Needles/Seeds 2521 Grant Hunter Competing Risk Analysis for Causes of Death in Men With High-risk Prostate Cancer 2522 Onyi Offor PSA Halving Time Of ≤2 Weeks and Post-RT PSA Nadir <0.1 ng/ml Are Associated With Excellent Biochemical Control for High-risk Prostate Cancer: Implications Regarding the Need For Long-term ADT With Dose Escalated RT 2523 Stephanie Markovina Serum Testosterone Levels in Men Treated With Intensity Modulated Radiation Therapy for Prostate Cancer 2524 Lili Chen Dosimetric Evaluation of Inter-factional Motion For Image Guided Prostate IMRT 2525 Andre Martin Does Phoenix Failure Definition Apply to EBRT + HDR Brachytherapy Boost in Prostate Cancer? 2526 Carolyn Kim Incidence and Predictors of Acute And Chronic Rectal Bleeding As Reported by Patients Through Epic Questionnaire for Prostate Brachytherapy Using Cesium 2527 Carolyn Kim Is There a Secondary Spike in Urinary Symptoms With Cs131 Prostate Brachytherapy? A Longitudinal Analysis With Patient Reported Epic Survey and AUA Score 2528 Robert Meier Long-term Outcomes of Stereotactic Body Radiotherapy for Organ-confined Prostate Cancer 2529 Sharon Lu Comparison of Acute and Late GI and GU Toxicity Following Whole-pelvis vs. Prostate-only IMRT With Daily Image Guidance

2530 William Lorentz Role of Multiparametric MRI in Defining Lesions for Targeted Dose Escalation in Prostate Cancer 2531 Oleg Sostin Impact of Real-time Tumor Tracking and Fraction Size on Treatment-related Morbidity in Prostate Cancer Patients Treated With IMRT 2532 Awad Ahmed A Novel Methodology to Predict Late Urinary Toxicity Following Prostate Radiotherapy Based on Bladder Wall Dosimetry 2533 Ananya Choudhury Tumour Necrosis Predicts Benefit From Hypoxia-modifying Therapy in High-risk Bladder Cancer 2534 Olivier Riou Combined Chemoradiotherapy With Gemcitabine and Cisplatinum for Organ Preservation in Muscle-invasive Bladder Cancer: Long-term Results of a Phase I Trial 2535 Meral Kurt The Effect of Her2/Neu Protein Overexpression on the Prognosis of Patients With Invasive Bladder Cancer Who Were Treated With Definitive Radiotherapy 2536 Kate Noa Adjuvant Radiation for Bladder Cancer: A Dosimetry Study 2537 Michael Folkert Second Cancer Risk Following Radiation Therapy for Seminoma: A Single-institution Retrospective Study 2538 Leah Katz Impact of Radiation Field Design on Inadvertent Cardiac and Kidney Dose Delivered During Treatment for Stage I/II Seminoma 2539 Jennifer Vogel Radiation Therapy in Management of Malignant Pheochromocytoma 2540 Jennifer Ho The Role of Radiotherapy in Adrenocortical Carcinoma

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 124

ASTRO 2012 / 54TH ANNUAL MEE TING

2541 Ron Allison Current Management of Penile Cancer 2542 Withdrawn 2543 Maria Cascales Garcia Conservative Treatment of Penile Cancer: Retrospective Analysis of One Cohort of Patients Treated With Brachytherapy 2544 Alexander Louie Photodynamic Therapy for Bowen’s Disease of the Penis 2545 Daniel Pham Analysis of Potential Surrogates for Kidney Motion Verification Imaging and Its Implications for Stereotactic Radiotherapy of the Kidney 2546 Richard Speight Producing a VMAT Class Solution for Adjuvant Pelvic Radiotherapy for Penile Cancer 2547 David Ly Demographics, Prognostic Factors and Treatment Outcomes of Adrenocorticotrophic Carcinoma: A SEER Database Analysis From 1988-2008 2548 Jonathan Paly Outcomes for a Multi-institutional Cohort of Patients Treated With Intra-operative Radiation Therapy for Advanced or Recurrent Renal Cell Carcinoma 2549 Chi Zhang A SEER Database Analysis of Urethral Cancer Management 2550 Kapila Kalakota Outcomes in Stage I and IIA-B Testicular Seminoma Patients Treated With Dog-leg Field Radiotherapy (DLRT)

GYNECOLOGICAL CANCER 2551 Brandon Barney Intraoperative Electron Beam Radiotherapy (IOERT) in the Management of Locally Advanced or Recurrent Cervical Cancer 2552 Hani Gaballa Cancer of the Cervix: Dosimetric Comparisons of Dose Prescription to Applicator Point a vs. Dose Prescription to CTV 2553 Kimiko Hirata Clinical Efficacy of Alternating Chemoradiotherapy With Moderate-Dose Brachytherapy for High-risk Patients of Cervical Cancer 2554 Rahul Krishnatry Comparison of Two Contouring Methods of Bone Marrow on CT and Correlation With Hematological Toxicities (HT) in Non Bone Marrow Sparing Pelvic IMRT (NBM-IMRT) With Concurrent Cisplatin for Cervical Cancer 2555 Miho Watanabe New Approach to Relief Pain and Distress during High-dose-rate Intracavitary Irradiation for Cervical Cancer 2556 Goro Kasuya Outcomes of Postoperative Radiotherapy for Early-stage Uterine Cervical Cancer 2557 Tamer Refaat Pulsed Dose Rate and Image Guided Brachytherapy: Outcomes and Comparison to ICRU 38 Reference Point 2558 Vasu Tumati Stereotactic Body Radiotherapy (SBRT) Can Be Dosimetrically Equivalent to High-dose Brachytherapy As a Boost for Locally Advanced Cervical Cancer: A New Clinical Trial Concept 2559 Fernanda Herrera Simultaneous Integrated Boost in Cervix Cancer: The Impact of Organ Motion and Tumor Regression

2560 Frederique Vasseur Long Follow-up of Pulsed-dose-rate Brachytherapy for Cervical Carcinoma: Analysis of Oscar Lambret Center Experience on 125 Patients Treated From 1999 to 2008 2561 Lichun Wei The Relationship Between the Late Toxicity and the Dose of Rectum and Bladder of the Patients With Local Advanced Cervical Cancer Treated With CT Image Guided High-dose-rate Brachytherapy 2562 Yu-Jen Chen A Novel Vagina Enhancement Modality Aids Vaginal Mucosa Delineation and Improves Dosimetric Parameters in Female Pelvic Intensity Modulated Radiotherapy 2563 Jasleen Khanuja Effect of Rectal Distension on Successful High-dose-rate Dwell Optimization in the Treatment of Cervical Cancer 2564 Keiko Murofushi The Impact of Vicril Mesh Sheet Placed on Pelvic Wall for Reducing the Irradiated Bowel Volume in RapidArc of Cervical Cancer: Planning Study 2565 Grant Clark A Dosimetric Comparison of Tandem and Mini-ovoid Applicator vs. Vaginal Cylinder With Tandem in the 3-D HDR Era of Cervical Cancer Brachytherapy 2566 Noamie Vulquin MRI Guided Cervical Cancer Brachytherapy: Inter- and Intra-observer Variation In HR-CTV Delineation In T2-weighted And Gadolinium-enhanced T1-weighted Images 2567 Neeta Kannan Complete Metabolic Response After Definitive Radiation Therapy for Cervical Cancer: Patterns and Factors Predicting for Recurrence 2568 Akiko Nakagawa The Efficacy of Reducing Point a Dose in Image Guided Brachytherapy for Stage I-II Cervical Cancer of the Atrophic Small Uterus

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

125

GYNECOLOGICAL CANCER/ continued 2569 Rafael D’Ambrosi Impact of Radiological Lymph Node Stage and Extended Field Radiotherapy on Survival in Cervical Cancer 2570 Yuan Rao A Clinically Useful Watershed-based Method of Auto-Segmenting Apparent Diffusion Coefficient (ADC) Maps of Cervical Cancer 2571 Shalini Vinod The Use of Cervical Cancer MRI Contouring Guidelines in Clinical Practice 2572 Jin Hee Kim A Comparison of Outcomes Between Concurrent Chemoradiotherapy and Radiotherapy Alone in Cancer of the Uterine Cervix: A Single Institutional Experience 2573 Jose Perez-Regadera Impact of Value of Squamous Cell Carcinoma Antigen (SCC) in the Survival of Advanced Cervical Cancer, Managed With Chemo-radiotherapy (CT-RT) 2574 James Anderson The Impact of Tandem and Ovoids Displacements on High-dose-rate (HDR) Plans 2575 Helen Chen Prognostic Value of Human Copper Transporter 1 (HCTR1) in Cervical Cancer Patients Treated With Radical Hysterectomy and Adjuvant Chemoradiotherapy or Salvage Chemoradiotherapy at Recurrence 2576 Dominique Rash Pelvic and Para-aortic Lymph Node Response to Chemoradiation Therapy in Patients With Locally Advanced Cervical Cancer: Does a Higher Boost Dose Impact Nodal Control? 2577 Pramod Julka Acute Gastrointestinal and Genitourinary Toxicities in Locally Advanced Carcinoma Cervix Treated With Intensity Modulated vs. Conventional Pelvic Radiotherapy: Results From a Prospective Randomized Study

2578 Jacqueline Esthappan A Novel MRI Technique for Adaptive Cervix Cancer Brachytherapy 2579 Anand Narayan Chinnachamy Correlation of EQD2, Local Control and Early Toxicity Following Image Guided IMRT and Interstitial Brachytherapy in Patients With Cervical Cancer 2580 Daya Nand Sharma Interstitial Brachytherapy With and Without Central Tandem in the Treatment of Cervical Carcinoma: A Dosimetric Study 2581 Hayeon Kim Calculation of Equivalent Dose to Target Volume and Critical Organs for Combination of IMRT and MRI Guided High Dose Rate Brachytherapy Using Deformable Image Registration in Cervical Cancer 2582 Anthony Apicelli Adaptive MRI Image Guided HDR Brachytherapy Treatment Planning for Cervical Cancer 2583 Christopher Tinkle Inverse Planned High-dose -rate Brachytherapy for Locoregionally Advanced Cervical Cancer: The UCSF Experience With 4-year Follow-up 2584 Supriya Chopra Evaluation of Correlation Between Dose Volume Parameters and Clinically Significant Bowel Toxicity After Postoperative Radiation for Cervical Cancers 2585 Eva Christensen Personalization of Fractionation Schedule for Cervical Cancer Brachytherapy Using Biologically Effective Dose and 3-D Treatment Planning 2586 Jyoti Mayadev CT Based Image Guided Brachytherapy for Locally Advanced Cervical Cancer: The Time Required for Optimal Implantation to Delivery 2587 Philippe Nickers Tomotherapy of Locally Advanced Cervix Carcinoma: Clinical Validation of 3 mm CTV-PTV Expansion

2588 Somorat Bhattacharjee Stereotactic Robotic Radio Surgery Improves Local Control Rates With Second Line Chemotherapy in Unfavourable Locally Recurrent Unresectable Gynaecologic Malignancies 2589 Henrik Hansen Results of PET/CT Planned IMRT and Concomitant Boost to Lymph Node Metastasis in Patients With Cervical Cancer 2590 Hidehiro Eto Usefulness of Small Pelvic Field for Stage IB-IIA Uterine Cervical Cancer Patients With Intermediate Recurrent Factors 2591 Null- Erpolat Dosimetric Parameters of Acute Hematologic Toxicity in Cervical Cancer Patients Treated With Concurrent Cisplatin and Pelvic Radiotherapy: Turkish Oncology Group Gynecological Tumor Subgroup Study 2592 Ying Zhang Relationship of Imaging and Pathological Gross Tumor Volume Determined by Whole-mount Serial Sections Technique in Primary Cervical Cancer 2593 Andrzej Roszak Correlation Between Proliferation Activity, Glucose Metabolizm and Tumor Volume in Patients With Cervical Cancer, Measeured by 18F-FLT-PET and 18F-FDG-PET- Preliminary Results 2594 Shanmuga Vallinayagam Can VMAT-based SBRT Be an Option in Patients Unsuitable for Intra Cavitory Brachytherapy in Locally Advanced Cancer Cervix? 2595 Narek Shaverdian Impact of Concomitant Chemotherapy on the Effects of Treatment Prolongation in Cervical Cancer 2596 Susan Msadabwe Chikuni Comparison of Two Dose Fractionation Regimens of High-dose-rate Brachytherapy in the Treatment of Cervical Cancer: The University of Alabama at Birmingham Experience

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 126

ASTRO 2012 / 54TH ANNUAL MEE TING

2597 Pawel Dyk Toxicity Following Adaptive MRI Image Guided HDR Brachytherapy and IMRT in the Treatment of Cervical Cancer 2598 Javier Lopez-Araujo The Importance of Overall Treatment Time in the Era of Concurrent Chemoradiation Therapy for Locally Advanced Cervical Cancer 2599 Sui Shen Inter-fractional Variation of Hot Spot Locations for Organs At Risk in High-dose-rate Brachytherapy for Cervical Cancer 2600 Yarah Haidar Dosing to Point a with Image Guided Brachytherapy and the Probability of Normal Tissue Excessive Dose in Cervical Cancer 2601 Philip Poorvu Duodenal and Other Gastrointestinal Toxicity in Cervical and Endometrial Cancer Treated With Intensity Modulated Radiation Therapy to Paraaortic Lymph Nodes 2602 Tony Eng Significant Rectal and Bladder Dose Reduction Using Intra-vaginal Balloons During High-dose-rate (HDR) Intracavitary Brachytherapy (ICBT) for Cervical Cancer 2603 Sunao Tokumaru Concurrent Chemoradiotherapy for Uterine Cervical Cancer: Correlation of MRI Findings With Histopathologic Results 2604 Qifeng Wang Evaluation of Intra- and Inter-fraction Movement of the Cervix and the Uterine Body During Intensity Modulated Radiation Therapy 2605 Ravindra Yaparpalvi Is Re-planning at Every T and O Insertion Necessary When Cervix HDR ICBT Is Performed Under Identical Conditions in a Brachytherapy Suite? 2606 Bae Kwon Jeong Characteristics and Prognosis of Patients With Cervical Cancer Who Show an Unusual Level of Squamous Cell Carcinoma Antigen at Diagnosis or Recurrence

2607 Larissa Lee Combined Chemotherapy and Radiation (RT) Improves Survival for Node-positive, High-grade Endometrial Cancer 2608

Withdrawn

2609 Melissa Young Adjuvant Carboplatin/Paclitaxel and Vaginal Brachytherapy for Locally Advanced Endometrial Cancer 2610 Huma Chaudhry Stereotactic Body Radiation Therapy (SBRT) for Single Small (< 5 cm) Extracranial Ovarian or Uterine Cancer Metastases: Promising Local Control and Normal Tissue Tolerance With 5 Fraction Approach 2611 Ismael Membrive Conejo Dosimetry Comparison Between Custom and Standard Dosimetry in the Treatment of the Vaginal Cuff With HDR Brachytherapy 2612 Steven Register The Role of Adjuvant Radiation in Stage III Endometrial Cancer 2613 Weisi Yan SEER Analysis of Adjuvant Pelvic Radiation Therapy or Vaginal Brachytherapy in Treating Patients With High-risk Stage I or Stage II Papillary Serous, Clear Cell and High-grade Endometrioid Carcinoma

2618 Sarah Milgrom Lymph Node Involvement: Indicator or Instigator of Poor Outcome in Stage III Endometrial Cancer? 2619 Mira Shah Sexual Function in Patients With Endometrial Carcinoma After Hysterectomy and Adjuvant Therapy 2620 Andy Chen Clinical Outcomes of Three-Dimensional vs. IMRT Post-operative Pelvic Radiation for Gynecologic Malignancies 2621 Shyamal Patel Organ at Risk Interfraction Dose Variance in Relationship to Insertion Angle of a Vaginal Cylinder for HDR Brachytherapy 2622 Jonathan Frandsen Survival Analysis of Endometrial Cancer Patients With Cervical Stromal Involvement 2623 Himanshu Nagar Outcome Determinants in Uterine Papillary Serous Carcinoma Based on Clinico-pathological and Treatment Factors 2624 Hualei Li Retrospective Review of Patients With Carcinosarcoma of Uterus Confined to Pelvis-outcome Analysis

2614 Jessica Zhou Single or Multi-channel Vaginal Cuff HDR Brachytherapy - Is Replanning Necessary Prior to Each Fraction?

2625 Kanokpis Townamchai Clinical Outcomes With Dose Escalation Using Intensity Modulated Radiotherapy for Node-positive Endometrial and Cervical Cancer

2615 Caitlin Gomez Combined Chemotherapy and Radiation Results in Improved Outcomes in High-risk Endometrial Cancer Patients

2626 Raphael Yechieli Adjuvant Radiation Therapy for Patients With Type II Endometrial Carcinoma: Impact on Tumor Recurrence and Survival

2616 Lijia Aviles Factors Influencing Outcome After Relapse of Endometrial Cancer: Role of Brachyterapy in the Salvage treatment

2627 Ann Klopp Management of Node Positive Endometrial Cancer With Multimodality Adjuvant Therapy

2617 Nathalie Rochet Consolidative Whole Abdomen Radiotherapy After Surgery and Carboplatin-Taxol Based Chemotherapy for Advanced Epithelial Uterine Endometrial Malignancy: Feasibility and Clinical Outcomes

2628 Lihong Zhu Urinary Catheterization Increases the Dose to Bowel During Vaginal Brachytherapy

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

127

GYNECOLOGICAL CANCER/ continued 2629 Saif Althaqfi Assessing Efficacy of Adjuvant Vaginal Vault Brachytherapy Among Intermediate-risk Stage I Endometrial Cancer Patients 2630 Aditya Juloori Radiation Therapy in the Management of Carcinosarcoma of the Uterus 2631 Alfred Chung Uterine Adenosarcoma and the Role of Radiotherapy: A Retrospective Study 2632 Lane Rosen An Optimization Study and Comparison of a Multichannel Vaginal Cylinder vs. Single Channel Cylinder Applicator in High-dose-rate Brachytherapy 2633 Bryan Macrie Patterns of Recurrence and the Role of Radiotherapy in Ovarian Clear Cell Adenocarcinoma 2634 Felipe Rey Dosimetric Impact of Daily MRI Guided Adaptive HDR Interstitial Brachytherapy for GYN Cancers 2635 Charu Sharma Patterns of Care in Locally Advanced Vulvar Carcinoma 2636 Austin Kirschner Outcomes and Evaluation of the Role of Radiation and Surgery in Vaginal Melanoma 2637 Susan Hiniker Primary Squamous Cell Carcinoma of the Vagina: Prognostic Factors, Treatment Patterns and Outcomes 2638 Nikhilesh Patil MRI Guided High-does-rate Vaginal Interstitial Brachytherapy for Locally Recurrent Endometrial Cancers 2639 Ericka Wiebe Integration of CT-planned Interstitial Brachytherapy Boost in Advanced Gynecologic Malignancies 2640 Suzanne Evans Surveillance, Epidemiology and End Results (SEER) Database Analysis of Verrucous Carcinoma of the Vulva

2641 Eugene Koay Definitive Radiation Therapy of Locally Advanced Squamous Cell Carcinoma of the Vulva: Factors Associated With Vulvar Disease Control 2642 Junzo Chino Multi-catheter Vaginal Balloon Brachytherapy: One Year’s Clinical Experience 2643 Ashley Ruby Stereotactic Body Radiation Therapy for Gynecologic Malignancies

HEAD AND NECK CANCER 2644 Ryuji Murakami Clinical Nodal Staging and Clinical Target Volume for Preoperative Concurrent Chemoradiotherapy in Patients With Advanced Oral Cancer 2645 Szu-Yuan Wu Irradiation Induced Nf-kb Dependent Vimentin Expression Is Related With the Evading Radiation Induced Apoptosis in Betel Quid Chewing Related Oral Squamous Cell Carcinoma Cells 2646 Ryo-ichi Yoshimura Results of Low-dose-rate Interstitial Brachytherapy Using Au-198 Grains in T1-2 Tongue Cancer Patients 2647 Kang-Hsing Fan Retrospective Analysis: Postoperative CCRT Improved Treatment Outcome of Oral Cavity Cancer With Multiple Nodal Metastases But Without Extracapsular Spreading 2648 Lilie Wang Feasibility of Optimizing IMRT Plans-based on Measured Mucosal Dose to Adjacent Metallic Dental Fillings for Head and Neck Cancer Patients 2649 Kanako Takayama Proton Beam Therapy Combined With Intra-arterial Infusion Chemotherapy for Locally Advanced Tongue Cancer 2650 Min Yao Recurrence Before Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma

2651 Yao Yu Association Between Number of Positive Lymph Nodes and Outcome Among Patients Treated by Surgery and Post-operative Radiation Therapy for Head and Neck Cancer 2652 Pablo H. Montero Neck dissection Without Postoperative Radiotherapy in Select Patients With Oral Cavity Carcinoma and pN1 neck 2653 Christine Chin Can Meaningful and Durable Loco-regional Control Be Achieved for Oral Cavity Squamous Cell Carcinoma (OCSCC) Treated With Definitive Radiation Therapy (RT)? 2654 Peter Hofner A MicroRNA Link Between Tumor Invasion and Radioresistance in Head and Neck Squamous Cell Carcinoma 2655 Prashant Desai Radiological-pathological Correlation for Cervical Lymph Nodes in Oral Cavity Cancers: Implications for Radiation Field Reduction 2656 Felix Ho IMRT vs. Conventional Radiotherapy for Post-operative Treatment of Oral Cavity Squamous Cell Carcinoma (OCSCC) 2657 Christine Chin Surgery Improves Outcome in Recurrent Squamous Cell Carcinoma of the Oral Cavity 2658 Wade Thorstad Surgical Treatment Intensification for HPV Negative Oropharyngeal Squamous Cell Carcinoma (OSCC) 2659 Tony Wang Correlation of Planned Dose to Area Postrema and Dorsal Vagal Complex With Clinical Symptoms of Nausea and Vomiting in a Series of Oropharyngeal Cancer (OPC) Patients Treated With Radiation Alone Using IMRT 2660 G. Brandon Gunn Symptom-free Cure Following Unilateral Radiation Therapy for Tonsil Cancer: A Patient-reported Outcomes (PRO) Benchmark

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 128

ASTRO 2012 / 54TH ANNUAL MEE TING

2661 Giuseppe Sanguineti Mid-treatment Volumetric Change of Parotids Is an Independent Predictor of Long-term Xerostomia 2662 Francesco Ricchetti PEG Dependence After IMRT for Oropharyngeal Cancer: Different Impact of CHT, Oral Mucosa and Superior Constrictor Dose-volume Parameters Between Short (>3months) and Long (>7months) Dependence

2671 Matthew Newcomb Comparison of Weekly and 3-Weekly Cisplatin-based Radiochemotherapy Regimens for the Treatment of Patients with Stage III/IV Squamous Cell Head and Neck Cancer 2672 David Fried Dosimetric Effect of Sparing the Primary Site for Oropharyngeal Squamous Cell Carcionoma After Transoral Laser Microsurgery

2663 Klaudia Hunter Aspiration Pneumonia After Chemo-IMRT of Head and Neck Cancer and Its Clinical and Dysphagia-related Predictors

2673 Samir Patel Transoral Laser Microsurgery (TLM) Followed by Radiation Therapy (RT) for Oropharyngeal Tumors: The Mayo Clinic Arizona (MCA) Experience

2664 Nadine Housri African Americans Face Significant Delays to Treatment After Diagnosis of Orophyaryngeal Carcinoma

2674 Michelle Mierzwa HPV Positive Squamous Cell Carcinoma of the Oropharynx is Adequately Treated With Radiotherapy Alone

2665 Beth Beadle Impact of Metformin on Outcomes in Patients With Oropharynx Cancer Treated With IMRT 2666 Andrew Baschnagel Predictors of Recurrence After Intensity Modulated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Head and Neck Carcinomas 2667 Ebru Karakaya Is a Routine Neck Dissection Necessary Following Chemoradiotherapy for N2 Head and Neck Squamous Cell Carcinoma?

2675 Adam Garsa Total Metabolic Tumor Volume Predicts Outcomes in p16 Positive and Negative Oropharyngeal Squamous Cell Carcinoma 2676 Chad Tang Radiologic Assessment of Lymph Node Involvement in HPV/p16+ Oropharyngeal Cancers 2677 Zoran Rakusic Impact of Human Papillomavirus on Clinicopathological Characteristics of Oropharyngeal Carcinomas 2678 Withdrawn

2668 Nicolas Lescut Assessment of a Predictive Score for Indications of Prophylactic Enteral Nutrition in Head and Neck Cancer Patients Treated by Radiotherapy or Chemoradiotherapy 2669 Hyebin Lee Tumor Volume Reduction Rate During Definitive Radiation Therapy: A Potential Prognosticator In Oropharynx Cancer 2670 Iain Nixon The Impact of Histopathologically Measured Gross Tumor Volume on Outcome in Patients Treated Surgically for Oropharyngeal Squamous Cell Carcinoma

2679 Paul Romesser Metabolic Tumor Volume Is Superior to Gross Tumor Volume in Predicting Outcomes in Patients With Oropharyngeal Cancer Treated With IMRT 2680 Nadeem Riaz Loco-regional Patterns of Failure in Oropharyngeal Carcinoma: Implications for Treatment De-escalation 2681 William Silveira Diffusion-Weighted Imaging Compared to 3-Month PET/CT to Predict Response in the Irradiated Neck

2682 Steven Frank Intensity-Modulated Proton Therapy for Head and Neck Cancer: The First Clinical Experience 2683 Robert Semrau Prognostic Importance of HPV-association in Locally Advanced Inoperable Oropharyngeal Cancer 2684 Ajeet Gandhi Re-irradiation in Head and Neck Cancers: An Indian Tertiary Cancer Centre Experience 2685 Withdrawn 2686 Anne-Marie Charpentier The Dosimetric/Clinical Impact on Parotids of Weight Change During Head and Neck IMRT 2687 Aryavarta Kumar A Dosimetric Analysis of IMRT vs. 3-D Planning and Its Impact on Acute Grade 3 Dysphagia and Xerostomia in Oropharyngeal Cancer Patients Treated With Chemoradiotherapy 2688 Jimmy Caudell Interim Analysis of a Phase II Trial to Examine Use of Post-Chemotherapy Volumes After Neo-adjuvant Treatment of Squamous Cell Carcinomas of the Head and Neck 2689 Michael Bishop Adaptive Planning of Intensity Modulated Radiation Therapy for Head and Neck Cancers for Improved Accuracy of Delivered Dose in Patients With Clinically Significant Anatomical Change Due to Therapy 2690 Trevor Bledsoe Oropharyngeal Squamous Cell Carcinoma (OPSCC) With Known Human Papillomavirus (HPV) Status Treated With Definitive Chemoradiotherapy: Patterns of Failure and Toxicity Outcomes 2691 Michael Rutenberg Salivary Preservation Using Submandibular Gland Transfer and Salivary Gland Sparing IMRT in Definitive Chemoradiotherapy for Oropharyngeal Cancer

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

129

HEAD AND NECK CANCER/ continued 2692 Joanne Jang Factors Associated With Prolonged Gastrostomy Tube Usage in Patients With Oropharyngeal Cancer Treated With Chemoradiation 2693 Matthew Palmer The Optimal Timing for Off-line Adaptive Planning for Bilateral Head and Neck IMPT Is Week 4 2694 Gordon Guo Dosimetric Predictors of Long Term Dysphagia in Oropharyngeal Cancer After IMRT in a Population-based Cohort 2695 Edwin Crandley Impact of p16 Status on the Patterns of Failure in Patients Treated With Definitive Intensity Modulated Radiation Therapy (IMRT) for Oropharyngeal Squamous Cell Carcinoma (OPSCC) 2696 Pranshu Mohindra Squamous Cell Carcinoma of the Oropharynx: 20-year Outcome Results From the University of Wisconsin 2697 Joseph Lee Outcomes of Concurrent Chemoradiotherapy (CRT) vs. Induction Plus CRT (ICRT) for Oropharynx Carcinoma 2698 Ryan Lee Oropharyngeal Cancer Patients and Mandibular Dose Distributions Following Intensity Modulated Radiation Therapy 2699 Nadeem Riaz Recursive Partition Analysis Identifies Oropharyngeal Cancer Patients at High Risk for Distant Metastasis 2700 Sujith Mullapally Image Guided Radiotherapy in Head and Neck Cancer: Static Dose vs. Dynamic Volumes: The Need for Adaptive Innovation 2701 Takeshi Kodaira Clinical Efficacy of Helical Tomotherapy for Nasopharyngeal Cancer Treated With Definite Concurrent Chemoradiotherapy

2702 Junlin Yi The Role of Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma in the Era of Intensity Modulated Radiotherapy 2703 Sefik Igdem Pretreatment SUVmax As a Prognostic Factor in Patients With Nasopharyngeal Cancer Treated With IMRT 2704 Jianji Pan Outcomes of Chemotherapy-based Multimodality Treatment for Metastatic Nasopharyngeal Carcinoma Patients With a Good Performance Status 2705 Jenny Ling-Yu Chen Intensity Modulated Radiation Therapy for T4 Nasopharyngeal Carcinoma: Treatment Outcomes, Patterns of Recurrence and Feasibility of Salvage Treatment for Locoregional Recurrence 2706 Yu-Wei Lin Impact of Reduced-volume Intensity-Modulated Radiation Therapy on Disease Control for Nasopharyngeal Carcinoma 2707 Kazuhiko Tsuchiya Retrospective Comparison Between Cisplatin Plus Fluorouracil and Weekly Cisplatin in Concurrent Chemoradiotherapy Setting for Stage II-IV Nasopharyngeal Carcinoma: Hokkaido University Hospital Experience 2708 Lin Ma Treatment of Nasopharyngeal Carcinoma With Helical Tomotherapy: A Retrospective Study of 121 Cases 2709 Daniel Golden Outcomes of Induction Chemotherapy and Concurrent Chemoradiation for Nasopharyngeal Carcinoma 2710 Xiaomin Ou Preliminary Results of 18F-FMISO PET In Evaluating Tumor Hypoxia and Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma

2711 Muhammad Fareed Intensity Modulated Radiotherapy With Simultaneous Modulated Accelerated Boost Technique in Patients With Nasopharyngeal Carcinoma: King Fahad Medical City Experience 2712 Qin Lin Comparison of 18F-FDG PET/CT and Conventional Imaging in Clinical N Staging of Nasopharyngeal Carcinoma and the Impact of PET/CT N Staging on Clinical Treatment 2713 Yu-Wen Wang Partial Volume Correction in FDG PET/ CT Enhances the Efficacy of Detecting the Equivocal Size Range for Lateral Retropharyngeal Nodal Metastases of Nasopharyngeal Carcinoma 2714 Lin Kong Neoadjuvant Chemotherapy With TPF Regimen Followed by Concurrent Chemoradiation for Locoregionally Advanced Stage Nasopharyngeal Carcinoma 2715 Yunsheng Gao Maximal Diameter of Lymph Node Was Not a Prognostic Factor for Stage II Nasopharyngeal Carcinoma Treated by Radiotherapy Alone 2716 Junxin Wu Study of Hippocampal Formation Protection as the Organ at Risk in IMRT for Nasopharyngeal Carcinoma 2717 Jin Wang Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Patients Treated With Combined Intensity Modulated Radiation Therapy and Cisplatin-based Chemotherapy 2718 Zhang Peng Studies on the Expression of P53, MDM2, eIF4e, EGFR in Nasopharyngeal Carcinoma and Its Correlation With the Nasopharyngeal Carcinoma Biological Behavior and Prognosis 2719 David Wilson The Prognostic Significance and Relationship Between p16, Human Papillomavirus (HPV) and Epstein-Barr Virus (EBV) in the Tumors of Adult Non-Asian Patients With Nasopharyngeal Squamous Cell Carcinoma (NPSCC)

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 130

ASTRO 2012 / 54TH ANNUAL MEE TING

2720 Yan Sun The Clinical Outcomes of Radiotherapy With RapidArc in Local-Regionally Advanced Nasopharyngeal Carcinoma 2721 Xu Peng Clinical Study of the Necessity of Multiple Replanning During the Course of Intensity Modulated Radiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma 2722 Klaudia Hunter Non-Intensity Modulated Proton vs. Intensity Modulated Photon Planning for Complex Head and Neck Tumors 2723 Haijun Lu Outcome of Intensity Modulated Radiotherapy Combined With Concurrent Chemotherapy for Recurrent Nasopharyngeal Carcinoma 2724 BaoQing Li Improved Survival With Chemoradiotherapy Compared to Radiation Therapy Alone for Asian-Americans: Results From the California Cancer Registry 2725 Hideki Nishimura Patterns of Local Recurrence and Metachronous Malignancy Following Radiation Therapy for Stage I or II Hypopharyngeal Carcinoma: Role of Close Observation and Multidisciplinary Approach 2726 Michio Yoshimura Intensity Modulated Radiotherapy Using Simultaneous Integrated Boost for Hypopharyngeal Cancer 2727 Takeshi Yanagi Usefulness of Induction Chemotherapy Followed by Chemoradiation in the Treatment of Hypopharyngeal Carcinoma 2728 Gary Mok Does IMRT for Hypopharyngeal Cancer Improve Loco-regional Control? A Comparison to 3-D Conformal Radiotherapy 2729 Chance Matthiesen A Comparative and Dosimetric Analysis Regarding the Practical Use of 3-D Conformal, IMRT, Rapid Arc and Proton Therapy for the Treatment of Early-stage T1/T2 Glottic Laryngeal Cancer

2730 Hideo Kawaguchi Efficacy and Safety of High Dose Accelerated Hyperfractionated Radiotherapy Alone for Early Glottic Carcinoma 2731 Richard Cassidy Primary Subglottic Carcinoma: The University of Florida Experience 2732 Jomon Raphael A Prospective Single Arm Study on the Feasibility and Response of Concurrent Docetaxel With Radiotherapy in Locally Advanced Head and Neck Malignancy 2733 Evangelia Katsoulakis Outcomes of Radiotherapy for Hypopharyngeal Squamous Cell Carcinoma: A Single Institution’s Experience

2741 Joseph Tung-Chieh Chang The Health Related Quality of Life for Hypopharyngeal and Laryngeal Caner Patients Received Organ Preservation Treatment 2742 Peter Ahn Primary Treatment With External Beam Radiation vs Partial and Radical Pharyngectomy for Hypopharyngeal Carcinoma: A SEER analysis 2743 Christopher Barker Multivariable Analysis of Factors Associated With Outcome in Localized Sinonasal Mucosal Melanoma (SM) 2744 David Fried Patterns of Local Recurrence for Sinonasal Malignancies

2734 Hong Zhang Pyriform Sinus Cancer in the US: A Population-based Study of 5,601 Patients Over Three Decades

2745 Robert Malyapa Outcomes of Nasal Cavity and Paranasal Sinus Cancers Treated With Proton Therapy

2735 Ben J.M. Heijmen Cone Beam CT (CBCT) Guided Tumor Positioning for Laryngeal Cancer Patients With Large Interfraction Time Trends in Tumor Set-Up

2746 XiYin Guan Clinical Significance of Lymph Node Metastasis in Sinonasal Squamous Cell Carcinoma Treated With IMRT/3-D CRT 2747 Anouchka Modesto Esthesioneuroblastomas: Bi Centric R0 review of Clinical Features, Multimodal Treatment and Long-term Outcome

2736 Withdrawn 2737 Jorgen Johansen Radiation Treatment of T1-T2N0 Squamous Cell Carcinoma of the Glottic Larynx in the Modern Era 2738 Nadeem Riaz Is IMRT Associated With Inferior Outcomes for T1-2N0 Squamous Cell Carcinoma of the Larynx? 2739 Man Hu Excellent Laryngeal Preservation Can Be Achieved With IMRT For Loco-regionally Advanced Laryngeal Cancer 2740 Shlomo Koyfman Outcomes in Human Papillomavirus (HPV-) Unrelated Locally Advanced Squamous Cell Cancers of the Head and Neck (LA-HNC) Treated With Definitive Chemoradiotherapy (CRT)

2748 Azusa Hasegawa Combined Chemotherapy and Carbon Ion Radiotherapy for Mucosal Malignant Melanoma of the Head and Neck 2749 Tyler Hollen Esthesioneuroblastoma of the Nasal Cavity 2750 Waleed Mourad Outcomes of Parotid Gland Tumors Treated With Surgery and Post-operative Radiation Therapy 2751 Xiaofeng Yang Ultrasound Histogram Assessment of Acute and Late Parotid Gland Injury Following Head and Neck Radiotherapy 2752 Youssef Zeidan Postoperative Radiation Therapy for Minor Salivary Glands Carcinomas of the Head and Neck: Long-term Outcomes

ASTRO 2012 54TH ANNUAL MEE TING

131

HEAD AND NECK CANCER/ continued 2753 Rebecca Israel Patterns of Practice in the Treatment of Adenoid Cystic Carcinoma Compared With NCCN Guidelines: A National Survey 2754 Rebecca Israel Neutron Radiotherapy for Treatment of Adenoid Cystic Carcinoma and Other Primary Salivary Gland Malignancies: A Patterns of Practice Survey 2755 Michael Herman Elective Neck Management for High-grade Salivary Gland Carcinoma 2756 Petra Stegmaier Xerostomia: Association Between Saliva Production and Patient Reported Grading 2757 Lucas Resende Salgado Definitive Photon Radiotherapy in the Treatment of Unresectable Salivary Gland Tumors 2758 Lucas Resende Salgado Surgery Followed by Post-operative Radiation Therapy for Minor Salivary Gland Tumors 2759 Pretesh Patel Postoperative Radiotherapy for Salivary Gland Tumors: Factors Associated With Treatment Failure and Toxicity 2760 Anisha Noble High Risk Factors Associated With Disease Recurrence in Patients With Salivary Gland Cancer Treated With Surgery +/- Adjuvant Radiotherapy or Chemoradiotherapy 2761 Kyle Arneson The Role of Radiation in Carcinoma Ex Pleomorphic Adenoma 2762 Jung Hun Oh A Novel Modeling for Salivary Toxicity Based on Salivary Flow Recovery Over Time in Head and Neck Cancer Patients Treated With Radiotherapy

2763 Nadeem Riaz Long Term Outcomes of Post-operative Radiation Therapy for Major Salivary Gland Tumors 2764 Paul Romesser External Beam Radiotherapy in Advanced Or Recurrent Non-Anaplastic Thyroid Cancer an Updated Experience 2765 Shruthi Arora Outcomes in Poorly-differentiated and Anaplastic Thyroid Cancers Treated With Radiation: A Seer Analysis 2766 Viktoras Rudzianskas Interstitial High-dose-rate Brachytherapy for Recurrent and Previously Irradiated Head and Neck Cancer 2767 Azmi Kumaravelu Toxicity and Response Assessment With Prolonged Infusion Gemcitabine and Gefitinib With Intensity Modulated Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma: A Pilot Study 2768 Christopher Hallemeier Adjuvant Hypofractionated Intensity Modulated Radiotherapy (IMRT) After Resection of Regional Lymph Node (LN) Metastases in Patients With Malignant Melanoma of the Head and Neck 2769 Waleed Mourad The Role of Chemo-radiotherapy (CRT) in the Management of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) ± HPV With Coexisting HIV 2770 Waleed Mourad Pattern of Failure of Head and Neck Malignancy (HNM) With Perineural Invasion (PNI) 2771 Gabriela Studer Late Term Tolerance Following Radiation Using Intensity Modulation in >700 Head Neck Cancer Patients 2772 Luis Perez-Romasanta Tumor Volume Delineation In Head and Neck Cancer With 18-Fluor-Fluorodeoxiglucose Positron Emission Tomography: Adaptive Thresholding Method Applied to Primary Tumors and Metastatic Lymph Nodes

2773 Charles Woods A Phase II Study of Definitive Radiotherapy With Concurrent Erlotinib and Docetaxel in Locally-advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) 2774 Arif Ali A SEER-based Probability Model Using HPV Status and Lymph Node Levels to Predict Primary Head and Neck Tumor Site for Squamous Cell Cancer Confined to Cervical Lymph Nodes 2775 Klaudia Hunter Dosimetric Predictors of Neck Spasm Following Chemoradiation for Head and Neck Cancer 2776 Hani Ashamalla The Anatomical Biological Value (ABV) on Pretreatment PET/CT Predicts Response and Survival in Locally Advanced Head and Neck Cancer 2777 Kazufumi Kagawa Clinical Significance of Salvage Surgery for Recurrent Pharyngeal or Oral Cancer After Definitive Radiation Therapy 2778 Withdrawn 2779 John Vargo The Impact of Treatment Duration and Volume on Toxicity Following SBRT for Locally-Recurrent, Previously Irradiated Head and Neck Cancer 2780 John Vargo Treatment Duration > 2 Weeks Negatively Impacts Disease Control Following SBRT for Locally-recurrent, Previously-irradiated Head and Neck Cancers 2781 Christopher Balamucki Impact of Radiographic Findings on Prognosis for Skin Cancer of the Head and Neck With Clinical Perineural Invasion 2782 Sven Steen Accuracy and Utility of a Screening FDG PET/CT 12 Months Post-Radiation for Head and Neck Squamous Cell Carcinoma

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 132

ASTRO 2012 / 54TH ANNUAL MEE TING

2783 Jessica Wobb A Matched Analysis Evaluating the Role of Triple-agent Induction Chemotherapy in the Context of Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer 2784 Nataliya Kovalchuk Comparison of Deformable vs. Rigid PET/CT Registration in Head and Neck Cancer (HNC) Patients Undergoing Post-operative Radiation Therapy (PORT) 2785 Rohan Deraniyagala Proton Therapy for Skull Base Chordomas: An Outcome Study From the University of Florida Proton Therapy Institute

2793 Takuya Yamazaki Retrospective Analysis of Definitive Radiotherapy for Neck Node Metastasis Fron Unknown Primary Tumor: Japanese Radiation Oncology Study Group Study 2794 Niranjan Bhandare Evaluating the Association Between Pre- and Post-radiation Therapy Otitis Media With Effusion and the Incidence of Sensory-neural Hearing Loss in Head and Neck Cancer Patients 2795 Irene Karam Retrospective Comparison of Two Feeding Tube Approaches for Head and Neck Cancer Patients Receiving Concurrent Chemo-radiation Therapy

2786 Julie Bradley Patient and Tumor Characteristics and Pre-treatment Swallowing Frequency and Duration in Head and Neck Cancer Patients

2796 Jason Kehrer Implementation of Intensity Modulated Radiation Therapy in the Treatment of Carcinoma of the Nasopharynx and Oropharynx: a Retrospective Single-institution Analysis

2787 Gregory Vlacich Dose to the Inferior Constrictor Predicts Persistent Dysphagia With Definitive ChemoIMRT in Locally-advanced Head and Neck Cancer (LAHNC)

2797 Sang-June Park Comparative Dosimetry of an Extensive Scalp Lesion: High-dose-rate Brachytherapy, Electronic Brachytherapy and Volumetric Modulated Arc Therapy

2788 Masaharu Hata Radiation Therapy for Primary Carcinoma of the Eyelid: Tumor Control and Visual Function

2798 Isabel Prieto Fentanyl Pectin Nasal Citrate (FPNC), To Control Breakthrough Pain (BP) And Improve Dysphagia, in Head and Neck Cancer Patients Receiving Radiotherapy (RT)

2789 James Douglas Fast Neutron Radiotherapy for the Treatment of Major Salivary Gland Neoplasms 2790 Lanea Keller p16 Status, Pathologic and Clinical Characteristics, and Long-term Outcomes in Unknown Primary Carcinomas of the Head and Neck 2791 Michinori Yamamoto Clinical Usefulness of Immediate Imaging Using a 64-Multidetector Computed Tomography (MDCT) in Treatment Planning of Patients With Head and Neck Neoplasm 2792 Sewit Teckie Ultra-high-dose Stereotactic Body Radiation Therapy (SBRT) Is Feasible for Tumors in the Head and Neck (HN)

2799 Withdrawn 2800 Paul Romesser Prognostic Utility of Pretreatment Metabolic Tumor Volume, Gross Tumor Volume, Maximum Standardized Uptake Value in Head and Neck Cancer Patients Receiving IMRT 2801 Nigel Anderson Correlation of Oral Cavity Dose, Acute Mucositis and PEG Dependency for Head and Neck IMRT

2802 Pinaki Dutta The Role of Post-operative PET/CT Imaging in Head and Neck Cancer Patients Prior to the Initiation of Adjuvant Radiation Therapy 2803 Lauren Kropp Incidental Perineural Invasion in Cutaneous Carcinoma of the Head and Neck: The University of Florida Experience With Postoperative Radiotherapy After Mohs Resection 2804 Karen Chu Evaluating the Prognostic Impact of Lean Body Mass on Head and Neck Cancer Outcomes 2805 David Berlach High-dose-rate Intraoperative Radiotherapy Combined With Neck Dissection to Salvage Isolated Cervical Nodal Recurrences 2806 Samy El-Sayed Patterns of Failure in Patients Treated With Intensity Modulated Radiation Therapy (IMRT) Using Helical Tomotherapy (HT) for Head and Neck Squamous Cell Carcinoma (HNSCC), Results of a Prospective Trial 2807 Masayuki Fujiwara Hypothyroidism After Radiation Therapy For Head and Neck Cancer – The Retrospective DVH Analysis of 75 Patients: The Volume of Thyroid Gland Spared From Doses Can Be a New Dose Constraint for Treatment Planning? 2808 Patricia Daly Can We Avoid Bilateral Radiotherapy in Head and Neck Carcinoma of Unknown Primary in the PET-CT Era? 2809 Christian Hansen Changes in Dose for Head and Neck Cancer Patients As a Consequence of Orthopedic Metal Artifact Reduction 2810 Dian Wang High Negative Predictive Value of FDG-PET/CT in Assessment of Tumor Response Following Radiation Treatment for Head and Neck Carcinomas: Long-term Update 2811 Nhu Tram Nguyen Restrospective Study of Hypofractionated Palliative Radiotherapy for Advanced Head and Neck Cancers 0-7-21

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

133

HEAD AND NECK CANCER/ continued 2812 Senzo Taguchi The Treatment Outcome of Squamous Cell Carcinoma of the External Auditory Canal and Middle Ear: A Single-institution Experience 2813 John Buatti Early Evaluation of Response to Chemoradiation in Head and Neck Squamous Cell Cancer (HNSCC) With F-18 Fluorothymidine Positron Emission Tomography (FLT PET) 2814 David Wilson Prognostic Significance and Relationship Between p16 and Human Papillomavirus (HPV) in Tumors of Patients With Pharyngeal Squamous Cell Carcinoma (SCC) 2815 Ryan Cotter Does Response to Induction Chemotherapy (IC) Predict Outcome After Concurrent Chemoradiotherapy (CCRT) in Locally-advanced Head and Neck Cancer (LAHNC)? 2816 Sudha Amarnath Early Patient Outcomes With Adaptive Radiation Therapy in Head and Neck Cancers: The University of Washington Experience 2817 Tarita Thomas Brachial Plexus Dose Tolerance in Head and Neck Cancer Patients Treated With Sequential Intensity Modulated Radiation Therapy 2818 Carryn Anderson Accuracy of F-18 Fluorodeoxyglucose PET/CT 3 Months After Completion of Radiation Therapy for Head and Neck Squamous Cancer 2819 Sara Alcorn Assessing Utility of Daily Cone Beam CT in Head And Neck Cancers: The Effect of Disease Site 2820 Shiva Das The Role of Intrinsic Fluctuation in Glucose Metabolism in the Use of FDG-PET in Assessing Metabolic Response to Chemoradiation in Head and Neck Cancer

2821 Hussain AlHussain Correlation of Neck Nodal Levels With the Risk of Distant Metastasis in Patients With Head and Neck Squamous Cell Carcinoma

2829 Trevor Bledsoe Safety and Efficacy of Definitive Split-Course Hypofractionated Radiotherapy in High-risk Patients With Head and Neck Cancer

2822 Isaac Kaufman Limitations of CT and MRI in Evaluation of Individual Neck Levels and Overall Nodal Staging of Head and Neck Cancer

2830 Nigel Anderson Dose Volume Response in Acute Dysphagia and PEG Dependence: Validating QUANTEC Recommendations for Head and IMRT

2823 Jason Sun Development of a Correlative CT/ Nasoendoscopy-based Head and Neck Anatomy Atlas at the University of Washington

2831 Jeanette Zhang Correlating Planned Radiation Dose to the Cochlea With Primary Site and Tumor Stage in Head and Neck Patients Treated With Intensity Modulated Radiotherapy

2824 Surbhi Grover A Single-institution Experience With Induction Chemotherapy (ICT) Followed by Chemoradiation (CRT) Versus CRT for Definitive Treatment of Locally-advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) 2825 Maria E. Rodriguez-Ruiz Induction Chemotherapy (I-CHT) Followed by Intensity Modulated Radiation Therapy Using Simultaneously Integrated Boost (IMRT-SIB) and Concomitant Chemotherapy and Cetuximab (C-CHT) for Locally-advanced Squamous Head and Neck Carcinomas (SHNC) 2826 Kyle Wang SUVmax on Initial Post-treatment PET-CT Predicts Local Failure in Patients With Previously-irradiated, Recurrent Head and Neck Cancer Treated With SBRT 2827 Felipe Rey Weight Loss During Head and Neck Radiation: Risk Factors and Implications on Treatment Outcome 2828 William Magnuson Impact of Node Negative (n0) Target Volume on Parotid Gland Dose Sparing in HNSCC

2832 Andrew Hoover Diagnostic Value of 3-Month F-18 Fluorodeoxyglucose PET/CT Among Head and Neck Cancer Patients With and Without Gross Disease at Initiation of Radiation Therapy 2833 Moein Alizadeh-Kashani The Role of PET-CT After Chemoradiation in Partially Regressed Nodal Disease

HEALTH SERVICES RESEARCH 2834 Abigail Stockham Results of a Questionnaire for Diagnosis and Treatment of Brain Radiation Necrosis 2835 Jordan Gutovich Predictors of Radiation Oncology Resident Research Productivity 2836 Lukasz Mazur Association Between Workload and Errors in Clinical Radiation Oncology 2837 Benjamin Mou Population-based Analysis of Preoperative Radiotherapy Utilization for Patients With Rectal Cancer 2838 Jessica Church Quality Assurance in Clinical Radiation Therapy: A Qualitative Assessment of the Impact of Physician Attendance on the Number/Nature of Peer Review-defined Changes to Planned Cases

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 134

ASTRO 2012 / 54TH ANNUAL MEE TING

2839 Robert Adams Multipronged Quality Initiatives In Radiation Oncology: Feasibility, Staff Satisfaction and Initial Outcomes 2840 Christine Min Whole Breast Hypo-fractionated Radiation Therapy: Outcomes, Toxicities and Cost-benefit Analysis 2841 Gaurav Bahl A Population-based Study on the Uptake and Utilization of Stereotactic Radio-surgery (SRS) for Brain Metastasis in a Canadian Province 2842 Anushree Vichare Performance Assessment for the Advancement of Radiation Oncology Treatment (PAAROT): A Practical Approach for Informing Practice Improvement 2843 Sarah Hegarty Predictors of Post-prostatectomy Radiotherapy Use: A Population-based Study Using SEER-medicare Data 2844 Clayton Hess CyberKnife Stereotactic Radiotherapy (SRT) for Solitary, Variably-Symptomatic, Intracranial Meningiomas: Clinical Outcomes, Cost Effectiveness and Prescribing Habits 2845 Andrea Russo Advancing Age Within Established Gleason Score Categories and the Risk of Prostate Cancer Specific Mortality 2846 Colin Champ Dietary Recommendations During Cancer Treatment: Consistently Inconsistent? 2847 Daniel Golden The Radiation Oncology Fourth-year Medical Student Clerkship: A Targeted Needs Assessment 2848 Nitesh Paryani Medical Student Understanding of the ACGME Core Competencies: A Survey of Residency Applicants 2849 Andrew Camarata A Surveillance, Epidemiology and End Results Registry (SEER) Analysis of Treatment in Prostate Cancer: Practice Trends With regard to Certificate of Need Policy

2850 Kevin Albuquerque Challenges and Cost of Non-interconnectivity in Re-treatment With Radiation-Results of a National Survey

2861 Mikel Eguiguren Bastida A Survey of the Perceived Quality of Patient Care in a Radiation Oncology Service: Results From 2002 to 2011

2851 Raymond Bernard Wynn Translating SBRT from Academic to Community Practice: The UPMC Experience

2862 Jennifer Johnson Improvement in IMRT Quality Assurance Rates: A Quality Improvement Project at a Large Academic Institution

2852 Yoshiko Doi The Frequency of Adverse Events by Radiation Therapy for Atomic Bomb Survivors With Cancer

2863 Anna McCullough Integration of Tobacco Cessation Services Into a Radiation Oncology Clinic

2853 Lucille Lee Operational Process for Treatment Pathways in Radiation Medicine

2864 Yee Ung Cancer Care Ontario’s Lung Cancer Disease Pathway Management Initiative: A Novel Approach to Provincial Quality Improvement

2854 A. William Blackstock Impact of Marital Status and Race on Survival for Patients With Colon Cancer: An Analysis of Data From the Surveillance, Epidemiology and End-Results (SEER) Program 2855 Muhammad Qureshi Gross Tumor Volume Presentation in Different Race/Ethnic Groups As a Determinant of Treatment Outcome in Head and Neck Cancer Patients Treated With Definitive Radiotherapy 2856 James Murphy Increasing Use of Technology With Palliative Radiotherapy 2857 Kristina Mirabeau-Beale Metachronous Cancer Diagnosis in Men with Prostate Cancer and the Risk of Prostate Cancer-specific Mortality: A Competing Risks Analysis

2865 Marie Andree Fortin Online Optimization of Radiotherapy Patient Scheduling 2866 Todd Pawlicki Investigation of RFID-based Workflow Analysis 2867 William Stokes Control of Cardiovascular Risk Factors In Cancer Survivors Compared to Non-Cancer Controls, Measured Outcomes From a Population-based Study 2868 Withdrawn 2869 Nathan Sheets Trends in Use of Post-prostatectomy Therapies for Prostate Cancer: A SEER-Medicare Analysis

2858 Daniel Gomez Treatment Modality and Other Prognostic Factors for Overall Survival in Stage III Non-small Cell Lung Cancer (NSCLC): A Population-based Analysis

2870 Anamaria Yeung Making Patient Safety a Priority: Standardizing Workflow from CT Simulation to Radiotherapy Start to Allow Adequate Time for Safety Checks

2859 Daniel Gomez Patient Selection for Treatment Modality In Stage III Non-small Cell Lung Cancer: A Population-based Analysis

2871 Nirav Kapadia Patterns of Practice and Outcomes for Stage I Non-small Cell Lung Cancer (NSCLC): Analysis of SEER-17 Data 1999-2008

2860 Tomas Dvorak Assessment of Compliance With NCCN Guidelines for Breast Cancer Patients Treated at a Comprehensive Cancer Center

2872 Inge Aivas Improving the Efficiency of Radiotherapy Delivery by Resource Optimization

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

135

HEALTH SERVICES RESEARCH/ continued 2873 Jean Archambault Radiotherapy Safety and Tolerance in 90+ Years Patients 2874 Shlok Gupta The Effect of the Adoption of Concomitant Chemoradiotherapy on Outcomes for Cancers of the Upper Aerodigestive Tract in Ontario

HISTORY 2875 Sanjay Aneja A 35-Year History of Radiation Therapy Utilization Across the United States 2876 Shushan Rana Scholastic Activity Among Radiation Oncology Residents at U.S. Academic Institutions: A Benchmark Analysis of H-Index 2877 Raphael Pfeffer Radiation Epilation for Tinea Capitis: A Historical Review 2878 Emma Holliday Gender Differences in Publication Productivity, Academic Position and Career Duration Among Current Academic Radiation Oncology Faculty 2879 Herbert Torres History of Respiratory Tumor Motion Assessment from Radiation Oncology Perspective

LUNG CANCER 2880 Michael Stauder Radiologic Tumor Regression and Correlation With Pathologic Findings After Neoadjuvant Therapy for Non-small Cell Lung Cancer 2881 Abdallah Mohamed Feasibility of Hypofractionated Radiotherapy (RT) for End-of-life Palliation: Preliminary Results From a Prospective Randomized Study 2882 David Palma Predicting Symptomatic Radiation Pneumonitis After Concurrent Chemoradiotherapy for Non-Small Cell Lung Cancer: Results of an International Individual Patient Data Meta-analysis 136

2883 Max Dahele Hypofractionated Stereotactic Radiotherapy for Large and Central Lung Tumors 2884 Xueying Qiao Prospective Study of Simultaneous Integrated Boost Conformal Radiotherapy in Locally Advanced Central Non-small Cell Lung Cancer 2885 Osamu Fujii Involved-Field Radiotherapy Using Protons or Carbon Ions for N1-2M0 Non-Small Cell Lung Cancer: A Retrospective Study 2886 Takeaki Ishihara Stereotactic Body Radiotherapy for Lung Cancer In Octogenarians 2887 Yukinori Matsuo Impact of Overall Treatment Time on Local Control After Stereotactic Body Radiation Therapy for Lung Cancer 2888 Voichita Bar Ad Treatment-related Esophagitis for Patients With Locoregionally Advanced Non-small Cell Lung Cancer Treated With Involved-field Radiotherapy and Concurrent Chemotherapy 2889 Chisa Hashizume Novalis Stereotactic Body Radiotherapy (SBRT) for Stage I Non-small Cell Lung Cancer (NSCLC): Analysis Based on the New TNM Classification and Difference Due to Histology 2890 Ji Hyun Chang Induction Chemotherapy Plus Concurrent Chemoradiotherapy (ICCRT) vs. Concurrent Chemoradiotherapy (CRT) in the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) 2891 Fumiya Baba Clinical Experience wWith Respiratory-Gated Stereotactic Body Radiotherapy (SBRT) for Lung Tumors Using Audio Coaching 2892 Connie Yip Pre-treatment FDG PET Tumour Heterogeneity in Non-Small Cell Lung Cancer is Associated With Poor Response and Survival Following Chemoradiotherapy

ASTRO 2012 / 54TH ANNUAL MEE TING

2893 Xiangpeng Zheng Comparisons of Local Control and Survival of Stereotactic Body Radiation Therapy vs. Surgery for Stage I Non-small Cell Lung Cancer: A Meta-Analysis 2894 Suneil Jain A Randomized Trial of Lung Stereotactic Body Radiation Therapy (SBRT) Delivered Over 4 or 11 Days: Acute Toxicity and Quality of Life 2895 Kitty Huang Radiographic Changes After Lung Stereotactic Ablative Radiotherapy (SABR): Can We Distinguish Fibrosis from Recurrence? A Systematic Review of the Literature 2896 Joo Ho Lee Radical Chemoradiotherapy As a Treatment of Choice for the Elderly With Locally Advanced NSCLC 2897 Stephanie Casey Impact of Respiratory Gating on Toxicity Outcomes for Locally Advanced Lung Cancer Treated With Radical Chemoradiotherapy 2898 Jordan Kharofa Symptomatic Radiation Pneumonitis in Elderly Patients Receiving Thoracic Irradiation: Comparative Analysis of Clinical and Dosimetric Predictors 2899 Maria Werner-Wasik No Difference in Outcome Between Biopsied vs. Non-biopsied Early-stage Medically Inoperable Non-small Cell Lung Cancer Patients Treated With Volumetric Image Guided Stereotactic Body Radiation Therapy (SBRT): Analysis of a Large Multi-institutional Database 2900 Lichung Ku Novel Hybrid Volumetric Modulated Arc Therapy (VMAT) for Stereotactic Body Radiation Therapy (SBRT) of Lung Tumors in Proximity to the Chest Wall 2901 Zuolin Xiang A Dosimetric Model for Predicting Radiation Pneumonitis After Stereotactic Ablative Radiotherapy for Stage I Non-small Cell Lung Cancer

2902 Shinya Takemoto Changes of Pulmonary Function and Correlation With Dose-volume Parameters in Patients Undergoing Stereotacic Body Radiotherapy (SBRT) for Lung Cancer 2903 Brendan Prendergast Stereotactic Body Radiation Therapy (SBRT) for Lung Malignancies: Preliminary Toxicity Results Using a Flattening Filter-free Linear Accelerator Operating at 2400 Monitor Units Per Minute 2904 Andrew Evans Sublobar Resection and Robotic Interstitial Brachytherapy for Early-stage Non-small Cell Lung Cancer 2905 Soha Atallah Impact of Pre-treatment Growth Rate on Outcome of Stage I Non-small Cell Lung Cancer After Stereotactic Body Radiotherapy 2906 Tetsuya Inoue Stereotactic Body Radiotherapy Using Gated Radiotherapy With Real-time Tumor-tracking for Stage I Non-small Cell Lung Cancer 2907 Liu Di Induction Chemotherapy With Cetuximab, Vinorelbine-Cisplatin followed by Intensity Modulated Thoracic Radiotherapy and Concurrent Cetuximab, Vinorelbine-Cisplatin in Patients With Unresectable Stage III Non-small Cell Lung Cancer 2908 Hunter Boggs Stereotactic Body Radiotherapy (SBRT) Using Tomotherapy for Early-stage NSCLC: The Utility of Mid-fraction CT Scans to Assess Intra-fraction Tumor Motion 2909 Edwin Crandley Survey of Institutional Practices for Internal Target Motion Management in Lung Stereotactic Body Radiation Therapy (SBRT) 2910 Masahiro Hiraoka Realization of Dynamic Tumor Tracking Irradiation with Real-time Monitoring in Lung Tumor Patients Using a Gimbaled X-ray Head Radiation Therapy Equipment

2911 Hong-Qing Zhuang The Preliminary Results and Early Response for Centrally Located Lung Cancer Treated by Stereotactic Radiotherapy in Consecutive Daily Fractions

2921 Susan Guo Outcomes of Hypofractionated Radiation Therapy in Poor Risk Non-small Cell Lung Cancer Patients and Validation of RTOG 0213

2912 Jinming Yu Impact of Intra-tumor 18F-FDG Uptake Heterogeneity on Different Target Delineation Methods by PET and CT for Non-small Cell Lung Cancer

2922 Yi Hsuan Chung The Impact of Anatomical Changes During the Course of Intensity Modulated Radiotherapy (IMRT) for Lung Cancer

2913 Gregory Videtic Mature experience in Stereotactic Body Radiotherapy for Early-stage Medically Inoperable Lung Cancer at Cleveland Clinic

2923 Radhe Mohan IMRT vs. Passively Scattered Proton Therapy (PSPT) for Locally-advanced NSCLC: Impact of Changing Techniques and Technologies Over the Course of a Randomized Trial

2914 Stephen Rosenberg Variability of Tumor Motion in 4-D CT: The Effects of Abdominal Compression on Lung Tumor Displacement 2915 Wesley Russell Predictors of Survival After Brain Metastases From Non-small Cell Lung Cancer 2916 Aruna Turaka Role of Radiation Therapy for Malignant Thymoma: A Single-institution Experience 2917 Kaori Asai Carcinoembryonic Antigen As a Predictive Factor for Recurrence After Stereotactic Body Radiotherapy in Stage I Lung Adenocarcinoma 2918 Christopher Peters Stereotactic Ablative Radiotherapy for Lung Tumors using Helical Tomotherapy: A Cost-effective Treatment Regimen 2919 Shinji Tsudou A Comparison of Lung Tumor Shadow on Maximum Intensity Projection and Average Intensity Projection of Respiratory Correlated Simulation CT 2920 Jonathan Whaley Incidental Nodal Irradiation in Stage III Lung Cancer Treated With Involved Field Radiation: Comparison Between 3-D CRT and IMRT

2924 Xiangrong Qi Analysis of Outcomes in Early Stage Non-small Cell Lung Cancer Irradiation: Fractionation Scheme Implications for Stage I vs. Stage II Disease 2925 James Russo Intensity Modulated Radiation Therapy (IMRT) in Advanced Inoperable Non-small Cell Lung Cancer: Toxicity, Survival and Patterns of Failure 2926 Elizabeth Nichols Marital Status Is an Independent Predictor of Survival for Patients Undergoing Definitive Chemoradiation for Stage III Non-small Cell Lung Cancer (NSCLC) 2927 Kaoru Uchiyama Invasive Thymoma: Results of Mediastinal and Low-dose Entire Hemithorax Irradiation 2928 Ryuji Mikami Preliminary Results of Definite Radiotherapy for Stage II Non-small Cell Lung Cancer at Tokyo Medical University 2929 Lee Jeongshim Intermediate Hypofractionated Radiotherapy for Lung Parenchymal Tumor 2930 Masahiko Aoki Radiation-induced Rib Fracture After Hypofractionated Stereotactic Body Radiotherapy for Patients With Peripheral Lung Tumor: Impact of the Maximum Dose and the Fraction Size

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

137

LUNG CANCER/ continued 2931 Marc Mahe Acute Radiation Pneumonitis After Conformal Radiation in Non-small Cell Lung Cancers: A Large French Prospective Study on Predictive Factors 2932 Varun Chowdhry Complications From CT-guided Needle Biopsy for Patients Receiving Stereotactic Body Radiation Therapy 2933 Christopher Kelsey Analysis of Prognostic Factors Affecting Local and Distant Recurrence Following Surgery for Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis 2934 Katsura Kosaki Safety and Efficacy of Second Stereotactic Body Radiotherapy (SBRT) for Local Recurrence of Non-small Cell Lung Cancer (NSCLC) or Lung Metastasis Previously Treated With SBRT 2935 Blake Currier A MCNP5 Comparison of the Dose Distribution From 169-Ytterbium LDR Brachytherapy Sources Within Heterogeneous Tissue to TG-43 Guidelines 2936 Ping Wang Prognostic Value of Serial FDG-PET/ CT Scanning in Stage I Non-small Cell Lung Cancer Patients Treated With Hypofractionated Radiotherapy 2937 Cory Knill Dosimetric Effect of Patient Weight Change on RapidArc Lung Treatments 2938 Xiong Wei Pretreatment Poor Pulmonary Function Is Prognostic of Poor Overall Survival in Patients With Stage III Non-small Cell Lung Cancer Treated With External Beam Radiotherapy 2939 Malcolm Mattes The Ratio of Lymph Node SUV to Primary Tumor SUV on PET/CT Predicts Nodal Pathology in Patients with Non-small Cell Lung Cancer (NSCLC)

2940 David Shultz Anatomic and Metabolic Predictors of Failure After Stereotactic Ablative Radiotherapy for Non-small Cell Lung Cancer

2950 Yuu Tajima Dosimetric Evaluation of Compensator Intensity Modulated Radiotherapybased Stereotactic Body Radiotherapy for Stage I Non-small Cell Lung Cancer

2941 Ryan Herde A Unique Geographical Analysis of Lung Cancer Patients in the State of Utah – Huntsman Cancer Hospital Experience

2951 Hitoshi Ikushima Treatment Effect of Neoadjuvant Chemoradiation Therapy for Non-small Cell Lung Cancer Evaluated by Multi-modality Imaging and Histopathological Analyses

2942 Jessica Freilich Outcomes for Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Treated With Concurrent Chemotherapy and Radiation Therapy to 70 Gy 2943 Kazuya Inoue Feasibility and Efficacy of Salvage Radiotherapy for Loco-regional Recurrence of Elderly Non-small Cell Lung Cancer After Resection 2944 Yunfeng Cui Can Use of an Atlas Decrease Contouring Variability in Non-small Cell Lung Cancer Radiotherapy? Analysis of the RTOG 1106 Pre-clinical Trial Planning Study 2945 Hideyuki Harada Clinical Comparison of Proton Beam Therapy and Stereotactic Body Radiotherapy for Medically Inoperable Stage I Non-small Cell Lung Cancer 2946 Monika Blake Phase II trial: Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Locally Advanced Non-small Cell Lung Cancer Patients 2947 Genevieve Maquilan Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-small Cell Lung Cancer Receiving Sequential Treatment 2948 Jiandong Zhang Radiotherapy in Combination With Nimotuzumab in Elderly Patients With Locally Advanced Squamous Cell Lung Cancer: A Pilot Study 2949 Rikiya Onimaru Stereotactic Body Radiotherapy (SBRT) Using Real-time Tracking Radiotherapy (RTRT) System for Patients With Lung Cancer Aged 80 and Over

2952 Michael MacManus Significant Numbers of Irradiated Tumor Cells Enter the Circulation Early During a Course of Fractionated Radiation Therapy for Non-small Cell Lung Cancer 2953 Kotoha Tatekawa Changes in Volumes of Stage I Non-small Cell Lung Cancer (NSCLC) During Stereotactic Body Radiotherapy (SBRT) 2954 Suzhen Wang Comparisons of Clinical Target Volumes Defined on 3-D CT and 4-D CT Images for the Mediastinal Metastatic Lymph Nodes in Non-small Cell Lung Cancer 2955 Vimoj Janardanan Nair Higher Dose Thoracic Radiotherapy is Associated With Improved Overall Survival in Limited-stage Small Cell Lung Cancer: Analysis of the 15 Year Experience From a Retrospective Cohort of 296 Patients at the Ottawa Hospital Cancer Centre (TOHCC) 2956 Aparna Kesarwala Feasibility of Proton Therapy for Elective Nodal Irradiation in Patients With Locally Advanced Non-small Cell Lung Cancer 2957 Zhongxing Liao Heart and Lung Radiation and Overall Survival in Non-small Cell Lung Cancer Patients After Chemoradiotherapy 2958 Elisabetta Parisi Accelerated Hypofractionated Radiotherapy Using Helical Tomotherapy for the Treatment of Medically Inoperable Pleural Mesothelioma: IRST Preliminary Data

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 138

ASTRO 2012 / 54TH ANNUAL MEE TING

2959 Pierina Navarria Lung Metastases in Oligometastatic Patients: A New SBRT Approach Using VMAT With Flattening Filter Free (FFF) Beams

2970 Ato Wright Non-small Cell Lung Cancer With Chest Wall Invasion is Associated With High Rates of Positive Margins and Local Failure After Surgery

2981 Takahiro Kishi Feasibility of Definitive Concurrent Chemoradiotherapy for Patients Over 80 Years Old With Non-small Cell Lung Cancer

2960 Andreas Rimner The Role of EGFR and KRAS Mutations in Locally-advanced Lung Adenocarcinoma Treated With Definitive Radiation Therapy

2971 Gonzalo Vazquez Late Pulmonary Injury After Irradiation for Lung Cancer at 5-year Follow-up

2982 Hongmei Wang Improved Survival Outcomes in Non-small Cell Lung Cancer Patients With Incidental Concurrent Use of Beta-blockers and Definitive Radiation Therapy

2961 Kumiko Karasawa Carbon Ion Radiotherapy for Lymph Node Recurrence 2962 Shalini Garg Patterns of Regional Failure in Stage III Non-small Cell Lung Cancer Managed With Neoadjuvant Chemoradiotherapy and Resection 2963 David Peterson A Prospective Study Measuring Interobserver Variability of GTV With FDG-PET-CT in Stage III Non-small Cell Lung Cancer Using 3-D Analysis 2964 Sindhu Ramamurthy A Study Comparing Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated With Radical Thoracic Radiotherapy Planned Using Pencil Beam Algorithm and Collapsed Cone Algorithm 2965 Withdrawn 2966 Aparna Kesarwala The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Prior to Prophylactic Cranial Irradiation in Limited-stage Small Cell Lung Cancer

2972 Sashendra Senthi Patterns of Recurrence Following Stereotactic Ablative Body Radiotherapy (SABR) for Stage I-II NSCLC: Initial Sites and Timing 2973 Naomi Nakajima Prognostic Value of Pre-treatment FDG-PET Parameter for Early-stage Non-small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy 2974 Naoko Okano The Efficacy of Three-dimensional Non-coplanar Conformal Radiation Therapy for T2N0M0 Non-small Cell Lung Cancer Compared With Stereotactic Body Radiotherapy 2975 Brandon Mancini Comparative Analysis of Stereotactic Body Radiation Therapy for Multiple Primary Non-small Cell Lung Cancer 2976 Dongryul Oh Hypofractionated Radiation Therapy for Central T1-3N0 Non-small Cell Lung Cancer 2977 Andrea McKee Initial Results of a NCCN Guideline-based Free Low-dose CT Lung Cancer Screening Program

2967 Joost Nuyttens Peripheral Early-stage Lung Tumors Treated With Real-time Tumor Tracking During Stereotactic Radiotherapy: A 6-year experience

2978 Joshua Siglin Assessing Normal Tissue Motion on Four-dimensional Computed Tomography Scan: Modeling the Internal Risk Volume of the Esophagus

2968 Carmen Perez Intensity Modulated vs. 3-D Conformal Radiation Therapy for Limited-stage Small Cell Lung Cancer

2979 William Silveira Bronchial Obstruction From Non-small Cell Lung Cancer: Factors Indicative of Benefit from High-dose External Beam Irradiation

2969 Raj Rajpara Analyzing Locoregional Tumor Failure in Association With Pre-treatment FDG PET Parameters and Radiation Dose Among Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)

2980 Dongryul Oh The Treatment Outcomes of Concurrent Chemoradiotherapy for Supraclaivcular Lymph Node Positive Non-small Cell Lung Cancer

2983 Wen Feng Study on the Rationale of Postoperative Radiation Therapy Target Volumes in Completely Resected Stage IIIa (N2) Non-small Cell Lung Cancer 2984 John Ng Comparing Lung Dosimetry and Secondary Malignancy Risks Associated With Stereotactic Body Radiation Therapy (SBRT) Using Intensity Modulated Radiotherapy (IMRT), Coplanar Volumetric- Modulated Arc Therapy (VMAT) and Non-Coplanar Volumetric-Modulated Arc T 2985 Martin King Evaluation of the Physiological Response to Stereotactic Ablative Radiation Therapy 2986 Tine B. Nielsen Increasing Local Control in NSCLC Patients With Inhomogeneous Dose Distributions 2987 Karl Wurstbauer Non-resected NSCLC: Tumor Size –Radiation Dose Related, Accelerated (1.8 Gy bid) Therapy– Definitive Results of a Prospective Study 2988 Lindsey Appenzoller Automation of Lung Treatment Planning With the Varian Eclipse Scripting Application Programming Interface 2989 Sean Vance Clinical Outcomes and Toxicity after Stereotactic Body Radiotherapy (SBRT) With or Without Adjuvant Chemotherapy for Stage I Non-small Cell Lung Cancer (NSCLC)

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

139

LUNG CANCER/ continued 2990 Abdul Dar Megavoltage Imaging: Patterns of Tumour Regression and Predictive Factor for Non-small Cell Lung Cancer Undergoing Radiation Therapy on Tomotherapy 2991 Jasper Nijkamp Relating Acute Esophageal Toxicity to Radiotherapy Dose Using 18FFDG-PET in Concurrent Chemo-radiotherapy for Locally Advanced Non-small Cell Lung Cancer 2992 Nicholas Roman Selection Bias in Lung Cancer Dose-escalation Protocols 2993 Yan Zhuang Prognostic Factors for Overall Survival in Stage IIIA/IIIB Non-small Cell Lung Cancer After Definitive Radio-chemotherapy

2999 Sara Alcorn Utility of Daily Cone Beam CT in Predicting Setup Within Clinical CTV-PTV Margins in Lung Radiotherapy 3000 Brandon Mancini Stereotactic Body Radiation Therapy for Patients With Clinically vs. Pathologically Diagnosed Non-small Cell Lung Cancer: A Comparative Analysis 3001 Deepinder Singh Local Control Rates With Stereotactic Body Radiotherapy (SBRT) for Primary Lung Tumors: Single Institution Experience of 153 Consecutive Patients 3002 Shripal Bhavsar Accelerated Hypofractionated Radiotherapy in Early-Stage Non-Small Cell Lung Carcinoma With Concurrent Chemotherapy

2994 Aditya Juloori Limited-Stage Small Cell Lung Cancer in the Contemporary Period: Impact of New Technologies on Outcomes

3003 Yoshiyasu Maehata What Is the Cause of Immune Suppression in Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer?

2995 Yoshiyuki Shioyama Usefulness of Electron Density in Gross Tumor Volume as a Prognostic Factor in Stage I Non-small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy

3004 Shervin Shirvani Patterns of Failure for Limited-stage Small Cell Lung Cancer Following Definitive Radiotherapy in the Modern Era

2996 Jianxin Xue High Dose to Large Volumes of Pericardium May Be Associated With Radiation-related Pericardial Effusion and Survival in Patients With NSCLC 2997 Jonathan Grant Impact of Chemotherapy Response and Radiation Dose on Overall Survival in Patients With Inoperable Non-small Cell Lung Cancer Treated With Induction Chemotherapy Followed by Concurrent Chemoradiotherapy 2998 Arjun Pennathur Stereotactic Radiosurgery for Stage I NSCLC in Medically Inoperable Patients: A Prospective Multicenter Phase II Study

3005 Mitsuhiko Oguri Rib Fractures After Stereotactic Body Radiation Therapy for Primary Non-small Cell Lung Cancer 3006 Sun Yi Prospective Evaluation of Cardiac Toxicity After Stereotactic Body Radiotherapy for Thoracic Tumors Using Echocardiographic Findings 3007 Orlan Macdonald What is the Impact of External Beam Radiotherapy (EBRT) Following Limited Resection of T1 or T2 Non-small Cell Lung Cancer (NSCLC)? A SEER Analysis 3008 David Palma Preliminary Statistical Dose Tolerance Limits for Radiation Pneumonitis (RP) When Treating Large Primary Lung Cancers With Stereotactic Body Radiotherapy (SBRT)

3009 Paula McCloskey Comparison of 3-D Conformal Radiotherapy (3-D CRT) and Intensity Modulated Radiotherapy (IMRT) in Stage III Non-small Cell Lung Cancer (NSCLC) 3010 Christoph Poettgen Post-pneumonectomy Radical Accelerated Re-Irradiation and Concurrent Chemotherapy for Patients With Contralateral Central Lung Cancer Relapses 3011 Pierre Thirion Implementation of Linac-based Stereotactic Ablative Radiotherapy (SABR) for Early-stage Non-operable Non-small Cell Lung Cancer (NSCLC) in Community-based Radiotherapy Practice: A Trans-atlantic Hub-and-Spoke Experience 3012 Carl Peterson Incidence of Second Primary Small Cell Lung Cancer Following Non-small Cell Lung Cancer Treated With and Without Radiation Therapy: An Analysis of SEER Data 3013 Thomas Dilling Clinical and Dosimetric Predictors of Radiation Pneumonitis (RP) in a Large Series of Patients Treated With Stereotactic Radiotherapy (SBRT) to the Lung 3014 Michael Corradetti An Analysis of Survival After Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer 3015 Victoria Ford Role of FDG-PET As an Early Imaging Biomarker of Esophagitis and Pneumonitis During the Course of Radiation Therapy for Lung Cancer 3016 Rita Murphy The Influence of the Inhomogeneity Correction Factor on Dose Distributions in Lung Cancer Radiation Therapy Treatment Plans: A Retrospective Study 3017 Vikren Sarkar Dosimetric Implications of Abdominal Compression for Lung SBRT Treatment

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 140

ASTRO 2012 / 54TH ANNUAL MEE TING

3018 Wenzhou Chen Quantitative Evaluation of Impact Upon Tumor Control Probability (TCP) From Quality Assurance Criteria for Non-small Cell Lung Cancer From RTOG 1106 Study 3019 Joseph Lee Predictors of Rib Fracture and Non-fracture Chest Wall Pain After Lung Stereotactic Body Radiotherapy (SBRT) 3020 Wenzhou Chen Is Recontouring Organs-at-Risk (OAR) for Adaptive Radiotherapy Plans for Locally Advanced Lung Cancer Necessary? A Pre-activation Analysis From Radiation Therapy Oncology Group (RTOG) 1106 3021 Jason Hearn Salvage Stereotactic Body Radiotherapy (SBRT) for Local Failure After Upfront Lung SBRT: If at First You Don’t Succeed... 3022 Amir Lavaf The Role of Pretreatment PET/CT Parameters in Predicting Response After Lung Cancer Treatment 3023 Katsuyuki Karasawa Three-dimensional Non-coplanar Conformal Radiotherapy With Middle Fraction Dose for the Treatment of Stage I Non-small Cell Lung Cancer 3024 Yee Ung Referral of Suspected Lung Cancer by Family Physicians and Other Primary Care Providers: A Clinical Practice Guideline 3025 Jeremy Kilburn Thoracic Re-irradiation In Patients With Stereotactic Body Radiotherapy (SBRT) As First or Second Course of Treatment 3026 Kevin Orcutt Dose Escalation Using PET Imaging for NSCLC While Maintaining RTOG 0915/0813 Criteria 3027 John Grecula MR-Predictive Assay in Preoperative Lung Cancer Therapy 3028 Taghrid Altoos Assessment of Local Control Following PET/CT Guided Adaptive Radiotherapy for Locally Advanced Non-small Cell Lung Cancer

3029 Iris Rusu A Clinical Guide to Evaluate NonMonte Carlo Treatment Plans in Lung SBRT

3038 Qing Chen Dosimetric Evaluation of Flattening-Filter Free (FFF) Photon Beams for Lung SBRT

3030 Stanley Kwong Incidental Mediastinal Nodal Radiation During Stereotactic Radiation for Lung Tumors: Implications for High-dose Treatment of Locally Advanced Disease

3039 Mike Soike Long-term Follow-up and Patterns of Failure for Patients With Medically Inoperable Stage I Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Body Radiotherapy (SBRT)

3031 John Greskovich Improved Four Year Overall and Local-Failure Free Survival in Stage IIIA Non-small Cell Lung Cancer After High-Dose, 3-D Conformal RT (3-D CRT) +/- Chemotherapy (CT): A Single Institution Experience

3040 Feng-Ming Kong Role of Radiation Therapy in Small Cell Lung Cancer (SCLC): Analysis of SEER-17 Data

3032 Huanpeng Qi Comparison of Internal Gross Tumor Volume for Peripheral Lung Cancer Based on Four-dimensional CT and Three-dimensional CT Assisted With Active Breathing Control 3033 Justin Rineer The Impact of Changing Practice Patterns on Outcomes in Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors: The MD Anderson Cancer Center Orlando Experience 3034 Yuko Nakayama Prognostic Value of Histopathological Response to Preoperative Therapy for the Patients With Non-small Cell Lung Cancer 3035 Matthew Johnson Survival and Toxicity After Standard Dose 3-D Conformal Radiotherapy or High-dose Intensity Modulated Radiotherapy for Locally-advanced Non-small Cell Lung Cancer 3036 Nicholas Trakul Improved Outcomes in Stage I NSCLC Patients Treated in the Stereotactic Ablative Radiotherapy Era: A Population-based Analysis 3037 Sarah McAvoy Reirradiation With Proton Beam Therapy or Intensity Modulated Radiation Therapy for Non-small Cell Lung Cancer: An Institutional Experience

3041 Salma Jabbour Ambulatory Pulse Oximetry As a Clinical Aid in the Diagnosis of Radiation Pneumonitis 3042 Yaping Xu Concomitant Chemoradiotherapy Phase II Study Comparing Pemetrexed/carboplatin With Paclitaxel/Carboplatin in Patients With Unresectable Stage III Non-small Cell Lung Cancer 3043 Huimin Xu The Combination of Elevation of Plasma TGF-β1 dDuring Radiotherapy and Pre-radiation Cyfra21-1 Level Predicts Radiation-induced Lung Toxicity in Patients With Non-small Cell Lung Cancer 3044 Ben Wilkinson Predictors of Local Recurrence After Stereotactic Body Radiotherapy for Early-stage Non-small Cell Lung Cancer 3045 Nan Bi Comparison of the Effectiveness of Radiofrequency Ablation with Strereotactic Body Radiation Therapy in Inoperable Stage I Non-small Cell Lung Cancer: A Systemic Review and Meta-analysis 3046 Chengbo Han Relationship Between Pulmonary Artery Invasion and High-dose Radiation and Overall Survival in Patients with Non-small Cell Lung Cancer 3047 Brian Lally What Disparities Exist in Stage I Non-small Cell Lung Cancer?

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

141

LYMPHOMA 3048 Benjamin Goldsmith A Novel Multileaf Collimator-based Photon-Proton Involved-Field Technique for Treatment of Hodgkin’s Lymphoma of the Neck and Mediastinum 3049 Miran Blanchard Evaluation of Limited-Volume Involved-Nodal Radiotherapy (IN) and Intensity Modulated Radiotherapy (IMRT) in the Treatment of Hodgkin Lymphoma (HL) 3050 Bradley Hunter Pleural Effusions in Patients With Hodgkin Lymphoma: Clinical Predictors and Associations With Outcome 3051 Withdrawn 3052 Evan Michaelson Thyroid Malignancies In Survivors of Hodgkin Lymphoma 3053 Julia Skliarenko Pattern of Failure in Patients With Stage I-ii Hodgkin Lymphoma Treated With CMT: Implications of Partial Nodal Region Coverage and the Need for Adjacent Uninvolved Nodal Region Coverage 3054 Matthew Vernon Involved-field Radiation Therapy Following TBI-containing Myeloablative and Non-myeloablative Conditioning Regimens in Hematopoietic Cell Transplant for Non-Hodgkin Lymphoma: No Impact on Relapse Rate 3055 Jennifer Dorth Radiotherapy Dose-response Analysis Ffor Diffuse Large B-cell Lymphoma With a Complete Response to Chemotherapy 3056 Sarah Hamilton Treatment and Outcomes of Patients With Limited Stage Primary Cutaneous B-cell Lymphoma 3057 Vladimir Valakh Clinical Characteristics and Use of Radiation Therapy for the Management of Plasmablastic Lymphoma (PBL): A Population Based Study

3058 Zhen Tao Dosimetric Comparison of Conventional Radiotherapy, Three-dimensional Conformal Radiotherapy and Intensity Modulated Radiotherapy for Non-Hodgkin’s Lymphoma in Pelvis 3059 Ximei Zhang Elevated Beta2-microglobulin Level is an Adverse Prognostic Factor for Patients With Extranodal Nasal-type NK/T-cell Lymphoma 3060 Ximei Zhang Clinical Features and Treatment Outcomes of Patients With Primary Systemic Anaplastic Large Cell Lymphoma: Report From a Single Institution in China 3061 Ximei Zhang Outcomes of ALK-negative Anaplastic Large-cell Lymphoma are Superior to Peripheral T-cell Lymphoma, Not Otherwise Specified: Report From a Single Chinese Institution 3062 Michio Iwabuchi Treatment of Primary Central Nervous System Lymphoma (PCNSL): Comparison of Whole-brain Radiotherapy and Partial-brain Radiotherapy 3063 Li-ming Xu Prognostic Importance of Rituximab and Radiotherapy in Patients With Primary Mediastinal B-cell Lymphoma Receiving Doxorubicin-containing Chemotherapy 3064 Shinya Otsuka Changes in Dose-volume Parameters of Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer by Calculation Algorithms and Relationship With Outcome: Pencil Beam Convolution With Batho Power Law vs. Anisotropic Analytical Algorithm 3065 Saiji Ohga Limited-stage Diffuse Large B Cell Lymphoma in Head and Neck Treated With CHOP or Rituximab -CHOP (R-CHOP) Plus Radiotherapy

3066 Cato Chan Evaluation of Radiation Therapy for NK-T Cell Lymphoma of the Head and Neck 3067 Ting Zhao Radiotherapy Improves the Prognosis of Locoregionally Recurrent Extranodal Nasal-type NK/T-cell Lymphoma 3068 JaYoung Kim Predictive Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography After Frontline Treatment and Consolidative Treatment in Patients With Extranodal NK/T Cell Lymphoma 3069 Sang-wook Lee Stage IE/IIE Extranodal NK/T Cell Lymphoma Arising From the Nasal Cavity: Investigation of Computed Tomography Findings and Its Prognostic Values 3070 Mauricio Gamez Extranodal Lymphoma and Radiation Therapy: A Single Institution Experience 3071 Luluel Khan A Single Institution Experience of Extranodal Natural Killer/T cell Lymphoma of Nasal type 3072 Aaron Wagner Mycosis Fungoides: Is There a Benefit to Concurrent and Adjuvant Interferon With Total Skin Electron Beam Therapy? 3073 Aruna Turaka Results of Radiation Therapy for Primary Extranodal Lymphoma of the Head and Neck: A Report of Case Series 3074 Kiran Turaka Vitreoretinal Lymphoma: Changing Trends in Diagnosis and Local Treatment Modalities 3075 Matthew Hall Radiation Therapy for Chloroma: Treatment Outcomes and Prognostic Factors 3076 Young Suk Kim The Role Of Radiotherapy in the Management of POEMS Syndrome

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 142

ASTRO 2012 / 54TH ANNUAL MEE TING

3077 Guy Jones Characterization of Unconventional Response of Gray Zone Lymphoma to Conventional Radiation Treatment 3078 Ji Hyun Kim Extramedullary (EM) Relapse Following Total Marrow and Lymphoid Irradiation (TMLI) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)

NON-MALIGNANT 3079 Waleed Mourad The Impact of Radiotherapy (RT) Duration and Dose Per Fraction on Long-term Outcomes in the Management of Benign Lymphoepithelial Cysts of Parotid Glands in HIV Seropositive Patients 3080 Caleb Dulaney Radiotherapy Prophylaxis for Heterotopic Ossification of the Elbow Following Trauma or Recurrent HO 3081 Roshan Prabhu Clinical Outcomes of Radiotherapy as Initial Local Therapy for Graves’ Ophthalmopathy and Predictors of the Need for Post-Radiotherapy Decompressive Surgery 3082 Jennifer Rosenberg Long-term Outcomes of Patients Treated With Gamma Knife Radiosurgery for Trigeminal Neuralgia 3083 Baldassarre Stea Minimally Invasive Retrobulbar Episcleral Brachytherapy for Treatment of Wet Age-related Macular Degeneration: Preliminary Results of a Feasibility Study

PALLIATIVE CARE 3084 Brock Debenham Multidisciplinary Prediction of Survival in Advanced Cancer Patients 3085 Naoki Nakamura Variability in the Point to Which Single Direct Field Irradiation Is Prescribed for Spinal Bone Metastases: A Survey of Practice Patterns in Japan

3086 Marie-Adele Kress Stereotactic Radiosurgery for Single Brain Metastases From Non-small Cell Lung Cancer: Progression of Extracranial Disease at Treatment Correlates With Distant Intracranial Control 3087 David Howell Spare the Midline! Midline Scalp Dose is Reduced Without Compromising Brain Dose in Whole Brain Radiation (WBRT) With Scalp Blocks. Whole Brain Radiation Using Opposed Lateral Fields With and Without Scalp Blocking: Dosimetric Considerations 3088 Carlo Furlan Extended-field Tomotherapy for Multiple Painful Pelvic Bone Metastases in Breast Cancer Patients: Feasibility and Toxicity 3089 Jeanny Kwon Prognostic Factors for Patients With Leptomeningeal Metastases From Solid Tumor

3096 Vladimir Turkevich Experience Of Treatment Painful Bone Metastases With Magnetic Resonance Guided Focused Ultrasound 3097 Mary Job Rapid Response Radiation Therapist: An Expanding Role in the Palliative Radiation Oncology Service in Australia 3098 Upendra Parvathaneni Effective and Durable Palliation Using a Novel Single Fraction Radiation Therapy Approach for Merkel Cell Carcinoma Metastatic Lesions 3099 John Suh The Use of Spine Stereotactic Body Radiation Therapy for the Treatment of Spinal Cord Compression 3100 Franco Casamassima Results of SBRT for 217 Consecutive Oligometastatic Patients Treated With Curative Intent 3101 Rachel Lei A Prospective Investigation of Definitive Targeted Therapy for Solid Malignancies With Oligometastases

3090 Nikola Cihoric Clinically Significant Bleeding in Incurable Cancer Patients: Effectiveness of Hemostatic Radiotherapy

3102 Bevan Ly Conventional vs. IMRT Planning for Palliation of Bone Metastases: A Dosimetric Comparison

3091 Sonali Rudra Patterns of Failure in Esophageal Cancer: What Is the Likelihood of Limited Metastatic Failure? 3092 Daniel Golden Linear-accelerator Based Stereotactic Radiosurgery Outcomes for Melanoma and Renal Cell Carcinoma Brain Metastases 3093 Edward Jung Repeated Stereotactic Radiosurgery for Progressive Brain Metastases from Melanoma After Initial Treatment 3094 Jovita Martin Prompt Referrals and Timely Interventions Leads to Cost Effective Palliation; Short vs. Long Course Radiation for Response to Palliation: A Single Institution Study in a Developing Country 3095 Taro Murai Stereotactic Body Radiotherapy Using Tomotherapy for Single or Multiple Vertebral Metastases

3103 Ehsan Balagamwala Higher Dose Spine Stereotactic Body Radiation Therapy Is Associated With Improved Pain Control in Radiosensitive Histologies

PEDIATRIC CANCER 3104 Nirav Kapadia Assessment of Bone Growth Effects Among Medulloblastoma (MB) Patients Treated With Electron vs. Photon Spinal Irradiation 3105 Shalini Moningi The Role of Adjuvant Therapy in the Management of Low-grade Pediatric Spinal Tumors: The Johns Hopkins Experience 3106 Daniel Indelicato Proton Therapy for Craniopharyngioma: Early Clinical Outcomes

ASTRO 2012 / 54TH ANNUAL MEE TING

143

PALLIATIVE CARE/ continued 3107 Martin King Parotid Gland As an Organ at Risk for Craniospinal Irradiation 3108 Robert Marcus One-year Quality of Life Results After Proton Irradiation for Pediatric Brain Tumors 3109 Ronica Hazariwala The Role of Frameless Stereotactic Radiosurgery in the Management of Pediatric Central Nervous System Tumors 3110 Michael Confer Proton Radiotherapy for Pediatric Craniopharyngiomas: Initial Results 3111 Christine Lauro The Relationship Between Thyroid Dose and Diagnosis of Primary Hypothyroidism in Pediatric Brain Tumor Patients Receiving Craniospinal Irradiation 3112 Nataniel Lester-Coll Proton Therapy for Sparing Fertility in Girls Requiring Craniospinal Irradiation: Is Tthere a Role for Ooophoropexy? 3113 Charles Hsu Supratentorial Primitive Neuroectodermal Tumors (PNETs) and Medulloblastoma in Children and the Elderly: A Surveillance, Epidemiology and End Results (SEER) Investigation of Prognosis, Tumor Characteristics and Predictors of Radiation Therapy 3114 Gustavo Ferraris Impact of Radiation Techniques – 3-D vs. IMRT – On Acute Toxicity and Local Control in Patients With Rhabdomyosarcoma 3115 Zhong Su Pediatric Chest Wall Ewing Sarcoma: A Retrospective Dosimetric Study of 3-D Conformal Proton Therapy and IMRT 3116 Kyle Denniston Factors Influencing Five-year Overall Survival in Patients With the Ewing Sarcoma Family of Tumors

144

3117 Joanna Yang Dose Painting Intensity Modulated Radiotherapy for Pediatric Sarcomas With Lung Metastases 3118 Jenna Kahn Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1 (NF1) Associated Malignant Peripheral Nerve Sheath Tumors (MPNST) 3119 Monica Roca Dosimetric Comparison of Photon and Proton Radiotherapy for Unresectable Ewing Sarcoma of the Pelvis 3120 Nancy El-Bared Preoperative Intensity Modulated Radiation Therapy for Retroperitoneal Sarcoma 3121 Charlotte Demoor-Goldschmidt Respiration Gated-radiotherapy for Bilateral Pulmonary Radiation In Paediatric Cancers : Benefits on the Liver 3122 Josefine S. Kornerup Influence of PET Data on the Radiation Therapy Planning of Pediatric Cancer 3123 Douglas Prah Cardiac Sparing by Respiratory-Gating During Whole Abdominal Irradiation Using 3-D CRT for Wilms’ Tumor Patients 3124 Kavita Dharmarajan Stereotactic Body Radiation Therapy for Palliation in Relapsed Neuroblastoma 3125 Hiroshi Fuji Assessment of the Organ-dose Reduction and Secondary Cancer Risk Associated With the Use of Proton Beam Therapy and Intensity Modulated Radiation Therapy in Treatment of Neuroblastoma 3126 Miho Watanabe Delayed Renal Dysfunction After Total Body Irradiation in Pediatric Malignancies 3127 Jordan Kharofa Feasibility of Cardiac Sparing Splenic Irradiation Using IMRT for Pediatric Patients Enrolled on the COG High-risk Hodgkin’s Lymphoma Protocol AHOD0831

ASTRO 2012 / 54TH ANNUAL MEE TING

3128 Joella Wilson A Comparison of Traditional vs. Response-based Involved-field Radiotherapy on Clinical Target Volume and Organs at Risk for Pediatric Rapid Early Responders with High-risk Hodgkin Lymphoma 3129 Charlotte Birk Christensen PET/CT in Radiation Therapy Planning of Malignant Tumors in Children: Impact on Gross Tumor Volume 3130 Chika Nwachukwu Optimal Spot Scanning Treatment Plans in Infants With Brain Tumors in the Posterior Fossa 3131 Daniel Arsenault Do Pediatric Patients Have Equal Access to Proton Beam Therapy? 3132 Justin Peacock Optimal Spot Scanning Treatment Plans for Centrally Located Infant Brain Tumors 3133 Douglas Rahn Clinical Outcomes of Palliative Radiotherapy for Children: 5-year Institutional Data

QUALITY OF LIFE 3134 Denise Rollmann Double- Blind, Placebo-controlled Pilot Study of Processed Ultra Emu Oil vs. Placebo in the Prevention of Radiation Dermatitis 3135 Ashley Burt Comparison of Methods for Eliciting Multiattribute Utilities for Prostate Cancer 3136 Todd Carpenter Quality of Life With Adjuvant Radiotherapy Following Transoral Robotic Surgery (TORS) for Head and Neck Cancer 3137 Silke Tribius Dry Mouth and Sticky Saliva: Quality of Life Domains Most Affected in the Acute Toxicity Phase of Radiation Therapy

3138 Arbind Dubey Effect of Insomnia on Patient’s Well Being During External Radiation in Outpatient Radiation Oncology Clinic 3139 Andrew Lee Multi-institutional Patient-reported Quality of Life After Proton Therapy for Prostate Cancer Compared to Non-treated Men 3140 Sumit Sood Stereotactic Body Radiation Therapy (SBRT) for Clinically Localized Prostate Cancer: Endoscopic Outcomes, Rectal Toxicity and Quality of Life 3141 Tzu-I Jonathan Yang Risk Factors Associated With Sacral Fractures After Pelvic Radiotherapy for Rectal Cancer 3142 Tsz Kin Lee Systematic Review of Epic Quality of Life Data After Prostate Cancer Treatment 3143 Afshin Rashtian Radiation Dose to the Parotid Glands in Patients Receiving Whole Brain Radiation Therapy (WBRT) 3144 Cristina Cigarral Garcia Psychosocial Distress Among Patients With Lung Cancer: An Approach to Assessment and Intervention 3145 Piotr Milecki Comparison of Quality of Life in Patients With Locally Advanced Head and Neck Cancer Prior and 1 Year After the Completion of Radiotherapy 3146 Shrinivas Rathod Change in Health Related Quality of Life Scores Predict Survival in Head Neck Squamous Cell Carcinoma Treated With Definitive High Precision Radiation Therapy: Evidence From a Prospective Study 3147 Anna Likhacheva Patient-reported Acute Symptoms During Chemoradiation for Cervical Cancer 3148 Rashmi Koul Determinants of Quality of Life and Depression in Patients Undegoing External Beam Radiation

3149 Sherry Soeder Outcomes of Spine Stereotactic Body Radiation Therapy in Patients Previously Treated With Conventional Radiation 3150 Curtis Bryant Does Race Influence Quality of Life, Toxicity or Early Relapse Following Proton Therapy in Men With Prostate Cancer? 3151 Todd Adams Markov Model Comparing Breast Conserving Therapy With Mastectomy 3152 Raju Raval Gabapentin Therapy for Prevention and Management of the Pain Syndrome in Oropharyngeal Carcinoma Patients Treated With Radiation: A Retrospective Study of the Johns Hopkins Experience

3158 Christopher Barker Tolerance and Efficacy of Extra-cranial Radiotherapy During Ipilimumab Immunotherapy for Metastatic Melanoma 3159 Josephine Kang Management of Atypical Lipomas With Radiation 3160 Nora Kramkimel Preliminary Results of the Use of Helical Tomotherapy (HT) in Advanced Non-Melanoma Skin Cancers: The Institut Curie Experience 3161 James Jackson Melanoma Brain Metastases: The Impact of Nodal Disease 3162 Upendra Parvathaneni Omitting Post Operative Radiotherapy in Selected Cases of Merkel Cell Carcinoma: When is it safe?

3153 Elizabeth Klein Quality of Life in Neuro-oncology: Presence at National Meetings 3154 May Abdel-Wahab Does Radiation Technique Influence Peg Dependence? A Comparison Between Intensity Modulated Radiation Therapy and Three-dimensional Conformal Techniques 3155 Lin Wang The Impact of Cystoscopy on the Quality of Life in Men Undergoing Permanent Prostate Brachytherapy 3156 Alireza Fotouhi Ghiam Hyperbaric Oxygen Treatment, Alpha-tocopherol and Ascorbic Acid Are Effective for Reducing Late Radiation-induced Side Effects of Pelvic Radiotherapy 3157 Ehsan Balagamwala Treatment of Three or More Contiguous Vertebral Bodies With Spine Stereotactic Body Radiation Therapy

SARCOMA AND SKIN CANCER

3163 Yoshitaka Miki Impact of Chemoradiotherapy Using Docetaxel for Treatment of Scalp Angiosarcoma 3164 Anna Cooper Primary Soft-tissue Sarcomas: Predictors of Local Disease Recurrence, Distant Metastasis and Overall Survival After Limb-sparing Surgery and Radiotherapy 3165 Niraj Mehta Safety and Efficacy of Stereotactic Body Radiation Therapy for Pulmonary Metastases From High-Grade Sarcomas 3166 Josephine Kang Management of Metastatic Melanoma With Stereotactic Body Radiotherapy 3167 Jessica Rooney Post Operative Radiation Therapy in Merkel Cell Carcinoma: The Mayo Clinic Experience 3168 Mersiha Hadziahmetovic Multifocal Scalp Angiosarcoma With Regional Metastases: SCUBA Technique for Homogenous Scalp and Regional Nodal Irradiation

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

145

QUALITY OF LIFE/continued 3169 Matthew Spraker An Analysis of Patient Characteristics and Clinical Outcomes in Primary Pulmonary Sarcoma 3170 Ashley Burt Treatment of Chest Wall Sarcomas: A Single Institution Experience Over Twenty Years 3171 Jun Won Kim High Dose Radiotherapy After Surgical Resection for the Management of Chordoma of the Skull Base: Early Clinical Experience With Helical Tomotherapy 3172 Fazilet Dinçbaş The Prognostic Factors And Results of Neoadjuvant Treatment Protocol in Extremity Soft Tissue Sarcomas: A Monoinstitution Results 3173 Andrew Sharabi Analysis of Cone Beam-CT Shifts in Image Guided Radiation Therapy for Abdominopelvic Soft Tissue Sarcomas 3174 Mark Stavas Stavas Treatment Approach and Outcomes in Patients With Extra-cranial Hemangiopericytoma 3175 Darwin Yip Electron Therapy for Non-Melanoma Skin Cancers: Computer Simulated Bolus vs. Actual Physical Bolus for Treatment Planning 3176 Monica Serban Dose Escalation Based on MR-PET/CT for Soft Tissue Sarcoma 3177 Shilpa Vyas Initial Experience With Three-dimensional Topographic Applicator Brachytherapy for Treatment of Non-melanoma Skin Cancers on the Nose and Ear

INFORMATICS/ BIOINFORMATICS

RADIATION AND CANCER BIOLOGY

3178 Ewa Szumacher Opinions From the Experts: What Prostate Cancer Patients Should Know About Post-operative Radiotherapy 3179 Yutaka Ando How did the particle therapy grow in Japan? Current Status of Proton and Carbon Ion Radiotherapy From 1979 to 2011 in Japan

3188 Andrew Vaughan Next Generation Sequencing as a Tool to Track Low-dose Effects Linked to Transformation

3180 Ajay Tejwani Assessing The “Readability” of Websites Regarding Lung Cancer Diagnosis and Treatment Information

3190 Samuel Bakhoum Examining the Cellular Mechanisms of Chromosomal Instability As Means for Enhanced Radiation-induced Cytotoxicity

3181 Sachin Jhawar All Atwitter About Radiation Oncology: A Content Analysis of Radiation Oncology-Related Traffic on Twitter 3182 Russell Fuhrer Quality Control Trigger: A Quality Assurance Process in Radiation Oncology 3183 Ajay Kapur An Audit Of Treatment Overrides in a Paperless Radiation Medicine Department 3184 James Sinicki Your Safety, Our Commitment: A Standardized Error Reporting Enabling a Culture of Patient Safety 3185 Ankit Agarwal Medical Student Education in Radiation Oncology: A Multi-year Analysis of the Oncology Education Initiative 3186 Pin-Chieh Wang Implementation of a Comprehensive Radiation Therapy Registry: Focus on Feasibility and Reliability 3187 Andrew Sharabi Automated Cross-referencing of Radiation Prescriptions to Diagnosis: A Proposed Mechanism to Improve Patient Safety

3189 ShengJun Ji Whole Brain Irradiation Induced Decrease of Histone H3 Acetylation in Hippocampus of Rats

3191 Jacqueline Williams Revisiting Inflammation As a Target for Normal Tissue Damage Mitigation: Interplay Among Interleukin Expression, Parenchyma and Inflammatory Cells in Lung Effects 3192 Shin-ichiro Masunaga Radio-sensitivity of Pimonidazoleunlabeled Intratumor Quiescent Cells to Gamma-rays, Accelerated Carbon Ion Beams and Boron Neutron Capture Reaction 3193 Cheng-Chia Wu The Role of Prostate Cancer 20-HETE in Tumor Vasculature 3194 Thomas Klein Ras Promotes Non-autonomous Cell Death in Response to Radiation: Insights From a Novel Drosophila-Based Model of Radiotherapy 3195 Tao Wang ERK1 Meddiated Epithelial-Mesenchumal Transition and Neuroendocrine Development in Prostate Cancer Cells that Survive High Dose Ionizing Radiation 3196 Guillem Pratx Radioluminescence Microscopy: A New Tool to Characterize Heterogeneous Radiopharmaceutical Uptake in Living Cells

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 146

ASTRO 2012 / 54TH ANNUAL MEE TING

3197 Zhibin Huang The Kinetics of Repair of Sublethal Damage in Rat Cervical Spinal Cord During Fractionated Irradiation - Application of the gLQ Model with Reciprocal Time Pattern 3198 Pamela Boimel MicroRNA-375 Expression Correlates With Increased Radiosensitivity, Decreased Invasion and Improved Patient Survival in Head and Neck Squamous Cell Carcinoma 3199 Catherine Park Ionizing Radiation Modifies Tissue Tension, Mechanosignaling and Apoptosis in Human Breast 3200 Kumara Swamy Evaluation of Immunological Changes in Patients Treated With SBRT and Radiotherapy: A Prospective Cohort Study 3201 Govindarajan Mallarajapatna Apparent Diffusion Coefficient (ADC) Value on MR Imaging As a Marker of Treatment Response in Prostate Cancer 3202 Ping Wang PI3K/AKT Signaling Pathway in the Regulation of Non-small Cell Lung Cancer Radiosensitivity After Hypofractionated Radiotherapy 3203 Jing Huang Convergence of Divergent Tumors: A Systems Biology Approach of Tumor-specific Signaling 3204 Masahiko Okamoto Radiation-induced HIF-1α Induces Radioresistance and Enhances the Migration Abilities in Glioblastoma Cells Through Pten-src-hif-1α Signaling Axis 3205 Brandon Dyer Hypoxic and Reperfusive Responses Are Selectively Altered During Non-small Cell Lung Cancer Progression 3206 Hitoshi I shikawa The Impact of Radiation-induced Up-regulations of Ifn-γ on Local Tumor Control of Malignant Melanoma in Vivo

3207 Carsten Herskind A Role for a Bystander Effect in Cell Inactivation After Large Single Doses?

3218 Anne Kiltie Differential Roles of DNA Repair Proteins in the MMEJ Phenotype

3208 Karl Butterworth Differential Mechanisms of Cellular Radiobiological Response Following Exposure to Intensity Modulated Radiation Fields

3219 Sara Samiee Dicentric Chromosome Assay: A Potential in Vitro Biomarker for Radiosensitivity

3209 Vivek Patel IMP1 Consensus Recognition Elements Identify Transcripts Affecting Tumor Cell Survival After Ionizing Radiation 3210 Iman Washington p21 Functions to Prevent Radiation-Induced Myocardial Injury in Mice 3211 Michael Epperly Irradiation Induction of mRNA for Redox-Sensitive Promoters and Inflammatory Cytokines in Conditional Manganese Superoxide Dismutase (MnSOD) Tet On -/- Mouse Bone Marrow Stromal Cells 3212 Adam Schmitt O6-methylguanine DNA Damage Signals Through Nfkb1/p50 to Potentiate DNA Strand Break-induced Cytotoxicity 3213 Sarah Krueger The Role of Bone Marrow-derived Progenitor Cells in the Systemic Response to Radiation-induced Lung Damage 3214 Michael Epperly Irradiation-induced Inhibition of Bone Repair in SAMP6 and SAMR1 Mice 3215 David Fried Estimating the Alpha/Beta Ratio for Radiation-Induced CT Density Changes in Patients Receiving Thoracic Radiation: Comparison of Data from SRS and Conventional Fractionation 3216 Ikuno Nishibuchi Reorganization of Damaged Chromatin by the Exchange of Histone Variant H2A.Z-2 3217 Liping Liang MiR-223 Modulates Radiosensitivity of U87-MG Cells Through Targeting ATM

3220 Hui Zhang SIRT2 Directs the Replication Stress Response Through CDK9 Deacetylation 3221 Sara Chiblak Photon vs. Proton vs. Carbon Irradiation of Glioma Initiating Cells 3222 Michael Epperly Oral Delivery of Mitochondrial Targeted GS-Nitroxide JP4-039 Protects Fanconi Anemia (FA) D2 -/Mice From Irradiation Mucositis 3223 Michael Epperly Induction of MnSOD Expression in MnSOD Tet On -/- Murine Bone Marrow Stromal Cell Lines Correlates With Temporal Radiation Resistance 3224 Michael Epperly Elevated Pulmonary MnSOD and Endothelial Gene Expression Heralds the Onset of Irradiation Fibrosis 3225 Matthew Janko IL-1 Generated Subsequent to Radiation-induced Tissue Injury Contributes to the Pathogenesis of Radiodermatitis 3226 Michael Bassetti CD24 Regulates Radiation Induced Lung Damage and Neutrophil Accumulation 3227 Ola Maria Mesenchymal Stem Cells for Recovery From Radiation-induced Lung Injury 3228 Michael Epperly MMS350: A Novel Bifunctional Sulfoxide With Radiation Protection and Mitigation Properties 3229 Julie Goff Identification of Ionizing Irradiation Damage Mitigators by Evaluation of Clonogenic Survival of Human Umbilical Cord Blood Progenitor Cells

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

147

RADIATION AND CANCER BIOLOGY/continued 3230 Liangjie Yin A Potent Amino Acid Mixture to Mitigate Radiation-induced Gastrointestinal Toxicity 3231 Abigail Milby Phase I Randomized Trial of Dietary Flaxseed in Non-small Cell Lung Cancer Patients Receiving Chemoradiation 3232 Jun Won Kim Development of a Porcine Skin Injury Model and Characterization of Dose-dependent Response to High-dose Radiation 3233 Zhenhuan Zhang The Antitumor Effects of MRx102: Novel, Potent and Synergistic 3234 Ross Mikkelsen Polymorphisms In Genes Involved in Nitric Oxide (NO) Signaling and the Risk for Late Normal Tissue Injury From Radiation Therapy (RT)

3241 Sei Sai The Role of XRCC4 in Sensitizing Human Colon Cancer Stem-Like Cells to X-ray or Carbon Ion Beam 3242 Paul Romesser Correlation of Brachial Plexus Dose With Gross Tumor Volume in Head and Neck IMRT 3243 Hiromitsu Iwata Compatibility of the Repairable Conditionally-repairable, Multi-target and Linear-quadratic Models in Converting Hypofractionated Radiation Doses to Single Doses 3244 Mahmoud Moustafa Comparison of Photon versus Carbon Irradiation in Pancreatic Cancer 3245 Masatoshi Hasegawa Gene Expression Profiles Induced by Carbon Ion Beams and X-rays in Human Brain Tumors 3246 Masayuki Matsuo Chronic and Cyclic Hypoxia in Fractionated Radiation Therapy

3253 Shihong Ma Depletion of Regulatory T Cells Does not Influence the Inflammatory Response Induced by High-dose Irradiation 3254 In Ah Kim Enhancement of the Radiosensitizing Effect of Temozolomide: Targeting EGFR-associated Signaling in Malignant Glioma Cells 3255 Satoshi Harada Imaging of Premetastatic Sites and Prophylaxis of Metastasis Using Radiosensitive Nanocapsules Via Radiotherapy 3256 Andrew Wang Development of a Novel Nanoparticle Formulation of Cisplatin to Improve Chemoradiotherapy 3257 David Guttmann Preclinical Investigation of Hsp27 LNA As a Novel Radiosensitizer in Head and Neck Cancer 3258

Withdrawn

3235 Jennifer Sattler Potentiation of Radiation-induced Cell Death in PC3 Prostate Cancer Cells by Genistein and the Soy Food Miso

3247 Sean McDermott Potential of Dynamic 18F-FDG PET Parameters for Use in Biological Adaptive Treatment Planning

3259 Caitlin Abidin Autophagy Inhibition by Chloroquine Radiosensitizes Colorectal Cancer Cells to Radiation Therapy

3236 Zeljko Vujaskovic Cerium Oxide Nanoparticles Protect Lung from Radiation-induced Injury in CBA/J Mice

3248 Yuan-Chia Kuo Liposome-based Nanoprobe With Antibody Conjugation Combined With MRI Contrast Encapsulation As a Potential Diagnostic and Therapeutic Agent for Human Head and Neck Cancer Cells

3260 Noriyuki Okonogi Cranial Irradiation Induces Migration of Bone Marrow Derived Microglia (BMDM) to the Cerebellum in Adult C57BL/6 Mice

3237 Leo Gerweck Out of Field Cancer Risk in Mice Following Exposure to a Clinical Proton Beam 3238 Rui Sun Effect of Low-dose Radiation on Cognitive Function of Rats at Different Ages 3239 Joshua Walker Effects of Total Body Irradiation on T-Cell and B-Cell Subsets as Well as Macrophage in Rhesus Macaque 3240 Thomas Schmid Relative Biological Effectiveness of Single-shot Irradiation With Laser-driven Nanosecond Proton Bunches

3249 Chun-Chieh Wang Diffusion-weighted MRI and FDG PET/ CT As Predictors of Tumor Treatment Response in Patients With Cervical Cancer Receiving Chemoradiotherapy 3250 Yi-ping Lin Detecting a Geometric Miss by Dynamic Contrast-enhanced Magnetic Resonance Imaging 3251 Chiwei Hung Multifunctional Molecular Probes for Targeting and Imaging of Epidermal Growth Factor Receptor 3252 Magdalena Bazalova X-ray Imaging beyond Transmission CT: Detecting Low Concentrations of Gold Nanoparticles

3261 Hiroki Ushjima Radiosensitizing Effects of mTOR Inhibitor (Temsirolimus) under Normoxic/Hypoxic Conditions 3262 Takahiro Oike Garcinol, a Histone Acetyltransferase Inhibitor, Radiosensitizes Cancer Cells by Inhibiting Non-homologous End Joining 3263 Michael Foote Nanoparticle Formulation of KU55933 as a Novel Radiosensitizer 3264 Lujun Zhao Inhibition of TGF-β1 Signaling With Halofuginone Can Enhance the Anti-tumor Effect of Irradiation in Lung Cancer Xenograft

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 148

ASTRO 2012 / 54TH ANNUAL MEE TING

3265 Paul Medin Unexpected Paralysis in a Swine Model Suggests a Tolerance Constraint for Single-fraction Spinal Nerve Irradiation 3266 Yuya Yoshimoto Requirement of Anti-tumor Immunity and Enhancement by CTL-associated Antigen-4 Blockade on Therapeutic Efficacy of Radiation Therapy in a Mouse Tumor Model 3267 Withdrawn 3268 Koh-ichi Sakata The Combination of Olaparib and Camptothecin Effectively Sensitize Radiation 3269 Corey Speers Intra-treatment Changes in RAD51 Foci Formation Predict Radiosensitization by PARP1 Inhibition in Breast Cancer Cell Lines 3270 Naoya Ishibashi An Iodine Labeled Porphyrin As a New Radiosensitizer in Vitro and Vivo, Combining Photodynamic Therapy (PDT) and Photon Activation Therapy (PAT) 3271 Joshua Dilworth Pulsed Low-dose-rate vs. Standard Irradiation in Orthotopic Glioblastoma Multiforme: Dose Escalation, Functional Imaging and the Small Animal Radiation Research Platform 3272 Roberto Diaz Ganetespib, an HSP90 Inhibitor, Sensitizes Colorectal Cancers to the Effects of Ionizing Radiation 3273 Te Vuong Targeted Treatment With Anti-egfr Antibodies and Radiation Therapy for Patients With Squamous Cell Carcinoma of the Anal Canal: Rationale for a New Treatment Strategy 3274 Jenna Kahn The mTORC1/mTORC2 Inhibitor AZD2014 Enhances the Radiosensitivity of Glioblastoma Stem-like Cells 3275 Jennifer Yu Hyperthermia Sensitizes Glioblastoma Stem Cells to Radiation

3276 Gopal Abbineni S-PAC-1, A Small Molecule Activator of Procaspase 3, Sensitizes Human Breast Cancer and Other Cell Lines To Ionizing Radiation 3277 Savita Dandapani Potential Role of Novel Wnt Modulator ICG-001 As a Radiosensitizer In Glioblastoma Cell Lines 3278 Ning Cao Monitoring the Radiosensitizing Effects of Implantable Micro-oxygen Generator in Pancreatic Cancer Xenografts 3279 Randall Kimple Direct-from-patient Tumorgrafts of Head and Neck Cancers: Preclinical Models for Evaluating Chemoradiation 3280 Christopher Corso Evaluating the HSP90 Inhibitor ` Ganetespib as a Radiosensitizing Agent in Breast Cancer Models in Vitro 3281 Susan Higgins The Standardized Herbal Formulation PHY906 Decreases the Toxicity of Abdominal Irradiation in Mice 3282 Masao Nakayama Novel Radiosensitization Through Reactive Oxygen Species Generation Using Titanium Peroxide Nanoparticle Compounds Against Pancreas Cancer 3283 Guangying Zhu New Gene Miip Enhances Radiosensitivity of Lung Adenocarcinoma Cell in Vitro and in Vivo 3284 Florence Perillo-Adamer Glioblastoma Expressing MGMT: Contribution of PaTrin-2 in Radiotherapy With Temozolomide

3287 Hiroaki Akasaka Efficacy of Surgically Implanted Flexible Spacer in Particle Therapy: A Novel Strategy Making Temporal Space Between Tumor and Adjacent Organs 3288 Bryan Allen High Dose Ascorbate Enhances Chemo-radio-sensitization in GBM 3289 Withdrawn 3290

Withdrawn

3291 Gilda Hillman Radioprotective Effects of Soy Isoflavones on Normal Lung Tissue Could Translate to Improve Radiotherapy Outcome of Lung Cancer 3292 Aisha Fasih Metformin As a Radiosensitizer in Pancreatic Cancer Cells 3293 Gilda Hillman Enhanced Therapeutic Efficacy by Radiotherapy Combined With Axitinib in a Pre-clinical Model of Lung Carcinoma 3294 Zili Tang Glioma Invasion Confers Radioresistance 3295 Natalie Cummings Preclinical Evaluation of a Polymeric Nanoparticle Micelle Formulation of Paclitaxel (genexol-pm) As a Radiosensitizer 3296 Michael Siedow Anti-EGFR/Radiation Therapy Enhanced Through Galectin-1 Suppression in Nsclc 3297 Dennis Hallahan A New Use of Radiation to Ignite an Immune Response to Cancer

3285 Mohamed Abazeed Development of a High-throughput Platform for Measuring Radiation Response

3298 Claudius Melzig Beneficial Effects of Combined Antiangiogenesis and Heavy Ion Radiotherapy

3286 Dhwani Parikh Des-methyl, Des-amino pateamine A, a Synthetic Analogue of Marine Natural Product Pateamine A, Sensitizes Non-small Cell Lung Cancer Cells to Radiation and Enhances BAX Expression

3299 Blaz Groselj The HDAC Inhibitor Panobinostat Promotes Expression of ∆133p53 Variants in TP53 Wild Type Bladder Cancer Cells

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

149

RADIATION AND CANCER BIOLOGY/continued 3300 Ying Dai Combined ALK-inhibtion and Radiotherapy in Lung Cancer 3301 Withdrawn 3302 William McBride Investigation of Radiation Therapy Response Enhancement of DC Magnetic Fields 3303 C.M. Charlie Ma In Vivo Investigation of Non-thermal Pulsed Focused Ultrasound for Prostate and Breast Cancer Therapy 3304 Roger Macklis Alpha Particle Radiobiology for Radium-223 (“Alpharadin”): The Fortuitous “Goldilocks” Effect Observed for Hormone-Resistant Metastatic Prostate Cancer 3305 Yaacov Lawrence NCI-RTOG Translational-program Strategic Guidelines for the Early Stage Development of Radiosensitizers 3306 Philip Blumenfeld The Lag-time in Initiating Clinical Testing of New Drugs in Combination With Radiation Therapy, a Significant Barrier to Progress in Radiation Oncology 3307 Mitra Heravi Combination of Ionizing Radiation and DNA/ EGFR Binary Targeting Molecule Delays DNA Double Strands Repair 3308 Tod Speer Feasibility of the Systemic Cure of Cancer With Targeted Radionuclide Therapy (TRT) 3309 Chaitanya G. Joshi Transcriptome Analysis of Human Buccal Mucosal Cancer 3310 Janet Horton Gene Expression Response to Ionizing Radiation in Luminal and Basal Breast Cancer Cell Lines

3312 William Hall C-Reactive Protein (CRP): Initial Exploratory Study of an Inflammatory Biomarker for Prostate Cancer Radiotherapy 3313 Jan Akervall Gene Expression Characterization of Chemoradiation Treatment Failure in HPV16 Positive Head and Neck Squamous Cell Carcinoma 3314 Dukagjin Blakaj Characterization of Human Papillomavirus 16 Variants in Head and Neck Squamous Cell Carcinoma Patients 3315 George Wilson The Role of CD44-Associated Stem Cells in the Recovery of Head and Neck Squamous Cell Carcinoma Following Radiation

3323 Anne Kiltie Predictive Biomarkers for Gemcitabine As a Chemoradiosensitiser in Bladder Cancer 3324 John Jarboe Marcks Regulates Growth, Radiation Sensitivity and Is a Novel Prognostic Factor for Glioblastoma 3325 Jennifer Jones nanoFACS: A New Tool for Studying Tumor- and Treatment-Associated Exosomes and Microparticles

3316 Nelson Leong Single Nucleotide Polymorphisms (SNPs) Associated With Late Radiation Urinary Toxicity After Prostate Brachytherapy

RADIATION PHYSICS

3317 Matthew Parliament Single-Nucleotide Polymorphisms (SNPs) Associated With Radiation Proctitis From Genome-wide False Discovery Rate Analysis

3327 Bassel Kassas Assessment of Using Endorectal Balloon in Prostate Radiotherapy on Daily Kilovoltage Cone Beam Computed Tomography Localization

3318 Scott Bratman Cell-free DNA As a Biomarker of Residual Disease Following Radiotherapy for Non-small Cell Lung Cancer

3328 Ivan Buzurovic Effects of Tumor Tracking Errors to the Quality of Radiation Treatment

3319 Bassem Zaki Determination of Predictive Markers of Chemoradiation Sensitivity and Resistance of Rectal Tumors 3320 Michael Chin Hyperspectral Imaging for Early Prediction of Chronic Microvascular Injury in Irradiated Skin 3321 Wendy Woodward EZH2 Expression Correlates With Locoregional Recurrence After Radiation in Inflammatory Breast Cancer

3311 Tomasz Rutkowski The Role of Biochemical Markers in Prediction of Radiotherapy Failure for Patients With Head and Neck Cancer

150

3322 Dong Wook Nathan Kim Loss of Tumor Suppressor DAB2IP Correlates With Decreased Biochemical Recurrence Free Survival in High-risk Prostate Cancer Patients Treated With Radiation Therapy

ASTRO 2012 / 54TH ANNUAL MEE TING

3326 John McGary Electromagnetic Tracking for TomoTherapy Systems

3329 Shinichi Ueda Evaluation of Prostate Motion and Optimum Planning Target Volume (PTV) Margin in Prostate Intensity Modulated Radiation Therapy (IMRT) Based on Fiducial Markers Using Two Modern, Online Image Guided Radiation Therapy (IGRT) Systems 3330 Ryan Foster An Analysis of SBRT Localization Errors and Intrafraction Motion Using CBCT 3331 Kiyonori Shirai Maximum Intensity Projection (MIP) and Average Intensity Projection (AIP) in Image Guided Stereotactic Body Radiotherapy (SBRT) for Lung Cancer 3332 Anoop Haridass Customised MoldCare Head Cushions Reduce Patient Movement During Intracranial Cyberknife Radio Surgery

3333 Mingyao Zhu Is the Prostatic Bed a Rigid Structure? Evaluation Using Real-time Electromagnetic Tracking 3334 Troels Bjerre A Feasible Real-time Multi-plane MRI-linac Guidance Strategy 3335 Irina Vergalasova Impact of Patient Anatomy Variations on a Fourier Technique for Markerless 4D-CBCT 3336 Masahiro Yamada Dependency of Imaging Conditions on a Marker Detectability Using kV X-ray Images in the Tracking Irradiation With Vero 4-D RT (MHI-TM2000) 3337 Shifeng Chen Respiratory-induced Setup Errors Should Be Considered for Patients With Tumor Affected by Respiratory Motion and Treated With free breathing IGRT: A pilot study on Patients With Pancreatic Head tumor 3338 Jean Peng The Assessment of Interfraction and Intrafraction Setup Error With Open Thermoplastic Masks for Head and Neck Cancer Using CBCT and 3-D Surface Imaging System 3339 Songbing Qin Motion Pattern for Liver Tumor and Its Correlation to External Surrogates 3340 Jason Samuelian High-field Open 1.0 T Magnetic Resonance Imaging Simulation for Radiation Treatment Planning in High-risk Prostate Cancer 3341 Jin Wang Positioning Accuracy and Efficacy of Different Correction Protocols Based on kV-Cone beam CT Guidance for Abdominal Pelvic Radiotherapy 3342 Norio Katoh Real-time Tumor-tracking Radiation Therapy for Lymphoma Of The Stomach 3343 Chi Wah Kong Amplitude Restricted RPM Technique for Lung Cancer Radiotherapy

3344 Zejian Liu Evaluation of the Dosimetric Effect of Patient Daily Setup Variations Suring Strut-Adjusted Volume Implant (SAVI) Breast Brachytherapy

3356 Dengwang Li Tumor Tracking for Adaptive Radiation Therapy System by Multi-resolution Wavelet Deformable Registration Framework

3345 Marco Trovo Fiducial Markers for Image-Guided Partial Breast Irradiation

3357 Bo Lu A Patient Alignment Solution For Lung SBRT Setups Based on a Deformable Registration Technique

3346 Yingjie Zhang A Study on the Contribution of Respiratory and Heart-beat to the Displacement of Mediastinal Lymph Nodes Based on 4-D CT 3347 Yingjie Zhang Displacement of Liver Cancer and Interested Structures During Respiration Detected by 4-D CT And 3-D CT

3358 Bernard Jones Dosimetric and Deformation Effects of Image Guided Interventions During Stereotactic Body Radiation Therapy of the Prostate Using an Endorectal Balloon 3359 George Ding Methods to Account for Additional Imaging Dose in the Era of IGRT

3348 Indra Das Dosimetric Impact of Gastric and Bowel Air Column in IMRT for Pancreatic Cancer

3360 Gabriella Pastore Correcting Rotational Errors by Couch Translations Can Lead Dosimetric Uncertainties on the Dose to OARs

3349 Christie Lin Shape Distribution-based 2-D/3-D Registration for Fast And Accurate 6 Degrees-of-freedom Stereotactic Patient Positioning

3361 Lindsay Jensen Magnitude and Agreement of Cone Beam Computed Tomography Shifts for Patients With Intact and Post-operative Prostate Cancer

3350 Wu Liu Feature-based Automatic Real-time Tumor Motion Monitoring With or Without Fiducial Markers

3362 Sean Vance Evaluation of Breathing Excursion Variability in Lung Cancer Patients During Conventional and Hypo-fractionated Radiotherapy

3351 Hania Al-Hallaq An Image-Guided Study of Setup Reproducibility of Chestwall Patients Treated With Inverse-planned IMRT 3352 Jun Lian Influence of Patient Setup and Target Delineation on Air Cavity Tomotherapy Dosimetry 3353 Terence Sio S-frame versus BodyFIX: A Comparison of Immobilization Techniques for Upper Lung Tumors With Stereotactic Body Radiotherapy 3354 Craig Hullett Impact Of BMI on Daily Setup Variation With Pelvic Radiotherapy: Is Prone Positioning a Class Solution? 3355 Sang Gyu Ju Development of a Video Guided Real-time Patient Motion Monitoring System for Helical Tomotherpay

3363 Jun Zhou Head and Neck Patient Setup Using 3-D Surface Matching: Accuracy and Performance Analysis 3364 Ruijiang Li Accurate Real-time Tumor Localization From Respiratory Surrogates Via Memory-Based Learning 3365 Sara Alcorn Multi-site Assessment of the Utility of Daily Cone Beam CT in Achieving Clinical CTV-PTV Setup Margin 3366 Tanja Langsenlehner Role of Residual Set-up Errors and Intrafraction Motion in the Evaluation of Planning Target Volume Margins for Prostate Cancer Radiotherapy

ASTRO 2012 54TH ANNUAL MEE TING

151

RADIATION PHYSICS/ continued 3367 Joo Hwan Lee Weekly Position, Volume and Dosimetric Changes During Image Guided Radiation Therapy With Kilovoltage CT-on-Rail for Head and Neck Cancer 3368 Mitsuhiro Inoue Estimation of Clinical Error With Respiratory Motion Tracking of the Image Guided Robotic Radiosurgery System 3369 Andrew Perkinson Assessment of the Benefit of MRI Immobilisation for Deformable Image Co-registration for Head and Neck Radiotherapy Planning 3370 Richard Speight Assessment of Accuracy and Reproducibility of Automatic Deformable Image Registration for Head and Neck Radiotherapy 3371 Marianne Falk A Dosimetric Comparison of MLC Tracking and Gated Delivery of Arc Therapy to a Moving Target

3377 Gregory Perkins A Novel Open Architecture Purpose Built Phased Coil Array for Head and Neck MR-SIM: Characterization, Protocol Optimization and Imaging Performance Using Subjects Immobilized in the Treatment Position 3378 Dimitrios Lazos Assessment of Fiducial -based 2d kV Orthogonal Imaging, Fiducial-based CBCT and Soft Tissue-based CBCT for Prostate Cancer Patients With Implanted Fiducial Markers 3379 Angie Hu Time Series Analysis of Interfraction Patient Setup in Image Guided Radiation Therapy 3380 Sarah Han-Oh Analysis of Tumor-motion Surrogate Signals Under Different Coaching Conditions Using Empirical Mode Decomposition and Hilbert-Huang Transformation 3381 Pankaj Mishra Fluoroscopic 3-D Images Based on 2-D Treatment Images Using a Realistic Modified XCAT Phantom

3372 Eduard Schreibmann Automated Quality Assurance for IGRT-based Patient Positioning

3382 Peter Wersall Spatial Accuracy and Visibility Studies of a MRI Compatible Gold AnchorTM Fiducial Marker

3373 Howard Hsu Daily CBCT vs. Biweekly CBCT vs. Portal Imaging for Partial Breast Irradiation

3383 Tracy Bray Rotational Dual-energy Image-guided Radiotherapy for Lung Tumors

3374 Rabih Hammoud Qa Procedures for The Assessment of Geometric Accuracy For Mri-sim Using a Novel Large Field of View Phantom: System Performance Tests and Validation of Clinical Protocols

3384 Cynthia Chuang Development of a Workflow to Quantitatively Validate Various Image Fusion Algorithms in Radiation Therapy

3375 Noam VanderWalde A Dosimetric Study of the Effect of Patient Positioning on the Incidental Radiation Dose to the Larynx for Patients Treated for Head and Neck Squamous Cell Carcinoma 3376 Biniam Tesfamicael Prediction of Lung Tumor Motion With Measured Breathing Motion

3385 Jatinder Saini Assessment of PTV Margins For Exactrac-based Frameless Intracranial Fractionated Stereotactic Radiotherapy 3386 Jing Wang High Quality Four-dimensional Cone-beam CT by Deforming Prior Images 3387 Juan Diego Azcona Assessment of the Prostate Motion During Volumetric Modulated Treatments

3388 Brian Wang Ultrasound Image Guidance for Abdominal Tumor 3389 Xiaoli Tang Investigation of the Immobilization Capability of Open Masks for Head and Neck Patient Setup and Treatment 3390 Yue Cao MRCT: Synthetic CT imaging for Radiation Oncology Using Magnetic Resonance Images 3391 Luis Silva Variability in Interpretations of Computed Radiography Portal Images Using Two Different Methods 3392 Haijun Song Study of Prostate Bed Motion Using Daily CBCT and Surgical Clips 3393 Anand Santhanam 3-D Feature Recognition-based Automated Patient Treatment Mismatch Verification System for Radiotherapy 3394 Jeff Olsen Feasibility of Single and Multi-plane Cine MR for Monitoring Tumor Volumes and Organs at Risk (OARs) Position During Radiotherapy 3395 Ting Chen A Quantitative Study of the Correlations of Lung Tumor Motion to Cardiac and Respiratory Motion 3396 Parvesh Kumar Four-dimensional Cone Beam CT (4-D CBCT) Significantly Improves Localization of Lung Tumors in Comparison to ExacTrac X-Ray 6-D Image Guidance (ExacTrac) in the Delivery of Stereotactic Body Radiotherapy (SBRT) 3397 Joo Han Park A 4-D Adaptive Approach to Improve Pre-treatment Patient Positioning Accuracy in Lung Cancer Radiation Treatments 3398 Haijun Lu The Use of 4-D CT for Radiation Treatment Planning of Esophageal Cancer

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 152

ASTRO 2012 / 54TH ANNUAL MEE TING

3399 Yongsook Lee Daily Localization Comparison Between Kilovoltage Cone-beam Computed Tomography and Electromagnetic Tracking System (Calypso) For Intensity Modulated Radiation Therapy-treated Prostate Patients 3400 Anna Arns Dose Exposure and Geometric Accuracy of Ultrafast Kilovoltage- Megavoltage (kV-MV) Cone-Beam CT for Image Guided Radiotherapy of Lung Cancer 3401 Anthony Michaud A Retrospective Analysis of Setup Reproducibility for Anorectal Cancer Patients Treated Prone on a Belly Board 3402 Ilsung Cho Feasibility Study of Using Lipiodol As Tumor Motion Surrogate for Liver IGRT 3403 Wing Fung To Evaluate the Advantages and Disadvantages Using 4 Degree of Freedom (DOF) vs. 6 Degree of Freedom (DOF) for Tomotherapy Treatment in Head and Neck Cancer 3404 Daniel Low Addition of Cardiac Motion in a Breathing Motion Model 3405 Sean Tanny Challenges in Clinical Electron Dosimetry: Over-response of Solid-state Detectors in Small Fields 3406 Caroline Olsson The Reference for Self-reported Complication Data: Reflections from the Swedish Program on Atomized Symptoms After Cancer Treatments (SPASACT) 3407 Mehran Zaini Temporal Analysis of Inter-fraction in vivo 3-D Dosimetry Using DVH Difference Curves, Based on Daily Exit Fluence Measures and Cone-beam CT Images 3408 Ruggero Ruggieri Computed 88 percent TCP Dose for SBRT of Non-small Cell Lung Cancer (NSCLC) 3409 Masao Tanooka Carbon-Fiber Couch Modeling Optimization for Monaco VMAT Planning and Delivery

3410 Michelle Ludwig Implanted Intrathecal Drug Delivery Systems and Radiation Treatment 3411 Pier-Yves Trepanier A Prospective Model-based Approach to Personalize Radiotherapy Treatment Plans for Glioblastoma Multiforme Patients 3412 Charles Shang A New Reliable SUV Index for Evaluating Local Control Using F-18 FDG PET Following Lung SBRT 3413 Vahid Entezari Computed Tomography-based Rigidity Analysis Affects Treatment Plan for Skeletal Metastasis 3414 Andrew Godley Comparison of Reproducibility of Manual and Automated Prostate Contouring Using Kilovoltage Cone-beam Computed Tomography and Diagnostic Quality Computed Tomography 3415 Sigolene Galland-Girodet Interest of [18F]-fluoromisonidazolepositron Emission Tomography in Radiotherapy for Glioblastomas : Evaluation of its Impact in a Dose Escalation Protocol 3416 Bertrand Biritz Three-dimensional MRT/CT Treatment Planning for 106Ru Eye Plaques Commissioned Using Radiochromic Film in a Solid Water Phantom 3417 Sigolene Galland Treatment of Cervical and Cranial Base Paragangliomas With Conformal Fractionated Radiotherapy: A 25-year Experience in Single Institution 3418 Samuel Park Developing Fuzzy Contour and Fuzzy Similarity Index to Consider Inter- and Intra-observer Variation in Image Segmentation 3419 Omar Chibani CT-based Monte Carlo Dose Calculations for Prostate Implants 3420 Allison Toltz Prediction of Excess Risks of Radiation-induced Cardiac Mortality and Secondary Cancers After Radiotherapy for Hodgkin’s Lymphoma

3421 Apryl Mensah Generalized Approach to Planning Multimodality Therapy Adapted to Periodically Obtained Maps of Tumor Evolution Which Will be Robust to Prediction Error 3422 Andrew Jackson Correlation of the Dose Delivered to the Nausea Center With Acute Onset of Nausea and Vomiting in Oropharynx Cancer Patients Treated With Chemoradiation 3423 Claudio Fiorino Weekly DSH/DVH of the Bladder Predicts a Worsening of the Ipps Value at the End of High-dose Radiotherapy for Localized Prostate Cancer 3424 Niranjan Bhandare Post-radiation Otitis Media With Effusion: Modeling the Complication Probability and Determining the Parameters of Clinical Significance 3425 Jenghwa Chang Analysis of Radiation-induced Toxicity in Patients Receiving Stereotactic Body Radiotherapy (SBRT) for Lung Tumors 3426 Yevgeniy Vinogradskiy Quantitative Assessment of Lung Function in Stage I and Stage III Lung Radiotherapy Patients Using 4-D CT-based Ventilation Imaging 3427 Ellis Ziel Integral Dose Delivered to Normal Brain With Conventional IMRT and Helical Tomotherapy IMRT During Partial Brain Radiotherapy for High Grade Gliomas With and Without Selective Sparing of the Hippocampus, Limbic Circuit and Neural Stem Cell Compartment 3428 Zhe Chen On the Use of Biologically Effective Dose (BED) and Iso-Effective Dose (IED) in Radiobiological Evaluations of Permanent Brachytherapy with Proliferating Tumors 3429 Oana Craciunescu Quantifying Temporal Fluctuations of DCE-MRI Extracted Parameters in Neck Nodal Metastases

ASTRO 2012 54TH ANNUAL MEE TING

153

RADIATION PHYSICS/ continued 3430 Yong Yue A Novel Hybrid Multi-modal Registration for Lung Radiotherapy Response Evaluation 3431 William Watkins Dose Differences in ITV Planning of Time Dependent Anatomy 3432 Jin Wang Impact of Dose-volume Parameters and Tumor Location on Severe Acute Radiation Pneumonitis for Lung Cancer Patients Treated With Concurrent Chemo-radiotherapy 3433 Antonio Damato Inter-fraction Uncertainties in Multi-fraction Gynecologic Interstitial Brachytherapy (MGIB) 3434 Michael Snyder Potential Gender Differences in a Normal Tissue Complication Probability Model for Heart Toxicity During Radiotherapy for Esophageal Cancer 3435 Omid Nohadani Unbiased Metrics of Dosimetric Variation in IMRT Planning 3436 Clay Holdsworth Adaptive IMRT Using a Multiobjective Evolutionary Algorithm Integrated With a Diffusion-Invasion Model for Glioblastoma 3437 Olga Green Observation of Radiation-induced Tissue Signal Intensity Changes With the First Commercial MRI-guided IMRT System 3438 Anthony Kim Predicting Dose in the Periphery Of Intensity Modulated Radiotherapy Treatment Fields 3439 Tianyu Zhao A Non-Uniform Dose Prescription Based on Tumor Position Probabilities for Patients With Lung Cancer 3440 Morad Nasseri Does Pseudoprogression Occur Beyond Three Months Following Standard Chemoradiotherapy in Glioblastoma Patients?

3441 William Yuh Biological Equivalent Dose (BED) - Application of the Generalized Linear-Quadratic Model for Spinal SBRT 3442 Tod Speer Monte Carlo Modeling of the Metastatic Formation of a Patient Treated With a Single Dose of Ibritumomab Tiuxetan: The Case for Radionuclide Combinations of Different Path Lengths 3443 Chiramana Haritha Accuracy of Stent Based 4-D CBCT Image Guidance for Inoperable Klatskin Tumor Treated by Chemoradiotherapy 3444 Prashantkumar Shinde Cone Beam CT-based 3-D Dose Verification in Head and Neck Cancers - Validation Study 3445 Lukasz Matulewicz Dosimetric Implications of CT Metallic Artifacts Correction in Current Radiotherapy Treatment Planning Systems 3446 Pengpeng Zhang Predictive Treatment Management: Incorporating a Predictive Tumor Response Model Into Robust Prospective Treatment Planning for Non-small Cell Lung Cancer 3447 Yi Wang Comparison of Imaging Dose From Daily Cone-beam CT to Out-of-field Therapeutic Dose in IMRT and VMAT Treatments of Prostate Cancer 3448 Naoki Tohyama Validation of IMRT Postal Dosimetry Audit Using Radiophotoluminescence Glass Dosimeter 3449 Raj Varadhan Testing Accuracy of Deformable Registration Studies Using Computational Modeling and Inverse Consistency Metrics 3450 Anthony Lo CyberKnife IGRT for Optic Nerve Sheath Meningioma

3451 Shrikant Deshpande An Integrated 2-D Dosimeter and Electronic Portal Imaging Device for in Vivo Dosimetry: A Feasibility Study 3452 Kai Ding Air-Bellow Belt and LED Display Based Compact Visual Biofeedback System Improves the Respiratory Regularities for Gated Radiation Therapy 3453 Takashi Hanada Variation of Rectal Volumes and Dosimetry Values Including NTCP Due to Inter-fractional Variability Receiving 2-D Based IG-IMRT for Prostate Cancer 3454 Shichao Wang Applied Analysis on the Biological Effect Dose (bed) Through the Dosimetric Comparison Between the IMRT and the VMAT Plans 3455 Pierre Graff A Tool for the Daily Management of Dose Guided RadioTherapy for Head and Neck IMRT Patients 3456 Hiroyuki Okamoto Probability of Human Errors in Operation of Treatment Planning System (TPS) 3457 Hui Geng The Application of Metal Artifact Reduction Algorithm in CT Spectral Imaging on Radiotherapy Dose Calculation 3458 Chor-yi Ng Dosimetric Evaluation of the Interplay Between LINAC Movement and Tumor Motion in Respiratory Gated VMAT of Lung Cancer 3459 Tonnis Nuver MVCT-Detector Based Dose Reconstruction Makes Phantom QA Measurements for Tomotherapy Prostate Treatments Redundant 3460 Xiao qin Jiang Automatic Adaptive Inverse Planning Optimization for Head and Neck Cancer Radiotherapy 3461 Ivaylo Mihaylov Dose-mass Based Inverse Optimization for Head and Neck Cancers

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 154

ASTRO 2012 / 54TH ANNUAL MEE TING

3462 Nathalie Rochet Multicriteria Optimization in IntensityModulated Radiation Therapy Treatment Planning for Large Target Volumes: First Experience With Whole Abdomen Radiotherapy 3463 Edward Obedian The Value of Repeat Cone Beam CT Scans in Image Guided Radiation Therapy for Prostate Cancer 3464 Masatoshi Hashimoto Verification of MLC Position Using Electric Portal Imaging Device During RapidArc Delivery 3465 Kentaro Nishioka Interfractional Setup Error and Intrafractional Bladder Motion During Radiotherapy for Bladder Tumors 3466 Akira Nakamura Fluoroscopic Lung Tumor Tracking-based on Gradient-based Features Without Fiducial Markers 3467 Suk Lee Development of Patient Specific 3-D Dose Real Evaluation Systems Using a Novel Patient-based 3-Dimensional Dose Scanner (P3DS) in Tomotherapy 3468 Jiazhou Wang Using Corrected Cone Beam CT Image for Accelerated Partial Breast Irradiation Treatment Dose Verification 3469 Eileen Cirino Using Dose Homogeneity Index and Conformity Index to Evaluate Prostate High-dose-rate Plan Quality and Consistency 3470 Tatsuya Toyoda How Much Does Field Size Become Larger With Interfractional Computed Tomography in Treating Gastric Malignant Lymphoma? 3471 Adam Reese Deformable Image Registration As a Method to Assess Motion for Pancreatic Cancer Using 4-D Computed Tomography (CT) Scans 3472 Malcolm Mattes The Dosimetric Effects of Photon Energy on the Quality of Prostate Volumetric-Modulated Arc Therapy (VMAT)

3473 Xiangrong Qi Interfraction Patient Setup for Multiple Volumetric-based Image Guidance Systems for Head-and-Neck IMRT 3474 Zijie Xu Comparison of Automatic and User-guided Methods for Isocenter Mapping 3475 Tomasz Piotrowski Tomotherapy: Implications on Daily Workload and Scheduling Patients Based on Three Years Experience in Poznan 3476 Roger Rice Evaluation of Portal Dosimetry for RapidArc Treatments 3477 Hyunjin Lee Location of Tumors Influencing Small Bowel Sparing in Intensity Modulated Radiation Therapy for Locally Advanced Rectal Cancer 3478 Dongwook Kim Secondary Radiation Doses of Intensity Modulated Radiotherapy in Patients With Lung And Liver Cancer 3479 HongSeok Jang Evaluation for Direct Aperture Optimization (DAO) in Intensity Modulation Radiotherapy (IMRT) Treatment Planning 3480 Tomohiro Yokoi Development of a New Simulation Method of Dose-distribution Changes for an IMRT Plan by Rotational Set-up Error 3481 Ana Cámara Quality Assurance of the Dose Delivered Throughout the Entire IMRT Treatment 3482 Claus Behrens Adaptive RT for Head and Neck Cancer: The Usefulness of Deformable Image Registration 3483 Daniel McDoland Dosimetric Effects of Balloon Positioning Errors for Partial Breast Irradiation Using Contura 3484 Mohammad Khan Prostate Motion Is Correlated in the Superior/Inferior (SI) and Anterior/ Posterior (AP) Direction: Use Statistical Margin Recipes With Extreme Caution

3485 Seungjong Oh Adaptive MRI Guided Brachytherapy of Cervix Cancer: Impact of Reference Image Selection on Dose Accumulation 3486 Christina Skourou Dosimetric Differences in Forward Planned IMRT Calculated and Delivered With Dynamic Fields or With Multiple Static Subfields: A Multimodality Comparison 3487 Pietro Mancosu Total Marrow Irradiation With Volumetric Modulated Arc Therapy: Technical Considerations and Early Experience 3488 Wensha Yang ITV Margin Definition and Deformable Motion Assessment Using Multiple Fiducial Markers for Pancreas/Liver SBRT 3489 Yong Hum Na Ultra-Fast Multi-Objective Optimization of VMAT Treatment Using Emerging Cloud Computing Platform 3490 Xiaocheng Yang Dosimetric Validation of Respiratory Motion Margins for Patients With Pancreatic Cancer Using Deformable 4-D Contour Propagation 3491 Lei Ren Can Standard Radiotherapy Quality Assurance (QA) Detect Potential Delivery Errors? 3492 Macharla A. Laviraj A Method to Validate the Four-Dimensional Cone Beam Computed Tomography (4-D CBCT) in External Beam Radiotherapy 3493 Alec Block Clinical Reduction of Daily kV Planar Imaging Dose: An Observer Study 3494 Hongwei Liu The Influence of Target Anatomic and Patient’s Characteristics on the Volume Obtained From Cone Beam CT (CBCT) in Lung Stereotactic Body Radiation Therapy 3495 Rafael Manon Effect of Re-imaging Frequency in Adaptive Radiation Therapy (ART) for Head and Neck Patients

ASTRO 2012 54TH ANNUAL MEE TING

155

RADIATION PHYSICS/ continued 3496 Heming Zhen Evaluation of a New Tomotherapy Treatment Planning System Utilizing Gpu Computing Capacity 3497 Katja Langen Do Adaptive Radiotherapy (ART) Assessments Depend on the Employed ART Workflow? 3498 Jingdong Li Study of Dose Variations Induced by Collimator Rotation for IMRT Delivery Using EPID Dosimetry 3499 Nzhde Agazaryan Intra-fraction Motion Management for Prostate SBRT: Clinical Experience and Motion Analysis 3500 An Tai Relationship of PTV Margin with Frequency of Image-Guided Positioning 3501 Dongwook Kim In vivo Verification of Rectal Wall Dose Distribution for Volumetric Modulation Arc 3502 Antonio Damato Dosimetric Uncertainties Associated With Inter-observer Contouring Variability in Gynecologic Interstitial Brachytherapy (GIB) 3503 Rachit Kumar SBRT Treatment Planning With VMAT vs. IMRT: Impact of Duodenal Sparing on Tumor Coverage in Patients With Locally Advanced Pancreatic Adenocarcinoma 3504 Kiran Kumar Evaluation of Gold Fiducial Marker Migration After Implantation in Prostate Image Guided Radiotherapy (IGRT)

3507 Jaegi Lee Patient Specific Quality Assurance Using a 4-D Programmable Motion Platform in Respiratory-Gated Radiotherapy 3508 Christian Thieke A New Planning Tool for Fast Online Dose Optimization of IMRT Plans 3509 Nozomi Kitamura The Threshold CT Value Difference in the Deformed Volume With Good Conformality 3510 Morten Hoyer A Dose Accumulation Study of Adaptive Plan Selection vs. Daily Re-optimization in Bladder Radiotherapy 3511 Ryo Takahashi Direct Measurement of Two-dimensional Dosimetric Leaf Gap Distribution Using Electric Portal Imaging Device 3512 Hye Young Kim Volumetric Modulated Arc Therapy for Multiple Brain Metastases: A More Efficient Modality than Dynamic Arc Stereotactic Radiosurgery 3513 Ugur Selek Volumetric Arc Therapy Seems More Promising to Spare Organ at Risk In Adjuvant Postoperative Radiotherapy for Pancreas Adenocarcinoma in Comparison to Step and Shoot Intensity Modulated Radiotherapy 3514 Rodney Ellis Improved Care Delivery and Operational Work Flow by Inter-departmental Coordination of PET/CT Exams and CT Simulations for IGRT

3505 Shunshan Li On The Regional Cross Correlation Metric to Predict Displacement Errors in Deformable Image Registration

3515 Adavikolanu Kesava Ramgopal Conventional Two Phase vs. Simultaneous Integrated Boost Methods of Intensity Modulated Radiotherpy in Carcinoma Prostate - Analysis of Volumetric and Dosimetric Parameters

3506 Henry Wang Treatment Planning Recommendation - Compensating for Perturbation via Prior Knowledge and Collaborative Filtering

3516 Richard Speight Assessing the Accuracy of Atlas-based Automatic Segmentation of Volumes for Adaptive Treatment in the Head and Neck

3517 Per Poulsen A Method of Dose Reconstruction for Moving Targets With Dynamic Treatments 3518 Adavikolanu Kesava Ramgopal Dynamic and Segmental Methods of Intensity Modulated Radiotherapy Delivery in Head and Neck Cancer - Analysis of Volumetric and Dosimetric Parameters 3519 Joseph Moore Use of In-beams Structures in Shape Relationship Driven Treatment Planning 3520 Giuseppe Roberto D’agostino Dice Similarity Index Assessment in Deformable Registration for Head and Neck Cancer Patients Undergoing Replanning Procedures 3521 Hassaan Alkhatib A Method to Ensure Consistent Delivery of Volumetric Modulated Arc Therapy 3522 Daniel Nguyen Evaluation of IMSureQA for Volumetric Modulated Arc Therapy (VMAT) Treatment Plan Quality Assurance (QA) in Lung SBRT and Abdomen Cancers 3523 Peter Winkler Correlations Between Changes in Morphology and Dose Distribution for Adaptive Radiation Therapy in the Head and Neck Region 3524 David Craft Effective Multi-criteria Optimization for Clinical IMRT Planning 3525 Xin Mei Impact of a Definition Bladder ITV on KV-CBCT Tailored Adaptive Radiotherapy in Bladder Cancer 3526 Georges Hobeika How Does ITV Density and Small Dynamic Dose Fields Affect Coverage in Moving Targets 3527 Dengwang Li Multi-resolution Deformable Registration Framework Using Dual-tree Complex Wavelet for Adaptive Radiation Therapy

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 156

ASTRO 2012 / 54TH ANNUAL MEE TING

3528 Ross McGurk Pet Tumor Volume Segmentation: A Comparison of Automated vs. Oncologist Drawn Volumes

3539 Hualiang Zhong Region-based Correction of Deformable Image Registration Errors for Adaptive Radiation Therapy

3529 James Wong Beyond IGRT-daily Real-time Planning (RTP) – Treatment of Prostate Cancer, Clinical Implementation and Technique

3540 Mark Phillips Optimization of Objective Functions Used in Inverse Planning by Means of a Multi-objective Evolutionary Algorithm

3530 Natalya Morrow Cumulative Dose With Organ Deformation for Cervical Cancer Treated With Multi-fraction High-dose-rate Brachytherapy

3541 Jason Pukala The Dosimetric Uncertainty Resulting From Contour Variability of the Parotid Glands and Its Application to Adaptive Radiotherapy

3531 Nguyen Daniel Quality Assurance (QA) of Volumetric Modulated Arc Therapy (VMAT) Treatment Plans: Analysis of 1 000 Patients

3542 Han Liu Investigation Discrepancy Between the Planned and Delivered Dose Using Weekly CBCT Images

3532 Leire Arbea Dosimetric Predictors of Gastrointestinal Toxicity During Intensity Modulated Radiation Therapy Concomitant With Capecitabine and Oxaliplatin, for Locally Advanced Rectal Cancer 3533 Fenghong Liu Propagation of Gastroesophageal Junction Target Contours on Respiration Correlated CT Images Using Deformable Image Registration 3534 Daniel Pak Weighted Sum Cost Function vs. Lexicographic Ordering for IMRT Treatment Planning 3535 Amar Kishan Quantification of Gross Tumor Volume Changes Between Simulation and First Day of Radiation Therapy for Patients With Locally Advanced Malignancies of the Lung And Head/Neck 3536 Kihwan Choi Iterative Optimization Using Normalized Transmission Map for IMRT With Arbitrary Beam Profiles 3537 Fenghong Liu Dosimetric Benefits of Respiratory Gating for Gastroesophageal Junction Tumors 3538 Ho Lee Binary Moving Blocker-based Scatter Correction for Single Scan Cone-Beam CT System With Off-centered Detector

3543 Sara Pirozzi Atlas-based Segmentation: Evaluation of a Multi-atlas Approach for Prostate Cancer

3551 Colleen Schinkel Dose Reduction of Rectum and Bladder Utilizing an Adaptive Strategy and Dual-Plan Superposition When Treating Pelvic Lymph Nodes and Prostate With IMRT 3552 Andre Minken First Experience With IMRT Treatment Plans Created With RayStation 3553 Louise Murray Ultrasound and Cone Beam CT for Image Guidance in Prostate Radiotherapy 3554 Nadya Shusharina Adaptive Proton Radiotherapy for Base of Skull Tumors 3555 Jing Cai Feasibility of MR-alone-based Brachytherapy Treatment Planning Using a Titanium Tandem and Ring Applicator for Cervical Cancer

3544 Dante Roa Dose Measurements Outside the Treatment Field From a VMAT Technique Using an Anthropomorphic Phantom: Preliminary Data

3556 Edward Dickerson Quantitative Analysis of Head Scatter and Jaw Transmission Correction Factor for Enhanced Dynamic Wedge Fields Using a Two-dimensional Diode Array

3545 Song Wang Sensitivity Calibration of a Two-dimensional Detector Array Using Two Shifts

3557 Eric Ford Lessons From the Nuclear Power Industry: Using Incident Learning to Improve Patient Safety

3546 Matthew Witten Optimization of Affine Transformation Parameters for Dose Matrix Warping in Patient-Specific Quality Assuance of Radiotherapy Dose Distribtuions Using an Evolutionary Algorithm

3558 Ergun Ahunbay Adaptive Replanning Considering Previously Delivered Dose for Head and Neck Cancers

3547 Ebbe Lorenzen Automatic Segmentation of Heart Evaluated With Multi-institution Inter-observer Variation

3559 Christoph Oehler Comparison of Cone Beam CT and kV/ kV-imaging Using Fiducial Marker for PTV Margin Definition in IGRT of Localized Prostate Cancer 3560 Silvia Chiesa A Predictive Model of Correlation Between Site and Diameter of Brain Metastases and Hippocampal Sparing Using Rotational Techniques

3548 Entesar Dalah PET-guided Dose Escalation for Pancreatic Cancer: A Treatment Planning Study 3549 Ronald Berg VMAT in Vivo Dose Delivery Verification 3550 Dimitrios Lazos Dosimetry Study of the Effects of Patient Positioning Correction in the Treatment of Prostate Cancer Patients With Image Guided Radiation Therapy

3561 Sook Kien Ng Does HD120 MLC Give an Advantage Over Millenium MLC in the Treatment of Head and Neck Cancer (HNC) Patients?

ASTRO 2012 / 54TH ANNUAL MEE TING

157

RADIATION PHYSICS/ continued 3562 Strahinja Stojadinovic Gamma Analysis of Normalized and Un-normalized Dose Distributions 3563 Issa Mohamad Implementation of Intensity Modulated Radiation Therapy in a Developing Country: Lessons for Everyone 3564 Feng Liu Dosimetric Benefits of Online Adaptive Replanning for Radiotherapy of Prostate Plus Seminal Vesicle: Evaluation-based on Cumulative Dose 3565 Penggang Bai Evaluation of Atlas-based Auto-segmentation for Head Neck Cancer Patient 3566 Amanda Walker Improving Patient Safety With a Prospective Safety Tool in the Academic and Community Radiation Oncology Setting: A Feasibility Study and Report of Outcomes 3567 Sonali Rudra Contouring of Breast and Axillary Nodal Volumes Per RTOG Guidelines Improves Dose Coverage at a Single Institution 3568 John Kipritidis 4-D Cone-beam CT Ventilation Imaging to Facilitate Adaptive Functional Avoidance Lung Cancer Radiotherapy 3569 Per Munck af Rosenschold The Transition From Conformal Photon Radiation Therapy to Arc Therapy for High-grade Gliomas 3570 Dengwang Li Deformable Registration of 4-D Computed Tomography Data Using Edge Preserving Scale Space 3571 Kurt Meyer Including Radiographic Shrinkage of Head and Neck Tumor in Adaptive Radiotherapy Process: Is it a Safe Consideration?

3572 Joo Ho Kim Stereotactic Body Radiotherapy for Metastatic Spine Tumors: Helical Tomotherapy Achieved High Conformity for Multiple Lesions 3573 Vivek Mehta VMAT Improves Clinical Efficiency 3574 Jessica Klaers Evaluation of Delivered Dose Distributions and Metrics: A New Patient Specific QA Protocol

3583 Jessica Schuster Influence of Volumetric Change and Tumor Motion on Inter- and Intra-fractional Positional Variations in Frameless Stereotactic Body Radiotherapy (SBRT) of Lung Tumors 3584 Michael Folkert Dosimetric Impact of Intraoperative 32P Plaque on Postoperative Stereotactic Radiation Therapy for Treatment of Recurrent and Metastatic Tumors of the Spine

3575 Jun Li Dosimetric Evaluation of RTOG 0815 Compliance Criteria for Volumetric Modulated Arc Therapy Treatment Planning

3585 Taoran Li Prostate SBRT in Five Fractions: Initial Report on Dosimetric Results and IGRT Experiences

3576 Vivian Rodriguez MVCT-detector Data Sinograms for in Vivo Quality Assurance of Helical TomoTherapy Treatments of Head and Neck Cancer Patients

3586 Olivier Blasi A Method to Objectively Evaluate Stereotactic Radiation Surgery (SRS) Treatments of Essential Tremor Patients

3577 Lilie Wang Monte Carlo Dose Calculations for IMRT Head and Neck Patients With Dental Fillings Using the Varian Generic Phase Space Files for TrueBeam

3587 Jing Wang Long-term Results of Gamma Ray-based Stereotactic Body Radiotherapy in Treatment of Medically Unfit or Inoperable Non-metastatic Pancreatic Adenocarcinoma

3578 Kai Ding Ventilation Imaging for Lung Radiation Therapy Planning: Free Breathing 4-D CT vs. Breath-hold MRI 3579 Sunyoung Jang Evaluation of Sequential and Simultaneously Integrated Boost IMRT Methods in Head and Neck Cancer 3580 Jonathan Ha Skin Flash in IMRT Plans 3581 Elisabetta Cagni Correlation of Delivery Reproducibility With Anatomical Modifications and Intra-fractions Motion During Treatments Using Helical Tomotherapy (HT) Integrated Detectors 3582 Sanath Kumar Establishment of Benchmark CBCT/ CT Deformable Image Registration in Radiotherapy of Prostate Cancer

3588 Javad Rahimian Comparative Study of Internal Target Volume (ITV) Based on PET-CT and 4-D CT for Stereotactic Body Radiotherapy of Non-small Cell Lung Cancer 3589 Matthew Orton Contour Variability During Stereotactic Body Radiation Therapy (SBRT) Treatment Planning, and the Effect of Physician Training 3590 Guang Li Frameless Stereotactic Radiosurgery With IGRT Setup and Optical Surface Imaging for Setup Verification and Motion Monitoring 3591 Takeaki Ishihara Hypofractionated Stereotactic Radiotherapy for Brain Metastases: Exploration of Adhibition and Key Factors Involved in Local Control Rate 3592 Tyler Gunter Quantitative Assessment of Gross Tumor Volume Changes During and After Completion of SBRT for NSCLC

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 158

ASTRO 2012 / 54TH ANNUAL MEE TING

3593 Ange Wambaka Mampuya Interfractional Variations in Lung Tumor Position Under Abdominal Compression in Stereotactic Body Radiotherapy for Lung Cancer

3605 Jinyu Xue Dose-volume Effects on Hearing Preservation in Gamma Knife Radiosurgery of Vestibular Schwannomas

3594 Wing Kei Rebecca Wong A Model-based Iterative Reconstruction Technique for Computer Tomography on Automated Contour of Small and Low Contrast Lesions

3606 Dukagjin Blakaj Radiation Necrosis After Radiosurgery: Correlation Of Volume and Dose Parameters in Patients With Metastatic Brain Lesions

3595 Yoshihiro Ueda Calculation of Cranial and Caudal Margins to Compensate Tumor Motion Change in Lung SBRT Using EPID Cine 3596 Ingrig Fumagalli Robotic Stereotactic Body Radiotherapy for Patients With Pulmonary and Hepatic Oligometastases 3597 Chuxiong Ding To Evaluate the Dosimetric Outcomes of Multi-stage Robotic Stereotactic Radio-surgery for Intracranial Arteriovenous Malformations Using Cyberknife

3616 Toufik Djemil Dosimetric Effect of Implanted Hardware in Spine SBRT: Comparison of the Actual Planned Dose Using Pencil Beam Calculation to Monte Carlo

3607 Yun Liang Intra-fraction Motion in Frameless Cranial Stereotactic Radiosurgery and Radiotherapy 3608 Siyong Kim Can Flattening-filter-free (FFF) Beams Be Used for Off-axis Targets in Conformal Arc Delivery Of SBRT? 3609 Grace Gwe-Ya Kim Stereotactic Radiosurgery With FFF Mode Photon Beams 3610 Yuichi Akino Impact of Heterogeneity Corrections in Stereotactic Radiotherapy Treatment of the Lung

3598 Gaurav Marwaha Lung Lesions treated With SBRT: Does Size Matter?

3611 John Lilley VMAT for Lung SABR With a New 160 Leaf MLC

3599 Claudio Sole Stereotactic Ablative Radiotherapy Delivered by Helical Tomotherapy for Early-stage Non-small Cell Lung Cancer: Dosimetric Evaluation and Toxicity

3612 Manuela Buleteanu Feasibility Of Using the Novel Vero SBRT System for Radiation Therapy and SRS of Intracranial Lesions

3600 Joao Seco Stereotactic Body Radiotherapy, SBRT, of Spine Lesions: Optimizing Number of IMRT Beams and Monte Carlo Assessment of Dose Predictions 3601 Withdrawn 3602 Qinghui Zhang How Much Margin Is Adequate for Single-fraction Stereotactic Radiosurgery Treatments? 3603 Withdrawn 3604 Vimoj Janardanan Nair Feasibility, Detectability and Experience With Platinum Seed Internal Fiducial Markers for CT-MRI Fusion and Real-time Tumor Tracking During Stereotactic Ablative Radiotherapy

3617 Mustafa Cengiz Comparison of Single vs. Two Fractions of Radiosurgery for Brain Metastases: A Prospective Randomized Study 3618 Wilko F.A.R. Verbakel Flattening Filter Free Beams for SBRT: Advantages and Risks 3619 Andrew Ju A Dosimetric and Clinical Evaluation of Monotherapy With Hypofractionated Stereotactic Body Radiation Therapy in the Treatment of Intermediaterisk Prostate Cancer 3620 Marie Pierre Sunyach Hypofractionated Stereotactic Radiotherapy for Symptomatic or Recurrent Meningioma: Two French Anticancer Center Experience 3621 Carnell Hampton Is a Single IGRT Localization Followed by a Planned Isocenter Shift Sufficient to Accurately Localize Multi-isocenter SBRT Targets? 3622 Varun Singh Thakur Delivery Accuracy of Stereotactic Radiosurgery (SRS) With TomoTherapy as Compared Linear Accelerator and Robotic Based Radiosurgery

3613 Teo Stanescu Quantification of the Magnetic Susceptibility Effects During MRI-guided Radiosurgery of Hemorrhagic Brain Metastases

3623 Haisong Liu Is Head Frame Still the Gold Standard Of Fixation for Linac Stereotactic Radiosurgery?

3614 Goldie Kurtz Salvage Radiosurgery for Brain Metastases: Prolonged Survival With Durable Tumor Control 3615 Mustapha Khordi On the Clinical and Dosimetric Accuracy o Recently Released Acuros Xb and Analytical Anisotropic Algorithm (AAA) Photon Dose Calculation Algorithms for SBRT Lung Treatment With Volumetric Modulated Arctherapy (VMAT)

3624 Qianyi Xu Study on Interfractional Liver Tumor Volume Variations-based on Reconstructed Fiducials in Three-dimension During CyberKnife-based Stereotactic Body Radiation Therapy (SBRT) 3625 Raj Varadhan Dosimetric Impact of Interplay Effect on a Single Arc VMAT Stereotactic Lung Delivery: Validation Using a 6-D Motion Platform

ASTRO 2012 54TH ANNUAL MEE TING

159

RADIATION PHYSICS/ continued 3626 Diane Ling Stereotactic Body Radiotherapy in Treatment of Adenocarcinoma of Pancreas in Elderly Patients 3627 Claudiu Diaconu Active Breathing Control Provides an Accurate Method for Stereotactic Body Radiation Therapy of Lung and Liver Tumors 3628 Fen Wang Validation and Reliability of Free Breathing Cone Beam Computed Tomography (FB-CBCT) Imaging Guidance in Stereotactic Ablative Radiotherapy (SABR) of Lung Tumors 3629 Rasim Meral Side Effects of Stereotactic Fractionated Radiotherapy for Malign and Benign Lesions 3630 Yoonsun Chung Intrafractional Movement During Stereotactic Body Radiotherapy in Spine Metastasis Using Helical Tomotherapy 3631 Hong Xiang Endorectal Balloon in CyberKnife Stereotactic Body Radiation Therapy (SBRT) for Early-stage Prostate Cancer: A Planning and Dosimetry Analysis 3632 Yulin Song Investigation of 3-D Optical Image Guided Frameless Stereotactic Radiosurgery Using Homegrown Volumetric Modulated Arc Therapy 3633 Akito Saito Patient Clearance Simulation for Stereotactic Body Radiation Therapy 3634 Carolyn Kim Steroid Prophylaxis Prevents Acute Pain Flare or Swelling Sensation Following Cervical Spine Stereotactic Radiosurgery 3635 Mariko Kawamura Usefulness of Vinyl Polysiloxane Dental Impression Material as a Proton Beam Stopper to Save Normal Tissue in Oral Cancer Irradiation: Basic and Clinical Verification

3636 Katrin Henkner Dosimetric Characterization of Scanned Ion Beam QA- and Patient Treatment Fields 3637 Jeong-Eun Rah Feasibility Study of Glass Dosimeter Postal Dose Intercomparison for Proton Beams 3638 Joao Seco Decreased Vertebral Column Dose in Spinal Irradiation With IMPT and Proton Arc Techniques: Potential for Protons to Allow for CSI Without Inducing Spinal Growth Impairment 3639 Yuanshui Zheng Range Uncertainty in Proton Therapy: An End-to-end Study Using Various Animal Tissues

3647 Samuel Swisher-McClure Post-Operative Radiotherapy (RT) for Salivary Gland Carcinoma: A Comparison of Intensity Modulated Radiation Therapy (IMRT) and Proton Treatment Techniques 3648 Daniel Yeung Dosimetric Characteristics In IMPT: Impact of Optimization Techniques and Pencil Beam Scanning Nozzle Designs 3649 Heng Li Automatic Dose Verification for Spot Scanning Proton Therapy Using Recorded Spot Positions and MUs 3650 Anita Mahajan Evaluation of Scanning Beam Proton Therapy for Medulloblastoma Boost Treatment

3640 Jun-ichi Saitoh Changes of the Range of Carbon Ion Beam During the Course of Radiation Therapy for the Treatment of Nasal and Paranasal Mucosal Malignant Melanoma

3651 Yoshifumi Kamikubo A New Clinical Dose-measuring Tool for Electron-beam Therapy Using Plastic Scintillator

3641 Eric Klein Single Room Proton Radiotherapy

3652 Shinichiro Mori Four-dimensional Treatment Planning in Layer-stacking Boost Irradiation for Carbon-ion Pancreatic Therapy

3642 Sandeep Dhanesar Comparison of Skin Doses in Spot Scanning and Passive Scattering Proton Therapy Treatment Plans for Pediatric Patients With Spinal Ependymomas 3643 Haruo Inokuchi Assessment of Acute Cervical Skin Toxicity Due to Fractionated Proton Beam Therapy for Head And Neck Cancer 3644 Sang Gyu Ju New Technique for Developing Proton Range Compensator Using Three-dimensional Printer 3645 Kristofer Kainz Plan Quality of Proton vs. Photon IG-IMRT 3646 Wei Liu Conventional PTV-based Optimization Lacks Robustness For IMPT Head and Neck (H and N) Planning

3653 Brian Yeh Intensity Modulated Proton Therapy Is Dosimetrically Superior to Intensity Modulated Radiation Therapy for Head and Neck Cancers 3654 Xun Jia Fast Monte Carlo Dose Calculation on GPU for Proton Therapy 3655 Masami Mukai Proposal of the Cooperation Method Between EMR/CPOE-RIS-TMS by Using the IHE (integrating the Healthcare Enterprise) - Implementation and Challenge At NIRS 3656 Ralf Schneider High-dose, Spot Scanning Based Proton Therapy for Sacral Neoplasms. Toxicities of Pelvic Organs and Dose Distribution Analysis in a Patient Cohort 3657 Yusuke Egashira Experimental Evaluation of the Interplay Effect of Scanning Proton-beam for Small Moving Target in Heterogeneity Using a Four-dimensional Phantom

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 160

ASTRO 2012 / 54TH ANNUAL MEE TING

3658 Jaiteerth Avadhani Dosimetric Analysis of Small Field 6 MeV Electrons to Replace Superficial X-Rays for Superficial Cancers

3669 Dragan Mirkovic Is Constant RBE Accurate Enough for Determination of Biological Effects in Proton Therapy?

3659 Tae Kyu Lee Characterization of Uniform Scanning Proton Beams With Proton Loss Model

3670 Abigail Milby Prospective Study of Thoracic Reirradiation With Proton Beam Radiotherapy: Feasibility and Safety Analysis

3660 Bijan Arjomandy A Comparative Study of Single vs. Two Field Daily Fraction for Treatment of Prostate Cancer Using IMPT, Double-scattered and SFUD Delivery Technique 3661 Seungtaek Choi Comparison of Scanning Beam Proton Therapy (SBPT) to Intensity Modulated X-ray Therapy (IMRT) for Post- operative Salvage Treatment of Prostate Cancer Patients 3662 Yuanshui Zheng Dosimetric Comparison Between IMRT and Uniform Scanning Proton Therapy for Prostate Cancer Treatment 3663 Quynh Nguyen Scanning Beam Proton Therapy Reduces Dose to Normal Tissue Compared to 3-D X-rays Or Passively-scattered Proton Therapy in Patients With Stage I Seminoma 3664 Drosoula Giantsoudi LET-Guided Biological Optimization in IMPT: Implications on RBE Value 3665 Daniel Habermehl Carbon Ion Therapy Applied In Raster Scanning Technique For Hepatocellular Carcinoma - First Results From the Heidelberg Ion-beam Therapy Center 3666 April Cook Development, Implementation and Results of an Automated Compensator Quality Assurance Device 3667 Matthew Palmer Dose Reduction to Small Bowel and Other Relevant Structures in Rectal Carcinoma With Proton Therapy 3668 Quynh Nguyen Utilization of Constraints in the Optimization Algorithm With Scanning Beam Proton Therapy Decreases Dose to the Rectum for Patients With Prostate Cancer

3671 Santosh Yajnik Proton Beam Therapy Reduces Dose to Pelvic Bone Marrow Compared with IMRT: A Dosimetric Study 3672 Su Yeon Park Comparison of Different Treatment Techniques in Radiotherapy for Hepatocellular Carcinoma: Dosimetric Analysis According to Tumor Location 3673 Xiaofei Song Application of Beam Specific PTV in Proton Therapy Treatment Planning 3674 Narayan Sahoo Determination of Spread Out Bragg Peak Factors and Range Shifter Factors From Measured Depth Dose Curves for Passively Scattered Proton Beams

3680 Mitsuhiro Nakamura Estimation of a Tracking Margin in Surrogate Signal-based Dynamic Tumor Tracking Irradiation With Vero 4-D RT (MHI-TM2000) 3681 Nobutaka Mukumoto Intra-fractional Tracking Accuracy in Surrogate Signal-based Dynamic Tumor-tracking Irradiation With Vero4DRT (MHI-TM2000) 3682 Yoshinori Miyahara Feasibility of Direct-Conversion Flat Panel Detector (FPD) System as Quality Assurance (QA) Tool for 192-Ir Source of High Dose Rate (HDR) Remote Afterloading Unit : Evaluation of Positional and Temporal Accuracy 3683 Hideo Yamamoto A New Method of Total Body Irradiation Using a Field-In-Field Technique 3684 Eric Paulson Feasibility of Generating Synthetic ED and CT Images from Conventional MR Images for Brain Radiation Treatment Planning and Delivery

3675 Enrique W. Izaguirre Polymer Scintillator Detector for Real Time Proton Beam Quality Assurance

3685 Yoshitomo Ishihara Four-dimensional Monte Carlo Dose Calculation Method For Dynamic Tumor Tracking Irradiation With a Gimbaled X-ray Head

3676 John Han-Chih Chang Dosimetric Comparisons of Uniform Scanning Proton Beam Therapy (US PBT) vs. Intensity Modulated Radiation Therapy (IMRT) vs. Conformal 3-Dimensional Radiation Therapy (3-D CRT) for Mediastinal Malignancies

3686 Taro Murai Intensity Modulated Radiation Therapy Using Static Ports of Tomotherapy (TomoDirect): Comparison With the TomoHelical Mode

3677 Ileana Iftimia HDR GYN: Syed and Tandem and Ring - Moving Forward Toward GEC-ESTRO Protocol Implementation 3678 Dror Alezra A New Beam and Delivery System for Radiotherapy 3679 Waleed Mourad Dosimetric and Biological Impacts of Simultaneous Integrated Brachytherapy Boost (SIBB) Delivered Via I125 Seeds Followed by External Beam Radiotherapy (EBRT) on Prostate Cancer

3687 Daniel Markel A Novel Semi-automated Multi-modality Segmentation Tool for Radiotherapy Treatment Planning in Sarcoma Patients 3688 Robert Cormack Locally Drug Enhanced Brachytherapy: A Comparison of Two Approaches Based on Biologically Effective Dose 3689 Guoqiang Cui Delivery Efficiency and Dosimetric Accuracy of Respiratory-gated Volumetric Modulated Arc Therapy Using An Elekta Digital Accelerator

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

161

RADIATION PHYSICS/ continued 3690 Abdulmecit Canbolat Investigation of Out-of-field Scattered Radiation Based on Dose Rate for Sliding Window IMRT 3691 Lanchun Lu NanoDots Dosimetry for RS 2000 X-Ray Biological Irradiator 3692 Kin Yin Cheung Gated VMAT Treatment of Moving Targets Using a FFF Linear Accelerator 3693 Yun Yang Design and Optimization of an HDR 192Ir Brachytherapy Applicator for Skin Irradiation Using Monte Carlo-Based Dosimetry 3694 Rania Hashem The Utilization of IMRT Planning in Decreasing the Risk of Accelerated Demyelination in Multiple Sclerosis Patients Following External Beam Radiation Therapy 3695 Mami Akimoto Improvement of Tracking Accuracy With Vero4-D RT(MHI-TM2000) Using Phase Shift Correction 3696 Nancy Lee The Immobilization Performance of a Novel “Open-face” Mask Used for the Setup of Claustrophobic Patients Being Treated for Head and Neck Cancers

3700 Michael Epperly Total Body Irradiation at High-dose-rate Using a TrueBeam Accelerator Results in Increased Survival in a Mouse Model 3701 Omar Mahmoud A Ten-year Single Institutional Experience Using Adjuvant External Beam Radiation Therapy for Extremity Soft Tissue Sarcomas 3702 Evan Thomas Improved Treatment Efficiency With Flattening Filter Free Mode and Implications for Common Clinical Scenarios

3711 Jian-Yue Jin A Novel Multi-field Grid Treatment Technique Using MLC Based IMRT 3712 Sai Subramanian Chest Wall Radiotherapy With Volumetric Modulated Arcs and the Potential Role of Flattening Filter Free Photon Beams 3713 Meng Welliver A New Method for Total Body Irradiation (TBI) Treatment Planning Using an “Irregular Surface Compensator”

3703 Lakshmi Santanam Risk Analysis of Real-time Adaptive Planning Using the ViewRay System

3714 Wonmo Sung Dose Perturbations Involving an Implanted Cardiac Pacemaker in High-dose-rate (HDR) Breast Balloon Brachytherapy

3704 Steffi Kantz Impact of MLC Properties and IMRT Technique in Meningeoma and Head and Neck

3715 Jung-in Kim Assessment of Tracking Jaws Based on MLC Aperture to Reduce Normal Tissue Irradiation in VMAT

3705 Ikeda Tsuyoshi Reduction of Patient Body Size Dependency of CT Number Using Dual Energy Computed Tomography

3716 Yu Ra Cho Development of Tissue Equivalent Gel Dosimeter for 3-Dimensional Dose Evaluation

3706 Ho jin Jeong A Dosimetric Effects of Four-dimensional and Monte Carlo Calculation Methods on Treatment Plans for Mobile Lung Cancer In Robotic Radiosurgery

3717 Magdalena Bazalova Cost-effective Radiation Therapy With Kilovoltage Photon Beams: A Monte Carlo Study

3707 Ivaylo Mihaylov Energy Minimization Approach to Inverse Optimization for Head and Neck Cancers

3718 Ilja Ciernik Evaluation of Different External Radiotherapy Techniques for the Treatment of Malignant Pleural Mesothelioma After Extrapleural Pleuropneumonectomy

3708 Laura Masi Impact of Control Point Angular Separation on the Dosimetric Accuracy of VMAT Plans

3719 Hans Martin Kjer Optimized Acquisition Parameters for MRI Only RT Using Ultrashort Echo Times

3698 Maria Clara Ferreira Comparative Study of Biologic Effective Dose for the Beta Emitters 142Pr and 90Y and Their Applications in Microsphere Brachytherapy of Hepatocellular Carcinoma

3709 Mohammed Almaghrabi Respiratory Gated Radiotherapy With Hypofractionated Doses for Lung Tumors: Four Years’ Experience of a Single-institution

3720 Deniz Yalman Comparison of Step-and-Shoot IMRT and Different Volumetric Modulated Arc Therapy (VMAT) Techniques for the Treatment of Prostate Cancer

3699 Houari Korideck Pre-clinical Image Guided Irradiation of Pancreatic Cancer Transgenic Mouse Model

3710 Qiuwen Wu Evaluation of IMRT and VMAT for Head and Neck Cancer With Flattening Filter Free (FFF) Beams

3721 Jiang Xie Breast Tangential Treatment Plan Using Flattening Filter Free Beams: A Planning Study

3697 Weigang Hu Implement of a Passive Breath Gating Equipment for Cone Beam CT guided Volumetric Modulated Radiotherapy in Gastric Cancer Treatment: Preliminary Results

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings 162

ASTRO 2012 / 54TH ANNUAL MEE TING

3722 Parthena Sansourekidou Computer Vision Based Automation of Verification of Treatment Field Parameters (Field Verification Timeout) Prior to Radiation Therapy 3723 Lydia Handsfield Current STAT Clinical Workflow and Proposed 30 Minute Scan, Plan, Treat STAT-RAD Workflow 3724 Jeffrey Kemp Facilitating 3-D Image Guided Treatment Planning of Shielded Tandem and Ovoid-based, Gynecological Brachytherapy Utilizing Mvct 3725 Colin Carpenter FDG-Cerenkov Imaging: A Molecular Approach to Real-time Treatment Guidance 3726 Elena Herranz Iterative Determination of Clinical Beam Phase Space From Dose Measurements 3727 Krishni Wijesooriya Novel Findings on 18F-FDG PET Uptake Distributions Within NSCLC Tumors 3728 Ericka Wiebe Customized Vaginal Vault Brachytherapy With CT Imaging-Derived Applicator Prototyping 3729 John Greskovich Improving Clinical Target Volume (CTV) Dose Homogeneity and Normal Tissue Maximum Dose for Endoesophageal High-dose-rate (HDR) Brachytherapy: One vs. Three HDR Tube Technique

3731 Nava Paudel Study of the Radiation Dose Enhancement at the Gold-tissue Interface in Gold Nanoparticle-aided Radiation Therapy With Micro-dosimetry Technique

3739 Rebecca Weinberg Dosimetric Comparison of Treatment Techniques for Skin Cancer Above the Clavicle: High-dose-rate 3-Dimensional Topographic Applicator Brachytherapy vs. Electron Therapy

3732 Tejan Diwanji Validation of High-resolution Multi-modality Imaging of Pre-treatment Lung Function in Pulmonary Neoplasms

3740 Daniel Joh A Novel ‘Theranostic’ Approach? Polymer-coated Gold Nanoparticles Show Durable Systemic Circulation, are Readily Imaged, and Radiosensitize Human Cancer Cells and Tumors

3733 Grace Gwe-Ya Kim A comparison of Lung SBRT Using Volumetric Modulated Arc Therapy With Static Field IMRT on TrueBeam 3734 Andre Vieira Evaluation of Dosimetric Accuracy in the Treatment of Multiple Brain Metastases With Volumetric Modulated Arc Therapy and Single Isocenter.

3741 James Kavanaugh Evaluation of Flattening Filter Free Lung/Tissue Heterogeneity Dose Calculations for Two Commercial Planning Systems 3742 Eric Ehler Evaluation of Multi-isocentric VMAT Plan Sensitivity to Setup Errors 3743 Yulin Song A Pragmatic Approach to Assessing Structure-Specific Dosimetric Error of VMAT Delivery

3735 Shahram Mashouf Optimization of Permanent Seed Implant Dosimetry Incorporating Tissue Heterogeneity 3736 Semra Unal Head and Neck IMRT With or Without Flattening Filter: A Dosimetric Comparison 3737 Long Huang Planning Quality and Delivery Accuracy Assessment of VMAT Plans for Whole Brain Treatment With Hippocampus Avoidance 3738 Aman Anand Dosimetric Evaluation of Tungsten Eye-Shield In 9, 12 And 16 Mev Electron Beams Using EBT2 Gafchromic Films

3730 Pedro Guerra Gutierrez Optimization of Monte Carlo Code for Clinical Simulation of Electron Beams

Poster # correlates with the abstract number listed in the Annual Meeting Proceedings ASTRO 2012 54TH ANNUAL MEE TING

163

NOTES

164

ASTRO 2012 / 54TH ANNUAL MEE TING

NOTES

ASTRO 2012 54TH ANNUAL MEE TING

165

AMERICAN SOCIE T Y FOR RADIATION ONCOLOGY

Help patients understand their treatment options.

A diagnosis of cancer can be overwhelming. Help your patients understand radiation therapy as a treatment option for their cancer by sharing ASTRO’s disease-site specific brochures or guiding them to RTAnswers.org.

® TAR GE TING CANCER CARE

INSIDE: Indexes Abstract by Author Abstract by Topic

2012 ANNUAL MEETING

S

UPPORTERS

Special thanks to the following companies for supporting ASTRO’s 54th Annual Meeting with an unrestricted educational grant.

PLATINUM

GOLD

SILVER

COPPER Sun Nuclear

|

Vertual, Ltd

(as of September 2012)

|

Xstrahl, Ltd

Index by Author (Abstracts only) A Abazeed, Mohamed Abazeed, Mohamed Abbineni, Gopal Abdel-Wahab, May Abdel-Wahab, May Abel, Ryan Abelson, Jonathan Abidin, Caitlin Abramowitz, Matthew Abrams, Matthew Abuodeh, Yazan Adams, Robert Adams, Todd Agarwal, Jai Prakash Agarwal, Ankit Agazaryan, Nzhde Agbahiwe, Harold Aggarwal, Aditi Ahmed, Kamran Ahmed, Awad Ahmed, Safia Ahmed, Kazi Ahn, Peter Ahunbay, Ergun Aivas, Inge Aizer, Ayal Akasaka, Hiroaki Akervall, Jan Akimoto, Mami Akino, Yuichi Al Sulaimani, Eman Albuquerque, Kevin Alcorn, Sara Alcorn, Sara Alcorn, Sara Aleman, Berthe Alexander, Jesse Alexander, Brian Alezra, Dror Al-Hallaq, Hania AlHussain, Hussain Ali, Arif Alizadeh-Kashani, Moein Alkhatib, Hassaan Allen, Bryan Allison, Ron Almaghrabi, Mohammed Al-Mamgani, Abrahim Al-Omair, Ameen Alongi, Filippo Althaqfi, Saif Altoos, Taghrid Amarnath, Sudha Anand, Aman Anderson, Carryn Anderson, James Anderson, Joshua

1034 3285 3276 2326 3154 2149 1018 3259 330 2071 2182 2839 3151 1114 3185 3499 162 2260 2378 2532 396 313 2742 3558 2872 1039 3287 3313 3695 3610 276 2850 2819 2999 3365 174 1047 253 3678 3351 2821 2774 2833 3521 3288 2541 3709 53 98 2438 2629 3028 2816 3738 2818 2574 55

Anderson, Nigel Anderson, Nigel Ando, Yutaka Aneja, Sanjay Aneja, Sanjay Aneja, Sanjay

2801 2830 3179 2124 2875 III

Barney, Brandon Baschnagel, Andrew Bassetti, Michael Batth, Sukhjeet Baumann, Brian Bayouth, John

2551 2666 3226 199 1035 76

Bortolus, Roberto Bowes, David Brade, Anthony Bradley, Julie Bratman, Scott Bray, Tracy

2436 2487 26 2786 7 6

Anton, Adrian Anwar, Moshiur Anwar, Moshiur Aoki, Manabu Aoki, Masahiko Apicelli, Anthony Appenzoller, Lindsey Appenzoller, Lindsey Arastu, Nabeel Arbea, Leire Arbea, Leire Arcangeli, Giorgio Arcangeli, Stefano Archambault, Jean Ares, Carmen Arjomandy, Bijan Arneson, Kyle Arns, Anna Arora, Shruthi Arsenault, Daniel Arvold, Nils Arvold, Nils Asai, Kaori Ashamalla, Hani Atallah, Soha Atsumi, Kazushige Ausborn, Natalie Avadhani, Jaiteerth Aviles, Lijia Awan, Musaddiq Ayala-Peacock, Diandra Azcona, Juan Diego Aznar, Marianne

2501 2491 2517 2401 2930 2582 196 2988 244 2344 3532 364 5 2873 81 3660 2761 3400 2765 3131 1055 2195 2917 2776 2905 2235 216 3658 2616 2067 2205 3387 176

Bazalova, Magdalena Bazalova, Magdalena Bazan, Jose Beadle, Beth Becker, Nathan Becker, Stefan Bedi, Manpreet Behrens, Claus Beitler, Jonathan Bejarano, Daniela Bekelman, Justin Berg, Ronald Berlach, David Berlach, David Bernad, Daniel Bernad, Daniel Bernstein, Michael Best, Lara Beyer, David Bhandare, Niranjan Bhandare, Niranjan Bhandari, Rahul Bhatnagar, Ajay Bhatt, Aashish Bhattacharjee, Somorat Bhavsar, Shripal Bi, Nan Bian, Shelly X. Bibault, Jean-Emmanuel Biritz, Bertrand Bishop, Andrew Bishop, Andrew Bishop, Michael Bjerre, Troels Blacksburg, Seth Blackstock, A. William Blakaj, Dukagjin Blakaj, Dukagjin Blake, Monika Blanchard, Miran Blasi, Olivier Bledsoe, Trevor Bledsoe, Trevor Block, Alec Block, Alec Blumenfeld, Philip Bodis, Stephan Boggs, Hunter Boimel, Pamela Bonavitacola, Patrick Joseph Bonner, James Boo, Dorothy

3252 3717 2352 2665 1024 2208 1002 3482 13 2076 298 3549 2519 2805 2214 2341 2406 1001 1045 2794 3424 2150 340 153 2588 3002 3045 2405 2294 3416 2126 2130 2689 3334 2482 2854 3314 3606 2946 3049 3586 2690 2829 1123 3493 3306 2141 2908 3198

Bray, Tracy Brink, Carsten Brodin, Patrik Brown, Aaron Bruce, Jeff Brunner, Thomas Brunner, Thomas Bryant, Curtis Buatti, John Buckstein, Michael Buleteanu, Manuela Burri, Ryan Burt, Ashley Burt, Ashley Buscariollo, Daniela Butterworth, Karl Buzurovic, Ivan

3383 1121 158 235 60 223 2274 3150 2813 124 3612 2368 3135 3170 108 3208 3328

B Baba, Fumiya Baden, Craig Badiyan, Shahed Bahl, Gaurav Bai, Penggang Baine, Michael Bakhoum, Samuel Bakst, Richard Balagamwala, Ehsan Balagamwala, Ehsan Balamucki, Christopher Barani, Igor Barker, Christopher Barker, Christopher Barnes, Carolyn Barney, Brandon

2891 2363 1077 2841 3565 413 3190 1033 3103 3157 2888 2158 2743 3158 1083 2284

C

Cagni, Elisabetta Cai, Gang Cai, Jing Cai, Yong Cairncross, Gregory Cámara, Ana Camarata, Andrew Cambeiro, Mauricio Canbolat, Abdulmecit Cannon, Donald Cao, Ning Cao, Yue Caparrotti, Francesca Carpenter, Colin Carpenter, Todd Casamassima, Franco Cascales Garcia, Maria A. Casey, Stephanie Cassidy, Richard Castle, Katherine Cattaneo II, Richard Catton, Charles CaudeII, Jimmy Cazoulat, Guillaume Cengiz, Mustafa Cha, Hyejung Cha, Yong Chadha, Manjeet Chakravarti, Arnab 2027 Challapalli, Amar 409 Champ, Colin 2507 Champ, Colin Chan, Annie ASTRO 2012 / 54TH ANNUAL MEE TING

3581 1072 3555 2337 10 3481 2849 1011 3690 2223 3278 3390 2187 3725 3136 3100 2543 2897 2731 1009 238 345 2688 70 3617 2139 312 1057 9 1044 95 2846 375 169

Chan, Cato 3066 Chang, Jee Suk 277 Chang, Jee Suk 2325 Chang, Ji Hyun 3425 Chang, John Han-Chih 3676 Chang, Joseph Tung-Chieh 2741 Chang, Lynn 2086 Chao, Samuel 1117 Chapet, Olivier 2499 Charissoux, Marie 2503 Charpentier, Anne-Marie 2686 Chaudhry, Huma 2610 Chen, Aileen 4 Chen, Andy 2620 Chen, Helen 2575 Chen, Jenny Ling-Yu 2705 Chen, Lili 2524 Chen, Linda 18 Chen, Peter 212 Chen, Qing 3038 Chen, Shifeng 3337 Chen, Ting 3395 Chen, Viola 2419 Chen, Wenzhou 3018 Chen, Wenzhou 3020 Chen, Xiaojian 67 Chen, Xiaoming 336 Chen, Yen-Lin Evelyn 341 Chen, Yu-Jen 2562 Chen, Zhe 3428 Cheng, Yufeng 2238 Cherian, Sheen 2320 Cheung, Kin Yin 3692 Cheung, Patrick 118 Chia, David 2330 Chiang, Andrew 1111 Chibani, Omar 3419 Chiblak, Sara 3221 Chiesa, Silvia 3560 Chilukuri, Srinivas 2239 Chin, Christine 2653 Chin, Christine 2657 Chin, Michael 3320 Chinnachamy, Anand N. 2579 Chino, Junzo 2642 Cho, Ilsung 3402 Cho, Yu Ra 3716 Choi, Serah 1027 Choi, Kihwan 3536 Choi, Seungtaek 3661 Chopra, Supriya 2584 Choudhury, Ananya 2533 Chowdhry, Varun 2932 Christensen, Charlotte Birk 3129 Christenson, Eric 2064 Christensen, Eva 2585 Christensen, James 1091 Christensen, Michael 2138 Chu, Karen 2804 Chua, Melvin 262 Chuang, Cynthia 3384

Chung, Yoonsun Chuong, Michael Chuong, Michael Church, Jessica Churilla, Thomas Churilla, Thomas Ciernik, Ilja Ciezki, Jay Cigarral Garcia, Cristina Cihoric, Nikola Cirino, Eileen Citrin, Deborah Clark, Grant Claude, Line Clayton, Ravinder Cohen, Dane Cohen, Randi Combs, Stephanie E. Confer, Michael Cook, April Coolens, Catherine Cooper, Anna Cooper, Samuel Cope, Frederick Coplowitz, Shana Cormack, Robert Corradetti, Michael Corso, Christopher Cotter, Ryan Coucke, Philippe Cox, Brett Cox, Brett Craciunescu, Oana Craft, David Crandley, Edwin Crandley, Edwin Crandley, Edwin Crehange, Gilles Crehange, Gilles Croke, Jennifer Crook, Juanita Cuaron, John Cui, Yunfeng Cui, Guoqiang Cummings, Natalie Cuneo, Kyle Currey, Adam Currey, Adam Currier, Blake Cuthbert, David Czerminska, Maria Anna Czito, Brian

Dabaja, Bouthaina D’agostino, Giuseppe Roberto Dahele, Max

3520 2883

Chung, Alfred Chung, Caroline Chung, Yi Hsuan

Dai, Ying Dai Kubicky, Charlotte Dalah, Entesar

3300 283 3548

170

2631 189 2922

3630 29 2354 2838 2017 2018 3718 38 3144 3090 3469 2030 2565 1023 2382 240 82 1084 3110 3666 268 3164 2237 2068 2063 3688 3014 3280 2815 2089 292 2471 3429 3524 2096 2695 2909 2505 2509 2407 2424 1014 2944 3689 3295 15 2032 2061 2935 2485 325 106

D

ASTRO 2012 / 54TH ANNUAL MEE TING

179

D’Alimonte, Laura Daly, Megan Daly, Patricia Damato, Antonio Damato, Antonio D’Ambrosi, Rafael Dandapani, Savita Dandapani, Savita Daniel, Nguyen Daniel, Nguyen Dar, Abdul Das, Indra Das, Saikat Das, Samayita Das, Shiva Dasgupta, Tina Dawson, Laura De Hertogh, Olivier de Souza-Lawrence, Lana de Souza-Lawrence, Lana de Souza-Lawrence, Lana Deasy, Joseph Debenham, Brock DeMarco, John Demoor-Goldschmidt, Charlotte Deng, Jun Deng, Meiling Denniston, Kyle Deraniyagala, Rohan Desai, Neil Desai, Prashant Deshpande, Shrikant Deviers, Alexandra DeWees, Todd Dhanesar, Sandeep Dharmarajan, Kavita Dharmarajan, Kavita Dharmarajan, Kavita Di, Liu Diaconu, Claudiu Diao, Kevin Diaz, Dayssy Diaz, Roberto Dickerson, Edward Diletto, Barbara Dilling, Thomas Dilworth, Joshua Dinçbaş, Fazilet Dinçbaş, Fazilet Ding, Chuxiong Ding, George Ding, Jie Ding, Kai Ding, Kai Diot, Quentin Diwanji, Tejan Djemil, Toufik Doi, Yoshiko Doll, Corinne Dominello, Michael Dong, Peng Dong, Peng Dorth, Jennifer

2513 1013 2808 3433 3502 2569 2173 3277 3522 3531 2990 3348 264 1032 2820 310 24 323 334 2004 2005 77 3084 207 3121 2041 17 3116 2785 1007 2655 3451 2140 1015 3642 12 401 3124 2907 3627 2411 278 3272 3556 2143 3013 3271 2442 3172 3597 3359 1065 3452 3578 193 3732 3616 2852 358 2392 1092 2081 3055

Dosoretz, Arie Douglas, James Drean, Gael Duarte, Catherine Dubey, Arbind Dulaney, Caleb Dunn, Emily Dutta, Pinaki Dvorak, Tomas Dyer, Brandon Dyk, Pawel

140 2789 2446 2413 3138 3080 239 2802 2860 3205 2597

E Eaton, Bree Eaton, Bree Ebeling III, Robert Edge, Stephen Edson, Mark Efstathiou, Jason Egashira, Yusuke Eguiguren Bastida, Mikel Ehler, Eric Eich, Hans Theodor El-Bared, Nancy Eldredge, Harriet Eldredge, Harriet Ellis, Rodney Ellis, Rodney El-Sayed, Samy Engineer, Reena Entezari, Vahid Eom, Keun Yong Epperly, Michael Epperly, Michael Epperly, Michael Epperly, Michael Epperly, Michael Epperly, Michael Epperly, Michael Epstein-Peterson, Zachary Ernst, Iris Erpolat, Petek Ester, Elizabeth Esthappan, Jacqueline Eto, Hidehiro Evans, Suzanne Evans, Andrew

2177 2296 2163 107 2166 297 3657 2861 3742 173 3120 185 2291 294 3514 2602 356 3413 2276 3211 3214 3222 3223 3224 3228 3700 1110 1064 2591 2496 2578 2590 2640 2904

F Fahimian, Benjamin Fairchild, Alysa Fakhreddine, Mohamad Falk, Marianne Famiglietti, Robin Fan, Kang-Hsing Fareed, Muhammad Farkas, Amy Fasih, Aisha Fasola, Carolina

1085 110 171 3371 247 2647 2711 2271 3292 2052

Fedewa, Stacey Feigenberg, Steven Felix, Armando Feng, Felix Feng, Wen Feng, Yuanming Ferraris, Gustavo Ferreira, Maria Clara Ferrer, Ferran Fields, Emma Finkelstein, Steven Finkelstein, Steven Fiorino, Claudio Flickinger, John Folkert, Michael Folkert, Michael Foote, Michael Ford, Eric Ford, Victoria Formenti, Silvia Chiara Fortin, Israel Fortin, Marie Andree Fosker, Chris Foster, Ryan Foster, William Fotouhi Ghiam, Alireza Frandsen, Jonathan Frank, Steven Frank, Steven Fratamico, Robert Freilich, Jessica Freilich, Jessica Fried, David Fried, David Fried, David Fuhrer, Russell Fuji, Hiroshi Fujii, Osamu Fujiwara, Masayuki Fukada, Junichi Fuller, Donald Fumagalli, Ingrig Fung, Wing Funk, Ryan Furet, Elise Furlan, Carlo Fuss, Martin Fyles, Tony

295 2057 2427 1025 2983 273 3114 3698 2423 1060 2078 2369 3423 2204 2537 3584 3263 3557 3015 1030 2383 2865 127 3330 2456 3156 2622 2461 2682 2453 361 2942 2672 2744 3215 3182 3125 2885 2807 2264 368 3596 3403 2213 2016 3088 2309 353

G Gaballa, Hani Gabriel, Peter Galerani, Ana Paula Galland-Girodet, Sigolene Galland-Girodet, Sigolene Gallant, Fleure Gambacorta, Maria A. Gamez, Mauricio Gan, Gregory

2552 392 2490 3417 3415 2353 2345 3070 166

Gandhi, Ajeet 2684 Gandhi, Nishant 1029 Gandhidasan, Senthilkumar 394

Gao, Yunsheng Garg, Shalini Garsa, Adam Gayou, Olivier Ge, Jiajia Gemici, Cengiz Geneser, Sarah Geng, Hui Gerber, Naamit Gerszten, Peter Gerweck, Leo Gewanter, Richard Ghadessi, Mercedeh Ghaly, Maged Ghaly, Maged Ghi, Maria Grazia Giantsoudi, Drosoula Godley, Andrew Godley, Andrew Goff, Julie Goggin, Lisa Goggin, Lisa Golden, Daniel Golden, Daniel Golden, Daniel Goldsmith, Benjamin Goldsmith, Benjamin Goldsmith, Tessa Gomez, Caitlin Gomez, Daniel Gomez, Daniel Gomez-Veiga, Francisco Gong, Youling Gore, Elizabeth Gospodarowicz, Mary Govers, Mieke Graff, Pierre Grant, Jonathan Gray, Phillip Greco, Carlo Grecula, John Green, Olga Greer, Lester Greskovich, John Greskovich, John Grew, David Grills, Inga Groselj, Blaz Gross, Cary Grover, Surbhi Guadagnolo, B. Ashleigh Guan, XiYin Guarnaschelli, Jessica Guckenberger, Matthias Guerra Gutierrez, Pedro Guerrero, Mariana Guix, Benjamin Gunn, G. Brandon Gunter, Tyler Guo, Susan Gupta, Gaorav Gupta, Pramod Gupta, Shlok

2715 2962 2675 390 269 2281 202 3457 339 2179 3237 2422 144 2272 2457 378 3664 1129 3414 3229 2104 2116 2709 2847 3092 300 3048 154 2615 2858 2859 2489 1069 254 08 2092 3455 2997 30 2464 3027 3437 2512 3031 3729 2083 2152 3299 109 2824 303 2746 2147 1075 3730 197 2506 2660 2694 2921 346 2302 2874

Gutovich, Jordan Guttmann, David

2835 3257

Ha, Jonathan 3580 Haas, Jonathan Andrew 2381 Habermehl, Daniel 3665 Hadziahmetovic, Mersiha 3168 Haidar, Yarah 2600 Hall, Matthew 3075 Hall, William 222 Hall, William 3312 Hallahan, Dennis 3297 Hallemeier, Christopher 301 Hallemeier, Christopher 2768 Hallman, Mark 2090 Hamilton, Sarah 3056 Hammer, Josef 2056 Hammoud, Rabih 3374 Hampton, Carnell 3621 Hamstra, Daniel 225 Han, Chengbo 3046 Han, Hee Ji 2324.5 Han, Jeannie 2184 Hanada, Takashi 3453 Hanasoge, Sheela 2358 Handsfield, Lydia 3723 Han-Oh, Sarah 3380 Hansen, Christian 2809 Hansen, Henrik 2589 Hansen, James 405 Harada, Hideyuki 2945 Harada, Satoshi 3255 Harasaki, Yasuaki 2219 Hardee, Matthew 2025 Hardee, Matthew 2156 Hardenbergh, Patricia 243 Haridass, Anoop 94 Haridass, Anoop 3332 Harima, Yoko 57 Haritha, Chiramana 3443 Harris, Timothy 2042 Hasegawa, Azusa 2748 Hasegawa, Masatoshi 3245 Hashem, Rania 43 Hashem, Rania 3694 Hashimoto, Masatoshi 3464 Hashimoto, Takayuki 2245 Hashizume, Chisa 2301 Hashizume, Chisa 2889 Hata, Masaharu 2788 Hatakenaka, Masamitsu 99 Hattangadi, Jona 93 Hattangadi, Jona 402 Hayashi, Akihiro 2462 Hayes, John 2488 Hazariwala, Ronica 3109 Hearn, Jason 3021 Hedayati, Mohammad 407

Helou, Joelle Henderson, Randal Henkner, Katrin Hennequin, Christophe Heravi, Mitra Herde, Ryan Herman, Michael Heron, Dwight Herranz, Elena Herrera, Fernanda Herskind, Carsten Hertan, Lauren Hess, Clayton Hess, Clayton Hess, Clayton Heydarian, Mostafa Higgins, Susan Hijazi, Hussam Hill-Kayser, Christine Hillman, Gilda Hillman, Gilda Hiniker, Susan Hinojosa Gomez, Jose Hiraoka, Masahiro Hirata, Kimiko HIrata, Herbert Hirata, Hidenari Hjalm-Eriksson, Marie Ho, Alice Ho, Clement Ho, Felix Ho, Jennifer Hobeika, Georges Hofner, Peter Holdsworth, Clay Hollander, Andrew Hollen, Tyler Hollensen, Christian Holliday, Emma Holtzer, Nienke Hong, Angela Hong, Ji-Hong Hong, Julian Hong, Robert Hoover, Andrew Hoppe, Bradford Horowitz, David Horton, Janet Hoskin, Peter Hou, Ying Housri, Nadine Howard, Michael Howell, David Hoyer, Morten Hristov, Dimitre Hsu, Charles Hsu, Feng-Ming Hsu, Howard Hu, Angie Hu, Kenneth Shung Hu, Man

2481 2514 3636 2393 3307 2941 2755 1036 3726 2559 3207 2318 123 1115 2844 2176 3281 2476 1116 3291 3293 2637 2408 2910 2553 2879 251 2500 2039 2131 2656 2540 3526 2654 3436 2450 2749 275 2878 69 1008 186 372 1050 2832 1119 1067 3310 LBA3 1118 2664 201 3087 3510 1122 3113 2254 3373 3379 52 377

Hegarty, Sarah Hegde, John Heijmen, Ben J.M.

Hu, Man Hu, Weigang Huang, Chun-Ming

2739 3697 2312

H

2843 2377 2735

ASTRO 2012 / 54TH ANNUAL MEE TING

171

Huang, Ellen Xiaoyan Huang, Jiayi Huang, Jing Huang, Kitty Huang, Kris Huang, Long Huang, Shao Hui Huang, Zhibin Huang, Zhibin Huber, Kathryn Huddart, Robert Hullett, Craig Hung, Chiwei Hunt, Margie Hunter, Bradley Hunter, Grant Hunter, Klaudia Hunter, Klaudia Hunter, Klaudia Hunter, Klaudia Hurwitz, Mark Hutcheson, Katherine

195 1106 3203 2895 1040 3737 1100 2162 3197 410 296 3354 3251 1131 3050 2521 1101 2663 2722 2775 1109 155

I Iftimia, Ileana Igdem, Sefik Ikushima, Hitoshi Im, Jung Ho Indelicato, Daniel Infusino, Erminia Ingledew, Paris-Ann Innocente, Roberto Inokuchi, Haruo Inomata, Taisuke Inoue, Kazuya Inoue, Mitsuhiro Inoue, Tetsuya Iori, Mauro Ishibashi, Naoya Ishida, Yuichi Ishihara, Takeaki Ishihara, Takeaki Ishihara, Yoshitomo Ishikawa, Hitoshi Ishiyama, Hiromichi Isohashi, Fumiaki Israel, Rebecca Israel, Rebecca Ito, Hitoshi Ito, Yoshinori Iuchi, Toshihiko Iwabuchi, Michio Iwata, Hiromitsu Izaguirre, Enrique W.

3677 2703 2951 2304 3106 2060 2087 2242 3643 2466 2943 3368 2906 1120 3270 2249 2886 3591 3685 3206 2374 2299 2753 2754 2233 2234 21 3062 3243 3041

J Jackson, James Jackson, Andrew Jacob, Naduparambil Jain, Anshu 172

3161 3422 259 2409

Jain, Suneil Janardanan Nair, Vimoj Janardanan Nair, Vimoj Jang, Joanne Jang, Joanne Jang, Joanne Jang, HongSeok Jang, Sunyoung Janko, Matthew Jarboe, John Jawad, Maha Jawad, Maha Jensen, Lindsay Jeong, Bae Kwon Jeong, Ho jin Jeongshim, Lee Jhaveri, Pavan Jhawar, Sachin Ji, ShengJun Jia, Xun Jiang, Xiaoqin Jimenez, Rachel Jin, Jian-Yue Job, Mary Joh, Daniel Johansen, Jorgen Johnson, Alex Johnson, Jennifer Johnson, Matthew Johnson, Matthew Johung, Kimberly Jones, Bernard Jones, Daniel Adam Jones, Guy Jones, Jennifer Jones, Tiffanie Joo, Jihyeon Joshi, Chaitanya G. Jotwani, Amit Ju, Sang Gyu Ju, Andrew Ju, Sang Gyu Julka, Pramod Juloori, Aditya Juloori, Aditya Jung, Edward Jung, Jinhong

2894 2955 3604 36 54 2692 3479 3579 3225 3324 1049 2073 3361 2606 3706 2929 307 3181 3189 3654 3460 161 3711 3097 3740 2737 2153 2862 3035 338 286 3358 2373 3077 3325 349 157 3309 2468 3355 3619 3644 2577 2630 2994 3093 2342

K Kabarriti, Rafi Kabolizadeh, Peyman Kachnic, Lisa Kagawa, Kazufumi Kahn, Leonel Kahn, Jenna Kahn, Jenna Kainz, Kristofer Kajiya, Yoshiki Kalakota, Kapila Kalakota, Kapila Kamikubo, Yoshifumi Kaminuma, Takuya

ASTRO 2012 / 54TH ANNUAL MEE TING

2504 2222 2360 2777 1078 3118 3274 3645 2225 291 2550 3651 2474

Kandula, Shravan Kane, Erin Kang, Josephine Kang, Josephine Kang, Julie Jung Kang, Ki Mun Kannan, Neeta Kannan, Neeta Kantz, Steffi Kapadia, Nirav Kapadia, Nirav Kapur, Ajay Kapur, Ajay Karakaya, Ebru Karam, Irene Karam, Irene Karasawa, Kumiko Karasawa, Katsuyuki Kariya, Shinji Karlin, Jeremy Karlsson, Kristin Kassas, Bassel Kasuya, Goro Kathpal, Madeera Katoh, Norio Katsoulakis, Evangelia Katz, Alan Katz, Alan Katz, Leah Kaufman, Isaac Kavanaugh, James Kawaguchi, Hideo Kawamura, Mariko Keall, Paul Kehrer, Jason Keiler, Louis Keller, Lanea Kelly, Douglas Kelsey, Christopher Kemp, Jeffrey Ken, Soleakhena Keole, Sameer Kerns, Sarah Kesarwala, Aparna Kesarwala, Aparna Kesarwala, Aparna Kesava Ramgopal, Adavikolanu Kesava Ramgopal, Adavikolanu Khan, Atif Khan, Luluel Khan, Luluel Khan, Mohammad Khanuja, Jasleen Kharofa, Jordan Kharofa, Jordan Kharofa, Jordan Khodri, Mustapha Khouri, Anton Kiess, Ana Kikuchi, Koyo Kil, Whoon Jong Kilburn, Jeremy

2172 1053 3159 3166 14 2322 2020 2567 3704 2871 3104 374 3183 2667 88 2795 2961 3023 2400 2396 79 3327 2556 2190 3342 2733 365 2380 2538 2822 3741 2730 3635 204 2796 2001 2790 2498 2933 3724 2134 2516 2486 284 2956 2966 3515 3518 350 3071 125 3484 2563 219 2898 3127 3615 2082 287 2435 2416 3025

Killoran, Joseph Kiltie, Anne Kiltie, Anne Kim, Anthony Kim, Byoung-Hyuck Kim, Carolyn Kim, Carolyn Kim, Carolyn Kim, Daniel Kim, Dong W. Nathan Kim, Dongwook Kim, Dongwook Kim, Grace Gwe-Ya Kim, Grace Gwe-Ya Kim, Hayeon Kim, Hye Young Kim, In Ah Kim, In Ah Kim, JaYoung Kim, Ji Hyun Kim, Ji Hyun Kim, Jin Hee Kim, Joo Ho Kim, Jun Won Kim, Jun Won Kim, Jun Won Kim, Jun Won Kim, Jung-in Kim, Michelle Kim, Siyong Kim, Sung hoon Kim, Taeho Kim, Young Suk Kim, Yusung Kimple, Randall Kimura, Tomoki King, Benjamin King, Christopher King, Martin King, Martin Kinoshita, Rumiko Kipritidis, John Kirichenko, Alexander Kirova, Youlia Kirschner, Austin Kishan, Amar Kishi, Takahiro Kitamura, Nozomi Kjer, Hans Martin Klaers, Jessica Klein, Elizabeth Klein, Eric Klein, Thomas Kleinberg, Lawrence Klement, Rainer Klepczyk, Lisa Klopp, Ann Knill, Cory Ko, Eric Koay, Eugene Kobayashi, Noriko Kodaira, Takeshi Koh, Hyeon Kang Koh, Wee Yao

2243 3218 3323 3438 2186 2526 2527 3634 2178 3322 3478 3501 3609 3733 2581 3512 184 3254 3068 237 3078 2572 3572 2315 2351 3171 3232 3715 2029 3608 2293 1128 3076 333 3279 2286 391 2448 2985 3107 2026 3568 25 2012 2636 3535 2981 3509 3719 3574 3153 3641 3194 16 121 2044 2627 2937 2492 2641 2228 2701 2122 2015

Kohutek, Zachary Koike, Ryuta Komaki, Ritsuko Kong, Chi Wah Kong, Feng-Ming Kong, Lin Koo, Tae Ryool Koom, Woong Sub Koontz, Bridget Korah, Mariam Korideck, Houari Kornerup, Josefine S. Kosaki, Katsura Kosztyla, Robert Koul, Rashmi Kovalchuk, Nataliya Kovalchuk, Nataliya Kowalchik, Kristin Kowalchik, Kristin Koyfman, Shlomo Kramkimel, Nora Krauss, Daniel Krengli, Marco Kress, Marie-Adele Krishnan, Monica Krishnatry, Rahul Kropp, Lauren Krueger, Sarah Kry, Stephen Ku, Lichung Kuang, Yu Kudo, Shigehiro Kumar, Aryavarta Kumar, Aryavarta Kumar, Aryavarta Kumar, Kiran Kumar, Parvesh Kumar, Rachit Kumar, Rachit Kumar, Sanath Kumaravelu, Azmi Kunaprayoon, Dan Kuo, Yuan-Chia Kupelian, Patrick Kuremsky, Jeffrey Kurt, Meral Kurtz, Goldie Kusano, Aaron Kuske, Robert Kwok, Young Kwon, Jeanny Kwong, Stanley

90 2232 169 3343 3040 2714 2285 360 1112 84 3699 3122 2934 2137 3148 2784 271 2034 2241 2740 3160 145 2053 3086 129 2554 2803 3213 319 2900 328 2231 1061 2347 2687 3504 3396 1103 3503 3582 2767 2174 3248 389 380 2535 3614 249 214 2495 3089 3030

Laack, Nadia Lai, Shihfan Lally, Brian Landry, Jerome Lane, Sophia

1 2118 3047 357 128

Lappinen, Erik Laser, Benjamin Lasley, Foster Latifi, Kujtim Laufer, Marsha Lauro, Christine Lavaf, Amir Laviraj, Macharla A. Lavrenkov, Konstantin Lawrence, Yaacov Lawton, Colleen Lazos, Dimitrios Lazos, Dimitrios Le, Yi Leapman, Michael Lecavalier-Barsoum, Magali Lee, Andrew Lee, Andrew Lee, Ann Shing Lee, Dong Soo Lee, Grace Lee, Ho Lee, Hyebin Lee, Hyunjin Lee, Jaegi Lee, Jayoung Lee, Joo Ho Lee, Joo Hwan Lee, Joseph Lee, Joseph Lee, Larissa Lee, Larissa Lee, Lucille Lee, Nancy Lee, Richard Lee, Richard Lee, Ryan Lee, Sang-wook Lee, Sangkyu Lee, Seung Heon Lee, Suk Lee, Tae Kyu Lee, Tsz Kin Lee, Yongsook Leeman, Jonathan Leggett, Heather Lei, Rachel Leonard, Kara Leonard, Kara Leong, Nelson Lescut, Nicolas Lester-Coll, Nataniel Lester-Coll, Nataniel Letourneau, Melanie Letourneau, Daniel Lewis, Stephen Leyrer, Marc Li, BaoQing Li, Dengwang Li, Dengwang

Langen, Katja Langsenlehner, Tanja Lanni, Thomas

3497 3366 2047

Li, Dengwang Li, Guang Li, Hao

L

2297 404 23 2070 2346 3111 3022 3492 2335 3305 2402 3378 3550 2458 2511

3649 2624 3498 3575 2327 2310 3364 3505 3267 3585 71 3352 3217 2311 3607 2957 3147 3611 2102 2270 2367 3349 2712 3250 2706 3626 2051 1019 1004 3564 3533 3537 2265 3623 3542 3494 2437 3646 3350 1016 3344 220 327 3450 2324 2598 2530 3547 279 2189 2544 1076 3404 3357 2723 3398 1104 3691 2328 2529 2246

Ly, Bevan Ly, Bevan Ly, David

2389 2395 3139 2305 2201 2107 3538 2669 3477 3507 2109 2896 3367 2697 3019 236 2607 2853 3696 2266 2510 2698 3069 194 2303 3467 3659 3142 3399 2203 2113 3101 2023 2343 3316 2668 308 3112 2075 326 2127 2220 2724 3356 3527

Li, Heng Li, Hualei Li, Jingdong Li, Jun Li, Ning Li, Ping Li, Ruijiang Li, Shunshan Li, Tao Li, Taoran Li, X. Allen Lian, Jun Liang, Liping Liang, Shixiong Liang, Yun Liao, Zhongxing Likhacheva, Anna Lilley, John Lin, Angela Lin, Chi Lin, Chi Lin, Christie Lin, Qin Lin, Yi-Ping Lin, Yu-Wei Ling, Diane Linne, Tamara Liriano, Melissa Liss, Adam Liu, Feng Liu, Fenghong Liu, Fenghong Liu, Gene-Fu Liu, Haisong Liu, Han Liu, Hongwei Liu, Jerry Liu, Wei Liu, Wu Liu, Yung Hsien Liu, Zejian Lloyd, Shane Lo, Andrea Lo, Anthony Lobo, Mark Lopez-Araujo, Javier Lorentz, William Lorenzen, Ebbe Louie, Alexander Louie, Alexander Louie, Alexander Lovelock, D. Michael Low, Daniel Lu, Bo Lu, Haijun Lu, Haijun Lu, Jiade Lu, Lanchun Lu, NingNing Lu, Sharon Lu, Wei

3570 3590 206

Lucas, John Ludwig, Michelle Lukens, John

92 3410 152

Martin, Jeffrey Martin, Andre Martin, Jovita

2106 3102 2547

M Ma, C.M. Charlie 3303 Ma, Jinli 2010 Ma, Lijun 2200 Ma, Lin 2708 Ma, Shihong 3253 MacArthur, Kelly 58 MacDonald, Shannon 281 Macdonald, Orlan 2084 Macdonald, Orlan 3007 Machtay, Mitchell 49 Macklis, Roger 3304 MacManus, Michael 2952 Macrie, Bryan 2633 Maehata, Yoshiyasu 3003 Magnan, Sindy 2515 Magnuson, William 2828 Maguire, Patrick 2021 Mahadevan, Anand 28 Mahajan, Anita 3650 Mahalingam, Sudha 2028 Mahe, Marc 2931 Mahmood, Usama 2480 Mahmoud, Omar 2356 Mahmoud, Omar 3701 Mailhot, Raymond 160 Maity, Amit 315 Mak, Kimberley 231 Mak, Raymond 33 Makita, Chiyoko 2283 Maletz, Kristina 2469 Mallarajapatna, Govindarajan 3201 Malone, Shawn 2384 Malyapa, Robert 2745 Mampuya, Ange Wambaka 3593 Mancini, Brandon 2975 Mancini, Brandon 3000 Mancosu, Pietro 3487 Mangona, Victor 256 Manon, Rafael 3495 Mantz, Constantine 2399 Maquilan, Genevieve 2947 Maraldo, Maja Vestmoe 175 Marchan, Edward 2206 Marcus, David 2031 Marcus, Robert 3108 Margalit, Danielle 143 Maria, Ola 3227 Marina, Ovidiu 2403 Marina, Ovidiu 2414 Markel, Daniel 3687 Markovina, Stephanie 2523 Marples, Brian 265 Marshall, Richard 2426

ASTRO 2012 / 54TH ANNUAL MEE TING

1048 2525 3094 173

Maruyama, Katsuya Marwaha, Gaurav Mashouf, Shahram Masi, Laura Masunaga, Shin-ichiro Mathew, Maya Matsuo, Masayuki Matsuo, Yukinori Matsuyama, Tomohiko Mattes, Malcolm Mattes, Malcolm Matthiesen, Chance Matulewicz, Lukasz Matuszak, Martha Mayadev, Jyoti Mayekar, Sonal Mayr, Nina Mazur, Lukasz McAvoy, Sarah McBride, Sean McBride, William McCloskey, Paula McCloskey, Susan McCormick, Beryl McCullough, Anna McCurdy, Matthew McDermott, Sean McDoland, Daniel McGary, John McGee, Lisa McGee, Mackenzie McGovern, Susan McGurk, Ross McKee, Andrea Medin, Paul Mehta, Minesh Mehta, Niraj Mehta, Vivek Mei, Xin Meier, Robert Meier, Robert Meier, Timothy Mellon, Eric Mellon, Eric Melzig, Claudius Membrive Conejo, Ismael Mena, Ana Maria Mendenhall, Nancy Mendenhall, Nancy Meng, Bowen Menichelli, Claudia Mensah, Apryl Menzel, Paul Meral, Rasim Merrick, Scott Meyer, Jeffrey Meyer, Joshua Meyer, Kurt Michaelson, Evan Michalski, Jeff Michaud, Anthony

344 3598 3735 3708 3192 2215 3246 2887 2196 2939 3472 2729 3445 64 2586 2125 45 2836 3037 343 3302 3009 245 11 2863 101 3247 3483 3326 2443 266 1028 3528 2977 3265 2135 3165 3573 3525 366 2528 395 2048 2279 3298 2611 2035 226 2441 203 1062 3421 2159 3629 68 1063 2350 3571 3052 34 3401

Mierzwa, Michelle Mihaylov, Ivaylo Mihaylov, Ivaylo

2674 3461 3707

174

Mikami, Ryuji 2928 Mikell, John 1066 Miki, Yoshitaka 3163 Mikkelsen, Ross 3234 Milano, Michael 1020 Milby, Abigail 2098 Milby, Abigail 3231 Milby, Abigail 3670 Milecki, Piotr 3145 Milgrom, Sarah 2618 Miller, Robert LBA 2 Min, Byung Jun 134 Min, Christine 2840 Min, Chul Hee 192 Minken, Andre 3552 Mirabeau-Beale, Kristina 2857 Mirkovic, Dragan 3669 Mishra, Kavita 1080 Mishra, Pankaj 3381 Mislmani, Mazen 2069 Mittal, Bharat 156 Miwa, Kazuhiro 2120 Miyahara, Yoshinori 3682 Miyakawa, Akifumi 2194 Mizoguchi, Nobutaka 2170 Mizowaki, Takashi 2379 Modesto, Anouchka 2747 Modlin, Leslie 289 Moghanaki, Drew 1046 Mohamed, Abdallah 2881 Mohamad, Issa 3563 Mohan, Radhe 2923 Mohindra, Pranshu 2696 Mok, Gary 2728 Molotievschi, Alerson 382 Moningi, Shalini 3105 Montero, Pablo H. 2652 Moore, Kevin 388 Moore, Joseph 3519 Moran, Brian 2520 Moraru, Ion 272 Moré, Jayaji 385 Morgan, Scott 230 Mori, Shinichiro 3652 Mori, Yoshimasa 2151 Morimoto, Masahiro 2376 Mornex, Francoise 221 Morris, Ann 2148 Morrow, Natalya 3530 Moskvin, Vadim 138 Mostafavi, Hassan 1130 Mou, Benjamin 2837 Mourad, Waleed 2371 Mourad, Waleed 2372 Mourad, Waleed 2508 Mourad, Waleed 2750 Mourad, Waleed 2769 Mourad, Waleed 2770 Mourad, Waleed 3079 Mourad, Waleed 3679 Moustafa, Mahmoud 3244 Msadabwe Chikuni, Susan 2596 Mueller, Sabine 114 Mukai, Masami 3655

ASTRO 2012 / 54TH ANNUAL MEE TING

Mukumoto, Nobutaka 3681 Mullapally, Sujith 2700 Munbodh, Reshma 2145 Munck af Rosenschold, Per 3569 Munoz Garcia, Julia Luisa 2404 Murai, Taro 3095 Murai, Taro 3686 Murakami, Ryuji 2644 Murakami, Yuji 2247 Murofushi, Keiko 2564 Murphy, James 2856 Murphy, James 126 Murphy, Rita 3016 Murray, Louise 3553 Musunuru, Hima 37

Noble, Anisha Noel, Camille Nohadani, Omid Nowak, Kamila Nowsheen, Somaira Numasaki, Hodaka Nuver, Tonnis Nuyttens, Joost Nuyttens, Joost Nuyttens, Joost Nwachukwu, Chika Nygaard, Ditte Eklund

N

Obedian, Edward Ochoa, Laura Octave, Nadia Oehler, Christoph Offor, Onyi Ogawa, Yasuhiro Ogura, Kengo Oguri, Mitsuhiko Oh, Daniel Oh, Dongryul Oh, Dongryul Oh, Jung Hun Oh, RyoongJin Oh, Seungjong Ohga, Saiji Ohri, Nitin Oike, Takahiro Ojerholm, Eric Okamoto, Hiroyuki Okamoto, Masahiko Okano, Naoko Okonogi, Noriyuki Olsen, Jeff Olson, Robert Olsson, Caroline Onimaru, Rikiya Onishi, Hiroshi Orcutt, Kevin Orton, Matthew Osa, Etin-Osa Osinga, Julia-Maria Ospina, Juan Otsuka, Shinya Otter, Sophie Ou, Xiaomin Ovalle, Valentina Ovalle, Valentina Ove, Roger Owen, Jean

Na, Yong Hum Nabid, Abdenour Nagar, Himanshu Nagar, Himanshu Nakagawa, Akiko Nakajima, Naomi Nakamura, Akira Nakamura, Mitsuhiro Nakamura, Naoki Nakamura, Naoki Nakamura, Satoshi Nakayama, Yuko Nakayama, Masao Nam, Jin-Min Nam, Jiho Narayana, Ashwatha Nasseri, Morad Nath, Sameer Navarria, Pierina Naydich, Boris Nelson, Carl Newcomb, Matthew Ng, Chor-yi Ng, John Ng, Sook Kien Ngan, Samuel Nguyen, Brandon Nguyen, Nhu Tram Nguyen, Quynh Nguyen, Quynh Nguyen, Sonia Ngwa, Wilfred Niazi, Tamim Nichols, Elizabeth Nickers, Philippe Nielsen, Tine B Nijkamp, Jasper Nishibuchi, Ikuno Nishimura, Hideki Nishimura, Takuya Nishimura, Yasumasa Nishioka, Akihito

3489 2415 2007 115 2568 2973 3466 3680 2003 3085 136 3034 3282 354 2117 2221 3440 2207 2959 2430 306 2671 3458 2984 3561 355 2472 2811 3663 3668 2088 332 2483 2926 2587 2986 2991 3216 2725 2473 167 2269

Nishioka, Kentaro Nixon, Iain Noa, Kate

3465 2670 2536

2760 66 3435 182 1026 250 3459 2359 2967 1010 3130 1017

O 3463 2160 72 3559 2522 280 2123 3005 61 2976 2980 2762 2290 3485 3065 2 3262 2210 3456 3204 2974 3260 3394 1097 3406 2949 122 3026 3589 208 133 2447 3064 148 2710 2095 2217 2267 2259

P Paganetti, Harald Pak, Daniel

137 3534

Palma, David Palma, David Palmer, Matthew

2882 3008 2693

Palmer, Matthew Palta, Manisha Paly, Jonathan Pan, Hubert Pan, Jianji Panoff, Joseph Papachristofilou, Alexandros Parashar, Bhupesh Parekh, Arti Parikh, Dhwani Parikh, Parag Parikh, Ravi Parisi, Elisabetta Parisi, Elisabetta Park, Catherine Park, Hae-jin Park, Henry Park, Joo Han Park, Sang-June Park, Samuel Park, Su Yeon Park, Wungki Park, Young Hee Parliament, Matthew Parvathaneni, Upendra Parvathaneni, Upendra Parvathaneni, Upendra Paryani, Nitesh Pashtan, Itai Pastore, Gabriella Patel, Nisha Patel, Nita Patel, Samir Patel, Shilpen Patel, Shilpen Patel, Shyamal Patel, Pretesh Patel, Vaiibhav Patel, Vivek Patil, Nikhilesh Patni, Nidhi Paudel, Nava Paulino, Arnold Paulson, Eric Paulsson, Anna Pawlicki, Todd Paximadis, Peter Peacock, Justin Pelloski, Christopher Peng, Jean Peng, Luke Peng, Ran Peng, Xu Peng, Zhang Pennathur, Arjun Pentimalli, Sara Perez, Bradford Perez, Carmen Perez-Regadera, Jose Perez-Romasanta, Luis Perillo-Adamer, Florence Perkins, Gregory Perkins, Gregory

3667 2099 2548 2191 2704 2079 1022 2252 229 3286 329 309 379 2958 3199 2229 2180 3397 2797 3418 3672 2282 2183 3317 3098 1005 3162 2848 2192 3360 2175 2494 2673 2251 2262 2621 2759 2364 3209 2638 2036 3731 163 3684 2146 2866 408 3132 3289 3338 2339 209 2721 2718 2998 2038 1079 2968 2573 2772 3284 270 3377

Perkinson, Andrew Peroski, Michael Persson, Gitte Peters, Christopher Peterson, Carl Peterson, David Pfeffer, Raphael Pfeffer, Raphael Pham, Daniel Pham, Ngoc Phillips, Mark Piotrowski, Tomasz Pirozzi, Sara Platta, Christopher Plimpton, Steven Podder, Tarun Poettgen, Christoph Poettgen, Christoph Pollack, Alan Poorvu, Philip Popescu, Carmen Potters, Louis Poulsen, Per Prabhu, Roshan Prabhu, Roshan Prah, Douglas Pratx, Guillem Prendergast, Brendan Price, Samantha Prieto, Isabel Prior, Phillip Prosnitz, Robert Pugh, Thomas Pukala, Jason

3369 2425 1088 2918 3012 2963 2165 2877 2545 80 3540 3475 3543 116 2062 321 381 3010 62 2601 2094 246 3517 2199 3081 3123 3196 2903 324 2798 2049 348 2439 3541

Q Qi, Huanpeng 3032 Qi, Xiangrong 2924 Qi, Xiangrong 3473 Qiao,Xueying 102 Qiao, Xueying 2884 Qin, Songbing 3339 Quero, Laurent 2226 Quirk, Sarah 2111 Quivrin, Magali 2394 Quon, Harry 1107 Quon, Harvey 367 Qureshi, Muhammad 2855

R Raben, David Racadot, Severine Rah, Jeong-Eun Rahimian, Javad Rahn, Douglas Rajagopalan, Malolan Rajpara, Raj Rakhra, Sunpreet Rakusic, Zoran Ramamurthy, Sindhu

386 2275 3637 3588 3133 2268 2969 218 2677 2964

Rana, Shushan Rancati, Tiziana Ranck, Mark Rao, Yuan Rao, Nikhil Rao, Shyam Raphael, Jomon Rash, Dominique Rashtian, Afshin Rashtian, Afshin Rashtian, Afshin Rashtian, Afshin Rath, Goura Kishor Rathod, Shrinivas Rava, Paul Rava, Paul Raval, Raju Ravi, Akkamma Reddy, Krishna Redmond, Kristin Reese, Adam Refaat, Tamer Register, Steven Reinartz, Gabriele Ren, Hua Ren, Lei Repka, Michael Resende Salgado, Lucas Resende Salgado, Lucas Rey, Felipe Rey, Felipe Riaz, Nadeem Riaz, Nadeem Riaz, Nadeem Riaz, Nadeem Ricchetti, Francesco Rice, Roger Riegel, Adam Rimner, Andreas Rineer, Justin Riou, Olivier Roa, Dante Robbins, Jared Robbins, Jared Roberge, David Roberts, Kenneth Rochet, Nathalie Rochet, Nathalie Rodrigues, George Rodrigues, George Rodriguez, Vivian Rodriguez de Dios, Nuria Rodriguez-Ruiz, Maria E. Rodriguez-Ruiz, Maria E. Roehrich, Manuel Roenjom, Marianne Feen Rollmann, Denise Roman, Nicholas Romesser, Paul Romesser, Paul Romesser, Paul Romesser, Paul Rong, Yi Rooney, Jessica

2876 35 2454 2570 1098 74 2732 2576 2101 2114 3143 1012 2428 3146 2197 2198 3152 2132 2133 164 3471 2557 2612 177 2256 3491 2497 2757 2758 2634 2827 2680 2699 2738 2763 2662 3476 1127 2960 3033 2534 3544 2463 2193 1006 3119 2617 3462 141 1038 3576 215 2144 2825 316 149 3134 2992 2679 2764 2800 3242 1126 3167

Rosen, Lane Rosen, Lane Rosenberg, Stephen Rosenberg, Jennifer Rostom, Yousri Roszak, Andrzej Rottmann, Joerg Roy, David Royce, Trevor Ruan, Dan Ruby, Ashley Rudra, Sonali Rudra, Sonali Rudzianskas, Viktoras Ruggieri, Ruggero Russell, Wesley Russo, Andrea Russo, Andrea Russo, James Rusu, Iris Rutenberg, Michael Rutkowski, Tomasz

2632 120 2914 3082 2298 2593 1086 2211 302 320 2643 3091 3567 2766 3408 2915 2845 178 2925 3029 2691 3311

S

Sabri, Siham Sachsman, Suzanne Sadek, Betro Sahoo, Narayan Sai, Sei Saini, Jatinder Saito, Akito Saitoh, Jun-ichi Sakata, Koh-ichi Salem, Ahmed Sales, Lindsay Salguero, Francisco Salinas, Juan Samiee, Sara Samuelian, Jason Sandler, Howard Sanfilippo, Nicholas Sanguineti, Giuseppe Sansourekidou, Parthena Santanam, Lakshmi Santhanam, Anand Santos, Marcos Sanuki, Naoko Sarkar, Vikren Sattler, Jennifer Sattler, Margriet Scala, L. Matthew Schefter, Tracey Schinkel, Colleen Schmid, Thomas Schmitt, Adam Schneider, Ralf Schoenfeld, Jonathan Schoenfeld, Jonathan Schonewolf, Caitlin Schreibmann, Eduard Schroyer, Daniel Schubert, Leah

ASTRO 2012 / 54TH ANNUAL MEE TING

20 2361 1051 3674 3241 3385 3633 3640 3268 2100 2278 78 2417 3219 3340 7 227 2661 3722 3703 3393 168 2066 2386 3235 2103 371 39 3551 3240 3212 3656 2181 142 2316 3372 2518 387 175

Schuster, Jessica Scorsetti, Marta Seco, Joao Seco, Joao Sedlmayer, Felix Seidel, Philipp Sekine, Hiroshi Selek, Ugur Semrau, Robert Sen, Sounok Sen, Amarjit Senan, Suresh Senthi, Sashendra Senthi, Sashendra Serban, Monica Sethi, Rajni Sethi, Rajni Sethi, Manish Shah, Chirag Shah, Chirag Shah, Mira Shah, Anand Shang, Charles Shankar, Vangipuram Sharabi, Andrew Sharabi, Andrew Sharma, Charu Sharma, Charu Sharma, Daya Nand Sharma, Daya Nand Sharma, Kuldeep Sharp, Hadley Shaverdian, Narek Sheets, Nathan Sheldon, Thomas Shen, Sui Shenouda, Mina Sheth, Nikul Sheybani, Arshin Shibamoto, Yuta Shibamoto, Yuta Shih, Helen Shilkrut, Mark Shimizu, Shinichi Shinde, Prashantkumar Shioyama, Yoshiyuki Shipley, William Shirai, Kiyonori Shiraishi, Yutaka Shirvani, Shervin Shiue, Kevin Shridhar, Ravi Shridhar, Ravi Shridhar, Ravi Shukla, Monica Shultz, David Shusharina, Nadya Shusharina, Nadya Siedow, Michael Siglin, Joshua Silva, Luis

3583 27 3600 3638 2484 406 2006 3513 2683 86 2479 117 1021 2972 3176 282 2157 335 211 2024 2619 242 3412 2002 3173 3187 2050 2635 2580 398 2128 2168 2595 2869 2421 2599 89 2410 2185 1081 183 91 369 1037 3444 2995 299 3331 2387 3004 2188 105 2253 2263 2493 2940 257 3554 3296 2978 3391

Simpson, Daniel Singh, Deepinder Sinicki, James Sio, Terence Sio, Terence Sio, Terence Siva, Shankar Siva, Shankar Sjödin, Kristina Skinner, Heath Skinner, Heath Skladowski, Krzysztof Skliarenko, Julia Skolny, Melissa Skourou, Christina Slomowitz, Alan Smith, Jessica Smith, Ryan Smith, Wade Sneed, Penny Snyder, Michael Soeder, Sherry Soike, Mike Sole, Claudio Sole, Claudio Soliman, Hany Soliman, Hany Soltys, Scott Son, Christina Song, Haijun Song, Yeohan Song, Yulin Song, Yulin Song, Xiaofei Sood, Sumit Sopka, Dennis Sostin, Oleg Spadea, Maria Francesca Speer, Tod Speer, Tod Speers, Corey Speight, Richard Speight, Richard Speight, Richard Spencer, Christopher Sperduto, Paul Spiotto, Michael Spira, Gregor Spraker, Matthew Spratt, Daniel Stanescu, Teo Stanic, Sinisa Stanic, Sinisa Stauder, Michael Stavas, Mark Stavas Stea, Baldassarre Steen, Sven Stegmaier, Petra Stessin, Alexander Stessin, Alexander Stinauer, Michelle

44 3001 3184 1071 342 3353 47 337 2475 103 363 48 3053 285 3486 2097 2334 2467 393 293 3434 3149 3039 1095 3599 2224 22 1074 130 3392 2460 3632 3743 3673 3140 1099 2531 131 3308 3442 3269 2546 3370 3516 51 352 412 2418 3169 32 3613 2451 119 2880 3174 3083 2782 2756 1082 267 2313

Silveira, William Silveira, William Simone, Charles

2681 2979 87

Stock, Richard Stockham, Abigail Stojadinovic, Strahinja

2440 2834 3562

176

ASTRO 2012 / 54TH ANNUAL MEE TING

Stokes, William Stone, Brandon Stoyanova, Radka Studer, Gabriela Sturgeon, Jared Su, Zhong Subramanian, Sai Suderman, Derek Suh, John Summers, Paige Sun, Jason Sun, Rui Sun, Yan Sung, Wonmo Sunyach, Marie Pierre Surapaneni, Aparna Swamy, Kumara Swisher-McClure, Samuel Swisher-McClure, Samuel Swisher-McClure, Samuel Symon, Zvi Symon, Zvi Szeja, Sean Szumacher, Ewa Szumacher, Ewa

2867 2045 147 2771 2348 3115 3712 2455 3099 73 2823 3238 2720 3714 3620 2072 3200 2477 150 3647 1043 2465 2218 2008 3178

T Taghian, Alphonse Taguchi, Senzo Tai, An Tait, Lauren Tajima, Yuu Takahashi, Ryo Takahashi, Shigeo Takahashi, Shinichi Takamatsu, Shigeyuki Takayama, Kanako Takemoto, Shinya Takiar, Vinita Takita, Cristiane Tam, Tiffany Tamura, Takeshi Tandberg, Daniel Tang, Chad Tang, Xiaoli Tang, Zili Taniguchi, Cullen Tanny, Sean Tanooka, Masao Tanzler, Emily Tao, Randa Tao, Zhen Tatekawa, Kotoha Taylor, Ben Taylor, Noah Taylor, Robert Teckie, Sewit Teckie, Sewit Tejwani, Ajay Tendulkar, Rahul Terakedis, Breanne Terashima, Kotaro

213 2812 3500 2212 2950 3511 2300 2391 2398 2649 2902 2431 2115 1052 2432 258 2676 3389 3294 263 3405 3409 96 373 3058 2953 2013 2093 1087 2171 2792 3180 232 2388 2375

Tesfamicael, Biniam Tey, Jeremy Thakur, Varun Singh Thariat, Juliette Thawani, Nitika Thieke, Christian Thirion, Pierre Thomas, Evan Thomas, Maria Thomas, Tarita Thorstad, Wade Tian, Junqiang Tinkle, Christopher Tohyama, Naoki Tokita, Kenneth Tokumaru, Sunao Toltz, Allison Tonlaar, Nathan Toramatsu, Chie Torrecilla, Jose Lopez Torres, Mylin Townamchai, Kanokpis Townsend, Natasha Toyama, Shingo Toyoda, Tatsuya Trepanier, Pier-Yves Trakul, Nicholas Tremmel, Christoph Tribius, Silke Trister, Andrew Troeller, Almut Trovo, Marco Trovo, Marco Truong, Pauline Tsai, Chiao-Ling Tseng, Chia-Lin Tseng, Yolanda Tsuchiya, Kazuhiko Tsudou, Shinji Tsutsumi, Yurie Tsuyoshi, Ikeda Tsvang, Lev Tumati, Vasu Tumati, Vasu Tunceroglu, Ahmet Tundisi, Carmen Turaka, Aruna Turaka, Aruna Turaka, Kiran Turkevich, Vladimir Turkevich, Vladimir Tward, Jonathan Tyagi, Neelam Tzeng, Ching-Wei

3376 2255 3622 50 2366 3508 3011 3702 46 2817 2658 261 2583 3448 2502 2603 3420 2478 2289 2420 1058 2625 1042 2169 3470 3411 3036 331 3137 19 190 383 3345 347 2319 2161 2273 2707 2919 2121 3705 2470 2558 317 2280 2209 2916 3073 3074 2449 3096 2445 146 2338

U Uchiyama, Kaoru Ueda, Shinichi Ueda, Yoshihiro Unal, Semra Ung, Yee Ung, Yee Urbanski, Bartosz Ushjima, Hiroki

2927 3329 3595 3736 2864 3024 2046 3261

V Vainshtein, Jeffrey Valakh, Vladimir Valliares, Martin Vallinayagam, Shanmuga S. van Lin, Emile van Sörnsen de Koste, John Vance, Sean Vance, Sean VanderWalde, Noam Varadhan, Raj Varadhan, Raj Vargo, John Vargo, John Vasseur, Frederique Vatner, Ralph Vaughan, Andrew Vazquez, Gonzalo Vazquez, Gonzalo Veeravalli, Krishna Kumar Velec, Michael Velker, Vikram Venarini, Sabina Vendrely, Veronique Verbakel, Wilko F.A.R. Verbakel, Wilko F.A.R. Vergalasova, Irina Verheij, Marcel Verma, Jonathan Vern-Gross, Tamara Vernon, Matthew Vichare, Anushree Videtic, Gregory Vieira, Andre Viertl, David Vigneault, Eric Villa, Salvador Vineberg, Karen Vinh-Hung, Vincent Vinod, Shalini Vinogradskiy, Yevgeniy Vinogradskiy, Yevgeniy Vivekanandan, Sindu Vlacich, Gregory Vogel, Jennifer Volz, Edna Vora, Sujay Vujaskovic, Zeljko

362 3057 1003 2594 2433 1125 2989 3362 3375 3449 3625 2779 2780 2560 2085 3188 1059 2971 2129 1090 2385 2022 2357 1096 3618 3335 1070 159 165 3054 2842 2913 3734 311 2397 2119 200 2105 2571 384 3426 2362 2787 2539 248 2444 3236

Vujovic, Olga Vulquin, Noamie Vuong, Te Vyas, Shilpa

2019 2566 3273 3177

W Wagner, Aaron Wakatsuki, Masaru Waldron, John Walker, Amanda Walker, Gary Walker, Joshua Wallace, Michelle Wallace, Harold Wang, Andrew Wang, Brian Wang, Chia-Chun Wang, Chun-Chieh Wang, Dian Wang, Feng-Ming Wang, Hongmei Wang, Jin Wang, Jin Wang, Jin Wang, Jing Wang, Jingya Wang, Kyle Wang, Lilie Wang, Lin Wang, Pin-Chieh Wang, Ping Wang, Ping Wang, Po-Ming Wang, Qifeng Wang, Qifeng Wang, Shichao Wang, Suzhen Wang, Suzhen Wang, Tao Wang, Tony Wang, Wei Wang, Wei Wang, Wei Wang, Weili Wang, Xin Wang, Yan-yang Wang, Yi Wang, Yu-Wen Wang, Yucai Washington, Iman Watanabe, Miho Watanabe, Miho Waters, Alexandra Watkins, William Weber, Damien Wei, Lichun Wei, Xiong Wei, Xiong Weinberg, Rebecca Weinshank, Lindsay Weiss, Elisabeth Weksberg, David

3072 40 1102 3566 304 3239 2059 2412 3256 3388 2336 3249 2810 2230 2982 2717 3341 3432 3386 100 2826 2659 3155 3186 2936 3202 2308 2604 187 3454 2954 2037 3195 376 2054 2055 2250 170 2257 2333 3447 2713 2167 3210 2555 3126 2778 3431 2370 2561 2938 59 3739 2080 1124 3713

Welsh, James Welsh, James Werner-Wasik, Maria Wernicke, A.Gabriella Wersall, Peter Whaley, Jonathan Whaley, Jonathan Whelan, Timothy White, Evan White, Ruth Whitley, Alexander Wiebe, Ericka Wiebe, Ericka Wijesooriya, Krishni Wilcox, Shea Wild, Aaron Wild, Aaron Wild, Aaron Wilkinson, Ben Wilkinson, Ben Willers, Henning Willey, Christopher Williams, Jacqueline Williams, Terence Wilson, David Wilson, David Wilson, George Wilson, Joella Windsor, Apsara Winkler, Peter Witten, Matthew Wo, Jennifer Wobb, Jessica Wobb, Jessica Wojcieszynski, Andrzej Wong, James Wong, Jason Wong, Michael Wong, Philip Wong, Rebecca Wong, William Wong, Wing Kei Rebecca Woods, Charles Woodward, Wendy Woolley, Amy Wright, Ato Wright, Jean Wu, Abraham Wu, Cheng-Chia Wu, Jia-Shing Wu, Junxin Wu, Q. Jackie Wu, Qiuwen Wu, Run-Ye Wu, Szu-Yuan Wuerschmidt, Florian Wuerschmidt, Florian Wurstbauer, Karl Wynn, Raymond Bernard

2452 172 2899 288 3382 2331 2920 LBA 1 2365 188 411 2639 3728 3727 2434 2277 2317 1094 255 3044 314 1031 3191 63 2719 2814 3315 3128 2459 3523 3546 2314 2033 2783 1068 3529 2429 2112 56 1073 1113 3594 2773 3321 2074 2970 2011 2244 3193 1108 2716 65 3710 180 2645 210 2009 2987 2851

X Xiang, Hong Xiang, Zuolin Xie, Jiang Xing, Ligang Xing, Ligang Xu, Benhua Xu, Huimin Xu, Li-ming Xu, Min Xu, Qianyi Xu, Yaping Xu, Zijie Xue, Jianxin Xue, Jinyu Xue, Jinyu

3631 2901 3721 2248 2261 2332 3043 3063 2040 3624 3042 3474 2996 2043 3605

Y Yajnik, Santosh Yalman, Deniz Yamada, Masahiro Yamada, Yoshiya Yamamoto, Hideo Yamamoto, Michinori Yamazaki, Takuya Yamoah, Kosj Yan, Di Yan, Heping Yan, Susu Yan, Weisi Yan, Weisi Yanagi, Takeshi Yang, Cungeng Yang, Eddy Yang, Joanna Yang, Joanna Yang, Joanna Yang, Joanna Yang, Tzu-I Jonathan Yang, Tzu-I Jonathan Yang, Wensha Yang, Wensha Yang, Xiaocheng Yang, Xiaofeng Yang, Xiaofeng Yang, Yun Yang, Zhaozhi Yao, Min Yap, Mei Ling Yaparpalvi, Ravindra Yassa, Michael Ye, Hong Yechieli, Raphael Yeh, Brian Yeh, Brian Yeung, Rosanna Yeung, Anamaria Yeung, Daniel Yi, Junlin Yi, Sun

ASTRO 2012 / 54TH ANNUAL MEE TING

3671 3720 3336 97 3683 2791 2793 113 198 318 2077 85 2613 2727 274 181 397 399 403 3117 3141 2340 1093 3488 3490 75 2751 3693 2058 2650 234 2605 1041 2390 2626 139 3653 2355 2870 3648 2702 3006

177

Yin, Liangjie Yip, Connie Yip, Connie Yip, Connie Yip, Darwin Yokoi, Tomohiro Yondorf, Menachem Yondorf, Menachem Yoo, Sua Yoon, Hannah Yoon, Hyunsik Yoon, Sang Min Yorozu, Atsunori Yoshikazu, Tsunashima Yoshimoto, Yuya Yoshimura, Ryo-ichi Yoshimura, Michio Youland, Ryan Young, Kristina Young, Melissa Young, Rebekah Yovino, Susannah Yu, David Yu, James Yu, Jennifer Yu, Jeong Il Yu, Jinming Yu, Naichang Yu, Yao Yuan, Zhi-Yong Yue, Yong Yuh, William Yusoff, Sarahatul Bahiah

178

3230 2227 2240 2892 3175 3480 2136 2142 2065 233 2321 2155 370 135 3266 2646 2726 90 2202 2609 2110 2216 217 31 3275 2292 2912 2349 2651 2288 3430 3441 2014

Z Zaccariotto, Audrey Zaini, Mehran Zakeri, Kaveh Zaki, Bassem Zaorsky, Nicholas Zeidan, Youssef Zelefsky, Michael Zeng, Zhao-Chong Zhai, Huifang Anna Zhai, Yi Rui Zhang, Chi Zhang, Chi Zhang, Chi Zhang, Hong Zhang, Hui Zhang, Jeanette Zhang, Jiandong Zhang, Li Zhang, Pengpeng Zhang, Qinghui Zhang, Ximei Zhang, Ximei Zhang, Ximei Zhang, Yingjie Zhang, Yingjie Zhang, Zhenhuan Zhao, Lujun Zhao, Tianyu Zhao, Ting Zhen, Heming Zhen, Heming Zheng, Xiangpeng Zheng, Yuanshui Zheng, Yuanshui Zhong, Hualiang Zhong, Yahua Zhou, Jessica Zhou, Jun Zhou, Su-Min Zhu, Guangying Zhu, He Zhu, Ji Zhu, Lihong Zhu, Mingyao Zhu, Shuchai Zhu, Xuping Zhuang, Hong-Qing Zhuang, Hong-Qing Zhuang, Yan Zhung, Joanne Zia, Yaseen Zia, Yaseen Ziegler, Mark Ziel, Ellis Zook, Jennifer Zumsteg, Zachary Zumsteg, Zachary

ASTRO 2012 / 54TH ANNUAL MEE TING

351 3407 112 3319 2154 2752 3 2287 2164 2306 228 2592 400 2734 3220 2831 2948 2258 3446 3602 3059 3060 3061 3346 3347 3233 3264 3439 3067 322 3496 2893 3639 3662 3539 1105 2614 3363 205 3283 42 2329 2628 3333 2236 132 252 2911 2993 1089 2685 2799 2323 3427 2108 1056 224

Index by Track (Abstracts only) BREAST CANCER McCormick, Beryl Sperduto, Paul Cohen, Randi Roberts, Kenneth Korah, Mariam Yan, Weisi Sen, Sounok Simone, Charles Karam, Irene Shenouda, Mina Osa, Etin-Osa Peng, Ran Wuerschmidt, Florian Shah, Chirag Chen, Peter Taghian, Alphonse Kuske, Robert Rodriguez de Dios, Nuria Chang, Jee Suk Diaz, Dayssy Louie, Alexander Ogawa, Yasuhiro MacDonald, Shannon Sethi, Rajni Dai Kubicky, Charlotte Kesarwala, Aparna Skolny, Melissa Gupta, Gaorav Prosnitz, Robert Jones, Tiffanie Khan, Atif Zaccariotto, Audrey Fyles, Tony Nam, Jin-Min Jawad, Maha Hong, Robert Sadek, Betro Tam, Tiffany Kane, Erin Weksberg, David Arvold, Nils Zumsteg, Zachary Chadha, Manjeet Torres, Mylin Vazquez, Gonzalo Fields, Emma Keiler, Louis Shankar, Vangipuram Nakamura, Naoki de Souza-Lawrence, Lana de Souza-Lawrence, Lana Sekine, Hiroshi Nagar, Himanshu Szumacher, Ewa Wuerschmidt, Florian Ma, Jinli Wright, Jean Kirova, Youlia

11 52 82 83 84 85 86 87 88 89 208 209 210 211 212 213 214 215 277 278 279 280 281 282 283 284 285 347 348 349 350 351 353 354 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

Taylor, Ben Yusoff, Sarahatul Bahiah Koh, Wee Yao Furet, Elise Churilla, Thomas Churilla, Thomas Vujovic, Olga Kannan, Neeta Maguire, Patrick Venarini, Sabina Leonard, Kara Shah, Chirag Hardee, Matthew Kinoshita, Rumiko Bonavitacola, Patrick Joseph Mahalingam, Sudha Kim, Michelle Claes, Stefan Marcus, David Currey, Adam Wobb, Jessica Kowalchik, Kristin Mena, Ana Maria Patni, Nidhi Wang, Suzhen Pentimalli, Sara Ho, Alice Xu, Min Deng, Jun Harris, Timothy Xue, Jinyu Klepczyk, Lisa Stone, Brandon Urbanski, Bartosz Lanni, Thomas Mellon, Eric Prior, Phillip Sharma, Charu Linne, Tamara Fasola, Carolina Krengli, Marco Wang, Wei Wang, Wei Hammer, Josef Feigenberg, Steven Yang, Zhaozhi Wallace, Michelle Infusino, Erminia Currey, Adam Plimpton, Steven Coplowitz, Shana Christenson, Eric Yoo, Sua Sanuki, Naoko Awan, Musaddiq Cope, Frederick Mislmani, Mazen Latifi, Kujtim Abrams, Matthew

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071

Surapaneni, Aparna Jawad, Maha Woolley, Amy Letourneau, Melanie Bejarano, Daniela Yan, Susu Finkelstein, Steven Panoff, Joseph Weinshank, Lindsay Dong, Peng Khouri, Anton Grew, David Macdonald, Orlan Vatner, Ralph Chang, Lynn Ingledew, Paris-Ann Nguyen, Sonia Coucke, Philippe Hallman, Mark Ravi, Akkamma Govers, Mieke Taylor, Noah Popescu, Carmen Ovalle, Valentina Crandley, Edwin Slomowitz, Alan Milby, Abigail Palta, Manisha Salem, Ahmed Rashtian, Afshin Lin, Angela Sattler, Margriet Goggin, Lisa Vinh-Hung, Vincent Ly, Bevan Lee, Grace Zook, Jennifer Lee, Jayoung Young, Rebekah Quirk, Sarah Wong, Michael Leggett, Heather Rashtian, Afshin Takita, Cristiane Goggin, Lisa Nam, Jiho Lai, Shihfan

2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118

CENTRAL NERVOUS SYSTEM Chakravarti, Arnab Laack, Nadia Cairncross, Gregory Kang, Julie Jung Cuneo, Kyle Kleinberg, Lawrence Deng, Meiling Chen, Linda Trister, Andrew Sabri, Siham

9 1 10 14 15 16 17 18 19 20

Iuchi, Toshihiko Youland, Ryan Shih, Helen Lucas, John Hattangadi, Jona Haridass, Anoop Champ, Colin Tanzler, Emily Yamada, Yoshiya Al-Omair, Ameen Johung, Kimberly Kiess, Ana Wernicke, A. Gabriella Modlin, Leslie Kohutek, Zachary Kalakota, Kapila Cox, Brett Sneed, Penny Wong, Rebecca Soltys, Scott Guckenberger, Matthias Lovelock, D. Michael Badiyan, Shahed Kahn, Leonel Perez, Bradford Shibamoto, Yuta Stessin, Alexander Barnes, Carolyn Combs, Stephanie E. Villa, Salvador Miwa, Kazuhiro Tsutsumi, Yurie Koh, Hyeon Kang Ogura, Kengo Aneja, Sanjay Mayekar, Sonal Bishop, Andrew Lewis, Stephen Sharma, Kuldeep Veeravalli, Krishna Kumar Bishop, Andrew Ho, Clement Reddy, Krishna Reddy, Krishna Ken, Soleakhena Mehta, Minesh Yondorf, Menachem Kosztyla, Robert Christensen, Michael Cha, Hyejung Deviers, Alexandra Bodis, Stephan Yondorf, Menachem Diletto, Barbara Rodriguez-Ruiz, Maria E. Munbodh, Reshma Paulsson, Anna Guarnaschelli, Jessica Morris, Ann Abel, Ryan

ASTRO 2012 / 54TH ANNUAL MEE TING

21 90 91 92 93 94 95 96 97 98 286 287 288 289 290 291 292 293 1073 1074 1075 1076 1077 1078 1079 1081 1082 1083 1084 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 179

Bhandari, Rahul Mori, Yoshimasa Grills, Inga Johnson, Alex Zaorsky, Nicholas Yoon, Sang Min Hardee, Matthew Sethi, Rajni Barani, Igor Menzel, Paul Ochoa, Laura Tseng, Chia-Lin Huang, Zhibin Ebeling III, Robert Zhai, Huifang Anna Pfeffer, Raphael Edson, Mark Wang, Yucai Sharp, Hadley Toyama, Shingo Mizoguchi, Nobutaka Teckie, Sewit Kandula, Shravan Dandapani, Savita Kunaprayoon, Dan Patel, Nisha Heydarian, Mostafa Eaton, Bree Kim, Daniel Gerszten, Peter Park, Henry Schoenfeld, Jonathan Abuodeh, Yazan Park, Young Hee Han, Jeannie Sheybani, Arshin Kim, Byoung-Hyuck Caparrotti, Francesca Shiue, Kevin Louie, Alexander Kathpal, Madeera Pan, Hubert Pashtan, Itai Roberge, David Miyakawa, Akifumi Arvold, Nils Matsuyama, Tomohiko Rava, Paul Rava, Paul Prabhu, Roshan Ma, Lijun Lee, Dong Soo Young, Kristina Leeman, Jonathan Flickinger, John Ayala-Peacock, Diandra Marchan, Edward Nath, Sameer Becker, Stefan Tundisi, Carmen Ojerholm, Eric Roy, David Tait, Lauren Funk, Ryan 180

2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213

Bernad, Daniel Mathew, Maya Yovino, Susannah Ovalle, Valentina Szeja, Sean Harasaki, Yasuaki Leyrer, Marc Narayana, Ashwatha Kabolizadeh, Peyman Cannon, Donald Soliman, Hany

2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224

GASTROINTESTINAL CANCER Soliman, Hany Lasley, Foster Dawson, Laura Kirichenko, Alexander Brade, Anthony Scorsetti, Marta Mahadevan, Anand Chuong, Michael Hatakenaka, Masamitsu Wang, Jingya McCurdy, Matthew Qiao, Xueying Skinner, Heath Shridhar, Ravi Czito, Brian Ausborn, Natalie Yu, David Rakhra, Sunpreet Kharofa, Jordan Lloyd, Shane Mornex, Francoise Hall, William Brunner, Thomas Ngan, Samuel Engineer, Reena Landry, Jerome Doll, Corinne Koom, Woong Sub Freilich, Jessica Vainshtein, Jeffrey Kumar, Aryavarta Menichelli, Claudia Meyer, Jeffrey Ernst, Iris Ding, Jie Mikell, John Horowitz, David Wojcieszynski, Andrzej Gong, Youling Verheij, Marcel Sio, Terence Cai, Gang Kajiya, Yoshiki Quero, Laurent Yip, Connie Kobayashi, Noriko Park, Hae-jin Wang, Feng-Ming Kudo, Shigehiro

ASTRO 2012 / 54TH ANNUAL MEE TING

22 23 24 25 26 27 28 29 99 100 101 102 103 105 106 216 217 218 219 220 221 222 223 355 356 357 358 360 361 362 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 2225 2226 2227 2228 2229 2230 2231

Koike, Ryuta Ito, Hitoshi Ito, Yoshinori Atsumi, Kazushige Zhu, Shuchai Cooper, Samuel Cheng, Yufeng Chilukuri, Srinivas Yip, Connie Kowalchik, Kristin Innocente, Roberto Killoran, Joseph Wu, Abraham Hashimoto, Takayuki Lu, Wei Murakami, Yuji Xing, Ligang Ishida, Yuichi Wang, Wei Patel, Shilpen Parashar, Bhupesh Shridhar, Ravi Hsu, Feng-Ming Tey, Jeremy Ren, Hua Wang, Xin Zhang, Li Owen, Jean Aggarwal, Aditi Xing, Ligang Patel, Shilpen Shridhar, Ravi Fukada, Junichi Liu, Gene-Fu Lee, Richard Ove, Roger Rajagopalan, Malolan Nishioka, Akihito Lin, Chi Farkas, Amy Ghaly, Maged Tseng, Yolanda Brunner, Thomas Racadot, Severine Eom, Keunyong Wild, Aaron Sales, Lindsay Mellon, Eric Tunceroglu, Ahmet Gemici, Cengiz Park, Wungki Makita, Chiyoko Barney, Brandon Koo, Tae Ryool Kimura, Tomoki Zeng, Zhao-Chong Yuan, Zhi-Yong Toramatsu, Chie Oh, RyoongJin Eldredge, Harriet Yu, Jeong Il Kim, Sung hoon Bibault, Jean-Emmanuel Eaton, Bree

2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 2274 2275 2276 2277 2278 2279 2280 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2296

Lappinen, Erik Rostom, Yousri Isohashi, Fumiaki Takahashi, Shigeo Hashizume, Chisa Gupta, Pramod Lee, Seung Heon Im, Jung Ho Lee, Ann Shing Zhai, Yi Rui Wang, Po-Ming Fuss, Martin Li, Ping Liang, Shixiong Huang, Chun-Ming Stinauer, Michelle Wo, Jennifer Kim, Jun Won Schonewolf, Caitlin Wild, Aaron Hertan, Lauren Tsai, Chiao-Ling Cherian, Sheen Yoon, Hyunsik Kang, Ki Mun Ziegler, Mark Lobo, Mark Han, Hee Ji Chang, Jee Suk Abdel-Wahab, May Li, Ning Zhu, Ji Chia, David Whaley, Jonathan Xu, Benhua Wang, Yan-yang Smith, Jessica Lavrenkov, Konstantin Wang, Chia-Chun Cai, Yong Tzeng, Ching-Wei Peng, Luke Yang, Tzu-I Jonathan Bernad, Daniel Jung, Jinhong Leonard, Kara Arbea, Leire Gambacorta, Maria Antonietta Laufer, Marsha Kumar, Aryavarta Sturgeon, Jared Yu, Naichang Meyer, Joshua Kim, Jun Won Bazan, Jose Gallant, Fleure Chuong, Michael Yeung, Rosanna Mahmoud, Omar Vendrely, Veronique Hanasoge, Sheela Nuyttens, Joost Kachnic, Lisa

2297 2298 2299 2300 2301 2302 2303 2304 2305 2306 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2324.5 2325 2326 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360

Sachsman, Suzanne Vivekanandan, Sindu Baden, Craig Patel, Vaiibhav White, Evan Thawani, Nitika Lin, Chi

2361 2362 2363 2364 2365 2366 2367

GENITOURINARY CANCER Zelefsky, Michael Sandler, Howard Gospodarowicz, Mary Gray, Phillip Yu, James Spratt, Daniel Mak, Raymond Michalski, Jeff Rancati, Tiziana Jang, Joanne Musunuru, Hima Ciezki, Jay Dosoretz, Arie Rodrigues, George Schoenfeld, Jonathan Margalit, Danielle Ghadessi, Mercedeh Krauss, Daniel Tyagi, Neelam Stoyanova, Radka Zumsteg, Zachary Hamstra, Daniel Mendenhall, Nancy Sanfilippo, Nicholas Zhang, Chi Parekh, Arti Morgan, Scott Mak, Kimberley Tendulkar, Rahul Ellis, Rodney Fedewa, Stacey Huddart, Robert Efstathiou, Jason Bekelman, Justin Shipley, William Goldsmith, Benjamin Hallemeier, Christopher Skinner, Heath Arcangeli, Giorgio Katz, Alan Meier, Robert Quon, Harvey Fuller, Donald Shilkrut, Mark Yorozu, Atsunori Shimizu, Shinichi Rodrigues, George Aizer, Ayal Huang, Kris Yassa, Michael Townsend, Natasha Symon, Zvi Challapalli, Amar

3 7 8 30 31 32 33 34 35 36 37 38 140 141 142 143 144 145 146 147 224 225 226 227 228 229 230 231 232 294 295 296 297 298 299 300 301 363 364 365 366 367 368 369 370 1037 1038 1039 1040 1041 1042 1043 1044

Beyer, David Moghanaki, Drew Alexander, Jesse Martin, Jeffrey Burri, Ryan Finkelstein, Steven Weber, Damien Mourad, Waleed Mourad, Waleed Jones, Daniel Adam Ishiyama, Hiromichi Terashima, Kotaro Morimoto, Masahiro Hegde, John Ahmed, Kamran Mizowaki, Takashi Katz, Alan Haas, Jonathan Andrew Clayton, Ravinder Fortin, Israel Malone, Shawn Velker, Vikram Sato, Hiraku Shiraishi, Yutaka Terakedis, Breanne Lecavalier-Barsoum, Magali Ye, Hong Takahashi, Shinichi Dominello, Michael Hennequin, Christophe Quivrin, Magali Karlin, Jeremy Vigneault, Eric Takamatsu, Shigeyuki Mantz, Constantine Kariya, Shinji Aoki, Manabu Lawton, Colleen Marina, Ovidiu Munoz Garcia, Julia Luisa Bian, Shelly X. Bernstein, Michael Croke, Jennifer Hinojosa Gomez, Jose Jain, Anshu Sheth, Nikul Diao, Kevin Wallace, Harold Duarte, Catherine Marina, Ovidiu Nabid, Abdenour Kil, Whoon Jong Salinas, Juan Spira, Gregor Chen, Viola Torrecilla, Jose Lopez Sheldon, Thomas Gewanter, Richard Ferrer, Ferran Crook, Juanita Peroski, Michael Marshall, Richard Felix, Armando

1045 1046 1047 1048 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 2385 2386 2387 2388 2389 2390 2391 2392 2393 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 2416 2417 2418 2419 2420 2421 2422 2423 2424 2425 2426 2427

Rath, Goura Kishor Wong, Jason Naydich, Boris Takiar, Vinita Tamura, Takeshi van Lin, Emile Wilcox, Shea Kikuchi, Koyo Bortolus, Roberto Liu, Jerry Alongi, Filippo Pugh, Thomas Stock, Richard Mendenhall, Nancy Dincbas, Fazilet McGee, Lisa Vora, Sujay Tward, Jonathan Drean, Gael Ospina, Juan King, Christopher Turkevich, Vladimir Hollander, Andrew Stanic, Sinisa Welsh, James Fratamico, Robert Ranck, Mark Suderman, Derek Foster, William Ghaly, Maged Le, Yi Windsor, Apsara Song, Yeohan Frank, Steven Hayashi, Akihiro Robbins, Jared Greco, Carlo Symon, Zvi Inomata, Taisuke Smith, Ryan Jotwani, Amit Maletz, Kristina Tsvang, Lev Cox, Brett Nguyen, Brandon Nishimura, Takuya Kaminuma, Takuya Sjödin, Kristina Hijazi, Hussam Swisher-McClure, Samuel Tonlaar, Nathan Sen, Amarjit Mahmood, Usama Helou, Joelle Blacksburg, Seth Niazi, Tamim Sedlmayer, Felix Cuthbert, David Kerns, Sarah Bowes, David Hayes, John Gomez-Veiga, Francisco Galerani, Ana Paula Anwar, Moshiur

2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491

Ko, Eric Shukla, Monica Patel, Nita Kwok, Young Ester, Elizabeth Repka, Michael Kelly, Douglas Chapet, Olivier Hjalm-Eriksson, Marie Anton, Adrian Tokita, Kenneth Charissoux, Marie Kabarriti, Rafi Crehange, Gilles Guix, Benjamin Boo, Dorothy Mourad, Waleed Crehange, Gilles Lee, Richard Leapman, Michael Greer, Lester D’Alimonte, Laura Henderson, Randal Agnan, Sindy Keole, Sameer Anwar, Moshiur Schroyer, Daniel Berlach, David Moran, Brian Hunter, Grant Offor, Onyi Markovina, Stephanie Chen, Lili Martin, Andre Kim, Carolyn Kim, Carolyn Meier, Robert Lu, Sharon Lorentz, William Sostin, Oleg Ahmed, Awad Choudhury, Ananya Riou, Olivier Kurt, Meral Noa, Kate Folkert, Michael Katz, Leah Vogel, Jennifer Ho, Jennifer Allison, Ron Cascales Garcia, Maria Almudena Louie, Alexander Pham, Daniel Speight, Richard Ly, David Paly, Jonathan Zhang, Chi Kalakota, Kapila

ASTRO 2012 / 54TH ANNUAL MEE TING

2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2543 2544 2545 2546 2547 2548 2549 2550

181

GYNECOLOGICAL CANCER Schefter, Tracey Wakatsuki, Masaru Gandhi, Ajeet Zhu, He Hashem, Rania Simpson, Daniel Mayr, Nina Thomas, Maria Siva, Shankar Yoon, Hannah Yap, Mei Ling Brown, Aaron Lee, Larissa Kim, Ji Hyun Cattaneo II, Richard Dunn, Emily Cohen, Dane Robbins, Jared Barney, Brandon Gaballa, Hani Hirata, Kimiko Krishnatry, Rahul Watanabe, Miho Kasuya, Goro Refaat, Tamer Tumati, Vasu Herrera, Fernanda Vasseur, Frederique Wei, Lichun Chen, Yu-Jen Khanuja, Jasleen Murofushi, Keiko Clark, Grant Vulquin, Noamie Kannan, Neeta Nakagawa, Akiko D’Ambrosi, Rafael Rao, Yuan Vinod, Shalini Kim, Jin Hee Perez-Regadera, Jose Anderson, James Chen, Helen Rash, Dominique Julka, Pramod Esthappan, Jacqueline Chinnachamy, Anand Narayan Sharma, Daya Nand Kim, Hayeon Apicelli, Anthony Tinkle, Christopher Chopra, Supriya Christensen, Eva Mayadev, Jyoti Nickers, Philippe Bhattacharjee, Somorat Hansen, Henrik Eto, Hidehiro Erpolat, Petek Zhang, Ying Roszak, Andrzej 182

39 40 41 42 43 44 45 46 47 233 234 235 236 237 238 239 240 241 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593

Vallinayagam, S. Subramanian Shaverdian, Narek Msadabwe Chikuni, Susan Dyk, Pawel Lopez-Araujo, Javier Shen, Sui Haidar, Yarah Poorvu, Philip Eng, Tony Tokumaru, Sunao Wang, Qifeng Yaparpalvi, Ravindra Jeong, Bae Kwon Lee, Larissa Young, Melissa Chaudhry, Huma Membrive Conejo, Ismael Register, Steven Yan, Weisi Zhou, Jessica Gomez, Caitlin Aviles, Lijia Rochet, Nathalie Milgrom, Sarah Shah, Mira Chen, Andy Patel, Shyamal Frandsen, Jonathan Nagar, Himanshu Li, Hualei Townamchai, Kanokpis Yechieli, Raphael Klopp, Ann Zhu, Lihong Althaqfi, Saif Juloori, Aditya Chung, Alfred Rosen, Lane Macrie, Bryan Rey, Felipe Sharma, Charu Kirschner, Austin Hiniker, Susan Patil, Nikhilesh Wiebe, Ericka Evans, Suzanne Koay, Eugene Chino, Junzo Ruby, Ashley

2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643

HEAD AND NECK CANCER Beitler, Jonathan Skladowski, Krzysztof Machtay, Mitchell Thariat, Juliette Spencer, Christopher Hu, Kenneth Shung Al-Mamgani, Abrahim Jang, Joanne Otter, Sophie Roenjom, Marianne Feen Swisher-McClure, Samuel

ASTRO 2012 / 54TH ANNUAL MEE TING

13 48 49 50 51 52 53 54 148 149 150

Lukens, John Bhatt, Aashish Goldsmith, Tessa Hutcheson, Katherine Mittal, Bharat Scala, L. Matthew Hong, Julian Tao, Randa Kapur, Ajay Chan, Annie Wang, Tony Hu, Man Ghi, Maria Grazia Olson, Robert Rao, Nikhil Sopka, Dennis Huang, Shao Hui Hunter, Klaudia Waldron, John Kumar, Rachit Lu, Jiade Zhong, Yahua Huang, Jiayi Quon, Harry Wu, Jia-Shing Murakami, Ryuji Wu, Szu-Yuan Yoshimura, Ryo-ichi Fan, Kang-Hsing Wang, Lilie Takayama, Kanako Yao, Min Yu, Yao Montero, Pablo H. Chin, Christine Hofner, Peter Desai, Prashant Ho, Felix Chin, Christine Thorstad, Wade Wang, Tony Gunn, G. Brandon Sanguineti, Giuseppe Ricchetti, Francesco Hunter, Klaudia Housri, Nadine Beadle, Beth Baschnagel, Andrew Karakaya, Ebru Lescut, Nicolas Lee, Hyebin Nixon, Lain Newcomb, Matthew Fried, David Patel, Samir Mierzwa, Michelle Garsa, Adam Tang, Chad Rakusic, Zoran Romesser, Paul Riaz, Nadeem Silveira, William Frank, Steven Semrau, Robert

152 153 154 155 156 371 372 373 374 375 376 377 378 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 2679 2680 2681 2682 2683

Ajeet Gandhi Zia, Yaseen Charpentier, Anne-Marie Kumar, Aryavarta Caudell, Jimmy Bishop, Michael Bledsoe, Trevor Rutenberg, Michael Jang, Joanne Palmer, Matthew Guo, Gordon Crandley, Edwin Mohindra, Pranshu Lee, Joseph Lee, Ryan Riaz, Nadeem Mullapally, Sujith Kodaira, Takeshi Yi, Junlin Igdem, Sefik Pan, Jianji Chen, Jenny Ling-Yu Lin, Yu-Wei Tsuchiya, Kazuhiko Ma, Lin Golden, Daniel Ou, Xiaomin Fareed, Muhammad Lin, Qin Wang, Yu-Wen Kong, Lin Gao, Yunsheng Wu, Junxin Wang, Jin Peng, Zhang Wilson, David Sun, Yan Peng, Xu Hunter, Klaudia Lu, Haijun Li, BaoQing Nishimura, Hideki Yoshimura, Michio Yanagi, Takeshi Mok, Gary Matthiesen, Chance Kawaguchi, Hideo Cassidy, Richard Raphael, Jomon Katsoulakis, Evangelia Zhang, Hong Heijmen, Ben J.M. Johansen, Jorgen Riaz, Nadeem Hu, Man Koyfman, Shlomo Chang, Joseph Tung-Chieh Ahn, Peter Barker, Christopher Fried, David Malyapa, Robert Modesto, Anouchka Hasegawa, Azusa

2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 2735 2737 2738 2739 2740 2741 2742 2743 2744 2746 2747 2748

Hollen, Tyler Mourad, Waleed Yang, Xiaofeng Zeidan, Youssef Israel, Rebecca Israel, Rebecca Herman, Michael Stegmaier, Petra Resende Salgado, Lucas Resende Salgado, Lucas Patel, Pretesh Noble, Anisha Arneson, Kyle Oh, Jung Hun Riaz, Nadeem Romesser, Paul Arora, Shruthi Rudzianskas, Viktoras Kumaravelu, Azmi Hallemeier, Christopher Mourad, Waleed Mourad, Waleed Studer, Gabriela Perez-Romasanta, Luis Woods, Charles Ali, Arif Hunter, Klaudia Ashamalla, Hani Kagawa, Kazufumi Waters, Alexandra Vargo, John Vargo, John Balamucki, Christopher Steen, Sven Wobb, Jessica Kovalchuk, Nataliya Deraniyagala, Rohan Bradley, Julie Vlacich, Gregory Hata, Masaharu Douglas, James Keller, Lanea Yamamoto, Michinori Teckie, Sewit Yamazaki, Takuya Bhandare, Niranjan Karam, Irene Kehrer, Jason Park, Sang-June Prieto, Isabel Zia, Yaseen Romesser, Paul Anderson, Nigel Dutta, Pinaki Kropp, Lauren Chu, Karen Berlach, David El-Sayed, Samy Fujiwara, Masayuki Daly, Patricia Hansen, Christian Wang, Dian Nguyen, Nhu Tram Taguchi, Senzo

2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 2791 2792 2793 2794 2795 2796 2797 2798 2799 2800 2801 2802 2803 2804 2805 2806 2807 2808 2809 2810 2811 2812

Buatti, John Wilson, David Cotter, Ryan Amarnath, Sudha Thomas, Tarita Anderson, Carryn Alcorn, Sara Das, Shiva AlHussain, Hussain Kaufman, Isaac Sun, Jason Grover, Surbhi Rodriguez-Ruiz, Maria E. Wang, Kyle Rey, Felipe Magnuson, William Bledsoe, Trevor Anderson, Nigel Zhang, Jeanette Hoover, Andrew Alizadeh-Kashani, Moein

2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833

HEALTH SERVICES RESEARCH Ohri, Nitin Fairchild, Alysa Edge, Stephen Buscariollo, Daniela Gross, Cary Aneja, Sanjay Zakeri, Kaveh Yamoah, Kosj Mueller, Sabine Shah, Anand Hardenbergh, Patricia McCloskey, Susan Potters, Louis Famiglietti, Robin Volz, Edna Kusano, Aaron Numasaki, Hodaka Royce, Trevor Guadagnolo, B. Ashleigh Walker, Gary Mackley, Heath Nelson, Carl Jhaveri, Pavan Lester-Coll, Nataniel Parikh, Ravi Stockham, Abigail Gutovich, Jordan Mazur, Lukasz Mou, Benjamin Church, Jessica Adams, Robert Min, Christine Bahl, Gaurav Vichare, Anushree Hegarty, Sarah Hess, Clayton Russo, Andrea Champ, Colin Golden, Daniel Paryani, Nitesh

2 110 107 108 109 111 112 113 114 242 244 245 246 247 248 249 250 302 303 304 305 306 307 308 309 2834 2835 2836 2837 2838 2839 2840 2841 2842 2843 2844 2845 2846 2847 2848

Camarata, Andrew Albuquerque, Kevin Wynn, Raymond Bernard Doi, Yoshiko Lee, Lucille Blackstock, A. William Qureshi, Muhammad Murphy, James Mirabeau-Beale, Kristina Gomez, Daniel Gomez, Daniel Dvorak, Tomas Eguiguren Bastida, Mikel Johnson, Jennifer McCullough, Anna Ung, Yee Fortin, Marie Andree Pawlicki, Todd Stokes, William Sheets, Nathan Yeung, Anamaria Kapadia, Nirav Aivas, Inge Archambault, Jean Gupta, Shlok

2849 2850 2851 2852 2853 2854 855 2856 2857 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2869 2870 2871 2872 2873 2874

HISTORY Aneja, Sanjay Rana, Shushan Pfeffer, Raphael Holliday, Emma Torres, Herbert

2875 2876 2877 2878 2879

LUNG CANCER Nagata, Yasushi Platta, Christopher Senan, Suresh Cheung, Patrick Stanic, Sinisa Rosen, Lane Klement, Rainer Onishi, Hiroshi Gan, Gregory Nishimura, Yasumasa Santos, Marcos Komaki, Ritsuko Wang, Weili Fakhreddine, Mohamad Welsh, James Zhuang, Hongqing Alexander, Brian Gore, Elizabeth Wilkinson, Ben Mangona, Victor Shusharina, Nadya Tandberg, Daniel Parisi, Elisabetta Kuremsky, Jeffrey Poettgen, Christoph Molotievschi, Alerson Trovo, Marco Vinogradskiy, Yevgeniy

115 116 117 118 119 120 121 122 166 167 168 169 170 171 251 252 253 254 255 256 257 258 379 380 381 382 383 384

Moré, Jayaji Raben, David Daly, Megan Cuaron, John DeWees, Todd Liu, Yung Hsien Nygaard, Ditte Eklund Abelson, Jonathan Liriano, Melissa Milano, Michael Senthi, Sashendra Papachristofilou, Alexandros Claude, Line Stauder, Michael Mohamed, Abdallah Palma, David Dahele, Max Qiao, Xueying Fujii, Osamu Ishihara, Takeaki Matsuo, Yukinori Bar Ad, Voichita Hashizume, Chisa Chang, Ji Hyun Baba, Fumiya Yip, Connie Zheng, Xiangpeng Jain, Suneil Huang, Kitty Lee, Joo Ho Casey, Stephanie Kharofa, Jordan Werner-Wasik, Maria Ku, Lichung Xiang, Zuolin Takemoto, Shinya Prendergast, Brendan Evans, Andrew Atallah, Soha Inoue, Tetsuya Di, Liu Boggs, Hunter Crandley, Edwin Hiraoka, Masahiro Zhuang, Hong-Qing Yu, Jinming Videtic, Gregory Rosenberg, Stephen Russell, Wesley Turaka, Aruna Asai, Kaori Peters, Christopher Tsudou, Shinji Whaley, Jonathan Guo, Susan Chung, Yi Hsuan Mohan, Radhe Qi, Xiangrong Russo, James Nichols, Elizabeth Chiyama, Kaoru Mikami, Ryuji Jeongshim, Lee

ASTRO 2012 / 54TH ANNUAL MEE TING

385 386 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 2880 2881 2882 2883 2884 2885 2886 2887 2888 2889 2890 2891 2892 2893 2894 2895 2896 2897 2898 2899 2900 2901 2902 2903 2904 2905 2906 2907 2908 2909 2910 2911 2912 2913 2914 2915 2916 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 183

Aoki, Masahiko Mahe, Marc Chowdhry, Varun Kelsey, Christopher Kosaki, Katsura Currier, Blake Wang, Ping Knill, Cory Wei, Xiong Mattes, Malcolm Shultz, David Herde, Ryan Freilich, Jessica Inoue, Kazuya Cui, Yunfeng Harada, Hideyuki Blake, Monika Maquilan, Genevieve Zhang, Jiandong Onimaru, Rikiya Tajima, Yuu Ikushima, Hitoshi MacManus, Michael Tatekawa, Kotoha Wang, Suzhen Janardanan Nair, Vimoj Kesarwala, Aparna Liao, Zhongxing Parisi, Elisabetta Navarria, Pierina Rimner, Andreas Karasawa, Kumiko Garg, Shalini Peterson, David Ramamurthy, Sindhu Kesarwala, Aparna Nuyttens, Joost Perez, Carmen Rajpara, Raj Wright, Ato Vazquez, Gonzalo Senthi, Sashendra Nakajima, Naomi Okano, Naoko Mancini, Brandon Oh, Dongryul McKee, Andrea Siglin, Joshua Silveira, William Oh, Dongryul Kishi, Takahiro Wang, Hongmei Feng, Wen Ng, John King, Martin Nielsen, Tine B. Wurstbauer, Karl Appenzoller, Lindsey Vance, Sean Dar, Abdul Nijkamp, Jasper Roman, Nicholas Zhuang, Yan Juloori, Aditya 184

2930 2931 2932 2933 2934 2935 2936 2937 2938 2939 2940 2941 2942 2943 2944 2945 2946 2947 2948 2949 2950 2951 2952 2953 2954 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 2994

Shioyama, Yoshiyuki Xue, Jianxin Grant, Jonathan Pennathur, Arjun Alcorn, Sara Mancini, Brandon Singh, Deepinder Bhavsar, Shripal Maehata, Yoshiyasu Shirvani, Shervin Oguri, Mitsuhiko Yi, Sun Macdonald, Orlan Palma, David McCloskey, Paula Poettgen, Christoph Thirion, Pierre Peterson, Carl Dilling, Thomas Corradetti, Michael Ford, Victoria Murphy, Rita Sarkar, Vikren Chen, Wenzhou Lee, Joseph Chen, Wenzhou Hearn, Jason Lavaf, Amir Karasawa, Katsuyuki Kilburn, Jeremy Orcutt, Kevin Grecula, John Altoos, Taghrid Rusu, Iris Kwong, Stanley Greskovich, John Qi, Huanpeng Rineer, Justin Nakayama, Yuko Johnson, Matthew Trakul, Nicholas McAvoy, Sarah Chen, Qing Soike, Mike Kong, Feng-Ming Jabbour, Salma Xu, Yaping Xu, Huimin Wilkinson, Ben Bi, Nan Han, Chengbo Lally, Brian

2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3024 3025 3026 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047

LYMPHOMA Eich, Hans Theodor Aleman, Berthe Maraldo, Maja Vestmoe Aznar, Marianne Reinartz, Gabriele Russo, Andrea Dabaja, Bouthaina Wu, Run-Ye Goldsmith, Benjamin

ASTRO 2012 / 54TH ANNUAL MEE TING

173 174 175 176 177 178 179 180 3048

Blanchard, Miran Hunter, Bradley Michaelson, Evan Skliarenko, Julia Vernon, Matthew Dorth, Jennifer Hamilton, Sarah Valakh, Vladimir Tao, Zhen Zhang, Ximei Zhang, Ximei Zhang, Ximei Iwabuchi, Michio Xu, Li-ming Otsuka, Shinya Ohga, Saiji Chan, Cato Zhao, Ting Kim, JaYoung Lee, Sang-wook Gamez, Mauricio Khan, Luluel Wagner, Aaron Turaka, Aruna Hall, Matthew Kim, Young Suk Jones, Guy Kim, Ji Hyun

3049 3050 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3074 3075 3076 3077 3078

NONMALIGNANT DISEASE Mourad, Waleed Dulaney, Caleb Prabhu, Roshan Rosenberg, Jennifer Stea, Baldassarre

3079 3080 3081 3082 3083

PALLIATIVE CARE Chen, Aileen Khan, Luluel Murphy, James Fosker, Chris Palma, David Krishnan, Monica Hurwitz, Mark Epstein-Peterson, Zachary Chiang, Andrew Chao, Samuel Debenham, Brock Nakamura, Naoki Kress, Marie-Adele Howell, David Furlan, Carlo Kwon, Jeanny Cihoric, Nikola Rudra, Sonali Golden, Daniel Jung, Edward Martin, Jovita Murai, Taro Turkevich, Vladimir Job, Mary

4 125 126 127 128 129 1109 1110 1111 1117 3084 3085 3086 3087 3088 3089 3090 3091 3092 3093 3094 3095 3096 3097

Parvathaneni, Upendra Suh, John Casamassima, Franco Lei, Rachel Ly, Bevan Balagamwala, Ehsan

3098 3099 3100 3101 3102 3103

PEDIATRIC CANCER Dharmarajan, Kavita 12 Joo, Jihyeon 157 Brodin, Patrik 158 Verma, Jonathan 159 Mailhot, Raymond 160 Jimenez, Rachel 161 Agbahiwe, Harold 162 Paulino, Arnold 163 Redmond, Kristin 164 Vern-Gross, Tamara 165 Ahmed, Safia 396 Yang, Joanna 397 Sharma, Daya Nand 398 Yang, Joanna 399 Zhang, Chi 400 Dharmarajan, Kavita 401 Hattangadi, Jona 402 Yang, Joanna 403 Laser, Benjamin 404 Kapadia, Nirav 3105 Indelicato, Daniel 3106 King, Martin 3107 Marcus, Robert 3108 Hazariwala, Ronica 3109 Confer, Michael 3110 Lauro, Christine 3111 Lester-Coll, Nataniel 3112 Hsu, Charles 3113 Ferraris, Gustavo 3114 Su, Zhong 3115 Denniston, Kyle 3116 Yang, Joanna 3117 Kahn, Jenna 3118 Roca, Monica 3119 El-Bared, Nancy 3120 Demoor-Goldschmidt, Charlotte 3121 Kornerup, Josefine S. 3122 Prah, Douglas 3123 Dharmarajan, Kavita 3124 Fuji, Hiroshi 3125 Watanabe, Miho 3126 Kharofa, Jordan 3127 Wilson, Joella 3128 Christensen, Charlotte Birk 3129 Nwachukwu, Chika 3130 Arsenault, Daniel 3131 Peacock, Justin 3132 Rahn, Douglas 3133 QUALITY OF LIFE Hess, Clayton Buckstein, Michael Son, Christina

123 124 130

Koontz, Bridget Wong, William Agarwal, Jai Prakash Hess, Clayton Hill-Kayser, Christine Hou, Ying Hoppe, Bradford Rollmann, Denise Burt, Ashley Carpenter, Todd Tribius, Silke Dubey, Arbind Lee, Andrew Sood, Sumit Yang, Tzu-I Jonathan Lee, Tsz Kin Rashtian, Afshin Cigarral Garcia, Cristina Milecki, Piotr Rathod, Shrinivas Likhacheva, Anna Koul, Rashmi Soeder, Sherry Bryant, Curtis Adams, Todd Raval, Raju Klein, Elizabeth Abdel-Wahab, May Wang, Lin Fotouhi Ghiam, Alireza Balagamwala, Ehsan

1112 1113 1114 1115 1116 1118 1119 3134 3135 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157

SARCOMA AND CUTANEOUS TUMORS Siva, Shankar Johnson, Matthew Gerber, Naamit Bhatnagar, Ajay Chen, Yen-Lin Evelyn Sio, Terence McBride, Sean Maruyama, Katsuya Catton, Charles Best, Lara Bedi, Manpreet Valliares, Martin Liss, Adam Parvathaneni, Upendra Roberge, David Desai, Neil Hong, Angela Castle, Katherine Nuyttens, Joost Cambeiro, Mauricio Rashtian, Afshin Barker, Christopher Kang, Josephine Kramkimel, Nora Jackson, James Parvathaneni, Upendra Miki, Yoshitaka Cooper, Anna Mehta, Niraj

337 338 339 340 341 342 343 344 345 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 3158 3159 3160 3161 3162 3163 3164 3165

Kang, Josephine Rooney, Jessica Hadziahmetovic, Mersiha Spraker, Matthew Burt, Ashley Kim, Jun Won Dinçbaş, Fazilet Sharabi, Andrew Stavas, Mark Stavas Yip, Darwin Serban, Monica Vyas, Shilpa

3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177

RADIATION AND CANCER BIOLOGY Anderson, Joshua 55 Wong, Philip 56 Harima, Yoko 57 MacArthur, Kelly 58 Wei, Xiong 59 Bruce, Jeff 60 Oh, Daniel 61 Pollack, Alan 62 Williams, Terence 63 Wu, Q. Jackie 65 Yang, Eddy 181 Nowak, Kamila 182 Shibamoto, Yuta 183 Kim, In Ah 184 Eldredge, Harriet 185 Hong, Ji-Hong 186 Wang, Qifeng 187 White, Ruth 188 Chung, Caroline 189 Appenzoller, Lindsey 196 DeMarco, John 207 Jacob, Naduparambil 259 Citrin, Deborah 260 Tian, Junqiang 261 Chua, Melvin 262 Taniguchi, Cullen 263 Das, Saikat 264 Marples, Brian 265 McGee, Mackenzie 266 Stessin, Alexander 267 Dasgupta, Tina 310 Viertl, David 311 Cha, Yong 312 Ahmed, Kazi 313 Willers, Henning 314 Maity, Amit 315 Roehrich, Manuel 316 Tumati, Vasu 317 Yan, Heping 318 Schubert, Leah 387 Moore, Kevin 388 Kupelian, Patrick 389 Gayou, Olivier 390 King, Benjamin 391 Gabriel, Peter 392 Smith, Wade 393 Gandhidasan, Senthilkumar 394 Meier, Timothy 395

Hansen, James Seidel, Philipp Hedayati, Mohammad Paximadis, Peter Bonner, James Huber, Kathryn Whitley, Alexander Spiotto, Michael Baine, Michael Feng, Felix Nowsheen, Somaira

405 406 407 408 409 410 411 412 413 1025 1026

Choi, Serah McGovern, Susan Gandhi, Nishant Formenti, Silvia Chiara Willey, Christopher Das, Samayita Bakst, Richard Abazeed, Mohamed Baumann, Brian Heron, Dwight Szumacher, Ewa Ando, Yutaka Tejwani, Ajay Jhawar, Sachin Fuhrer, Russell Kapur, Ajay Sinicki, James Agarwal, Ankit Wang, Pin-Chieh Sharabi, Andrew Vaughan, Andrew Ji, ShengJun Bakhoum, Samuel Williams, Jacqueline Masunaga, Shin-ichiro Wu, Cheng-Chia Klein, Thomas Wang, Tao Pratx, Guillem Huang, Zhibin Boimel, Pamela Park, Catherine Swamy, Kumara Mallarajapatna, Govindarajan Wang, Ping Huang, Jing Okamoto, Masahiko Dyer, Brandon Ishikawa, Hitoshi Herskind, Carsten Butterworth, Karl Washington, Iman Epperly, Michael Schmitt, Adam Krueger, Sarah Epperly, Michael Fried, David Nishibuchi, Ikuno Liang, Liping Kiltie, Anne Samiee, Sara Zhang, Hui

1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 3178 3179 3180 3181 3182 3183 3184 3185 3186 3187 3188 3189 3190 3191 3192 3193 3194 3195 3196 3197 3198 3199 3200

Chiblak, Sara Epperly, Michael Epperly, Michael Epperly, Michael Janko, Matthew Bassetti, Michael Maria, Ola Epperly, Michael Goff, Julie Yin, Liangjie Milby, Abigail Kim, Jun Won Zhang, Zhenhuan Mikkelsen, Ross Sattler, Jennifer Vujaskovic, Zeljko Gerweck, Leo Sun, Rui Walker, Joshua Schmid, Thomas Sai, Sei Romesser, Paul Iwata, Hiromitsu Hasegawa, Masatoshi Matsuo, Masayuki McDermott, Sean Kuo, Yuan-Chia Wang, Chun-Chieh Lin, Yi-Ping Hung, Chiwei Bazalova, Magdalena Ma, Shihong Kim, In Ah Harada, Satoshi Wang, Andrew Guttmann, David Abidin, Caitlin Okonogi, Noriyuki Ushjima, Hiroki Oike, Takahiro Foote, Michael Zhao, Lujun Medin, Paul Yoshimoto, Yuya Li, Tao Sakata, Koh-ichi Speers, Corey Ishibashi, Naoya Dilworth, Joshua Diaz, Roberto Vuong, Te Kahn, Jenna Yu, Jennifer Abbineni, Gopal Dandapani, Savita Cao, Ning Kimple, Randall Corso, Christopher Higgins, Susan Nakayama, Masao Zhu, Guangying Perillo-Adamer, Florence Abazeed, Mohamed Parikh, Dhwani

3221 3222 3223 3224 3225 3226 3227 3228 3229 3230 3231 3232 3233 3234 3235 3236 3237 3238 3239 3240 3241 3242 3243 3245 3246 3247 3248 3249 3250 3251 3252 3253 3254 3255 3256 3257 3259 3260 3261 3262 3263 3264 3265 3266 3267 3268 3269 3270 3271 3272 3273 3274 3275 3276 3277 3278 3279 3280 3281 3282 3283 3284 3285 3286

ASTRO 2012 / 54TH ANNUAL MEE TING

185

3201 3202 3203 3204 3205 3206 3207 3209 3210 3211 3212 3213 3214 3215 3216 3217 3218 3219 3220

Akasaka, Hiroaki Allen, Bryan Pelloski, Christopher Hillman, Gilda Fasih, Aisha Hillman, Gilda Tang, Zili Cummings, Natalie Siedow, Michael Hallahan, Dennis Melzig, Claudius Groselj, Blaz Dai, Ying McBride, William Ma, C.M. Charlie Macklis, Roger Lawrence, Yaacov Blumenfeld, Philip Heravi, Mitra Speer, Tod G.Joshi, Chaitanya Horton, Janet Rutkowski, Tomasz Hall, William Akervall, Jan Blakaj, Dukagjin Wilson, George Leong, Nelson Parliament, Matthew Bratman, Scott Zaki, Bassem Chin, Michael Woodward, Wendy Kim, Dong Wook Nathan Kiltie, Anne Jarboe, John Jones, Jennifer

3287 3288 3289 3291 3292 3293 3294 3295 3296 3297 3298 3299 3300 3302 3303 3304 3305 3306 3307 3308 3309 3310 3311 3312 3313 3314 3315 3316 3317 3318 3319 3320 3321 3322 3323 3324 3325

RADIATION AND CANCER PHYSICS Arcangeli, Stefano Bray, Tracy Matuszak, Martha Noel, Camille Chen, Xiaojian Merrick, Scott Holtzer, Nienke Cazoulat, Guillaume Li, X. Allen Octave, Nadia Summers, Paige Rao, Shyam Yang, Xiaofeng Bayouth, John Deasy, Joseph Salguero, Francisco Karlsson, Kristin Pham, Ngoc Ares, Carmen Spadea, Maria Francesca Zhu, Xuping Osinga, Julia-Maria Min, Byung Jun 186

5 6 64 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 131 132 133 134

Yoshikazu, Tsunashima Nakamura, Satoshi Paganetti, Harald Moskvin, Vadim Yeh, Brian Troeller, Almut Min, Chul Hee Diot, Quentin Lee, Sangkyu Huang, Ellen Xiaoyan Guerrero, Mariana Yan, Di Batth, Sukhjeet Vineberg, Karen Howard, Michael Geneser, Sarah Meng, Bowen Keall, Paul Zhou, Su-Min Li, Hao Coolens, Catherine Ge, Jiajia Perkins, Gregory Kovalchuk, Nataliya Moraru, Ion Feng, Yuanming Yang, Cungeng Hollensen, Christian Al Sulaimani, Eman Kry, Stephen Ruan, Dan Podder, Tarun Zhen, Heming De Hertogh, Olivier Price, Samantha Czerminska, Maria Anna Letourneau, Daniel Lo, Andrea Kuang, Yu Parikh, Parag Abramowitz, Matthew Tremmel, Christoph Ngwa, Wilfred Kim, Yusung de Souza-Lawrence, Lana Sethi, Manish Chen, Xiaoming Becker, Nathan Mishra, Kavita Fahimian, Benjamin Rottmann, Joerg Taylor, Robert Persson, Gitte Zhung, Joanne Velec, Michael Christensen, James Dong, Peng Yang, Wensha Wild, Aaron Sole, Claudio Verbakel, Wilko F.A.R. Iori, Mauro Brink, Carsten Hristov, Dimitre

ASTRO 2012 / 54TH ANNUAL MEE TING

135 136 137 138 139 190 192 193 194 195 197 198 199 200 201 202 203 204 205 206 268 269 270 271 272 273 274 275 276 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 1024 1080 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1120 1121 1122

Block, Alec Weiss, Elisabeth van Sornsen de Koste, John Rong, Yi Riegel, Adam Kim, Taeho Godley, Andrew Mostafavi, Hassan Hunt, Margie McGary, John Kassas, Bassel Buzurovic, Ivan Ueda, Shinichi Foster, Ryan Shirai, Kiyonori Haridass, Anoop Zhu, Mingyao Bjerre, Troels Vergalasova, Irina Yamada, Masahiro Chen, Shifeng Peng, Jean Qin, Songbing Samuelian, Jason Wang, Jin Katoh, Norio Kong, Chi Wah Liu, Zejian Trovo, Marco Zhang, Yingjie Zhang, Yingjie Das, Indra Lin, Christie Liu, Wu Al-Hallaq, Hania Lian, Jun Sio, Terence Hullett, Craig Ju, Sang Gyu Li, Dengwang Lu, Bo Jones, Bernard Ding, George Pastore, Gabriella Jensen, Lindsay Vance, Sean Zhou, Jun Li, Ruijiang Alcorn, Sara Langsenlehner, Tanja Lee, Joo Hwan Noue, Mitsuhiro Perkinson, Andrew Speight, Richard Falk, Marianne Schreibmann, Eduard Hsu, Howard Hammoud, Rabih VanderWalde, Noam Tesfamicael, Biniam Perkins, Gregory Lazos, Dimitrios Hu, Angie

1123 1124 1125 1126 1127 1128 1129 1130 1131 3326 3327 3328 3329 3330 3331 3332 3333 3334 3335 3336 3337 3338 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 3355 3356 3357 3358 3359 3360 3361 3362 3363 3364 3365 3366 3367 3368 3369 3370 3371 3372 3373 3374 3375 3376 3377 3378 3379

Han-Oh, Sarah Mishra, Pankaj Wersall, Peter Bray, Tracy Chuang, Cynthia Saini, Jatinder Wang, Jing Azcona, Juan Diego Wang, Brian Tang, Xiaoli Cao, Yue Silva, Luis Song, Haijun Santhanam, Anand Olsen, Jeff Chen, Ting Kumar, Parvesh Park, Joo Han Lu, Haijun Lee, Yongsook Arns, Anna Michaud, Anthony Cho, Ilsung Fung, Wing Low, Daniel Tanny, Sean Olsson, Caroline Zaini, Mehran Ruggieri, Ruggero Tanooka, Masao Ludwig, Michelle Trepanier, Pierre-Yves Shang, Charles Entezari, Vahid Godley, Andrew Galland-Girodet, Sigolene Biritz, Bertrand Galland, Sigolene Park, Samuel Chibani, Omar Toltz, Allison Mensah, Apryl Jackson, Andrew Fiorino, Claudio Bhandare, Niranjan Chang, Jenghwa Vinogradskiy, Yevgeniy Ziel, Ellis Chen, Zhe Craciunescu, Oana Yue, Yong Watkins, William Damato, Antonio Snyder, Michael Nohadani, Omid Holdsworth, Clay Green, Olga Kim, Anthony Zhao, Tianyu Nasseri, Morad Yuh, William Haritha, Chiramana Shinde, Prashantkumar Matulewicz, Lukasz

3380 3381 3382 3383 3384 3385 3386 3387 3388 3389 3390 3391 3392 3393 3394 3395 3396 3397 3398 3399 3400 3401 3402 3403 3404 3405 3406 3407 3408 3409 3410 3411 3412 3413 3414 3415 3416 3417 3418 3419 3420 3421 3422 3423 3424 3425 3426 3427 3428 3429 3430 3432 3433 3434 3435 3436 3437 3438 3439 3440 3442 3443 3444 3445

Zhang, Pengpeng Wang, Yi Tohyama, Naoki Varadhan, Raj Lo, Anthony Deshpande, Shrikant Ding, Kai Hanada, Takashi Wang, Shichao Graff, Pierre Okamoto, Hiroyuki Geng, Hui Ng, Chor-yi Nuver, Tonnis Jiang, Xiaoqin Mihaylov, Ivaylo Rochet, Nathalie Obedian, Edward Hashimoto, Masatoshi Nishioka, Kentaro Nakamura, Akira Lee, Suk Wang, Jiazhou Cirino, Eileen Toyoda, Tatsuya Reese, Adam Mattes, Malcolm Qi, Xiangrong Xu, Zijie Piotrowski, Tomasz Rice, Roger Lee, Hyunjin Kim, Dongwook Jang, HongSeok Yokoi, Tomohiro Cámara, Ana Behrens, Claus McDoland, Daniel Khan, Mohammad Oh, Seungjong Skourou, Christina Mancosu, Pietro Yang, Wensha Na, Yong Hum Yang, Xiaocheng Ren, Lei Laviraj, Macharla Anjaneyulu Block, Alec Liu, Hongwei Manon, Rafael Zhen, Heming Langen, Katja Li, Jingdong Agazaryan, Nzhde Tai, An Kim, Dongwook Damato, Antonio Kumar, Rachit Kumar, Kiran Li, Shunshan Wang, Henry Lee, Jaegi Thieke, Christian

3446 3447 3448 3449 3450 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 3461 3462 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 3506 3507 3508

Kitamura, Nozomi 3509 Hoyer, Morten 3510 Takahashi, Ryo 3511 Kim, Hye Young 3512 Selek, Ugur 3513 Ellis, Rodney 3514 Kesava Ramgopal, Adavikolanu 3515 Speight, Richard 3516 Poulsen, Per 3517 Kesava Ramgopal, Adavikolanu 3518 Moore, Joseph 3519 D’agostino, Giuseppe Roberto 3520 Alkhatib, Hassaan 3521 Daniel, Nguyen 3522 Winkler, Peter 3523 Craft, David 3524 Mei, Xin 3525 Hobeika, Georges 3526 Li, Dengwang 3527 McGurk, Ross 3528 Wong, James 3529 Morrow, Natalya 3530 Daniel, Nguyen 3531 Arbea, Leire 3532 Liu, Fenghong 3533 Pak, Daniel 3534 Kishan, Amar 3535 Choi, Kihwan 3536 Liu, Fenghong 3537 Lee, Ho 3538 Zhong, Hualiang 3539 Phillips, Mark 3540 Pukala, Jason 3541 Liu, Han 3542 Pirozzi, Sara 3543 Roa, Dante 3544 Wang, Song 3545 Witten, Matthew 3546 Lorenzen, Ebbe 3547 Dalah, Entesar 3548 Berg, Ronald 3549 Lazos, Dimitrios 3550 Schinkel, Colleen 3551 Minken, Andre 3552 Murray, Louise 3553 Shusharina, Nadya 3554 Cai, Jing 3555 Dickerson, Edward 3556 Ford, Eric 3557 Ahunbay, Ergun 3558 Oehler, Christoph 3559 Chiesa, Silvia 3560 Ng, Sook Kien 3561 Stojadinovic, Strahinja 3562 Mohamad, Issa 3563 Liu, Feng 3564 Bai, Penggang 3565 Walker, Amanda 3566 Rudra, Sonali 3567 Kipritidis, John 3568 Munck af Rosenschold, Per 3569 Li, Dengwang 3570

Meyer, Kurt Kim, Joo Ho Mehta, Vivek Klaers, Jessica Li, Jun Rodriguez, Vivian Wang, Lilie Ding, Kai Jang, Sunyoung Ha, Jonathan Cagni, Elisabetta Kumar, Sanath Schuster, Jessica Folkert, Michael Li, Taoran Blasi, Olivier Wang, Jing Rahimian, Javad Orton, Matthew Ishihara, Takeaki Gunter, Tyler Mampuya, Ange Wambaka Wong, Wing Kei Rebecca Ueda, Yoshihiro Fumagalli, Ingrig Ding, Chuxiong Marwaha, Gaurav Sole, Claudio Seco, Joao Zhang, Qinghui Janardanan Nair, Vimoj Xue, Jinyu Blakaj, Dukagjin Liang, Yun Kim, Siyong Kim, Grace Gwe-Ya Akino, Yuichi Lilley, John Buleteanu, Manuela Stanescu, Teo Kurtz, Goldie Khodri, Mustapha Djemil, Toufik Cengiz, Mustafa Verbakel, Wilko F.A.R. Ju, Andrew Sunyach, Marie Pierre Hampton, Carnell Thakur, Varun Singh Liu, Haisong Xu, Qianyi Varadhan, Raj Ling, Diane Diaconu, Claudiu Wang, Fen Meral, Rasim Chung, Yoonsun Xiang, Hong Song, Yulin Saito, Akito Kim, Carolyn Kawamura, Mariko Henkner, Katrin

3571 3572 3573 3574 3575 3576 3577 3578 3579 3580 3581 3582 3583 3584 3585 3586 3587 3588 3590 3591 3592 3593 3594 3595 3596 3597 3598 3599 3600 3602 3604 3605 3606 3607 3608 3609 3610 3611 3612 3613 3614 3615 3616 3617 3618 3619 3620 3621 3622 3623 3624 3625 3626 3627 3628 3629 3630 3631 3632 3633 3634 3635 3636

Rah, Jeong-Eun Seco, Joao Zheng, Yuanshui Saitoh, Jun-ichi Klein, Eric Dhanesar, Sandeep Inokuchi, Haruo Ju, Sang Gyu Kainz, Kristofer Liu, Wei Swisher-McClure, Samuel Yeung, Daniel Li, Heng Mahajan, Anita Kamikubo, Yoshifumi Mori, Shinichiro Yeh, Brian Jia, Xun Mukai, Masami Schneider, Ralf Egashira, Yusuke Avadhani, Jaiteerth Lee, Tae Kyu Arjomandy, Bijan Choi, Seungtaek Zheng, Yuanshui Nguyen, Quynh Giantsoudi, Drosoula Habermehl, Daniel Cook, April Palmer, Matthew Nguyen, Quynh Mirkovic, Dragan Milby, Abigail Yajnik, Santosh Park, Su Yeon Song, Xiaofei Sahoo, Narayan Izaguirre, Enrique W. Chang, John Han-Chih Iftimia, Ileana Alezra, Dror Mourad, Waleed Nakamura, Mitsuhiro Mukumoto, Nobutaka Miyahara, Yoshinori Yamamoto, Hideo Paulson, Eric Ishihara, Yoshitomo Murai, Taro Markel, Daniel Cormack, Robert Cui, Guoqiang Canbolat, Abdulmecit Lu, Lanchun Cheung, Kin Yin Yang, Yun Hashem, Rania Akimoto, Mami Lee, Nancy Hu, Weigang Ferreira, Maria Clara Korideck, Houari Epperly, Michael

ASTRO 2012 / 54TH ANNUAL MEE TING

3637 3638 3639 3640 3641 3642 3643 3644 3645 3646 3647 3648 3649 3650 3651 3652 3653 3654 3655 3656 3657 3658 3659 3660 3661 3662 3663 3664 3665 3666 3667 3668 3669 3670 3671 3672 3673 3674 3675 3676 3677 3678 3679 3680 3681 3682 3683 3684 3685 3686 3687 3688 3689 3690 3691 3692 3693 3694 3695 3696 3697 3698 3699 3700 187

Mahmoud, Omar Thomas, Evan Santanam, Lakshmi Kantz, Steffi Tsuyoshi, Ikeda Jeong, Ho Jin Mihaylov, Ivaylo Masi, Laura Almaghrabi, Mohammed Wu, Qiuwen Jin, Jian-Yue Subramanian, Sai Welliver, Meng Sung, Wonmo Kim, Jung-in Cho, Yu Ra Bazalova, Magdalena Ciernik, Ilja Kjer, Hans Martin Yalman, Deniz Xie, Jiang Sansourekidou, Parthena Handsfield, Lydia Kemp, Jeffrey Carpenter, Colin Herranz, Elena Wijesooriya, Krishni Wiebe, Ericka Greskovich, John Guerra Gutierrez, Pedro Paudel, Nava Diwanji, Tejan Kim, Grace Gwe-Ya Vieira, Andre Mashouf, Shahram Unal, Semra Huang, Long Anand, Aman Weinberg, Rebecca Joh, Daniel Kavanaugh, James Ehler, Eric Song, Yulin

188

3701 3702 3703 3704 3705 3706 3707 3708 3709 3710 3711 3712 3713 3714 3715 3716 3717 3718 3719 3720 3721 3722 3723 3724 3725 3726 3727 3728 3729 3730 3731 3732 3733 3734 3735 3736 3737 3738 3739 3740 3741 3742 3743

ASTRO 2012 / 54TH ANNUAL MEE TING

INSIDE: Exhibitor List Exhibitor List by Product/Service Floor Plan

INDUSTRY-EXPERT THEATER Front of Hall A, Exhibit Hall This activity allows companies to present their noteworthy products and services through a live presentation in the Industry-Expert Theater located in the Exhibit Hall. Seating is available on a first-come, first-served basis. A box lunch will be provided. The Industry-Expert Theater content and views expressed therein are those of the Exhibitor and not of ASTRO.

Sunday

Monday

Tuesday

12:45 p.m. - 1:45 p.m.

12:30 p.m. - 1:30 p.m.

12:00 p.m. - 1:00 p.m.

October 28, 2012

Clinical Trial Update: Anchored Transponder in Lung Cancer Patients Goals and Objectives of the Trial, Current Status and Future Potential Presented by Varian Medical Systems Contact: Shari Huffine Phone: 650-424-5938

October 29, 2012

Accuray Showcases Leading-edge Treatment Solutions at ASTRO 2012 with New Clinical Advancements in the Field of Radiosurgery and Radiation Therapy Presented by Accuray Contact: [email protected]

October 30, 2012

The Role of Zevalin in the Treatment of Low Grade or Follicular Lymphoma Presented by Spectrum Pharmaceuticals Inc. Contact: Linda Azarbal Phone: 949-743-9347

Thank you

Recognizing ASTRO’s 2012 Corporate Members .decimal a-fabco Inc. Acceletronics/Rad Parts Accuray Advanced Particle Therapy Aktina Corporation Alliance Oncology AMAC Amgen Inc. BARD Medical Division Bayer Healthcare Pharmaceuticals The Bergendahl Institute Biocompatibles Inc. Bionix Radiation Therapy Boehringer Ingelheim Pharmaceuticals Bogardus Medical Systems Inc. Brainlab Bristol-Myers Squibb Cancer CarePoint Inc. Cianna Medical CIVCO Medical Solutions CompHealth Locum Tenens D3 Radiation Planning Diacor Inc. Eckert & Ziegler Bebig Elekta Equicare Health Inc. Gammex Inc. GE Healthcare

Genomic Health Hologic Inc. IBA IntraOp Medical Corporation IsoRay Medical Inc. James L. Davis Inc. Klarity Medical Products Landauer Inc. LAP of America LLC Leighton McGinn MedTech Billing Services Inc. Mevion Medical Systems Mick Radio-Nuclear Instruments Inc. MIM Software Inc. Modus Medical Devices Inc. MRP Inc. NELCO New Bedford Corporation Nuclear Shielding Supplies & Service Oncology Services International Oncura Inc. Oncure Medical Corporation Philips Healthcare Pitts Little Corporation ProNova Solutions LLC ProTom International Inc. Prowess Inc. PTW Qfix RAD Technology Medical Systems

CO R P O R AT E M E M B E R

RadiaDyne Radiation Business Solutions Radiation Oncology Resources Radiation Products Design Inc. Radiological Imaging Technology (RIT) RADMAX Ltd. RaySearch Laboratories RC Billing Revenue Cycle Inc. Scandi Dos Sensus Healthcare Siemens Healthcare Spectrum Pharmaceuticals Standard Imaging Sun Nuclear Corporation TGM2 Theragenics Corporation TRG Oncology Equipment US Radiosurgery Vantage Oncology Varian Medical Systems Veritas Medical Solutions Veriteq Corporation Vertual Ltd. ViewRay Inc. Vision RT VisionTree Weatherby Healthcare Xoft Inc. Xstrahl

Exhibitor List EXHIBITOR NAME

BOOTH#

.decimal 7003 121 Central Park Place Sanford, FL 32771 Phone: 1-800-255-1613 Email: [email protected] Website: www.dotdecimal.com 21st Century Oncology 6055 2270 Colonial Boulevard Fort Myers, FL 33907 Phone: 239-931-7333 Email: [email protected] Website: www.21stcenturyoncology.com A2J Laser America Corporation 11085 Parc d’Activité des Vallières, 5 allée des Rousselets Thorigny sur Marne, 77 77400 France Phone: 0033-0-160-9422-99 Email: [email protected] Website: www.a2jlaser.com Acceletronics/RadParts 11013 602 Gordon Drive Exton, PA 19341 Phone: 1-800-543-5144 Email: [email protected] Website: www.acceletronics.com R AccuBoost 3055 1 Industrial Way Tyngsboro, MA 01879 Phone: 978-649-0007 Email: [email protected] Website: www.accuboost.com R Accuray Inc. 1310 Chesapeake Terrace Sunnyvale, CA 94089 Phone: 408-716-4757, ext. 226 Email: [email protected] Website: www.accuray.com A R Advanced Radiation Inc. Measurements 601 NE Emerson Street Port St. Lucie, FL 34983 Phone: 772-340-3279 Email: [email protected] Website: www.armx2000.com

LEGEND A Ambassador P Platinum Sponsor G Gold Sponsor S B

Silver Sponsor Bronze Sponsor

C Copper Sponsor R Enhanced RO MarketPlace Listing Corporate members in bold.

7101

7011

EXHIBITOR NAME

BOOTH#

Advanced Shielding Technologies Inc. 11059 23355 L&N Turnpike, Building F West Point, KY 40177 Phone: 502-922-3009 Email: [email protected] Website: www.advancedshieldingtechnologies.com Advanced Technology and Co. Ltd. Materials 7096 Zone C. No. 10 Youngcheng Beilu, Young Feng Industrial Base, Haidium Beijing, 100096 China Phone: 86-587-173-0180-08 Email: [email protected] Aktina Medical Corporation 4077 360 Route 9W North Congers, NY 10920 Phone: 888-433-3380 Email: [email protected] Website: www.aktina.com R ALATRO 9097 C/ Castelló 128 1º Madrid, 28006 Spain Phone: 51-142-295-94 Email: [email protected] Website: www.alatro.org Algeta 11062 210 Broadway Street, 4th Floor Cambridge, MA 02139 Phone: 617-225-2301 Email: [email protected] Website: www.algeta.com Alphatron Linac 8008 5 Penn Plaza, 23rd Floor New York, NY 10001 Phone: 646-845-1914 Website: www.alphatronlinac.com R American Association of Medical Dosimetrists 8011 2201 Cooperative Way, Suite 600 Herndon, VA 20171 Phone: 703-677-8071 Email: [email protected] Website: www.medicaldosimetry.org American College of Radiology 7092 1891 Preston White Drive Reston, VA 20191 Phone: 703-648-8900 Email: [email protected] Website: www.acr.org R AMAC 8014 2864 Johnson Ferry Boulevard Suite 150 Marietta, GA 30062 Phone: 770-693-6031 Email: [email protected] Website: www.amac-usa.com R

EXHIBITOR NAME

BOOTH#

American Radium Society 6056 11300 West Olympic Boulevard Suite 600 Los Angeles, CA 90064 Phone: 310-437-0581 Email: [email protected] Website: www.americanradiumsociety.org ASTRO Resource Center 8043 8280 Willow Oaks Corporate Drive, Suite 500 Fairfax, VA 22031 Phone: 1-800-962-7876 Email: [email protected] Website: www.astro.org American Society of Clinical Oncology 10118 2318 Mill Road, Suite 800 Alexandria, VA 22314 Phone: 703-299-0158 Email: [email protected] Website: www.asco.org American Society of Radiologic Technologists 7006 15000 Central Avenue SE Albuquerque, NM 87123-3909 Phone: 505-298-4500 Email: [email protected] Website: www.asrt.org Anatom-e XRT Information Systems Ltd. 6107 2047 University Boulevard Houston, TX 77030 Phone: 713-382-3638 Email: [email protected] Website: www.anatom-e.com AQUILAB 7095 Parc Eurasante 250, rue Salvador Allende Loos Les Lille, 59120 France Phone: 00-333-696-1515-1 Email: [email protected] Website: www.aquilab.com R architection 10073 425 W. Market Street Louisville, KY 40202 Phone: 502-561-1024 Email: [email protected] Website: www.architection.com R Augmenix 2023 204 2nd Avenue, Lower Level Waltham, MA 02451 Phone: 781-902-1625 Email: [email protected] Website: www.augmenix.com Azimuth Therapy 2021 68 B Amal Street Petach Tikva, 49513 Israel Phone: 972-3-927-8111 Email: [email protected] Website: www.azimutherapy.com

ASTRO 2012 / 54TH ANNUAL MEE TING

191

EXHIBITOR NAME

BOOTH#

Bard, Rao + Athanas Consulting Engineer LLC 7062 311 Arsenal Street Watertown, MA 02472 Phone: 617-925-8374 Email: [email protected] Website: www.brplusa.com Bayer HealthCare 4055 6 West Belt Wayne, NJ 07470 Phone: 973-305-5000 Email: [email protected] Website: www.bayerus.com G Best Medical International Inc. 4005, 6003, 9079,10031 7643 Fullerton Road Springfield, VA 22153 Phone: 703-451-2378 Email: [email protected] Website: www.teambest.com R Biocompatibles Inc. 8037 115 Hurley Road, Building 3 Oxford, CT 06478 Phone: 203-262-4198 Email: [email protected] Website: www.biocompatiblesinc.com R Bionix Radiation Therapy 9067 5154 Enterprise Boulevard Toledo, OH 43612 Phone: 419-727-8421, ext. 222 Email: [email protected] Website: www.bionixrt.com BK Medical 6013 BK Medical, 8 Centennial Drive Peabody, MA 01960 Phone: 978-326-1300 Email: [email protected]om Website: www.bkmed.com Bogardus Medical Systems Inc. 5055 3555 N. W. 58th Street, Suite 500 Oklahoma City, OK 73112 Phone: 405-917-0500 Email: [email protected] Website: www.oncochart.com R

LEGEND A Ambassador P G S

Platinum Sponsor Gold Sponsor Silver Sponsor

B Bronze Sponsor C Copper Sponsor R Enhanced RO MarketPlace Listing

EXHIBITOR NAME

Cangene Corporation 920 Cassatt Rd., Suite 100 Berwyn, PA 19312 Email: [email protected] Website: www.cangene.com Carl Zeiss Meditec Inc. 5160 Hacienda Drive Dublin, CA 94568 Phone: 925-557-4100 Email: [email protected] Website: www.meditec.zeiss.com CDR Systems Inc. #33, 235105 Wrangler Drive, SE Calgary, AB T1X 0K3 Canada Phone: 403-850-7035 Email: [email protected] Website: www.cdrsys.ca R Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Phone: 202-690-8267

Corporate members in bold. 192

BOOTH#

Brainlab 5037 3 Westbrook Corporate Center, Suite 400 Westchester, IL 60154 Phone: 708-409-1343 Email: [email protected] Website: www.brainlab.com A R BSD Medical Corp. 6007 2188 W 2200 S Salt Lake City, UT 84119 Phone: 801-972-5555 Email: [email protected] Website: www.bsdmedical.com R Business Services International Inc. 13045 22 East Church Street Martinsville, VA 24112 Phone: 1-866-768-6886 Email: [email protected] Website: www.bizservint.com Cancer CarePoint Inc. 8015 17 Executive Park Drive, Suite 520 Atlanta, GA 30329 Phone: 1-800-998-5859 Email: [email protected] Website: www.cancercarepoint.com R Cancer Treatment Centers of America 10063 2610 Sheridan Road Zion, IL 60099 Phone: 847-746-4441 Email: [email protected] Website: www.cancercenter.com

ASTRO 2012 / 54TH ANNUAL MEE TING

3030

2049

3063

3060

EXHIBITOR NAME

BOOTH#

Cholangiocarcinoma Foundation, The 13009 10 West Broadway, Suite 700 Salt Lake City, UT 84101 Phone: 707-481-8045 Website: www.cholangiocarcinoma.org Churchill Consulting Inc. 7012 384 Route 148 Killingworth, CT 06419 Phone: 860-663-5630 Email: [email protected] Website: www.churchillconsulting.com R Cianna Medical 7002 6 Journey, Suite 125 Aliso Viejo, CA 92656 Phone: 949-360-0059 Email: [email protected] Website: www.ciannamedical.com CIRS 5101 2428 Almeda Avenue, Suite 316 Norfolk, VA 23513 Phone: 757-855-2765 Email: [email protected] Website: www.cirsinc.com R CIVCO Medical Solutions 10003 1401 8th Street SE Orange City, IA 51041 Phone: 712-737-8688 Email: [email protected] Website: www.civco.com S R ClinicMax 9062 20271 Goldenrod Lane, Suite 2045 Germantown, MD 20876 Phone: 240-668-4825 Email: [email protected] Website: www.clinicmax.com Cold Shot Chillers 12062 14020 Interdrive West Houston, TX 77032 Phone: 281-227-8400 Email: [email protected] Website: www.waterchillers.com R Computerized Radiation Scanners Inc. 9006 140 Sopwith Drive Vero Beach, FL 32968 Phone: 772-562-0405 Email: [email protected] Website: www.beamscanners.com CR Bard Inc. 11054 13183 Harland Drive Covington, GA 30014 Phone: 770-784-6399 Email: [email protected] Website: www.bardbiopsy.com

EXHIBITOR NAME

BOOTH#

C-RAD Incorporated 3077 8059 Rose Marie Avenue East Boynton Beach, FL 33472 Phone: 561-742-9260 Email: [email protected] Website: www.c-rad.se R D3 Oncology Solutions 13031 5750 Centre Avenue, Suite 500 Pittsburgh, PA 15206 Phone: 412-365-0719 Email: [email protected] Website: www.d3onc.com R Dana-Farber/ Brigham and Women’s 7009 Cancer Center 450 Brookline Avenue Boston, MA 02215 Phone: 617-632-5859 Email: [email protected] Dansko’s by Alexanders 13067 999 Pontiac Avenue Cranston, RI 02920 Phone: 401-490-2910 Demos Medical Publishing 8005 11 West 42nd Street, 15th Floor New York, NY 10036 Phone: 212-683-0072, ext. 217 Email: [email protected] Website: www.demosmedpub.com Department of Veterans Affairs (HRRO) 13010 1555 Poydras Street, Suite 1971 New Orleans, LA 70112 Phone: 504-565-4844 Email: [email protected] Website: www.vacareers.va.gov R Destiny Educational Services Inc. 2019 15 Noble Avenue Pittsburgh, PA 15205 Phone: 412-875-5992 Email: [email protected] Website: www.destinyeducates.com R DIACOR 4031 2550 Decker Lake Boulevard, Suite #26 Salt Lake City, UT 84119 Phone: 763-227-2256 Email: [email protected] Website: www.diacorinc.com R DOSIsoft 8092 45-47 Avenue Carnot Cachan, 94230 France Phone: 33-141-242-626

EXHIBITOR NAME

BOOTH#

e+CancerCare 9055 104 Woodmont Boulevard, Suite 500 Nashville, TN 37205 Phone: 615-467-7407 Email: [email protected] Website: www.epluscancercare.com e2v 8006 520 White Plains Road, Suite 450 Tarrytown, NY 10591 Phone: 914-592-6050 Email: [email protected] Website: www.e2v.com Eckert & Ziegler BEBIG 8094 Robert-Rössle-Strasse 10 Berlin, 13125 Germany Phone: 49-30-941084-272 Email: [email protected] Website: www.bebig.eu El Dorado Metals Inc. 12029 122 Pellizzari Place El Dorado, AR 71730 Phone: 870-863-5757 Email: [email protected] Website: www.eldomet.com R Elekta 5067 4775 Peachtree Industrial Boulevard Norcross, GA 30092 Phone: 770-670-2592 Email: [email protected] Website: www.elekta.com A R Elsevier 9002 1600 JFK Boulevard Philadelphia, PA 19103 Phone: 215-239-3490 Email: [email protected] Website: www.us.elsevierhealth.com Enterade USA LLC 9119 14407 SW 2nd Place, Building F-2 Newberry, FL 32669 Phone: 1-855-ENTERADE Email: [email protected] Website: www.enterade.com Equal-Estro Inc. 185 Alewife Brook Parkway, #40 Cambridge, MA 02138 Phone: 32-277-681-53 Website: www.equal-estro.org Everson Tesla Inc. 615 Daniels Road Nazareth, PA 18064 Phone: 610-216-6279 Email: [email protected] Website: www.eversontesla.com Foss Therapy Services Inc. 5938 Satsuma Avenue North Hollywood, CA 91601 Phone: 626-818-3880 Email: [email protected] Website: www.fosstherapyservices.net

12015

11072

12013

EXHIBITOR NAME

BOOTH#

Gamma Basics 3032 175 Strafford Avenue, Suite 1 #509 Wayne, PA 19087 Phone: 1-888-980-0077 Email: [email protected] Website: www.gammabasics.com Gammex Inc. 9037 7600 Discovery Drive Middleton, WI 53562 Phone: 608-828-7000 Email: [email protected] Website: www.gammex.com R GE Healthcare 4036 P.O. Box 414 Milwaukee, WI 53201 Phone: 414-788-1880 Email: [email protected] Website: www.gehealthcare.com A Genomic Health Inc. 8059 301 Penobscot Drive Redwood City, CA 94063 Phone: 866-ONCOTYPE Email: [email protected] Website: www.OncotypeDX.com Global Physics Solutions 13019 2 Science Road Glenwood, IL 60425 Phone: 1-877-476-8433 Email: [email protected] Website: www.landauermp.com GMV 6101 Isaac Newton, 11 Tres Cantos, Madrid 28760 Spain Phone: 34-918-072-100 Email: [email protected] Website: www.gmv.com R Gold Anchor 6061 Vassvagen 21 Huddinge, 14139 Sweden Phone: 46-706-105-411 Email: [email protected] Website: www.fineneedlemarker.com Grensuny Medical Technology Stock Co. Ltd. 11049 Room 2110 Profit Yinglong Plaza No. 76, West Huangpu Road Guangzhou, Guangdong 510623 China Phone: 86-203-839-1505 /38391508 Email: [email protected] Website: www.grensuny.com H & H Design-Build 5054 130 East Main Street New Albany, IN 47150 Phone: 812-944-2396 Email: [email protected] Website: www.hhdesignbuild.com R

ASTRO 2012 / 54TH ANNUAL MEE TING

193

EXHIBITOR NAME

BOOTH#

Healthcare Administrative Partners 12054 112 Chesley Drive Media, PA 19063 Phone: 610-892-8889 Email: [email protected] Website: www.hapusa.com R Healthcare Global Enterprises 7093 # 8, P Kalinga Rao Road, Tower IV, HCG, Sampaniramnagar Bangalore, Karnataka 560027 India Phone: 91-804-020-6058 Website: www.hcgoncology.com Hermes Medical Solutions Inc. 7007 710 Cromwell Drive, Suite A Greenville, NC 27858 Phone: 866-437-6372 Email: [email protected] Website: www.hermesmedical.com Hitachi Aloka Medical 4088 10 Fairfield Boulevard Wallingford, CT 06492 Phone: 1-800-872-5652 Email: [email protected] Website: www.hitachi-aloka.com Hitachi America Ltd. 4084 50 Prospect Avenue Tarrytown, NY 10591 Phone: 914-332-5800 Email: [email protected] Website: www.hitachi-america.us Hologic Inc. 3049 35 Crosby Drive Bedford, MA 01730 Phone: 781-999-7300 Website: www.hologic.com R IBA 3019 Chemin du Cyclotron, 3 Louvain-la-Neuve, 1348 Belgium Phone: 32-470-048-622 Email: [email protected] Website: www.iba-worldwide.com A

LEGEND A Ambassador P G S

Platinum Sponsor Gold Sponsor Silver Sponsor

B Bronze Sponsor C Copper Sponsor R Enhanced RO MarketPlace Listing

EXHIBITOR NAME

Imaging Technology News 3030 West Salt Creek Lane, Suite 201 Arlington Heights, IL 60005 Phone: 847-391-1000 Email: [email protected] Website: www.itnonline.com ImpediMed Inc. 2850 Clover Street Pittsford, NY 14534 Phone: 1-877-247-0111 Website: www.impedimed.com R InSightec Ltd. 5 Nachum Heth Street Tirat Carmel, 39120 Israel Phone: 972-54-6374738 Email: [email protected] Website: www.insightec.com Integrated Oncology Network 2865 E. Coast Highway, Suite 210 Corona del Mar, CA 92625 Phone: 949-208-3111 Email: [email protected] Website: www.ion-llc.com IntraOp Medical Corporation 570 Del Rey Avenue Sunnyvale, CA 94085 Phone: 408-636-1020 Website: www.intraopmedical.com R IOP Publishing 150 S. Independence Mall W., Suite 929 Philadelphia, PA 19106 Phone: 215-627-0880 Email: [email protected] Website: publishing.iop.org Iron Medical Systems Inc. 3104 E. Camelback Road #562 Phoenix, AZ 85016 Phone: 602-343-6440 Email: [email protected] Website: www.ironmedicalsystems.com IsoAid LLC 7824 Clark Moody Boulevard Port Richey, FL 34668 Phone: 727-207-5973 Email: [email protected] Website: www.isoaid.com R IsoRay Medical Inc. 350 Hills Street, Suite 106 Richland, WA 99354 Phone: 520-240-4840 Email: [email protected] Website: www.isoray.com

Corporate members in bold. 194

ASTRO 2012 / 54TH ANNUAL MEE TING

BOOTH#

7010

2048

3033

11091

7094

8010

8013

6060

10055

EXHIBITOR NAME

BOOTH#

IZI Medical Products a Landauer Company 9059 5 Easter Court, Suite J Owings Mills, MD 21117 Phone: 410-594-9403 Email: [email protected] Website: www.izimed.com James L. Davis 7015 13521 Walsingham Road Largo, FL 33774 Phone: 727-596-0408 Email: [email protected] Website: www.jld-radcon.com R Karger Publishers Inc. 8003 26 West Avon Road, P.O. Box 529 Unionville, CT 06085 Phone: 860-675-7834 Email: [email protected] Website: www.karger.com Klarity 7063 80 Westgate Drive Newark, OH 43055 Phone: 740-788-8107 Email: [email protected] Website: www.klaritymedical.com R KOS Systems 1217 Floribunda Avenue, #4 Burlingame, CA 94010 Phone: 714-655-3152 Website: www.kossystems.com Kyoto Kagaku Co. Ltd. 3109 Lomita Boulevard Torrance, CA 90505 Phone: 310-325-8860 Email: [email protected] Website: www.kyotokagaku.com Landauer Medical Physics 2 Science Road Glenwood, IL 60425 Phone: 1-877-476-8433 Email: [email protected] Website: www.landauermp.com LAP of America LLC 1701 Avenda del Sol Boca Raton, FL 33432 Phone: 561-416-9250 Email: [email protected] Website: www.lap-laser.com R Liberty Medical Inc. 22135 Davis Drive #112 Sterling, VA 20164 Phone: 1-888-257-2408 Email: [email protected] Website: www.libertymedicalinc.com R

3058

11055

13019

3001

6100

EXHIBITOR NAME

BOOTH#

LifeLine Software Inc. 8119 2407 Pemberton Place Austin, TX 78703 Phone: 866-592-1343, ext. 1 Email: [email protected] Website: www.lifelinesoftware.com R LinaTech LLC 8086 1294 Kifer Road, Suite 705 Sunnyvale, CA 94086 Phone: 408-733-2051 Email: [email protected] Website: www.linatech.com R Linbeck Group LLC 3031 3900 Essex Lane, Suite 1200 Houston, TX 77027 Phone: 832-922-0244 Email: [email protected] Website: www.linbeck.com Lippincott Williams and Wilkins/WKH 4028 Two Commerce Square 2001 Market Street Philadelphia, PA 19103 Phone: 215-521-8300 Email: [email protected] Website: www.lww.com Locumtenens.com 5105 2655 Northwinds Parkway Alpharetta, GA 30009-2280 Phone: 770-643-5559 Email: [email protected] Website: www.locumtenens.com Logos Systems Int’l 175 El Pueblo Road Scotts Valley, CA 95066 Phone: 831-439-9440 Email: [email protected] Website: www.logosvisionsystem.com MASEP Infini 17870 Castleton Street, Suite 395 Industry, CA 92509 Phone: 626-965-3200 Email: [email protected] Website: www.masepinfini.com

3062

11079

Math Resolutions LLC 1019 5975 Gales Lane Columbia, MD 21045 Website: www.mathresolutions.com Maxim Government Services 12060 7227 Lee DeForest Drive Columbia, MD 21046 Phone: 1-877-306-4429 Email: [email protected] Website: www.maximgov.com Medical Business Systems 6011 59 Damonte Ranch Parkway, B-185 Reno, NV 89521 Phone: 775-453-3193 Email: [email protected] Website: www.iridiumsuite.com

EXHIBITOR NAME

BOOTH#

Medical Dosimetrist Certification Board (MDCB) 9058 15000 Commerce Parkway, Suite C Mt. Laurel, NJ 08054 Phone: 856-642-4430 Email: [email protected] Website: www.mdcb.org Medical Mediation Services LLC 13073 P.O. Box 2409 Pearland, TX 77588 Phone: 225-439-2977 Email: [email protected] Medspira 11060 2718 Summer Street NE Minneapolis, MN 55413 Phone: 612-789-0013 Website: www.medspira.com MEI Healthcare Group 4091 11772 West Sample Road Coral Springs, FL 33065 Phone: 954-341-3302 Email: [email protected] Website: www.mei.com R Mevion Medical Systems 12037 300 Foster Street Littleton, MA 01460 Phone: 978-540-1500 Email: [email protected] Website: www.mevion.com G R MGS Research 6103 1 Orchard Park Road, Suite 6 Madison, CT 06443 Phone: 203-245-3251 Email: [email protected] Website: www.mgsresearch.com Miaderm at Aiden Industries 6054 2412 Calle San Miguel Encinitas, CA 92024 Phone: 617-461-5959 Email: [email protected] Website: www.miaderm.com Mick Radio Nuclear-Instruments Inc. 9036 521 Homestead Avenue Mount Vernon, NY 10550 Phone: 914-667-3999 Website: www.micknuclear.com R Micropos Medical AB 4073 Stena Center 1 Gothenburg, 41292 Sweden Phone: 46-31-772-8099 Email: [email protected] Website: www.micropos.se R

EXHIBITOR NAME

BOOTH#

MIM Software 25200 Chagrin Boulevard, Suite #200 Cleveland, OH 44122 Phone: 216-455-0600 Email: [email protected] Website: www.mimsoftware.com R Mirada Medical 999 18th Street, Suite 2025N Denver, CO 89292 Phone: 1-877-872-2617 Email: [email protected] Website: www.mirada-medical.com

3013

5109

Mission Search 5072 2203 N. Lois Avenue, Suite 1225 Tampa, FL 33607 Phone: 1-800-410-2009 Email: [email protected] Website: www.missionsearchusa.com Mitsubishi Electric 8061 2-7-3 Marunouchi Chiyoda-ku Tokyo, 100-8310 Japan Phone: 81-3-3218-9780 Email: [email protected] Website: www.mitsubishielectric.com/bu/ particlebeam R Mobius Medical Systems LP 13037 512 Tamarisk Street Bellaire, TX 77401 Phone: 1-888-263-8541 Email: [email protected] Website: www.mobiusmed.com Modus Medical Devices Inc. 5059 1570 North Routledge Park London, ON N6H 5L6 Canada Phone: 519-438-2409 Email: [email protected] Website: www.modusmed.com MPM Medical Inc. 3029 2301 Crown Court Irving, TX 75038 Phone: 972-893-4090 Website: www.mpmmed.com R MuCheck-Oncology Data Systems 5090 1601 SW 89th Street E-100 Oklahoma City, OK 73159 Phone: 405-680-5222 Email: [email protected] Website: www.mucheck.com Multidata Systems International Corp. 6102 10816 Indian Head Industrial Boulevard St Louis, MO 63132 Phone: 314-968-6880 Email: [email protected] Website: www.multidata-systems.com

ASTRO 2012 / 54TH ANNUAL MEE TING

195

EXHIBITOR NAME

BOOTH#

National Medical Professional RRG Inc. 10096 P.O. Box 50933 Fort Myers, FL 33994 Phone: 1-888-804-9556 Email: [email protected] Website: www.nmpinsurance.com R NELCO 9085 2 Burlington Woods Drive, Suite 300 Burlington, MA 01803 Phone: 781-933-1940 Email: [email protected] Website: www.nelcoworldwide.com R Niigata Mechatronics Co. Ltd. 7091 3268-18, Shimami-cho, Kita-ku Niigata-city, 950-3102 JP Japan Phone: 81-25-255-3932 Email: [email protected] Website: www.niigata-kiden.co.jp Oncolink-University of Pennsylvania 10056 Perleman Center for Advanced Medicine 3400 Civic Center Boulevard Radiation Oncology Admin Offices Suite 2338 Philadelphia, PA 19104 Phone: 215-349-8895 Email: [email protected] Website: www.oncolink.org Oncology Interactive Navigator (OIN) 301-645 King Street West Toronto, Ontario Canada M5V 1M5 Phone: 416-504-7506 Website: www.oncologyinteractive.com Oncology Services International 400 Rella Boulevard, Suite 123 Montebello, NY 10901 Phone: 845-357-6560 Email: [email protected] Website: www.thinkosi.com R Oncology Systems Limited 14 Longbow Professional Centre Shrewsbury, Shropshire SY1 3GZ United Kingdom Phone: 44-017-434-6269-4 Email: [email protected] Website: www.osl.uk.com LEGEND

A Ambassador P G

Platinum Sponsor Gold Sponsor

S Silver Sponsor B Bronze Sponsor C Copper Sponsor R Enhanced RO MarketPlace Listing

4097

9073

5127

EXHIBITOR NAME

Corporate members in bold. 196

BOOTH#

Oncura Inc. 4049 3350 North Ridge Avenue Arlington Heights, IL 60004 Phone: 1-800-228-0126 Email: [email protected] Website: www.oncura.com Oncure Medical Corp 9008 188 Inverness Drive West, Suite 650 Englewood, CO 80112 Phone: 303-643-6510 Email: [email protected] Website: www.oncure.com R Onics Direct 9063 P.O. Box 53 Hornell, NY 14843 Phone: 607-968-1220 Website: www.i-notz.com Orfit Industries America 12077 350 Jericho Turnpike, Suite 101 Jericho, NY 11753 Phone: 516-935-8500 Email: [email protected] Website: www.orfit.com R Oxford Instruments Service 1031 64 Union Way Vacaville, CA 95687 Phone: 1-888-673-5151 Email: [email protected] Website: www.oxford-instruments.com/ct-mr P-Cure Ltd. 13043 500 Lake Cook Road Deerfield, IL 60015 Phone: 847-874-7771 Email: [email protected] Website: www.p-cure.com Phantom Laboratory, The 10054 P.O. Box 511 Salem, NY 12865 Phone: 518-692-1190 Email: [email protected] Website: www.phantomlab.com Philips Healthcare 10037 3000 Minuteman Road Andover, MA 01810 Phone: 1-800-229-6417 Email: [email protected] Website: www.philips.com/healthcare A Pitts Little Corp. 6015 2711 Alton Road Birmingham, AL 35210 Phone: 205-833-5911 Email: [email protected] Website: www.pittslittle.com P

ASTRO 2012 / 54TH ANNUAL MEE TING

EXHIBITOR NAME

BOOTH#

Precise Construction Inc. 8097 5026 Trenton Street Tampa, FL 33619 Phone: 813-241-2403, ext. 14 Email: [email protected] Website: www.preciseconstruction.com Precision X-Ray 5096 15 Commerce Drive, Unit 1 North Branford, CT 06471 Phone: 203-484-2011 Email: [email protected] Website: www.pxinc.com ProTom International Inc. 12019 1100 Parker Square, Suite 230 Flower Mound, TX 75028 Phone: 972-410-3551 Email: [email protected] Website: www.protominternational.com R Prowess Inc. 10093 1844 Clayton Road Concord, CA 94520 Phone: 925-356-0360 Email: [email protected] Website: www.prowess.com PTW-New York 5117 205 Park Avenue Hicksville, NY 11801 Phone: 516-827-3181 Email: [email protected] Website: www.ptwny.com R Qfix 7037 440 Church Road Avondale, PA 19311 Phone: 610-268-0585 Email: [email protected] Website: www.qfix.com R QLRAD 11061 80 South West 8th Street, Suite 2000 Miami, FL 33130 Phone: 770-335-5601 Email: [email protected] Website: www.qlrad.com QUALIFORMED Sarl 7060 14 Rue de la Vieille Horloge La Roche Sur Yon, 85000 France Phone: 33-9-77-00-91-29 Email: [email protected] Website: www.qualiformed.com RAD Technology Medical Systems 10077 20801 Biscayne Boulevard, Suite 403 Aventura, FL 33180 Phone: 305-898-2544 Email: [email protected] Website: www.rad-technology.com

EXHIBITOR NAME

BOOTH#

RadiaDyne 6087 11931 Wickchester Lane, Suite 360 Houston, TX 77043 Phone: 281-759-9600 Email: [email protected] Website: www.radiadyne.com Radia-Guard 3004 419 Erin Drive, Suite 5 Knoxville, TN 37919 Phone: 1-866-400-8080 Email: [email protected] Website: www.radiaguard.com Radialogica LLC 12073 114 N. Gay Avenue, Suite A Clayton, MO 63105 Phone: 1-800-515-9132 Email: [email protected] Website: www.radialogica.com Radiation Business Solutions 5012 1044 Jackson Felts Road Joelton, TN 37080 Phone: 615-746-4711 Email: [email protected] Website: www.radiationbusiness.com S Radiation Oncology Resources 8055 P.O. Box 76 Goshen, IN 46527 Phone: 1-866-312-3499 Email: [email protected] Website: www.roresources.com R Radiation Products Design Inc. 12099 5218 Barthel Industrial Drive Albertville, MN 55301 Phone: 1-800-497-2071 Email: [email protected] Website: www.rpdinc.com R Radiation Therapy Oncology Group 9060 1818 Market Street, Suite 1600 Philadelphia, PA 19103 Phone: 215-717-0843 Email: [email protected] Website: www.rtog.org Radiological Imaging Technology 10085 5065 List Drive Colorado Springs, CO 80919-3321 Phone: 719-590-1077 Email: [email protected] Website: www.radimage.com Radiology Oncology Systems Inc. 10049 6725 Mesa Ridge Road, Suite 100 San Diego, CA 92121 Phone: 858-454-8100 Email: [email protected] Website: www.oncologysystems.com

EXHIBITOR NAME

BOOTH#

RADMAX Ltd. 8002 3304 S. Broadway Avenue, Suite 200 Tyler, TX 75701 Phone: 903-531-2371 Email: [email protected] Website: www.radmaxonline.com R RaySearch Laboratories AB 3067 401 Franklin Avenue, Suite 100A Garden City New York, NY 11530 Phone: 1-877-778-3849 Email: [email protected] Website: www.raysearchlabs.com G Red Journal/PRO 9004 1600 JFK Boulevard Philadelphia, PA 19103 Phone: 702-260-4628 Website: www.us.elsevierhealth.com R Remetronix 13032 2190 NW Reserve Park Trace Port Saint Lucie, FL 34986 Phone: 1-800-875-0856 Website: www.remetronix.com Revenue Cycle Inc. 10058 1817 West Braker Lane Building F, Suite 200 Austin, TX 78758 Phone: 512-583-2000 Email: [email protected] Website: www.revenuecycleinc.com R RS & A Inc. 4094 465 Forum Parkway Rural Hall, NC 27045 Phone: 336-969-0583 Email: [email protected] Website: www.rsa-inc.com RTI Electronics Inc. 4059 33 Jacksonville Road, Building 1 Towaco, NJ 07082 Phone: 973-439-0242 Email: [email protected] Website: www.rtielectronics.com S+S Par Scientific 7008 10625 Telge Road Houston, TX 77095 Phone: 281-815-1300 Email: [email protected] Website: www.ParScientific.com ScandiDos 7055 Uppsala Science Park Uppsala, SE-751 83 Sweden Phone: 46-018-472-3030 Email: [email protected] Website: www.scandidos.com

EXHIBITOR NAME

BOOTH#

SciMedix Co. Ltd. 12055 8 Fl. B-dong, Samho Building 275-6 Yangjae-dong, Seocho-gu 137-941 Korea Phone: 82-258-907-75 Sensus Healthcare 9054 851 Broken Sound Parkway #215 Boca Raton, FL 33487 Phone: 1-800-324-9890 Email: [email protected] Website: www.sensushealthcare.com R Shandong Xinhua Medical Instruments Co. Ltd. 1001 No.7 Taimei Road, Zibo New and Hi-Tech Zone Shandong, 255086, China Phone: 86-533-358-7719 Email: [email protected] Website: www.shinva.com Shielding Construction Solutions Inc. 10013 4620 South Coach Drive Tucson, AZ 85714 Phone: 520-917-0661 Email: [email protected] Website: www.shieldingconstruction.com R Siemens Medical Solutions USA Inc. 10019 51 Valley Stream Parkway Malvern, PA 19355 Phone: 610-448-4252 Email: [email protected] Website: www.medical.siemens.com A Skin Clinical P.O. Box 5005 #69 16921-C Via de Santa Fe Rancho Santa Fe, CA 92067 Phone: 858-756-0467 Email: [email protected] Website: www.skinclinicallabs.com Sky Factory 801 N. 18th Street, PO 1177 Fairfield, IA 52556 Phone: 641-472-1747 Email: [email protected] Website: www.skyfactory.com Source Production & Equipment 113 Teal Street St. Rose, LA 70087 Phone: 504-464-9471 Email: [email protected] Website: www.spec-med.com Spectrum Pharmaceuticals Inc. 157 Technology Drive Irvine, CA 92618 Phone: 949-788-6700 Email: [email protected] Website: www.sppirx.com R A

6105

6063

ASTRO 2012 / 54TH ANNUAL MEE TING

8090

2013

197

EXHIBITOR NAME

BOOTH#

Springer 8007 233 Spring Street New York, NY 10013 Phone: 212-460-1500 Email: [email protected] Website: www.springer.com Staff Care Inc. 10122 5001 Statesman Drive Irving, TX 75063 Phone: 1-800-685-2272 Email: [email protected] Website: www.staffcare.com Standard Imaging 7045 3120 Deming Way Middleton, WI 53562 Phone: 1-800-261-4446 Email: [email protected] Website: www.standardimaging.com R Sumitomo Heavy Industries Ltd. 11067 Think Park Tower 1-1, Osaki 2-chome, Shinagawa Tokyo, 141-6025 Japan Phone: 61-079-167-16 Email: [email protected] Website: www.shi.co.jp/english/ R Sun Nuclear Corporation 425-A Pineda Court Melbourne, FL 32940 Phone: 321-259-6862-275 Email: [email protected] Website: www.sunnuclear.com C superDimension Inc. 161 Cheshire Lane, Suite 100 Plymouth, MN 55441 Phone: 763-210-4013 Email: [email protected] Website: www.superdimension.com Suremark Company, The 4645 Industrial Street, 2C Simi Valley, CA 93063 Phone: 1-800-406-3399 Email: [email protected] Website: www.suremark.com

12000

Teva 41 Moores Road Frazer, PA 19355 Phone: 1-800-782-3656 Website: www.tevapharm.com TGM2 Inc. 15375 Roosevelt Boulevard, Suite 300 Clearwater, FL 33760 Phone: 727-507-8500 Email: [email protected] Website: www.tgm2.com R

7119

198

3000

6058

4013

EXHIBITOR NAME

BOOTH#

Theragenics Corporation 10067 5203 Bristol Industrial Way Buford, GA 30518 Phone: 770-831-5151 Email: [email protected] R Top Grade Medical Equipment Co. Ltd. 6111 No. 11 Yongchang North Road, BDA Beijing, P.R.C. 10076 China Phone: 86-10-6788-5599-398 Email: [email protected] Website: www.topgradehc.com TRG Oncology Equipment 9012 5318 E. 2nd Street, #682 Long Beach, CA 90803 Phone: 949-622-0022 Email: [email protected] Website: www.oncologyequipment.com Tsoi/Kobus and Associates 12027 One Brattle Square P.O. Box 9114 Cambridge, MA 02238 Phone: 617-475-4312 Email: [email protected] Website: www.tka-architects.com US Radiosurgery 7087 40 Burton Hills Boulevard, Suite 220 Nashville, TN 37215 Phone: 615-263-7888 Email: [email protected] Website: www.usradiosurgery.com R Vantage Oncology 5095 1500 Rosecrans Avenue, Suite 400 Manhattan Beach, CA 90266 Phone: 310-335-4000 Email: [email protected] Website: www.vantageoncology.com Varian Medical Systems 5019 3100 Hansen Way Palo Alto, CA 94304 Phone: 650-424-5927 Email: [email protected] Website: www.varian.com A R Velocity Medical Solutions 11073 1350 Spring Street, Suite 275 Atlanta, GA 30309 Phone: 404-920-1966 Email: [email protected] Website: www.velocitymedical.com Veritas Medical Solutions 2037 5 Great Valley Parkway, Suite 210 Malvern, PA 19355 Phone: 1-888-242-6760 Email: [email protected] Website: www.veritas-medicalsolutions.com R

ASTRO 2012 / 54TH ANNUAL MEE TING

EXHIBITOR NAME

BOOTH#

Vertual Ltd. 4085 Logistics Institute Hull, UK HU6 7RX United Kingdom Phone: 44-148-234-7572 Email: [email protected] Website: www.vertual.co.uk C ViewRay Inc. 12067 2 Thermo Fisher Way Oakwood Village, OH 44146 Phone: 440-703-3210 Email: [email protected] Website: www.viewray.com S Vision RT Ltd. 12047 Dove House, Arcadia Avenue London, UK N3 2JU United Kingdom Phone: 00-44-771-432-7781 Email: [email protected] Website: www.visionrt.com R VisionTree Software Inc. 3054 8885 Rio San Diego Drive #220 San Diego, CA 92108 Phone: 619-295-2800 Website: www.visiontree.com Water-Jel Technologies 4063 50 Broad Street Carlstadt, NJ 07072 Phone: 201-507-8300 Email: [email protected] Website: www.Radiaderm.com R Wells Fargo Equipment Finance Inc. 5062 608 Second Avenue South, N9303-116, 11th Floor Minneapolis, MN 55402 Phone: 612-667-0855 Email: [email protected] Website: www.wellsfargo.com/healthcarefinancing Xecan 8012 275 Grove Street, Building 2, Suite 400 Newton, MA 02466 Phone: 617-686-9953 Xoft-a subsidiary of iCAD Inc. 345 Potrero Avenue Sunnyvale, CA 94085 Phone: 408-419-2300 Email: [email protected] Website: www.xoftinc.com Xstrahl Ltd. 480 Brogdon Road, Suite 100 Suwanee, GA 30024 Phone: 678-482-6800 Email: [email protected] Website: www.xstrahl.com C

5087

4067

Exhibitor Listing by Product/Service ACCELERATOR

DOSIMETRY/DETECTORS

IMAGING PRODUCTS

A2J Laser America 11085 Acceletronics/RadParts 11013 Brainlab 5037 Gamma Basics 3032 Grensuny Medical Technology Stock Co. Ltd. 11049 Hitachi America Ltd. 4084 IBA 3019 LAP of America L.C. 3001 MEI Healthcare Group 4091 Mitsubishi Electric 8061 Oncology Services International 9073 ProTom International Inc. 12019 Radiology Oncology Systems Inc. 10049 RS & A Inc. 4094 Shandong Xinhua Medical Instruments Co. Ltd. 1001 Shielding Construction Solutions Inc. 10013 Siemens Medical Solutions USA Inc. 10019 Sumitomo Heavy Industries Ltd. 11067 TGM2 Inc. 4013 TRG Oncology Equipment 9012 Varian Medical Systems 5019 ViewRay Inc. 12067

Acceletronics/RadParts 11013 Anatom-e XRT Information Systems Ltd. 6107 Best Medical 4005, 6003 9079, 10031 International Inc. CIRS 5101 Gammex Inc. 9037 IBA 3019 MGS Research 6103 Micropos Medical AB 4073 Multidata Systems International Corp. 6102 Phantom Laboratory, The 10054 PTW-New York 5117 QLRAD 11061 Radiation Products Design Inc. 12009 Radiological Imaging Technology 10085 RTI Electronics Inc. 4059 ScandiDos 7055 Shandong Xinhua Medical Instruments Co. Ltd. 1001 Standard Imaging 7045 Sun Nuclear Corporation 12000 Varian Medical Systems 5019 Velocity Medical Solutions 11073

A2J Laser America 11085 Acceletronics/RadParts 11013 Anatom-e XRT Information Systems Ltd. 6107 AQUILAB 7095 Best Medical 4005, 6003 9079, 10031 International Inc. Biocompatibles Inc. 8037 BK Medical 6013 Brainlab 5037 C-RAD Incorporated 3077 Gamma Basics 3032 Gammex Inc. 9037 Hermes Medical Solutions Inc. 7007 Hitachi Aloka Medical 4088 Hologic Inc. 3049 IBA 3019 IZI Medical Products a Landauer Company 9059 Kyoto Kagaku Co. Ltd. 11055 LAP of America L.C. 3001 MEI Healthcare Group 4091 MGS Research 6103 MIM Software 3013 Oncology Systems Limited 5127 Oxford Instruments Service 1031 P-Cure Ltd. 13043 Phantom Laboratory, The 10054 Philips Healthcare 10037 Radiation Products Design Inc. 12009 Radiological Imaging Technology 10085 Radiology Oncology Systems Inc. 10049 Siemens Medical Solutions USA Inc. 10019 Suremark Company, The 6058 TGM2 Inc. 4013 Top Grade Medical Equipment Co. Ltd. 6111 Velocity Medical Solutions 11073 ViewRay Inc. 12067 Vision RT Ltd. 12047 Xoft-a subsidiary of iCAD Inc. 5087 Xstrahl Ltd. 4067

BRACHYTHERAPY

ELECTRONIC MEDICAL RECORDS

21st Century Oncology 6055 AccuBoost 3055 Best Medical 4005, 6003 9079, 10031 International Inc. Biocompatibles Inc. 8037 BK Medical 6013 Cianna Medical 7002 CIRS 5101 CIVCO Medical Solutions 10003 Dana-Farber/Brigham and Women’s Cancer Center 7009 DIACOR 4031 Eckert and Ziegler BEBIG 8094 Elekta 5067 Gamma Basics 3032 Grensuny Medical Technology Stock Co. Ltd. 11049 Hologic Inc. 3049 IsoAid LLC 6060 IsoRay Medical Inc. 10055 Liberty Medical Inc. 6100 LifeLine Software Inc. 8119 MEI Healthcare Group 4091 Mick Radio Nuclear-Instruments Inc. 9036 MIM Software 3013 MuCheck-Oncology Data Systems 5090 Oncura Inc. 4049 Prowess Inc. 10093 PTW-New York 5117 QLRAD 11061 Radiation Products Design Inc. 12009 Shandong Xinhua Medical Instruments Co. Ltd. 1001 Siemens Medical Solutions USA Inc. 10019 Source Production and Equipment 8090 Standard Imaging 7045 Theragenics Corporation 10067 Varian Medical Systems 5019 Xoft-a subsidiary of iCAD Inc. 5087

Anatom-e XRT Information Systems Ltd. 6107 Bogardus Medical Systems Inc. 5055 Churchill Consulting Inc. 7012 ClinicMax 9062 Elekta 5067 Medical Business Systems 6011 MEI Healthcare Group 4091 Onics Direct 9063 Siemens Medical Solutions USA Inc. 10019 Varian Medical Systems 5019 VisionTree Software Inc. 3054

FACILITY CONSTRUCTION AND DESIGN architection 10073 Bard, Rao + Athanas Consulting Engineers LLC 7062 H & H Design-Build 5054 IBA 3019 James L. Davis 7015 Linbeck Group LLC 3031 MEI Healthcare Group 4091 NELCO 9085 Precise Construction Inc. 8097 RAD Technology Medical Systems 10077 Radiation Business Solutions 5012 Shielding Construction Solutions Inc. 10013 Sky Factory 6063 TGM2 Inc. 4013 Tsoi/Kobus & Associates 12027 Veritas Medical Solutions 2037

FINANCIAL SERVICES Business Services International Inc. Churchill Consulting Inc. MEI Healthcare Group RAD Technology Medical Systems Radiation Business Solutions Siemens Medical Solutions USA Inc. US Radiosurgery Wells Fargo Equipment Finance Inc.

13045 7012 4091 10077 5012 10019 7087 5062

INFORMATION/TECHNOLOGY Anatom-e XRT Information Systems Ltd. 6107 AQUILAB 7095 Bogardus Medical Systems Inc. 5055 Churchill Consulting Inc. 7012 ClinicMax 9062 Destiny Educational Services Inc. 2019 Gamma Basics 3032 Hermes Medical Solutions Inc. 7007 Iron Medical Systems Inc. 8013 Medical Business Systems 6011 MEI Healthcare Group 4091 MIM Software 3013 MuCheck-Oncology Data Systems 5090 Onics Direct 9063 Philips Healthcare 10037 Radialogica LLC 12073 Siemens Medical Solutions USA Inc. 10019 Varian Medical Systems 5019 VisionTree Software Inc. 3054

ASTRO 2012 / 54TH ANNUAL MEE TING

199

INSURANCE PROVIDER Business Services International Inc. National Medical Professional RRG Inc.

13045 10096

MEDICAL DEVICE .decimal 7003 A2J Laser America 11085 Accuray Inc. 7101 Anatom-e XRT Information Systems Ltd. 6107 AQUILAB 7095 Augmenix 2023 Azimuth Therapy 2021 Best Medical 4005, 6003, 9079, 10031 International Inc. Biocompatibles Inc. 8037 BK Medical 6013 Brainlab 5037 Carl Zeiss Meditec Inc. 2049 DIACOR 4031 e2v 8006 Eckert & Ziegler BEBIG 8094 Elekta 5067 Foss Therapy Services Inc. 12013 Gammex Inc. 9037 Gold Anchor 6061 Grensuny Medical Technology Stock Co. Ltd. 11049 Hitachi Aloka Medical 4088 Hitachi America Ltd. 4084 Hologic Inc. 3049 InSightec Ltd. 3033 IsoAid LLC 6060 Klarity 7063 LAP of America L.C. 3001 Liberty Medical Inc. 6100 LinaTech LLC 8086 Medspira 11060 MEI Healthcare Group 4091 Mevion Medical Systems 12037 MGS Research 6103 Mick Radio Nuclear-Instruments Inc. 9036 Micropos Medical AB 4073 MIM Software 3013 MPM Medical Inc. 3029 Niigata Mechatronics Co. Ltd. 7091 Oncology Services International 9073 Oncura Inc. 4049 Oxford Instruments Service 1031 P-Cure Ltd. 13043 Philips Healthcare 10037 ProTom International Inc. 12019 Qfix 7037 QLRAD 11061 Radiation Products Design Inc. 12009 RS & A Inc. 4094 Sensus Healthcare 9054 Shandong Xinhua Medical Instruments Co. Ltd. 1001 Source Production & Equipment 8090 Standard Imaging 7045 Sumitomo Heavy Industries Ltd. 11067 Sun Nuclear Corporation 12000 superDimension Inc. 3000 TGM2 Inc. 4013 Theragenics Corporation 10067 Varian Medical Systems 5019 Vision RT Ltd. 12047 Xstrahl Ltd. 4067

200

OTHER

PRACTICE MANAGEMENT

Acceletronics/RadParts 11013 Alphatron Linac 8008 AMAC 8014 American Radium Society 6056 Anatom-e XRT Information Systems Ltd. 6107 BK Medical 6013 BSD Medical Corp. 6007 CDR Systems Inc. 3063 Churchill Consulting Inc. 7012 CIVCO Medical Solutions 10003 Cold Shot Chillers 12062 D3 Oncology Solutions 13031 Dana-Farber/Brigham and Women’s Cancer 7009 Center Foss Therapy Services Inc. 12013 Gammex Inc. 9037 Genomic Health Inc. 8059 Global Physics Solutions 13019 Healthcare Administrative Partners 12054 Hermes Medical Solutions Inc. 7007 InSightec Ltd. 3033 Landauer Medical Physics 13019 MIM Software 3013 Niigata Mechatronics Co. Ltd. 7091 Oncology Services International 9073 Radiation Therapy Oncology Group 9060 RADMAX Ltd. 8002 Revenue Cycle Inc. 10058 Sky Factory 6063 US Radiosurgery 7087 Vertual Ltd. 4085 Water-Jel Technologies 4063

21st Century Oncology 6055 Anatom-e XRT Information Systems Ltd. 6107 Churchill Consulting Inc. 7012 ClinicMax 9062 Destiny Educational Services Inc. 2019 e+CancerCare 9055 Healthcare Administrative Partners 12054 Integrated Oncology Network 11091 Medical Business Systems 6011 Mission Search 5072 Oncure Medical Corp 9008 Onics Direct 9063 Radiation Business Solutions 5012 Vantage Oncology 5095 VisionTree Software Inc. 3054

PATIENT HANDLING/POSITIONING A2J Laser America 11085 Acceletronics/RadParts 11013 Aktina Medical Corporation 4077 Best Medical 4005, 6003 9079, 10031 International Inc. Bionix Radiation Therapy 9067 Brainlab 5037 CDR Systems Inc. 3063 CIVCO Medical Solutions 10003 C-RAD Incorporated 3077 DIACOR 4031 Elekta 5067 Gold Anchor 6061 Grensuny Medical Technology Stock Co. Ltd. 11049 Klarity 7063 LAP of America L.C. 3001 Micropos Medical AB 4073 Philips Healthcare 10037 Qfix 7037 QLRAD 11061 Radiation Products Design Inc. 12009 Radiology Oncology Systems Inc. 10049 S+S Par Scientific 7008 Vision RT Ltd. 12047

PHARMACEUTICAL Algeta 11062 Bayer HealthCare 4055 Miaderm at Aiden Industries 6054 Radia-Guard 3004 Spectrum Pharmaceuticals Inc. 2013

ASTRO 2012 / 54TH ANNUAL MEE TING

PROFESSIONAL SOCIETY ALATRO 9097 American Association of Medical Dosimetrists 8011 American College of Radiology 7092 American Radium Society 6056 American Society of Clinical Oncology 10118 American Society of Radiologic Technologists 7006 ASTRO Resource Center 8043

PUBLISHER Anatom-e XRT Information Systems Ltd. 6107 Demos Medical Publishing 8005 Elsevier 9002 Imaging Technology News 7010 IOP Publishing 8010 Karger Publishers Inc. 8003 Lippincott Williams and Wilkins/WKH 4028 Red Journal/PRO 9004 Springer 8007

QUALITY ASSURANCE Aktina Medical Corporation 4077 AMAC 8014 AQUILAB 7095 Churchill Consulting Inc. 7012 CIRS 5101 CIVCO Medical Solutions 10003 Computerized Radiation Scanners Inc. 9006 D3 Oncology Solutions 13031 Foss Therapy Services Inc. 12013 Gammex Inc. 9037 Hermes Medical Solutions Inc. 7007 IBA 3019 LAP of America L.C. 3001 LifeLine Software Inc. 8119 Math Resolutions LLC 1019 MGS Research 6103 Mick Radio Nuclear-Instruments Inc. 9036 Micropos Medical AB 4073 Mission Search 5072 Mobius Medical Systems LP 13037 Modus Medical Devices Inc. 5059 MuCheck-Oncology Data Systems 5090 Multidata Systems International Corp. 6102 Phantom Laboratory, The 10054 PTW-New York 5117 QUALIFORMED Sarl 7060 Radiation Products Design Inc. 12009 Radiation Therapy Oncology Group 9060 Radiological Imaging Technology 10085

RTI Electronics Inc. 4059 ScandiDos 7055 Standard Imaging 7045 Sun Nuclear Corporation 12000 TGM2 Inc. 4013

RADIATION PROTECTION/SHIELDING Acceletronics/RadParts 11013 architection 10073 Brainlab 5037 El Dorado Metals Inc. 12029 Enterade USA LLC 9119 Gamma Basics 3032 James L. Davis 7015 NELCO 9085 Pitts Little Corp. 6015 RAD Technology Medical Systems 10077 Radiation Products Design Inc. 12009 Shielding Construction Solutions Inc. 10013 Siemens Medical Solutions USA Inc. 10019 Veritas Medical Solutions 2037

RADIATION THERAPY 21st Century Oncology 6055 A2J Laser America 11085 Acceletronics/RadParts 11013 Accuray Inc. 7101 Advanced Radiation Measurements Inc. 7011 ALATRO 9097 Anatom-e XRT Information Systems Ltd. 6107 Azimuth Therapy 2021 Best Medical 4005, 6003 9079, 10031 International Inc. Biocompatibles Inc. 8037 Bionix Radiation Therapy 9067 Brainlab 5037 CDR Systems Inc. 3063 Cianna Medical 7002 CIRS 5101 CIVCO Medical Solutions 10003 Computerized Radiation Scanners Inc. 9006 Dana-Farber/Brigham and Women’s Cancer 7009 Center Destiny Educational Services Inc. 2019 DIACOR 4031 e2v 8006 Eckert & Ziegler BEBIG 8094 Elekta 5067 Enterade USA LLC 9119 Foss Therapy Services Inc. 12013 Global Physics Solutions 13019 GMV 6101 Grensuny Medical Technology Stock Co. Ltd. 11049 Hologic Inc. 3049 IBA 3019 IsoAid LLC 6060 IZI Medical Products a Landauer Company 9059 Klarity 7063 Landauer Medical Physics 13019 LAP of America L.C. 3001 LifeLine Software Inc. 8119 MASEP Infini 11079 Medspira 11060 Mevion Medical Systems 12037 MGS Research 6103 Miaderm at Aiden Industries 6054 Micropos Medical AB 4073 MIM Software 3013 Mirada Medical 5109

Mitsubishi Electric 8061 Mobius Medical Systems LP 13037 Modus Medical Devices Inc. 5059 MuCheck-Oncology Data Systems 5090 Multidata Systems International Corp. 6102 Oncolink-University of Pennsylvania 10056 Oncology Services International 9073 Oncology Systems Limited 5127 Orfit Industries America 12077 Oxford Instruments Service 1031 P-Cure Ltd. 13043 Phantom Laboratory, The 10054 Philips Healthcare 10037 Precision X-Ray 5096 PTW-New York 5117 Qfix 7037 QLRAD 11061 QUALIFORMED Sarl 7060 RadiaDyne 6087 Radiation Oncology Resources 8055 Radiation Products Design Inc. 12009 Radiation Therapy Oncology Group 9060 Radiological Imaging Technology 10085 Radiology Oncology Systems Inc. 10049 RaySearch Laboratories AB 3067 RS & A Inc. 4094 S+S Par Scientific 7008 ScandiDos 7055 Sensus Healthcare 9054 Shandong Xinhua Medical Instruments Co. Ltd. 1001 Siemens Medical Solutions USA Inc. 10019 Sky Factory 6063 Standard Imaging 7045 Sumitomo Heavy Industries Ltd. 11067 Sun Nuclear Corporation 12000 TGM2 Inc. 4013 Top Grade Medical Equipment Co. Ltd. 6111 TRG Oncology Equipment 9012 US Radiosurgery 7087 Vantage Oncology 5095 Varian Medical Systems 5019 Vertual Ltd. 4085 ViewRay Inc. 12067 Xoft-a subsidiary of iCAD Inc. 5087 Xstrahl Ltd. 4067

RADIOISOTOPE SOURCE MANUFACTURER Biocompatibles Inc. IBA IsoAid LLC Theragenics Corporation

8037 3019 6060 10067

SEARCH FIRM/STAFFING/RECRUITMENT Cancer CarePoint Inc. 8015 Cancer Treatment Centers of America 10063 Department of Veterans Affairs (HRRO) 13010 Global Physics Solutions 13019 Landauer Medical Physics 13019 Locumtenens.com 5105 Maxim Government Services 12060 Mission Search 5072 Staff Care Inc. 13009

TREATMENT ACCESSORIES A2J Laser America 11085 Aktina Medical Corporation 4077 Alphatron Linac 8008 Best Medical 4005, 6003 9079, 10031 International Inc. Biocompatibles Inc. 8037 Brainlab 5037 BSD Medical Corp. 6007 CDR Systems Inc. 3063 DIACOR 4031 Eckert and Ziegler BEBIG 8094 Grensuny Medical Technology Stock Co. Ltd. 11049 Hitachi America Ltd 4084 IsoAid LLC 6060 Liberty Medical Inc. 6100 Medspira 11060 Miaderm at Aiden Industries 6054 Micropos Medical AB 4073 MIM Software 3013 Mitsubishi Electric 8061 QLRAD 11061 Radia-Guard 3004 Radiology Oncology Systems Inc. 10049 S+S Par Scientific 7008 Shandong Xinhua Medical Instruments Co. Ltd. 1001 Sky Factory 6063 Suremark Company, The 6058

TREATMENT PLANNING Acceletronics/RadParts 11013 Accuray Inc. 7101 Anatom-e XRT Information Systems Ltd. 6107 AQUILAB 7095 Azimuth Therapy 2021 Best Medical 4005, 6003 9079, 10031 International Inc. Brainlab 5037 CIRS 5101 CIVCO Medical Solutions 10003 D3 Oncology Solutions 13031 Dana-Farber/Brigham and Women’s Cancer 7009 Center Eckert & Ziegler BEBIG 8094 Elekta 5067 GMV 6101 Grensuny Medical Technology Stock Co. Ltd. 11049 IsoAid LLC 6060 LAP of America L.C. 3001 LifeLine Software Inc. 8119 LinaTech LLC 8086 Medspira 11060 MIM Software 3013 Mirada Medical 5109 Mobius Medical Systems LP 13037 Oncolink-University of Pennsylvania 10056 Oxford Instruments Service 1031 Phantom Laboratory, The 10054 Philips Healthcare 10037 Precision X-Ray 5096 Prowess Inc. 10093 QUALIFORMED Sarl 7060 Radiation Oncology Resources 8055 RaySearch Laboratories AB 3067 ScandiDos 7055 Shandong Xinhua Medical Instruments Co. Ltd. 1001 TGM2 Inc. 4013 Top Grade Medical Equipment Co. Ltd. 6111 Varian Medical Systems 5019 Velocity Medical Solutions 11073 ViewRay Inc. 12067

2012 ASTRO Annual Meeting | Boston Convention

Posters beyond this point in Hall C.

Concession Area

Concession Area

Cyber Cafe

202

ASTRO 2012 / 54TH ANNUAL MEE TING

and Exhibition Center | Halls A-B Exhibitor Service Center

ASTRO Resource Center

Industry-Expert Theater

Exhibitor Sales Office and Lounge

EXHIBIT H

ALL HOUR

S

:00 p.m. :00 a.m. – 5 Sunday: 10 5:00 p.m. 0:00 a.m. – Monday: 1 5:00 p.m. 0:00 a.m. – Tuesday: 1

ASTRO 2012 / 54TH ANNUAL MEE TING

203

NOTES

204

ASTRO 2012 / 54TH ANNUAL MEE TING

NOTES

ASTRO 2012 / 54TH ANNUAL MEE TING

205

A S T R O 5 4 TH A N N U A L M E E T I N G

Advancing Patient Care through iNNOVATiON

Stop by the ASTRO Resource Center – Booth #8043

2012 CIRCLSURVIVOR E VISIT THE RESOURCE CENTER TO:  See a demonstration of the new PQRIwizard, an easy online tool for the Medicare PQRS program.  Check out ROhub, the new ASTRO online community—have your picture taken for the ASTRO membership directory and set up your profile.  Pick up free patient brochures and browse our patient website RTAnswers.org.  Purchase the ASTRO/ACR Guide to Radiation Oncology Coding and multi-year Web subscription.  Download the new Journals’ app to your smart phone for full text access.

Stop b y the S urvivo in the r Circle Resou r c e Cent more a er. Lea bout t rn his yea Circle A r ’s Surviv ward w or inner a Surviv nd the or Circ 2 le 012 Grant the va recipie luable nts an service cancer d s they patien offer to ts. Plus drop o , don’t ff your forget stamp for a ch to ed Pas ance to sport win gr eat priz es.

ANNUAL MEE TING

S C I E N C E B A S E D, PAT I E N T D R I V E N

A M E R I C A N S O C I E T Y F O R R A D I AT I O N O N C O LO G Y

meetings2013 STAY ON TOP OF WHAT’S NEW IN CANCER CARE Cancer Imaging and Radiation Therapy Symposium: A Multidisciplinary Approach February 8-9, 2013 Hilton Lake Buena Vista in the Walt Disney World Resort | Orlando Spring Refresher Course March 22-24, 2013 JW Marriott Chicago | Chicago State of the Art Techniques Symposium May 17-19, 2013 San Antonio Marriott Rivercenter | San Antonio ASTRO/AAPM/NCI Workshop: Technology for Innovation in Radiation Oncology June 13-14, 2013 NIH Campus | Bethesda, Md. ASTRO’s 55th Annual Meeting September 22-25, 2013 Georgia World Congress Center | Atlanta Best of ASTRO November 8-9, 2013 Hilton Bayfront San Diego | San Diego

TA R G E T I N G C A N C E R C A R E

www.astro.org

Free yourself from hours of tedious contouring. Are you tired of spending hours manually contouring for each treatment plan? Philips Pinnacle 3 Auto-Segmentation with SPICE streamlines the process to just a few fast clicks. It provides consistent contours in minutes that require little or no editing. Plus, it automatically identifies challenging structures like head and neck nodes. Experience the freedom at www.philips.com/SPICE.

Loading...

Final Program - American Society for Radiation Oncology

Final Program ASTRO 54th Annual Meeting Meeting Dates: October 28-31, 2012 | Exhibit Dates: October 28-30, 2012 BOSTON CONVENTION AND EXHIBITION CENTE...

16MB Sizes 3 Downloads 16 Views

Recommend Documents

(SBRT) For Lung Cancer - American Society for Radiation Oncology
increase the tumor control probability (TCP) and decrease the normal tissue complication probability (NTCP). ... is furt

Safety is No Accident - American Society for Radiation Oncology
members or other representatives, shall have any liability for any claim, whether founded or unfounded, of any kind what

Final Program - American Society of Mechanical Engineers
A loose nut or bolt might be considered a nuisance, but can be detrimental in a critical application. Request the size y

Stereotactic Radiosurgery (SRS) - American Society for Radiation
Jan 14, 2011 - device, other immobilization technology and/or a stereotactic-guidance system, but can be performed ... A

Radiation Oncology - Springer Link
Preface. The aim of writing “Radiation Oncology: An MCQ and Case Study-Based Review” ... MCQs along with explanatory

Program for 2018 NASAP Conference-final - North American Society
interest. This workshop will describe a model of Adlerian group therapy and demonstrate a variety of practical group the

Introduction to Radiation Oncology
Radiation Oncology – acute side effects. ▫ Worse with increased or more rapid dose, when given with chemo or poor nu

Applied Physics For Radiation Oncology Solution Manual.pdf
If you are searched for the ebook Applied physics for radiation oncology solution manual in pdf format, then you have co

conference program - American Society for Public Administration
Mar 2, 2017 - We are delighted to recognize and thank Honorary Co-Chairs Gail Christopher and Charles Goodsell for their

Program Summary - American Chemical Society
Twenty Project SEED students representing the Central New York, Indiana, New York, Northeastern, North ..... Keileen Alv